data_2kfg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kfg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.472 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 20.9 t90 . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 109.115 -0.698 . . . . 1.16 109.115 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.96 -41.36 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 1.94 112.04 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.417 HG22 HD22 ' A' ' 108' ' ' LEU . 11.0 t -79.93 -1.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.363 0.602 . . . . 1.14 110.708 -174.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.13 76.95 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.673 -0.775 . . . . 0.78 112.562 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.54 -28.46 28.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.863 0.363 . . . . 3.71 110.952 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -124.18 34.7 4.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.172 0.987 . . . . 2.39 109.227 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 17.8 ttpt -78.78 -44.29 1.88 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 114.066 -1.425 . . . . 1.9 112.281 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 83.2 Cg_exo -49.15 -24.26 7.67 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.632 2.222 . . . . 0.99 113.67 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -69.89 -45.45 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.696 -0.483 . . . . 1.03 109.696 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 5.9 m-85 -73.49 -22.95 60.01 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.916 -0.584 . . . . 1.15 109.96 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -69.61 -44.59 70.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.48 0.657 . . . . 0.73 110.32 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -60.31 -45.58 92.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.279 -0.873 . . . . 1.86 109.765 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 77.3 mt -64.83 -39.92 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.669 . . . . 1.11 110.455 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.423 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 58.1 t80 -52.88 -50.72 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.5 111.306 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 45.1 m-85 -76.77 -22.4 53.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.275 -0.421 . . . . 1.23 112.071 -177.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.9 p -88.73 8.24 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.677 -0.409 . . . . 1.3 111.337 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 85.1 mt -104.88 1.34 28.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 1.79 110.589 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m 69.14 87.06 0.12 Allowed Pre-proline 0 N--CA 1.467 0.379 0 O-C-N 123.902 0.751 . . . . 1.51 110.586 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HA ' HG22 ' A' ' 67' ' ' ILE . 1.2 Cg_endo -84.61 163.84 12.4 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.174 2.583 . . . . 1.1 112.755 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.85 102.57 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 2.4 110.087 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 m120 68.87 23.23 6.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 2.02 110.358 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.16 65.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.771 -0.728 . . . . 0.9 112.428 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.611 ' HD3' ' CB ' ' A' ' 100' ' ' LEU . 14.8 ttmm -133.4 126.78 32.0 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.982 -0.748 . . . . 1.52 108.982 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 62' ' ' PRO . 39.0 pt -87.36 151.18 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.094 -0.642 . . . . 1.09 110.473 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.5 p -90.42 177.43 6.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.192 -0.458 . . . . 1.84 110.613 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.15 -16.78 67.21 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.695 -0.764 . . . . 0.33 112.088 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -69.65 -59.37 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.049 0.452 . . . . 1.05 110.381 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -43.64 98.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.733 . . . . 1.79 110.162 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.54 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.65 -47.32 86.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.075 -0.966 . . . . 1.02 111.35 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.27 -34.59 76.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.157 -0.312 . . . . 1.83 110.157 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.2 mtpt -58.04 -46.92 84.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 2.96 110.502 174.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -64.11 -44.72 91.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.885 -0.598 . . . . 2.16 110.254 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.595 ' HB3' HD23 ' A' ' 86' ' ' LEU . 94.5 mtp -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.589 . . . . 1.27 112.209 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.21 -24.82 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.944 -0.703 . . . . 1.99 110.664 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -75.5 -12.03 60.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.71 110.476 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -72.86 -14.93 61.6 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.49 -0.559 . . . . 1.25 109.49 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 68.25 29.96 5.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.133 -0.939 . . . . 3.08 111.455 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.423 ' HB2' HD21 ' A' ' 86' ' ' LEU . 80.7 mt -104.56 154.88 38.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.537 -0.301 . . . . 1.94 110.651 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.489 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 40.4 Cg_endo -68.37 155.59 68.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.843 2.362 . . . . 0.59 112.558 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -66.06 -25.18 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.486 -0.325 . . . . 2.32 111.283 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.3 m -63.35 -52.69 60.71 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.937 0.399 . . . . 1.77 110.675 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 89' ' ' ILE . 84.8 t -62.76 -46.08 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.09 -0.505 . . . . 1.13 109.806 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.595 HD23 ' HB3' ' A' ' 76' ' ' MET . 83.0 mt -59.94 -37.7 80.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 1.26 111.4 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.12 87.94 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.25 112.685 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 20.5 ptmt -66.54 -33.27 75.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.494 -0.482 . . . . 2.34 109.789 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 85' ' ' VAL . 83.8 mt -57.47 -50.04 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.722 -0.473 . . . . 1.15 109.722 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 34.1 t-105 -58.89 -49.92 75.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.545 -0.752 . . . . 0.57 111.133 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.515 ' HB3' ' HZ2' ' A' ' 91' ' ' LYS . 8.0 mtpm? -65.41 -20.27 66.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.184 0.438 . . . . 3.03 112.184 -174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.662 HD13 ' HA ' ' A' ' 124' ' ' ALA . 29.7 mt -93.58 -35.63 12.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.863 0.363 . . . . 1.75 111.384 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.57 -16.39 36.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.054 -0.521 . . . . 1.0 112.058 -172.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -79.13 80.56 5.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.692 0.758 . . . . 0.45 109.83 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.78 -44.55 90.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.583 -1.189 . . . . 1.79 112.207 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.425 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 33.8 m-20 -70.63 -24.52 62.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.399 -0.364 . . . . 1.64 110.089 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 57.12 51.48 10.31 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.608 -0.886 . . . . 2.31 108.608 -169.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.58 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 18.2 p-10 -125.5 8.4 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.928 -1.033 . . . . 0.78 112.146 -167.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.82 -0.13 62.65 Favored Glycine 0 CA--C 1.507 -0.406 0 C-N-CA 120.441 -0.885 . . . . 0.5 112.785 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.611 ' CB ' ' HD3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -118.83 163.49 16.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.012 -0.736 . . . . 2.0 109.012 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 mt -115.69 110.02 18.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.423 -0.584 . . . . 1.06 109.423 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -76.43 -173.95 2.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.559 -0.746 . . . . 1.39 109.274 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -55.85 -44.91 78.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.694 -0.685 . . . . 1.69 111.239 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -81.63 -31.25 32.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.638 -0.71 . . . . 2.29 110.743 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.59 -47.43 66.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.39 110.338 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -65.92 -35.1 79.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.35 109.942 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.44 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -57.3 -49.79 74.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.002 -0.544 . . . . 1.1 110.693 174.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.472 ' HG ' ' HZ2' ' A' ' 44' ' ' TRP . 12.9 mt -60.5 -43.95 96.5 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.59 -0.277 . . . . 2.42 111.509 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.34 -56.74 17.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 1.08 111.238 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -33.68 73.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.91 111.28 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.605 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.8 t60 -62.86 -50.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.929 -0.578 . . . . 0.93 110.733 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 89' ' ' ILE . 49.2 mt -63.17 -36.83 84.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.673 0.273 . . . . 1.06 110.447 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 109' ' ' ALA . 89.7 mt -56.95 -48.53 81.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.117 -0.492 . . . . 1.27 110.644 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.638 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 34.6 pttt -74.6 -24.1 58.82 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 120.678 -0.409 . . . . 2.57 110.879 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 111' ' ' HIS . 76.6 t -62.25 -39.71 85.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.498 -0.556 . . . . 1.64 109.498 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.871 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 2.4 mmmp? -67.19 -37.45 83.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 1.69 109.957 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -64.68 -38.69 91.85 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 2.3 110.161 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 7.1 mm-40 -66.98 -9.0 34.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.152 -0.476 . . . . 2.05 110.55 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.82 35.19 5.69 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.961 -0.638 . . . . 0.68 112.417 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.493 ' HB2' HG11 ' A' ' 115' ' ' VAL . 99.5 m-70 -121.78 -176.98 3.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 1.32 111.283 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -124.7 160.61 28.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 2.69 109.805 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.871 ' HG ' ' HD3' ' A' ' 116' ' ' LYS . 26.6 mt -104.51 115.33 62.99 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.252 -0.647 . . . . 1.74 109.252 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.09 2.88 7.91 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.256 2.637 . . . . 1.47 113.333 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.662 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 63.81 19.22 11.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.935 -0.575 . . . . 1.78 111.243 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -111.24 147.11 35.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.874 -0.603 . . . . 1.93 109.788 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 tp -125.05 94.23 44.19 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.325 -0.398 . . . . 2.5 110.382 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 25.7 Cg_exo -62.94 152.07 81.16 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.194 2.596 . . . . 1.12 112.11 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.09 -26.9 43.59 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.371 2.714 . . . . 1.24 113.822 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -99.85 5.84 45.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.781 -0.368 . . . . 1.23 111.129 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 3.8 mm? . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.704 -0.48 . . . . 1.88 109.704 171.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.267 0.556 . . . . 1.41 111.327 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.71 0.15 5.27 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 123.527 2.818 . . . . 0.79 113.892 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.35 -45.51 6.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 0.56 111.038 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 70.1 p . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 112.181 0.438 . . . . 1.89 112.181 -174.434 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.472 ' CZ3' ' HG3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 109.33 -0.619 . . . . 1.16 109.33 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.65 -36.67 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 1.94 110.75 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.409 HG22 HD22 ' A' ' 108' ' ' LEU . 39.6 t -76.94 -17.44 14.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.744 -0.662 . . . . 1.14 110.496 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -66.21 -14.86 62.35 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.78 112.989 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -73.77 -25.55 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 3.71 109.912 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -131.1 33.23 4.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.714 0.768 . . . . 2.39 109.342 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HB2' ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -79.46 -46.38 1.59 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.338 -0.846 . . . . 1.9 111.304 -177.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.62 -24.66 37.9 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.418 2.079 . . . . 0.99 112.715 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -46.69 64.21 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.447 0.641 . . . . 1.03 110.204 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.413 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.1 m-85 -75.1 -21.99 58.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 1.15 109.329 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.61 -38.85 64.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.422 -0.808 . . . . 0.73 109.16 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -54.02 -52.69 60.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.29 -0.868 . . . . 1.86 109.591 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.455 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.4 mt -62.3 -41.48 91.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.658 -0.701 . . . . 1.11 110.766 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -52.47 -42.82 64.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.616 -0.72 . . . . 0.5 111.476 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.712 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 4.7 m-85 -83.18 -22.44 33.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.935 0.346 . . . . 1.23 111.935 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.08 -7.62 58.29 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.546 -0.462 . . . . 1.3 111.161 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.1 mt -102.73 15.47 29.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 1.79 110.877 -177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m 61.19 78.4 0.32 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.51 111.127 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.712 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 94.2 Cg_endo -85.75 119.44 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.532 2.155 . . . . 1.1 112.241 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.57 132.86 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.93 -0.396 . . . . 2.4 109.93 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 p30 48.39 25.37 0.88 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.926 0.89 . . . . 2.02 112.604 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.86 15.24 78.02 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.981 -0.628 . . . . 0.9 113.449 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.664 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 10.0 ttmm -141.54 126.26 18.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.543 -0.539 . . . . 1.52 109.543 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 62' ' ' PRO . 44.7 pt -94.04 146.06 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 121.709 -0.619 . . . . 1.09 111.191 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.769 ' HA ' HD22 ' A' ' 100' ' ' LEU . 9.7 t -76.74 157.69 31.5 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.001 -0.545 . . . . 1.84 110.115 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -16.84 38.46 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.156 -0.929 . . . . 0.33 114.232 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -61.83 -52.97 61.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.377 0.588 . . . . 1.05 110.903 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 18.6 m-80 -65.81 -43.21 89.36 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.101 0.477 . . . . 1.79 110.07 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.71 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.19 -49.19 78.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.297 -0.865 . . . . 1.02 110.792 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.705 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 84.0 tttt -61.56 -40.37 94.49 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.25 -0.432 . . . . 1.83 110.391 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.639 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.8 mtpt -64.8 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.927 -0.579 . . . . 2.96 111.6 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -70.67 -41.96 71.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.838 0.828 . . . . 2.16 109.465 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.763 ' HB3' HD21 ' A' ' 86' ' ' LEU . 69.7 mtp -65.86 -31.47 72.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.139 -0.937 . . . . 1.27 111.222 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 74' ' ' LYS . 4.4 p -76.51 -27.5 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.599 -0.441 . . . . 1.99 110.759 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 84.2 mttt -64.02 -28.14 69.59 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.299 -0.56 . . . . 2.71 110.11 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 15.2 m -66.8 -26.78 67.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.562 -0.745 . . . . 1.25 111.071 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 79' ' ' SER . 95.8 mttt 71.74 22.45 3.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.861 -0.609 . . . . 3.08 112.213 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.03 158.38 55.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.111 -0.7 . . . . 1.94 109.111 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.516 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 2.0 Cg_endo -76.05 160.9 36.31 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.434 2.09 . . . . 0.59 111.705 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -62.63 -23.04 66.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 2.32 110.253 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -58.82 -53.67 55.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.725 -0.671 . . . . 1.77 110.217 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 89' ' ' ILE . 54.4 t -72.65 -42.72 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 1.13 110.373 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 76' ' ' MET . 67.3 mt -60.12 -39.26 85.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 1.26 110.489 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.95 79.72 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.856 -0.687 . . . . 0.25 111.859 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -51.49 -51.4 55.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.755 0.312 . . . . 2.34 110.735 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.7 mt -62.36 -49.08 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.615 -0.721 . . . . 1.15 110.748 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.447 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 51.3 t-105 -57.79 -50.29 73.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.235 -0.439 . . . . 0.57 111.764 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -81.08 -14.7 57.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.57 -0.452 . . . . 3.03 112.005 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.732 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -94.69 -27.39 15.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.926 0.393 . . . . 1.75 110.26 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.17 -42.33 12.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.609 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.52 71.78 4.02 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.589 -0.893 . . . . 0.45 108.589 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.68 -22.74 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.033 -0.985 . . . . 1.79 110.706 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.12 -23.66 51.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.69 -0.686 . . . . 1.64 109.936 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.4 mttt 57.78 49.25 12.48 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.173 -0.921 . . . . 2.31 111.483 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.668 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.6 p-10 -117.26 9.25 13.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.282 -0.872 . . . . 0.78 110.743 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.12 17.64 66.02 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.233 -0.747 . . . . 0.5 111.233 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.769 HD22 ' HA ' ' A' ' 68' ' ' THR . 33.2 mt -139.24 140.58 37.75 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.353 -0.924 . . . . 2.0 109.309 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.3 mt -110.43 114.95 28.78 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.022 0.439 . . . . 1.06 111.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.98 170.71 9.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.308 -0.997 . . . . 1.39 108.308 165.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.72 -27.27 69.15 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.558 . . . . 1.69 110.035 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.27 -52.74 44.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.391 0.615 . . . . 2.29 110.625 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.65 -35.36 77.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.39 110.898 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.72 -32.23 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.35 110.204 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.413 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -64.64 -44.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.679 -0.692 . . . . 1.1 110.212 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 95.4 mt -58.23 -47.46 83.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 2.42 110.365 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.462 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -53.54 -56.56 16.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.006 -0.543 . . . . 1.08 111.42 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -63.46 -35.65 81.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.91 111.53 -176.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.25 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.93 110.557 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 115' ' ' VAL . 86.8 mt -76.31 -30.5 57.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 1.06 111.042 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 109' ' ' ALA . 82.7 mt -75.53 -41.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.061 -1.088 . . . . 1.27 108.061 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.567 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 29.9 ttmt -68.12 -40.71 82.45 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.056 -1.429 . . . . 2.57 110.718 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 120' ' ' HIS . 2.0 p -64.54 -37.55 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.115 -0.328 . . . . 1.64 110.115 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 28.7 mmmt -66.97 -42.74 84.62 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.73 -0.213 . . . . 1.69 110.513 173.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.89 -37.9 86.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 2.3 111.23 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 31.4 mm-40 -71.73 -5.02 30.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 2.05 111.239 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.11 36.23 6.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 0.68 112.584 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.538 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 63.8 m-70 -118.44 170.34 9.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.59 -0.522 . . . . 1.32 109.59 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -115.48 132.65 56.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.948 0.404 . . . . 2.69 111.319 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 122' ' ' LEU . 1.7 pp -95.27 139.37 21.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.519 -0.549 . . . . 1.74 109.519 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.89 11.62 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.633 2.222 . . . . 1.47 113.348 -175.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 58.74 28.8 17.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.228 0.537 . . . . 1.78 110.419 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -130.51 164.84 23.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.551 -0.75 . . . . 1.93 109.79 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.708 HD21 HD12 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -125.37 88.66 53.84 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 109.514 -0.551 . . . . 2.5 109.514 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HB2' HD22 ' A' ' 130' ' ' LEU . 55.2 Cg_exo -52.54 150.49 21.15 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.786 2.99 . . . . 1.12 113.586 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.98 -30.32 48.13 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.386 2.724 . . . . 1.24 113.82 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -94.47 9.05 39.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.206 -0.597 . . . . 1.23 111.309 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 127' ' ' PRO . 3.8 mm? . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 1.88 110.742 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.49 0.662 . . . . 1.41 110.5 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.705 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 61.5 Cg_endo -72.07 0.4 7.3 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 123.445 2.763 . . . . 0.79 113.763 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.647 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 36.3 m-85 -95.74 -30.1 13.9 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.16 -0.338 . . . . 0.56 111.256 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 20.5 p . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 1.89 112.277 -175.085 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.2 t90 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.843 -0.799 . . . . 1.16 108.843 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -62.68 -17.22 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.726 -0.67 . . . . 1.94 112.678 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 t -73.22 -26.8 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.87 0.367 . . . . 1.14 110.697 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.04 9.58 52.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.139 -0.553 . . . . 0.78 112.91 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -86.54 -25.65 24.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.749 0.309 . . . . 3.71 111.062 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.44 36.26 1.33 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 2.39 110.152 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HA ' ' HD2' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -65.16 -43.49 66.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.095 -0.957 . . . . 1.9 112.121 -174.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.425 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 73.2 Cg_exo -52.68 -22.46 17.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.448 2.099 . . . . 0.99 114.197 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 m -72.65 -47.04 50.77 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.231 0.539 . . . . 1.03 110.231 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.498 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 8.5 m-85 -71.74 -22.5 61.61 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.529 -0.915 . . . . 1.15 108.529 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.484 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 15.0 t70 -69.4 -41.29 76.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.788 -1.096 . . . . 0.73 109.801 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.26 -53.8 53.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.987 -0.551 . . . . 1.86 109.594 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.475 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.6 mt -54.47 -43.21 62.76 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 CA-C-N 115.851 -0.613 . . . . 1.11 109.979 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 73.4 t80 -55.15 -55.05 35.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.482 -0.781 . . . . 0.5 111.55 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.577 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 38.4 m-85 -71.57 -21.18 61.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.217 0.451 . . . . 1.23 112.217 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -82.92 0.86 42.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.759 -0.376 . . . . 1.3 111.046 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 81.9 mt -104.67 6.38 34.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.79 110.372 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m 66.34 86.84 0.13 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.308 -0.86 . . . . 1.51 111.569 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -83.28 117.81 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.11 2.54 . . . . 1.1 112.192 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.5 t -90.15 118.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 2.4 109.586 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 63.19 23.23 13.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.808 -0.633 . . . . 2.02 110.711 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.87 12.55 66.09 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.872 -0.68 . . . . 0.9 113.05 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.633 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 11.4 ttmt -138.43 142.92 39.5 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.798 -0.445 . . . . 1.52 109.798 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.597 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 49.8 pt -100.32 153.11 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 1.09 111.097 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.634 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 15.5 p -88.74 160.89 17.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.48 -0.782 . . . . 1.84 110.938 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.24 -8.65 31.72 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.649 -0.786 . . . . 0.33 113.172 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.12 -58.17 5.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.914 0.388 . . . . 1.05 110.996 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.597 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.0 OUTLIER -74.76 -31.27 61.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.376 -0.374 . . . . 1.79 110.587 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.2 -50.99 70.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 1.02 110.112 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -64.09 -33.07 74.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.197 -0.456 . . . . 1.83 110.137 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.55 -45.11 85.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 2.96 110.168 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.7 -51.76 67.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.979 -0.749 . . . . 2.16 108.979 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.684 ' HB3' HD23 ' A' ' 86' ' ' LEU . 77.8 mtp -60.48 -32.1 71.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.542 -0.754 . . . . 1.27 112.335 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -81.72 -20.46 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 O-C-N 121.927 -0.483 . . . . 1.99 110.811 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.54 -23.66 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.135 -0.32 . . . . 2.71 110.135 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -64.41 -23.4 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 1.25 110.083 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 67.95 33.41 4.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.447 -0.797 . . . . 3.08 111.531 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.7 mt -96.76 158.56 33.35 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.021 -0.536 . . . . 1.94 109.661 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HG2' HG23 ' A' ' 85' ' ' VAL . 38.3 Cg_endo -68.52 146.83 69.2 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.358 2.039 . . . . 0.59 112.229 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -58.72 -29.46 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.933 -0.576 . . . . 2.32 111.723 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.42 -52.93 63.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 1.77 110.375 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' HG13 ' A' ' 89' ' ' ILE . 75.6 t -68.04 -42.02 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.56 -0.745 . . . . 1.13 110.169 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.684 HD23 ' HB3' ' A' ' 76' ' ' MET . 83.9 mt -58.46 -46.63 86.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 1.26 111.458 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -63.32 -41.85 99.37 Favored Glycine 0 C--O 1.235 0.205 0 C-N-CA 120.827 -0.701 . . . . 0.25 111.483 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.586 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 39.9 ttmt -56.64 -46.77 80.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.219 -0.491 . . . . 2.34 110.298 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 85' ' ' VAL . 77.0 mt -63.02 -40.81 90.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 1.15 110.884 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -61.85 -51.67 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.614 -0.266 . . . . 0.57 110.512 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.05 -21.14 66.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.427 -0.351 . . . . 3.03 111.799 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 77.7 mt -85.51 -54.02 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.947 0.403 . . . . 1.75 111.135 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.15 -34.07 72.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.31 -0.859 . . . . 1.0 111.711 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -87.58 93.24 9.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.363 0.601 . . . . 0.45 109.836 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 m -74.12 -29.94 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 1.79 111.843 -174.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.61 -25.39 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.034 -0.53 . . . . 1.64 109.985 -178.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.4 mttt 60.15 32.15 20.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.892 -1.049 . . . . 2.31 108.541 -171.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.4 p-10 -94.69 10.19 35.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.663 -1.153 . . . . 0.78 110.983 -172.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.16 20.58 62.99 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.369 -0.693 . . . . 0.5 111.369 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.634 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 14.9 mt -141.52 145.51 35.25 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.84 -0.68 . . . . 2.0 110.028 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.0 mt -115.56 118.18 32.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.866 0.365 . . . . 1.06 111.103 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.14 174.42 5.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.41 -0.959 . . . . 1.39 108.41 168.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -63.35 -32.62 74.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.959 -0.386 . . . . 1.69 109.959 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.98 -50.72 54.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 2.29 110.432 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.54 -44.15 97.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.39 110.69 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -69.82 -25.09 63.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.35 111.081 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.77 31.93 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.599 -0.889 . . . . 1.1 108.599 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.1 -36.5 79.88 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.347 -1.297 . . . . 2.42 110.057 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.46 33.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 1.08 110.712 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -59.51 -30.71 68.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.349 -0.387 . . . . 0.91 110.568 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.415 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 32.2 t60 -69.01 -39.17 79.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.93 110.552 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.658 ' O ' HG11 ' A' ' 115' ' ' VAL . 95.5 mt -71.66 -40.77 69.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.257 0.551 . . . . 1.06 110.318 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 76' ' ' MET . 84.2 mt -58.29 -51.27 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 1.27 110.722 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.8 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 12.0 ptmm? -75.67 -24.34 56.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.58 -0.448 . . . . 2.57 111.121 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.658 HG11 ' O ' ' A' ' 112' ' ' LEU . 1.4 p -66.46 -34.28 69.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 120.024 -0.67 . . . . 1.64 109.246 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.408 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 27.8 mmmt -66.94 -43.67 82.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.25 -0.432 . . . . 1.69 110.001 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.25 -38.73 80.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 2.3 111.894 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.8 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 3.7 mm-40 -73.86 -7.15 51.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.695 -0.229 . . . . 2.05 110.825 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.46 10.48 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.518 -0.849 . . . . 0.68 113.123 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.498 ' HB2' HG22 ' A' ' 115' ' ' VAL . 90.9 m-70 -105.84 172.96 6.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.885 0.374 . . . . 1.32 110.315 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.408 ' CD ' ' HZ3' ' A' ' 116' ' ' LYS . 7.4 tp10 -124.67 134.56 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.377 -0.601 . . . . 2.69 109.377 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.19 140.77 28.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.915 0.388 . . . . 1.74 110.26 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.47 1.23 7.65 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.387 2.724 . . . . 1.47 113.652 -172.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.14 22.72 12.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.164 0.507 . . . . 1.78 110.864 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.47 171.99 12.38 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.241 -0.651 . . . . 1.93 109.241 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.422 ' CD2' ' HB3' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -125.61 89.07 53.18 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.834 0.349 . . . . 2.5 110.603 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 32.5 Cg_endo -66.34 155.96 67.44 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.952 2.435 . . . . 1.12 111.865 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.3 -34.19 39.51 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.599 2.866 . . . . 1.24 114.298 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -88.32 14.4 9.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.612 -0.435 . . . . 1.23 111.931 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.3 mt . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 1.88 111.185 177.294 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.007 0.432 . . . . 1.41 110.872 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -70.86 -2.18 10.56 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.219 2.613 . . . . 0.79 113.48 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.449 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 40.1 m-85 -102.54 -23.31 13.9 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.244 -0.285 . . . . 0.56 111.376 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.458 0.647 . . . . 1.89 111.155 175.532 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 110.031 -0.359 . . . . 1.16 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.44 -42.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 1.94 111.826 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.02 -5.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.072 -0.513 . . . . 1.14 111.042 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.37 -15.85 75.2 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.248 -1.141 . . . . 0.78 110.248 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -80.28 -29.86 38.3 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.735 -0.733 . . . . 3.71 111.226 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -124.39 34.64 4.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.723 . . . . 2.39 109.824 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 22.1 ttpp -79.11 -43.98 1.72 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.79 -1.095 . . . . 1.9 112.031 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 12.4 Cg_exo -39.15 -40.72 1.8 Allowed 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 123.43 2.753 . . . . 0.99 115.015 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.4 m -69.47 -43.96 72.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.995 0.426 . . . . 1.03 110.515 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -71.24 -22.16 62.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.224 -0.658 . . . . 1.15 109.224 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.93 -41.2 71.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.872 . . . . 0.73 109.595 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.71 -45.32 93.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 1.86 109.713 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 63.9 mt -58.7 -43.52 87.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 1.11 110.454 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -54.38 -38.46 66.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.533 -0.758 . . . . 0.5 111.011 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.572 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 49.1 m-85 -98.83 7.84 45.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.004 0.742 . . . . 1.23 113.004 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 56' ' ' ILE . 2.6 p -109.9 -3.02 16.85 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.791 -0.364 . . . . 1.3 110.935 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 3.8 pp -118.13 18.56 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.398 -0.365 . . . . 1.79 111.343 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 m 74.85 90.82 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.051 -0.977 . . . . 1.51 111.939 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.757 ' HA ' HG22 ' A' ' 67' ' ' ILE . 97.0 Cg_endo -92.95 125.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.947 2.431 . . . . 1.1 111.976 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.21 113.0 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 2.4 109.691 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.0 p30 48.48 26.95 1.28 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.072 0.949 . . . . 2.02 113.029 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 11.34 58.05 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.916 -0.659 . . . . 0.9 113.345 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.613 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 8.6 ttmm -140.46 126.56 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.927 -0.768 . . . . 1.52 108.927 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 62' ' ' PRO . 36.7 pt -95.97 141.49 15.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.128 -0.629 . . . . 1.09 111.141 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.741 ' HA ' HD23 ' A' ' 100' ' ' LEU . 3.6 t -79.88 158.54 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.711 -0.677 . . . . 1.84 110.75 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.84 -23.14 21.27 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.496 -0.775 . . . . 0.33 113.414 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.19 -55.93 27.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 1.05 111.113 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.5 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 42.2 m-80 -78.25 -28.91 47.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.379 . . . . 1.79 110.634 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.641 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.85 -52.88 61.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 1.02 110.09 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.581 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 86.1 tttt -61.69 -35.43 77.98 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.559 -0.291 . . . . 1.83 110.432 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.5 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 26.2 ttpp -54.39 -46.16 73.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.228 0.537 . . . . 2.96 110.457 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB2' HD22 ' A' ' 60' ' ' LEU . 13.9 tp10 -67.6 -41.44 84.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 2.16 110.234 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.793 ' HB3' HD21 ' A' ' 86' ' ' LEU . 72.8 mtp -67.66 -28.41 67.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.897 -0.592 . . . . 1.27 112.012 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.51 -16.17 11.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 O-C-N 121.857 -0.527 . . . . 1.99 110.638 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 99.0 mttt -75.59 -22.47 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.254 0.549 . . . . 2.71 109.626 168.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -73.78 -11.99 60.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.691 -0.686 . . . . 1.25 111.331 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt 63.92 37.14 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.153 -0.476 . . . . 3.08 111.697 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.546 ' HB2' HD22 ' A' ' 86' ' ' LEU . 84.1 mt -106.16 153.15 40.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 1.94 110.696 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.451 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 43.7 Cg_endo -67.8 152.65 77.23 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.164 2.576 . . . . 0.59 112.604 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -57.35 -34.63 69.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.863 -0.608 . . . . 2.32 111.942 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.7 m -58.05 -54.13 50.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.14 0.495 . . . . 1.77 111.365 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.41 HG21 ' HG2' ' A' ' 82' ' ' PRO . 60.6 t -67.11 -38.95 82.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 1.13 110.402 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.793 HD21 ' HB3' ' A' ' 76' ' ' MET . 88.9 mt -59.59 -46.61 88.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 1.26 110.795 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.17 -42.6 97.24 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.263 -0.494 . . . . 0.25 112.079 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.471 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 66.5 mttm -55.6 -53.6 54.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.843 0.354 . . . . 2.34 110.279 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.49 -36.71 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 1.15 110.364 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.461 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 74.4 t-105 -61.11 -56.45 20.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.57 111.182 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.71 -0.88 28.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.057 0.392 . . . . 3.03 112.057 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 74.9 mt -94.37 -46.95 6.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.031 0.443 . . . . 1.75 110.523 169.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -72.05 -36.21 69.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.531 -0.758 . . . . 1.0 111.175 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -86.71 70.42 10.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.896 0.855 . . . . 0.45 109.947 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.7 -15.63 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.542 -1.208 . . . . 1.79 110.826 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -18.27 40.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.724 -1.126 . . . . 1.64 110.171 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 61.58 35.66 17.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.089 -0.96 . . . . 2.31 111.144 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.672 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.3 p-10 -116.64 7.99 13.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.916 -0.584 . . . . 0.78 111.64 -172.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.16 10.53 59.62 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.326 -0.71 . . . . 0.5 111.326 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 68' ' ' THR . 87.1 mt -133.68 141.19 47.48 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.726 -0.737 . . . . 2.0 109.182 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.1 mt -109.99 113.13 25.59 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.984 0.421 . . . . 1.06 111.022 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.58 172.26 7.65 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.963 -0.754 . . . . 1.39 108.963 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.2 -32.27 72.03 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.825 -0.35 . . . . 1.69 110.701 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -66.35 -51.52 56.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.884 0.374 . . . . 2.29 110.497 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -62.39 -41.5 98.69 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.925 -0.58 . . . . 0.39 110.645 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CZ ' HD23 ' A' ' 60' ' ' LEU . 66.3 t80 -70.53 -23.82 62.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.749 -0.659 . . . . 0.35 110.96 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.79 32.89 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.579 -0.897 . . . . 1.1 108.579 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 93' ' ' ALA . 29.6 tp -59.41 -39.79 84.58 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.627 -1.17 . . . . 2.42 109.772 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -59.07 -55.44 35.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.011 -0.54 . . . . 1.08 111.189 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -33.63 75.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.287 -0.415 . . . . 0.91 111.426 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.413 ' O ' HG23 ' A' ' 115' ' ' VAL . 16.7 t60 -63.5 -44.04 95.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.93 109.932 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.71 -39.2 90.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 1.06 110.655 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.2 mt -60.14 -53.51 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.63 . . . . 1.27 111.385 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 16.0 pttp -70.9 -26.84 63.4 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 120.584 -0.446 . . . . 2.57 110.209 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.662 HG12 ' HB2' ' A' ' 120' ' ' HIS . 2.6 t -56.6 -48.76 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.665 -0.495 . . . . 1.64 109.665 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -62.29 -46.15 90.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.223 -0.444 . . . . 1.69 111.051 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 8.9 mp -59.36 -38.22 79.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 2.3 111.822 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 12.2 mm-40 -81.92 6.63 15.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.529 -0.305 . . . . 2.05 111.799 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 27.84 27.9 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.915 -0.66 . . . . 0.68 112.913 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.662 ' HB2' HG12 ' A' ' 115' ' ' VAL . 90.6 m-70 -109.69 119.59 39.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.776 -0.453 . . . . 1.32 109.776 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -83.25 106.37 14.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.995 0.426 . . . . 2.69 110.845 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 122' ' ' LEU . 3.1 pp -68.66 146.98 97.95 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 1.74 110.34 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.5 Cg_endo -83.21 -1.86 10.47 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.911 2.408 . . . . 1.47 112.671 -173.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.83 19.24 11.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.774 -0.648 . . . . 1.78 111.322 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -115.63 165.99 12.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.142 -1.058 . . . . 1.93 108.142 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.0 tp -118.34 95.35 48.48 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 120.481 -0.487 . . . . 2.5 110.628 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 18.1 Cg_endo -61.66 150.37 85.89 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.767 2.312 . . . . 1.12 112.255 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 52.0 Cg_exo -55.74 -25.44 51.37 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.713 2.942 . . . . 1.24 113.578 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -86.27 3.92 41.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.68 0.252 . . . . 1.23 111.68 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--N 1.329 -0.296 0 O-C-N 122.352 -0.217 . . . . 1.88 111.486 177.501 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.787 0.327 . . . . 1.41 110.121 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.581 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.8 Cg_exo -76.51 -2.35 12.55 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.566 2.844 . . . . 0.79 113.488 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.471 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 15.4 m-85 -98.18 -9.68 25.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.188 0.518 . . . . 0.56 110.077 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 1.89 111.138 175.794 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.553 -0.536 . . . . 1.16 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.76 -23.09 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.427 -0.806 . . . . 1.94 112.625 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG23 HD23 ' A' ' 108' ' ' LEU . 21.2 t -82.27 -10.72 12.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.07 0.462 . . . . 1.14 110.708 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.09 -23.83 69.92 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.118 -0.563 . . . . 0.78 113.176 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -73.89 -23.38 59.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.913 0.387 . . . . 3.71 111.549 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -134.13 32.95 3.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.965 0.888 . . . . 2.39 109.648 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 11.3 ttpp -82.99 -44.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.232 -0.895 . . . . 1.9 110.841 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 84.6 Cg_exo -49.37 -28.0 14.67 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.533 2.155 . . . . 0.99 113.574 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 m -69.28 -47.08 65.62 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.349 0.595 . . . . 1.03 109.987 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -75.85 -20.63 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.723 -0.843 . . . . 1.15 108.723 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -70.03 -42.04 73.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.885 -1.052 . . . . 0.73 109.431 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.31 -41.01 97.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.62 . . . . 1.86 109.808 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.3 -34.78 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.395 0.616 . . . . 1.11 110.283 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.94 -48.13 83.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.228 -0.896 . . . . 0.5 111.021 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.465 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 64.9 m-85 -73.81 -22.49 59.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.039 0.385 . . . . 1.23 112.039 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -85.24 1.73 46.95 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.508 -0.477 . . . . 1.3 111.16 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.9 mt -106.42 3.29 27.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.79 110.473 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.3 m 67.08 80.98 0.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.47 -0.786 . . . . 1.51 111.068 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.465 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 83.3 Cg_endo -88.63 111.23 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.804 2.336 . . . . 1.1 112.567 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.07 121.9 39.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.139 -0.482 . . . . 2.4 109.971 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.29 23.59 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.48 0.488 . . . . 2.02 110.846 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.58 22.79 59.49 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.9 112.528 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -137.71 142.14 41.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.625 0.25 . . . . 1.52 110.487 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.652 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 42.9 pt -104.78 132.83 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.215 -0.661 . . . . 1.09 109.215 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -73.39 162.42 29.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.119 -0.491 . . . . 1.84 109.841 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.461 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -63.08 -11.54 39.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.967 -0.635 . . . . 0.33 114.08 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.73 -63.25 1.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.489 0.644 . . . . 1.05 111.006 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.652 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 2.7 p30 -71.73 -29.42 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 1.79 110.9 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.14 -51.05 70.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.337 -0.392 . . . . 1.02 110.502 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -61.78 -34.74 76.43 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.938 -0.393 . . . . 1.83 109.938 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 36.1 ttmt -57.87 -45.8 85.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 2.96 110.994 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.842 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -65.87 -36.37 83.24 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.286 0.565 . . . . 2.16 110.007 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.53 ' HB3' HD22 ' A' ' 86' ' ' LEU . 90.7 mtp -67.75 -34.29 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 1.27 111.36 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.2 m -81.49 -15.38 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.872 -0.331 . . . . 1.99 110.822 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.842 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 50.2 mtpt -72.79 -28.95 62.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.922 -0.769 . . . . 2.71 108.922 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.0 m -68.51 -29.73 68.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.963 -1.017 . . . . 1.25 110.306 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 70.6 26.3 4.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.372 -0.831 . . . . 3.08 112.48 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.07 159.87 67.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.269 -0.641 . . . . 1.94 109.269 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.86 142.22 92.64 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.659 2.24 . . . . 0.59 112.32 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.76 -31.05 58.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.859 -0.61 . . . . 2.32 111.763 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p -63.54 -51.33 65.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.947 0.403 . . . . 1.77 111.139 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 89' ' ' ILE . 98.2 t -66.83 -41.5 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 1.13 110.317 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 76' ' ' MET . 75.2 mt -58.09 -43.07 86.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 1.26 110.797 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' A' ' 91' ' ' LYS . . . -61.03 -43.84 98.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.042 -0.599 . . . . 0.25 111.939 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.569 ' HE3' HD11 ' A' ' 122' ' ' LEU . 53.5 mtmt -57.21 -42.63 81.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.39 . . . . 2.34 110.437 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.0 mt -64.76 -42.21 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.615 . . . . 1.15 109.972 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.506 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 75.2 t-105 -62.09 -51.78 66.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.28 -0.873 . . . . 0.57 111.185 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 87' ' ' GLY . 31.0 mmmt -70.14 -18.15 63.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 3.03 111.907 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.842 HD12 ' HA ' ' A' ' 124' ' ' ALA . 92.7 mt -90.71 -45.58 8.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 1.75 111.501 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.91 63.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.301 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -95.55 95.24 8.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.496 0.665 . . . . 0.45 110.77 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 m -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.095 -0.957 . . . . 1.79 111.806 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -76.36 -25.28 54.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.121 -0.49 . . . . 1.64 110.837 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttt 62.16 34.29 16.33 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 124.124 0.89 . . . . 2.31 109.434 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -129.64 8.19 5.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.349 -0.387 . . . . 0.78 111.949 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.41 12.47 76.94 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.686 -0.768 . . . . 0.5 113.247 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.47 126.98 55.9 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.586 -0.361 . . . . 2.0 110.138 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 mt -102.93 112.86 25.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 1.06 111.323 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.78 170.12 11.64 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.495 -0.928 . . . . 1.39 108.495 167.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.73 -30.6 71.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.926 0.393 . . . . 1.69 110.67 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -67.26 -46.92 72.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.061 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.19 -41.47 94.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.274 -0.875 . . . . 0.39 110.952 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.519 ' CD1' HD12 ' A' ' 67' ' ' ILE . 47.3 t80 -65.84 -33.23 75.37 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.017 -0.538 . . . . 0.35 110.094 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.17 95.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 1.1 110.192 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 46' ' ' VAL . 92.0 mt -62.53 -41.68 99.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 2.42 110.633 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.465 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.13 -55.46 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 1.08 111.089 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -37.19 84.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.91 110.913 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.7 t60 -58.29 -50.06 74.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.416 . . . . 0.93 110.832 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.99 -29.57 70.72 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.883 0.373 . . . . 1.06 111.265 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 109' ' ' ALA . 85.0 mt -75.18 -42.51 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.537 0.684 . . . . 1.27 109.468 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -65.24 -36.12 83.15 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.821 -1.081 . . . . 2.57 110.79 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 111' ' ' HIS . 68.6 t -60.87 -54.2 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.748 0.309 . . . . 1.64 110.455 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.523 ' HG2' HG11 ' A' ' 85' ' ' VAL . 40.7 tptt -55.35 -48.25 74.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.403 -0.362 . . . . 1.69 111.619 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.48 -40.05 81.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 2.3 112.03 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.97 7.78 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.037 0.384 . . . . 2.05 112.037 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.47 35.54 6.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.552 -0.832 . . . . 0.68 112.966 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -121.83 -168.99 1.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.449 -0.442 . . . . 1.32 110.066 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -139.55 150.44 45.08 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.213 -0.662 . . . . 2.69 109.213 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.569 HD11 ' HE3' ' A' ' 88' ' ' LYS . 0.9 OUTLIER -104.01 129.39 25.3 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.667 -0.494 . . . . 1.74 109.667 178.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 6.64 2.19 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.271 2.647 . . . . 1.47 113.832 -169.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.842 ' HA ' HD12 ' A' ' 92' ' ' LEU . . . 58.77 28.67 17.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.389 -0.369 . . . . 1.78 111.416 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -112.34 171.25 7.63 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.043 0.449 . . . . 1.93 110.084 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.66 86.67 55.47 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.38 -0.97 . . . . 2.5 108.38 168.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.68 141.08 21.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.999 2.466 . . . . 1.12 112.126 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.24 -31.27 75.61 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.94 2.427 . . . . 1.24 112.664 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -91.51 12.94 19.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.755 -0.378 . . . . 1.23 111.43 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.3 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 1.88 110.847 173.123 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 9.5 t70 . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 110.075 -0.343 . . . . 1.41 110.075 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.9 Cg_exo -74.85 -2.01 11.93 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.471 2.781 . . . . 0.79 113.627 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 86' ' ' LEU . 20.0 m-85 -99.17 -12.86 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.441 . . . . 0.56 110.359 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.847 -0.615 . . . . 1.89 110.584 177.27 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.576 ' HZ3' ' HD3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.067 -0.716 . . . . 1.16 109.067 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.652 HG21 HD22 ' A' ' 130' ' ' LEU . 21.2 m -62.71 -14.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 1.94 112.398 -172.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.498 ' HB ' ' CZ3' ' A' ' 44' ' ' TRP . 15.7 t -90.75 -11.07 9.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.482 . . . . 1.14 110.252 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -70.39 -10.42 66.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.171 -0.538 . . . . 0.78 112.673 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -75.67 -27.75 58.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.045 0.45 . . . . 3.71 110.435 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.8 34.0 4.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.961 0.886 . . . . 2.39 109.332 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HD3' ' HZ3' ' A' ' 44' ' ' TRP . 0.7 OUTLIER -70.17 -52.45 12.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.861 -1.063 . . . . 1.9 111.825 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.09 -24.48 58.43 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.041 1.827 . . . . 0.99 113.667 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -69.07 -45.76 69.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.682 -0.69 . . . . 1.03 109.895 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.472 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 6.7 m-85 -74.18 -21.59 59.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.677 -0.692 . . . . 1.15 109.385 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.73 110.208 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.28 -44.19 95.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.86 110.046 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.472 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 61.0 mt -68.82 -36.79 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 1.11 110.546 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 53' ' ' TYR . 51.8 t80 -59.31 -52.32 66.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.5 110.931 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.641 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 33.5 m-85 -76.81 -11.4 59.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.57 0.582 . . . . 1.23 112.57 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 p -93.5 2.98 56.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 1.3 110.812 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 82.2 mt -101.11 1.32 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.005 -0.543 . . . . 1.79 110.386 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m 69.45 85.07 0.13 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 115.496 -0.775 . . . . 1.51 111.103 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.641 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.8 Cg_endo -86.28 150.66 9.25 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.145 2.563 . . . . 1.1 112.539 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.36 119.8 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 2.4 110.532 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.46 27.0 16.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.747 -0.66 . . . . 2.02 111.267 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.28 4.9 83.34 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.734 -0.745 . . . . 0.9 112.65 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 58.1 mttm -123.32 148.48 45.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.35 -0.241 . . . . 1.52 110.35 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.698 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 40.9 pt -112.45 128.52 69.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.723 -0.473 . . . . 1.09 109.723 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.494 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 8.2 t -70.97 161.74 30.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.029 -0.532 . . . . 1.84 110.252 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -7.02 10.02 Favored Glycine 0 C--O 1.223 -0.534 0 CA-C-N 115.624 -0.716 . . . . 0.33 113.992 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 -64.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.479 0.64 . . . . 1.05 110.816 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.698 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 4.0 p30 -68.52 -34.06 75.21 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.848 0.356 . . . . 1.79 110.555 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.594 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -59.2 -52.6 64.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.012 -0.54 . . . . 1.02 110.54 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.776 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.3 tttt -62.11 -35.51 78.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.535 -0.302 . . . . 1.83 110.658 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 40.1 ttpt -53.77 -49.97 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.962 0.41 . . . . 2.96 110.468 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -66.52 -38.28 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.003 0.43 . . . . 2.16 110.54 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.799 ' HB3' HD21 ' A' ' 86' ' ' LEU . 93.0 mtp -64.99 -38.22 90.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 1.27 111.356 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.41 -16.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 1.99 110.668 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 68.1 mttm -85.74 -12.53 50.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.072 0.463 . . . . 2.71 110.327 172.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -77.54 -4.92 48.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.689 -0.687 . . . . 1.25 110.135 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.97 22.02 8.7 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.597 -0.729 . . . . 3.08 112.135 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.558 ' HB2' HD22 ' A' ' 86' ' ' LEU . 87.8 mt -93.84 153.92 40.93 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 1.94 110.36 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HG2' HG21 ' A' ' 85' ' ' VAL . 57.0 Cg_endo -72.41 160.52 46.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.835 2.357 . . . . 0.59 112.526 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -55.45 -34.46 64.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.761 -0.654 . . . . 2.32 111.092 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -57.39 -59.2 5.49 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.863 -0.608 . . . . 1.77 111.288 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.449 HG21 ' HG2' ' A' ' 82' ' ' PRO . 65.9 t -64.5 -45.15 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.572 -0.74 . . . . 1.13 110.657 -177.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 76' ' ' MET . 86.1 mt -60.65 -42.76 97.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.815 0.34 . . . . 1.26 110.864 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.487 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -61.37 -46.29 94.69 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.002 -0.544 . . . . 0.25 112.642 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.442 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 19.3 ptmt -72.17 -35.22 68.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.37 -0.532 . . . . 2.34 110.917 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 112' ' ' LEU . 46.8 mt -60.65 -41.08 86.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.996 -0.372 . . . . 1.15 109.996 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CD1' ' HB3' ' B' ' 149' ' ' ASP . 49.6 t-105 -64.25 -48.9 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.57 110.541 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -58.5 -24.78 61.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.929 -0.578 . . . . 3.03 111.878 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 31.8 mt -92.41 -52.16 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.353 . . . . 1.75 111.281 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.03 73.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.097 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -86.93 94.75 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.455 0.645 . . . . 0.45 109.358 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.91 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.323 -0.853 . . . . 1.79 111.381 -171.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -10.71 59.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 1.64 109.402 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 45.92 46.42 12.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.081 0.863 . . . . 2.31 109.873 -172.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -109.49 5.33 23.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.78 111.676 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.77 -4.88 84.03 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.307 -0.717 . . . . 0.5 111.307 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mp -122.41 142.89 50.05 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.151 -0.524 . . . . 2.0 110.153 177.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.53 115.22 28.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.89 -0.782 . . . . 1.06 108.89 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 175.79 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.848 -0.797 . . . . 1.39 108.848 167.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -56.67 -40.39 75.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.221 0.534 . . . . 1.69 110.735 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.52 -33.18 62.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 2.29 110.631 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.34 -41.72 69.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.39 110.373 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -67.54 -32.27 72.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.807 -0.633 . . . . 0.35 109.439 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -60.83 -46.75 89.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 1.1 110.86 173.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 82.5 mt -61.84 -42.75 99.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.375 -0.375 . . . . 2.42 110.635 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.36 -57.17 13.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 1.08 110.901 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.47 -34.22 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.91 111.197 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.418 ' O ' HG22 ' A' ' 115' ' ' VAL . 59.3 t60 -65.41 -46.2 80.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.93 110.179 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 79.9 mt -60.43 -40.8 92.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.91 0.386 . . . . 1.06 110.264 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 109' ' ' ALA . 83.8 mt -61.13 -54.38 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.38 -0.827 . . . . 1.27 111.065 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.661 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 14.8 ptpt -67.37 -33.85 76.08 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.051 -0.659 . . . . 2.57 111.23 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 111' ' ' HIS . 39.9 t -58.92 -50.4 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.127 -0.323 . . . . 1.64 110.127 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 42.5 tptt -53.96 -48.81 69.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.884 0.374 . . . . 1.69 111.096 172.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 117' ' ' LEU . 4.0 mm? -67.01 -20.16 65.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.389 0.515 . . . . 2.3 112.389 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.1 mt-10 -76.59 -6.22 51.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.83 0.348 . . . . 2.05 110.626 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.75 27.51 14.27 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.178 -0.769 . . . . 0.68 111.178 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -113.27 -176.98 3.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 1.32 109.865 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.4 ' CD ' ' HZ3' ' A' ' 116' ' ' LYS . 8.6 tp10 -123.94 142.31 51.26 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.612 -0.885 . . . . 2.69 108.612 172.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -85.07 141.24 37.39 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.449 -0.341 . . . . 1.74 110.321 -179.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 39.3 Cg_exo -58.54 -16.44 29.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.438 2.759 . . . . 1.47 114.197 -170.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.34 18.03 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.701 0.626 . . . . 1.78 110.992 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -135.58 173.63 11.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.717 -0.674 . . . . 1.93 109.548 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.54 95.76 44.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.608 -0.516 . . . . 2.5 109.608 174.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 51.2 Cg_exo -54.1 147.47 43.91 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.221 2.614 . . . . 1.12 112.847 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 41.9 Cg_exo -58.42 -25.19 72.42 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.196 2.597 . . . . 1.24 112.763 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.416 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 7.4 p-80 -85.79 3.34 41.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.458 -0.337 . . . . 1.23 111.03 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.652 HD22 HG21 ' A' ' 45' ' ' VAL . 31.2 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 1.88 111.385 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.9 p30 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.163 0.506 . . . . 1.41 110.906 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.776 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 14.3 Cg_exo -69.57 0.49 5.43 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.666 2.911 . . . . 0.79 113.69 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.487 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 28.5 m-85 -97.47 -45.93 6.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.006 0.431 . . . . 0.56 110.312 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 76.4 p . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 121.561 0.696 . . . . 1.89 110.35 -179.745 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 112.349 0.5 . . . . 1.16 112.349 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.49 -7.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.888 0.851 . . . . 1.94 109.035 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 t -96.83 -11.93 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.887 -1.051 . . . . 1.14 109.802 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.67 -23.68 69.09 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.773 -0.649 . . . . 0.78 112.996 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -74.35 -27.32 60.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.999 0.428 . . . . 3.71 110.67 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.39 31.39 5.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 2.39 109.637 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -75.81 -56.44 1.73 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.51 -0.314 . . . . 1.9 111.692 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 51.0 Cg_endo -66.94 -14.75 44.87 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.707 1.605 . . . . 0.99 112.569 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.41 -46.59 63.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.548 0.689 . . . . 1.03 109.177 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -80.82 -20.8 41.65 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.453 -0.794 . . . . 1.15 109.922 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 11.2 t70 -66.29 -44.55 83.18 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.212 -0.662 . . . . 0.73 109.212 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.93 -50.89 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.86 110.229 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.51 -38.81 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.062 -0.517 . . . . 1.11 110.338 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.486 ' HE1' HG12 ' A' ' 67' ' ' ILE . 65.2 t80 -56.72 -47.56 79.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.317 -0.856 . . . . 0.5 111.134 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -76.09 -22.36 55.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.27 0.471 . . . . 1.23 112.27 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.45 -6.71 57.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.6 -0.44 . . . . 1.3 111.032 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.14 0.73 38.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 1.79 111.228 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m 69.65 88.15 0.1 Allowed Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 123.84 0.713 . . . . 1.51 111.201 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.0 136.27 5.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.809 2.34 . . . . 1.1 112.438 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.3 m -107.71 115.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.113 0.482 . . . . 2.4 110.828 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 58.0 28.33 16.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.717 -0.674 . . . . 2.02 112.016 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.88 -2.4 69.4 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.94 -0.648 . . . . 0.9 113.352 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.505 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 57.3 mttm -127.11 142.25 51.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.501 -0.411 . . . . 1.52 110.546 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.486 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -99.06 138.67 22.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.201 -0.666 . . . . 1.09 109.201 170.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.714 ' HA ' HD23 ' A' ' 100' ' ' LEU . 1.1 p -71.53 164.55 25.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.254 -0.43 . . . . 1.84 111.067 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.56 -25.25 41.97 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 115.719 -0.673 . . . . 0.33 113.175 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.26 -42.91 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 1.05 111.074 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.725 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 25.6 m-80 -76.72 -43.03 39.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.14 0.495 . . . . 1.79 110.234 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.98 -41.15 86.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.022 -0.99 . . . . 1.02 110.516 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.682 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.6 tttt -70.59 -35.93 73.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.009 -0.541 . . . . 1.83 110.122 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.725 ' HE2' ' HA ' ' A' ' 71' ' ' ASN . 52.3 mtmt -54.45 -46.37 73.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.906 0.384 . . . . 2.96 110.203 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.76 -52.54 63.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.693 -0.685 . . . . 2.16 110.176 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.527 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 32.8 mtt -56.23 -41.96 76.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.128 0.49 . . . . 1.27 112.01 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 73' ' ' LYS . 99.6 t -68.74 -31.17 49.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.707 -0.678 . . . . 1.99 110.72 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 98.4 mttt -71.53 -28.15 63.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.88 0.371 . . . . 2.71 110.348 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 m -74.17 -15.07 61.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 1.25 111.122 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 73.15 24.38 2.47 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.821 0.674 . . . . 3.08 112.821 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.664 ' HB2' HD21 ' A' ' 86' ' ' LEU . 3.9 mm? -87.84 158.15 50.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.655 -0.418 . . . . 1.94 110.271 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.487 ' HG2' HG23 ' A' ' 85' ' ' VAL . 73.5 Cg_endo -76.31 157.21 37.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.125 2.55 . . . . 0.59 113.274 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -53.69 -42.99 68.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.661 -0.7 . . . . 2.32 111.703 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 p -55.78 -56.88 15.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.235 0.54 . . . . 1.77 111.785 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.487 HG23 ' HG2' ' A' ' 82' ' ' PRO . 87.9 t -62.39 -45.15 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.81 -0.632 . . . . 1.13 111.171 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 81' ' ' LEU . 70.3 mt -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 1.26 110.376 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.94 -48.07 79.61 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.02 -0.536 . . . . 0.25 112.48 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.426 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 40.9 pttt -74.05 -33.68 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 2.34 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 85' ' ' VAL . 43.5 mt -60.66 -41.44 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.851 -0.425 . . . . 1.15 109.851 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -60.88 -48.75 80.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.57 110.377 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -67.84 -14.03 62.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.055 0.391 . . . . 3.03 112.055 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 61.5 mt -93.31 -51.18 5.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.331 . . . . 1.75 110.79 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.03 -33.66 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.775 . . . . 1.0 111.544 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -84.32 86.26 7.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.672 0.748 . . . . 0.45 109.494 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.66 -30.62 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.562 -1.199 . . . . 1.79 112.405 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.44 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 2.7 m-20 -72.78 -24.34 60.92 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 116.514 -0.312 . . . . 1.64 110.265 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 mttt 58.37 40.33 24.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.277 -1.008 . . . . 2.31 108.277 -167.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 p-10 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.995 -1.002 . . . . 0.78 111.22 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.65 22.16 65.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.72 . . . . 0.5 111.793 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 68' ' ' THR . 15.3 mt -140.67 143.95 35.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.503 -0.555 . . . . 2.0 109.503 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' A' ' 105' ' ' GLU . 71.0 mt -121.56 114.2 20.86 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.451 0.469 . . . . 1.06 109.973 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -79.19 -177.57 5.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.971 -0.752 . . . . 1.39 108.971 169.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.65 -30.85 69.03 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.985 -0.286 . . . . 1.69 111.385 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.36 -58.05 3.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.075 -0.343 . . . . 2.29 110.075 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HB3' HD23 ' A' ' 101' ' ' LEU . 38.6 mt-10 -56.94 -39.71 75.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.323 0.582 . . . . 0.39 110.653 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.75 -29.43 66.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.549 -0.751 . . . . 0.35 110.945 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.47 -42.23 30.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.918 0.866 . . . . 1.1 108.925 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.505 -1.225 . . . . 2.42 110.044 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.18 -52.02 67.32 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.965 -0.561 . . . . 1.08 110.754 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -27.09 68.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.91 111.668 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.487 ' O ' HG22 ' A' ' 115' ' ' VAL . 21.9 t60 -67.19 -47.18 71.7 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 0.93 109.841 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.48 -41.88 99.09 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.996 0.427 . . . . 1.06 110.234 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.503 HD13 ' HE1' ' A' ' 76' ' ' MET . 73.6 mt -61.22 -50.77 79.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 1.27 111.313 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 45.4 pttt -73.48 -21.42 60.44 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 120.336 -0.545 . . . . 2.57 110.236 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 111' ' ' HIS . 2.8 t -58.96 -46.45 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.638 -0.504 . . . . 1.64 109.638 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.487 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 13.1 mmmm -72.73 -31.98 65.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.397 -0.365 . . . . 1.69 111.249 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 37.0 tp -65.41 -42.0 93.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 2.3 111.317 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 80.8 mm-40 -69.98 -26.01 63.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.027 0.441 . . . . 2.05 110.619 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.33 34.48 3.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.653 -0.784 . . . . 0.68 112.65 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.66 177.24 4.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.962 -0.384 . . . . 1.32 109.962 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.79 149.41 24.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.832 0.349 . . . . 2.69 111.631 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 122' ' ' LEU . 1.4 pp -124.91 130.67 24.14 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.117 -0.697 . . . . 1.74 109.117 167.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 -13.62 20.19 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.689 2.26 . . . . 1.47 113.726 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.6 18.94 9.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.586 -0.734 . . . . 1.78 110.571 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -106.14 170.17 8.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.332 -0.849 . . . . 1.93 108.904 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.1 tp -123.15 96.83 44.02 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.651 -0.419 . . . . 2.5 110.758 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.21 152.67 40.1 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.899 2.4 . . . . 1.12 112.125 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.3 -39.69 62.42 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.537 2.825 . . . . 1.24 114.237 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -81.02 13.92 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 1.23 111.716 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.281 -0.418 . . . . 1.88 110.217 173.776 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.676 0.274 . . . . 1.41 110.382 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.682 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -72.75 -1.59 10.61 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.464 2.776 . . . . 0.79 113.936 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.447 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 25.2 m-85 -100.31 -20.31 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.101 0.476 . . . . 0.56 110.91 -175.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.8 -0.637 . . . . 1.89 110.57 175.791 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.456 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.6 t90 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.895 -0.409 . . . . 1.16 109.895 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.85 -35.34 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 1.94 111.786 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.9 -21.0 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.145 -0.48 . . . . 1.14 111.174 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -68.67 -5.93 47.58 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.084 -0.579 . . . . 0.78 112.98 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -74.64 -28.25 60.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.089 0.471 . . . . 3.71 110.867 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -135.02 33.16 3.15 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.53 -0.915 . . . . 2.39 108.53 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 82.3 tttt -84.33 -44.71 0.74 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 114.946 -1.025 . . . . 1.9 113.409 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 19.7 Cg_endo -56.18 -23.84 47.11 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.426 2.084 . . . . 0.99 113.132 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 m -69.9 -41.21 74.99 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.273 -0.876 . . . . 1.03 110.378 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.59 -21.95 60.18 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.362 -0.607 . . . . 1.15 109.362 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 3.6 t70 -66.3 -45.18 81.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.443 0.64 . . . . 0.73 109.75 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -59.59 -40.8 88.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.072 -0.967 . . . . 1.86 109.902 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.603 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 65.9 mt -70.29 -37.89 72.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.071 0.462 . . . . 1.11 110.731 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -61.54 -51.09 70.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.142 -0.481 . . . . 0.5 111.235 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -82.24 14.18 3.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.231 0.456 . . . . 1.23 112.231 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -118.5 3.58 11.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 1.3 110.467 172.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 72.5 mt -106.35 11.97 30.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.919 -0.582 . . . . 1.79 110.513 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t 66.35 80.77 0.22 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.371 -0.831 . . . . 1.51 111.325 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.77 128.67 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.313 2.008 . . . . 1.1 111.526 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.0 t -106.81 107.79 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.398 -0.364 . . . . 2.4 110.191 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.3 m120 68.61 29.22 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.478 -0.783 . . . . 2.02 110.52 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.24 -3.62 72.93 Favored Glycine 0 C--O 1.23 -0.142 0 CA-C-N 115.655 -0.702 . . . . 0.9 113.333 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -122.03 140.36 52.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.407 -0.22 . . . . 1.52 110.407 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -101.13 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.835 -0.802 . . . . 1.09 108.835 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.72 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 72.0 p -80.75 164.94 22.38 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.483 -0.487 . . . . 1.84 110.207 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.38 -20.73 52.02 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 120.999 -0.62 . . . . 0.33 112.802 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 -43.84 81.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.907 0.384 . . . . 1.05 111.308 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.3 -44.21 37.94 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.524 0.678 . . . . 1.79 109.767 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.674 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.72 -50.82 72.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.771 -1.104 . . . . 1.02 110.182 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.565 ' O ' HG21 ' A' ' 77' ' ' VAL . 76.3 tttt -56.73 -40.62 76.03 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.1 -0.5 . . . . 1.83 110.539 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -51.88 -49.25 63.34 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.003 0.43 . . . . 2.96 110.218 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.27 -39.88 89.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.89 -0.595 . . . . 2.16 110.517 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.723 ' HB3' HD22 ' A' ' 86' ' ' LEU . 66.4 mtp -67.26 -27.01 66.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.001 -0.545 . . . . 1.27 110.451 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 73' ' ' LYS . 77.7 t -70.94 -38.05 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 1.99 109.97 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -66.44 -21.87 66.21 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 2.71 110.885 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.4 t -73.88 -17.28 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.25 -0.432 . . . . 1.25 111.069 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 65.65 24.22 11.62 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.581 0.585 . . . . 3.08 112.581 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.544 ' HB2' HD23 ' A' ' 86' ' ' LEU . 69.3 mt -85.59 151.61 56.01 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.574 -0.45 . . . . 1.94 110.219 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HG2' HG22 ' A' ' 85' ' ' VAL . 33.1 Cg_endo -65.34 149.7 87.99 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.771 2.314 . . . . 0.59 111.918 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -53.13 -35.55 59.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.317 -0.401 . . . . 2.32 111.621 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 m -61.97 -45.05 95.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.348 -0.387 . . . . 1.77 111.017 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.626 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 86.6 t -73.37 -39.19 54.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.971 0.415 . . . . 1.13 110.332 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.723 HD22 ' HB3' ' A' ' 76' ' ' MET . 84.4 mt -59.58 -48.76 80.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 1.26 110.563 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.57 -41.15 99.83 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.727 -0.669 . . . . 0.25 112.415 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 0.4 OUTLIER -66.67 -38.78 87.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.359 -0.536 . . . . 2.34 110.084 -179.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.81 -39.6 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 110.085 -0.339 . . . . 1.15 110.085 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -62.26 -51.56 67.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.57 110.445 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.465 ' HB3' ' HZ2' ' A' ' 91' ' ' LYS . 7.6 mtpm? -67.39 -12.44 60.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 3.03 112.159 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.3 mt -93.97 -49.77 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 1.75 111.21 174.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.518 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -72.34 -32.27 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.705 -173.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -88.3 83.73 6.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.45 109.861 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.14 -28.9 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.206 -0.906 . . . . 1.79 111.497 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.545 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 57.5 m-20 -74.21 -19.9 60.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 121.002 -0.279 . . . . 1.64 110.271 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mttt 58.75 27.81 16.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.898 0.856 . . . . 2.31 109.097 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.58 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.6 p-10 -98.69 9.7 42.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.347 -1.297 . . . . 0.78 111.366 -169.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.94 9.23 52.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.93 -0.653 . . . . 0.5 111.522 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.72 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 15.5 mt -131.18 136.86 48.66 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.998 -0.601 . . . . 2.0 110.046 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.8 mt -105.83 112.59 25.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 1.06 110.414 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.11 -178.11 3.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.89 -0.595 . . . . 1.39 109.55 170.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -56.8 -42.94 80.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.12 0.486 . . . . 1.69 110.339 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.456 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 19.2 mm-40 -66.08 -54.77 21.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.922 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.37 -39.19 86.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.39 111.202 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 -25.47 59.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.35 110.959 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.77 -42.41 40.96 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.533 -0.914 . . . . 1.1 108.533 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 93' ' ' ALA . 22.8 tp -63.56 -37.62 88.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.608 -1.178 . . . . 2.42 109.845 174.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.74 -56.63 19.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.187 -0.46 . . . . 1.08 110.972 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.73 -31.13 72.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.33 -0.396 . . . . 0.91 111.242 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.464 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.0 t60 -66.93 -40.91 87.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.477 -0.329 . . . . 0.93 110.319 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.581 ' O ' HG13 ' A' ' 115' ' ' VAL . 94.7 mt -70.6 -39.4 73.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.159 0.504 . . . . 1.06 110.058 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 65.7 mt -56.45 -53.7 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.844 . . . . 1.27 111.177 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 28.3 pttt -76.42 -25.05 54.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.293 -0.412 . . . . 2.57 111.042 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 112' ' ' LEU . 1.2 p -68.68 -38.88 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.245 -0.65 . . . . 1.64 109.245 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -66.53 -39.53 88.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.163 -0.472 . . . . 1.69 110.082 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.51 -39.76 92.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.879 -0.6 . . . . 2.3 111.149 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 71.3 mt-10 -71.55 -9.48 58.27 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.42 -0.354 . . . . 2.05 111.023 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.92 16.84 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.612 -0.804 . . . . 0.68 112.59 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.538 ' HB2' HG22 ' A' ' 115' ' ' VAL . 83.7 m-70 -99.49 121.16 40.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.336 -0.616 . . . . 1.32 109.336 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -81.07 100.6 9.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.911 0.386 . . . . 2.69 110.411 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.4 ' O ' HD13 ' A' ' 122' ' ' LEU . 2.6 pp -61.09 133.47 92.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 1.74 109.81 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.26 4.84 3.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.952 2.434 . . . . 1.47 113.56 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.59 27.63 14.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.172 0.511 . . . . 1.78 110.854 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.68 163.49 16.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.926 -0.579 . . . . 1.93 109.97 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -126.56 85.65 59.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.128 -0.942 . . . . 2.5 109.124 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.55 145.62 95.39 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.18 1.92 . . . . 1.12 111.612 174.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.39 -32.33 14.76 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.494 2.796 . . . . 1.24 114.277 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -81.28 3.88 22.47 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.032 0.382 . . . . 1.23 112.032 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.59 0.233 . . . . 1.88 111.128 176.344 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 6.3 t70 . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.198 0.523 . . . . 1.41 110.373 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.5 Cg_exo -74.61 -2.02 11.88 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.43 2.754 . . . . 0.79 113.825 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.471 ' HZ ' ' SD ' ' A' ' 76' ' ' MET . 10.1 m-85 -105.13 -25.23 12.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.84 0.352 . . . . 0.56 110.771 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.485 . . . . 1.89 111.775 -177.967 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.1 t90 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.089 -0.708 . . . . 1.16 109.089 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.17 -17.33 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.708 -0.678 . . . . 1.94 112.56 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 t -89.25 -7.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.313 0.578 . . . . 1.14 110.049 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -20.82 78.51 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.723 -0.751 . . . . 0.78 112.852 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -75.0 -29.37 60.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.137 0.494 . . . . 3.71 109.703 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.49 33.36 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.447 -0.797 . . . . 2.39 109.992 -172.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 18.5 ttpp -83.88 -48.96 0.69 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.87 -0.604 . . . . 1.9 111.401 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 84.8 Cg_exo -50.13 -29.29 21.88 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.654 2.236 . . . . 0.99 114.359 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.6 m -70.78 -46.5 62.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.318 0.58 . . . . 1.03 110.209 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -73.94 -20.07 60.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.353 -0.61 . . . . 1.15 109.353 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.506 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 14.4 t70 -68.94 -42.34 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.24 -0.891 . . . . 0.73 109.467 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.64 -41.84 95.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 1.86 110.135 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.3 mt -61.98 -39.4 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.104 0.478 . . . . 1.11 110.029 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -57.11 -52.88 63.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.855 . . . . 0.5 111.584 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.653 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 63.8 m-85 -74.9 -21.25 59.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.123 0.416 . . . . 1.23 112.123 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.7 p -83.25 2.31 36.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.411 . . . . 1.3 111.374 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.21 9.28 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.64 0.257 . . . . 1.79 110.485 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m 66.72 87.37 0.12 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.321 -0.854 . . . . 1.51 111.095 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.653 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -81.08 132.51 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.776 2.317 . . . . 1.1 112.044 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.95 123.63 67.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.832 -0.622 . . . . 2.4 110.464 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 65.43 23.2 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.655 -0.702 . . . . 2.02 110.817 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.79 -0.62 79.94 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.886 -0.673 . . . . 0.9 112.628 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.664 ' HB2' HD13 ' A' ' 100' ' ' LEU . 44.6 mttm -123.5 164.82 18.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.999 -0.371 . . . . 1.52 109.999 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.678 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 48.2 pt -111.5 130.24 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.925 -0.71 . . . . 1.09 109.302 167.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -71.25 154.89 41.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.973 -0.558 . . . . 1.84 110.674 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.4 -9.01 2.01 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.9 -0.591 . . . . 0.33 113.981 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.75 -67.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.14 0.47 . . . . 1.05 110.581 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.836 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 4.3 p30 -69.32 -28.25 66.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.79 110.62 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.595 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.68 -49.09 78.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 1.02 110.333 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 42.8 tttp -64.54 -36.81 85.43 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.905 0.383 . . . . 1.83 110.22 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.836 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 28.5 mtpp -54.85 -42.15 71.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.632 . . . . 2.96 110.82 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -71.16 -38.86 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.661 . . . . 2.16 110.123 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.736 ' HB3' HD23 ' A' ' 86' ' ' LEU . 87.5 mtp -68.17 -28.08 66.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.481 -0.781 . . . . 1.27 111.41 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -81.11 -22.69 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.362 -0.535 . . . . 1.99 110.28 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 44.2 mttp -66.49 -28.93 68.95 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.304 -0.558 . . . . 2.71 109.666 170.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -67.03 -17.56 64.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.569 -0.741 . . . . 1.25 110.797 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mttp 67.28 22.83 9.5 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.839 -0.619 . . . . 3.08 111.582 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.558 ' HB2' HD21 ' A' ' 86' ' ' LEU . 84.5 mt -89.4 155.76 48.59 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.657 -0.498 . . . . 1.94 109.657 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.513 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 35.4 Cg_endo -66.53 147.26 81.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.564 2.176 . . . . 0.59 112.232 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.29 -36.9 69.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.652 -0.704 . . . . 2.32 111.276 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.2 m -60.02 -48.51 81.41 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.838 -0.619 . . . . 1.77 111.214 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.543 ' O ' HG13 ' A' ' 89' ' ' ILE . 78.7 t -67.6 -38.31 80.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 1.13 110.162 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 76' ' ' MET . 81.8 mt -57.49 -42.27 82.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 1.26 110.556 175.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.67 -41.21 98.86 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.953 -0.567 . . . . 0.25 112.132 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.03 -47.74 81.74 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.23 -0.188 . . . . 2.34 110.84 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 85' ' ' VAL . 69.3 mt -53.35 -45.55 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 123.339 0.4 . . . . 1.15 110.365 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.451 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 32.0 t-105 -59.71 -52.68 64.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.731 -0.668 . . . . 0.57 110.963 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.93 -13.55 61.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.308 0.484 . . . . 3.03 112.308 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.49 -39.77 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.142 0.496 . . . . 1.75 110.648 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 105' ' ' GLU . . . -78.53 -36.18 45.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.56 -176.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.432 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 44.0 t0 -83.56 70.61 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.869 0.842 . . . . 0.45 109.467 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.45 ' CG1' HD13 ' A' ' 126' ' ' LEU . 15.0 m -77.32 -16.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.944 -1.025 . . . . 1.79 109.619 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.56 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . 2.1 t70 -86.23 -20.72 28.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.186 -1.37 . . . . 1.64 109.295 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttt 60.77 40.34 16.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.667 -1.152 . . . . 2.31 111.359 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.602 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 7.2 p-10 -114.27 9.21 16.96 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.505 -0.478 . . . . 0.78 111.299 -174.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.6 -2.41 67.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 120.843 -0.694 . . . . 0.5 111.992 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.664 HD13 ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -120.71 134.02 55.31 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.752 -0.832 . . . . 2.0 108.752 -176.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.47 HD13 ' HB1' ' A' ' 72' ' ' ALA . 62.3 mt -83.23 108.6 16.57 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 118.743 -1.183 . . . . 1.06 108.012 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.88 171.22 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.711 -1.218 . . . . 1.39 107.711 171.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -57.6 -42.01 82.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.996 0.362 . . . . 1.69 111.212 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.8 -42.21 77.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.291 0.567 . . . . 2.29 110.28 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.56 ' OE2' ' HB3' ' A' ' 96' ' ' ASP . 25.4 mt-10 -66.89 -38.63 86.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.516 -0.765 . . . . 0.39 110.627 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 38.9 t80 -73.1 -25.06 60.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.35 110.625 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 -41.57 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.244 -1.021 . . . . 1.1 108.244 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 93' ' ' ALA . 40.7 tp -65.25 -35.52 81.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.449 -1.25 . . . . 2.42 109.826 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -55.88 29.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.133 -0.485 . . . . 1.08 110.84 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.541 HD21 HD12 ' A' ' 113' ' ' ILE . 13.8 m120 -61.62 -28.16 69.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.91 110.928 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.519 ' O ' HG22 ' A' ' 115' ' ' VAL . 61.7 t60 -63.95 -48.01 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 0.93 110.585 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.471 ' HB3' HD21 ' A' ' 122' ' ' LEU . 36.4 mt -66.24 -33.39 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.792 -0.448 . . . . 1.06 109.792 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.541 HD12 HD21 ' A' ' 110' ' ' ASN . 88.2 mt -60.49 -51.39 73.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.83 -0.623 . . . . 1.27 111.511 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.28 -41.02 86.14 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 120.601 -0.439 . . . . 2.57 110.444 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 111' ' ' HIS . 69.4 t -54.62 -47.83 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.027 0.442 . . . . 1.64 109.867 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 44.4 tptt -57.8 -56.58 20.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.54 -0.755 . . . . 1.69 111.306 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.89 -31.81 72.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 2.3 111.73 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 44.4 mt-10 -80.5 4.29 18.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 2.05 111.353 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.07 33.17 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.699 . . . . 0.68 113.467 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.51 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 97.7 m-70 -131.5 173.55 10.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.778 0.289 . . . . 1.32 110.444 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -120.0 155.13 33.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.269 -0.423 . . . . 2.69 111.163 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' A' ' 112' ' ' LEU . 21.9 mt -93.47 128.16 43.48 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.946 -0.57 . . . . 1.74 109.582 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.49 -6.81 19.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.792 2.328 . . . . 1.47 113.57 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.89 9.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 1.78 112.404 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -127.6 174.61 8.92 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.661 -0.496 . . . . 1.93 109.661 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.45 HD13 ' CG1' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -124.36 88.96 52.6 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.696 -0.483 . . . . 2.5 109.696 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 32.5 Cg_endo -66.57 150.34 83.97 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.859 2.373 . . . . 1.12 112.256 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 32.3 Cg_exo -58.25 -21.4 52.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.218 2.612 . . . . 1.24 113.856 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -96.94 13.14 29.86 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.487 -0.485 . . . . 1.23 111.576 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 mt . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 1.88 111.418 177.06 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.2 p30 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.056 0.455 . . . . 1.41 111.388 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.597 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 30.7 Cg_exo -63.24 0.22 1.86 Allowed 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 124.118 3.212 . . . . 0.79 114.114 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.461 ' HZ ' ' SD ' ' A' ' 76' ' ' MET . 28.9 m-85 -100.4 -49.8 4.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.925 0.393 . . . . 0.56 110.813 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 116.054 -0.521 . . . . 1.89 111.706 -177.072 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.4 t90 . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 107.542 -1.281 . . . . 1.16 107.542 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 130' ' ' LEU . 16.5 m -57.82 -20.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.989 0.737 . . . . 1.94 112.989 -169.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.45 -25.81 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 1.14 110.723 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -69.84 -23.58 76.82 Favored Glycine 0 CA--C 1.516 0.101 0 C-N-CA 121.167 -0.54 . . . . 0.78 113.0 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -73.91 -20.48 60.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.583 0.706 . . . . 3.71 109.907 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -134.48 34.38 3.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.413 1.101 . . . . 2.39 108.683 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HZ1' ' CG ' ' A' ' 103' ' ' ASP . 16.1 ttpp -79.57 -42.1 1.53 Allowed Pre-proline 0 C--O 1.215 -0.718 0 CA-C-N 114.637 -1.165 . . . . 1.9 111.19 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 42.9 Cg_exo -44.0 -29.37 2.63 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.909 2.406 . . . . 0.99 114.419 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -70.19 -46.54 64.4 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.461 0.648 . . . . 1.03 109.792 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -74.75 -17.03 60.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.604 -0.725 . . . . 1.15 109.567 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 10.7 t70 -72.86 -44.61 61.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.158 -0.928 . . . . 0.73 109.442 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.64 -42.86 97.78 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.712 -0.676 . . . . 1.86 109.671 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 60' ' ' LEU . 60.7 mt -61.01 -42.44 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 1.11 109.788 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -53.74 -35.08 60.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 0.5 110.975 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.596 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 39.2 m-85 -84.83 -22.86 29.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.57 0.581 . . . . 1.23 112.57 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 p -77.26 -11.27 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.3 -0.56 . . . . 1.3 110.446 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.515 HD12 ' OE1' ' A' ' 75' ' ' GLU . 10.1 mp -99.76 7.04 45.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.959 -0.564 . . . . 1.79 111.321 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m 64.92 88.12 0.11 Allowed Pre-proline 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 1.51 110.793 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 90.4 Cg_endo -84.28 102.6 0.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.213 1.942 . . . . 1.1 112.151 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.85 110.35 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.79 -0.641 . . . . 2.4 110.918 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 65.38 26.5 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.799 . . . . 2.02 111.052 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.85 19.86 64.64 Favored Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 121.176 -0.535 . . . . 0.9 112.269 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.746 ' HB3' HD11 ' A' ' 100' ' ' LEU . 52.7 mttm -139.9 155.53 47.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.866 -0.42 . . . . 1.52 109.866 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.537 HD13 ' CD1' ' A' ' 106' ' ' PHE . 38.1 pt -131.35 131.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.196 0.522 . . . . 1.09 110.247 171.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 p -66.98 161.89 23.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.683 -0.69 . . . . 1.84 111.061 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.17 -16.8 62.81 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 121.304 -0.474 . . . . 0.33 113.696 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.69 -51.45 68.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.104 0.478 . . . . 1.05 110.829 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 18.2 m-80 -68.38 -43.05 78.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 1.79 109.954 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.563 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.22 -53.65 55.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.241 -0.891 . . . . 1.02 111.425 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.629 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.7 tttt -61.59 -35.73 78.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 1.83 110.296 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 16.7 ttpp -51.66 -47.26 63.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 2.96 110.344 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.515 ' OE1' HD12 ' A' ' 60' ' ' LEU . 3.4 tp10 -65.97 -38.08 87.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.454 0.645 . . . . 2.16 110.155 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.751 ' HB3' HD21 ' A' ' 86' ' ' LEU . 76.4 mtp -71.56 -31.27 66.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.423 -0.808 . . . . 1.27 111.486 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.56 -24.05 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.913 -0.315 . . . . 1.99 110.46 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -70.87 -28.29 64.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.24 0.543 . . . . 2.71 109.904 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.5 m -66.48 -19.31 65.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.203 -0.908 . . . . 1.25 111.058 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 62.43 36.3 14.31 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.871 -0.604 . . . . 3.08 111.407 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.645 ' HB2' HD22 ' A' ' 86' ' ' LEU . 85.9 mt -97.13 161.17 27.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.894 -0.41 . . . . 1.94 109.894 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 81' ' ' LEU . 36.5 Cg_endo -67.19 143.08 63.36 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.463 2.109 . . . . 0.59 112.136 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -56.32 -31.47 63.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.849 -0.614 . . . . 2.32 111.604 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p -59.68 -54.7 43.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 1.77 111.373 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 89' ' ' ILE . 59.9 t -66.1 -41.94 90.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 1.13 110.187 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.751 HD21 ' HB3' ' A' ' 76' ' ' MET . 90.6 mt -55.68 -52.71 62.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.16 -0.473 . . . . 1.26 111.113 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.53 -39.26 96.17 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 121.155 -0.545 . . . . 0.25 112.116 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.497 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 25.6 ttmm -61.27 -44.13 97.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 2.34 110.419 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 85' ' ' VAL . 84.5 mt -62.85 -39.78 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 1.15 110.614 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.462 ' HZ2' ' C ' ' A' ' 99' ' ' GLY . 57.7 t-105 -60.43 -49.05 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.57 110.327 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -65.67 -16.22 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 3.03 112.16 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 34.2 mt -92.37 -44.39 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.147 0.499 . . . . 1.75 111.497 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.69 -27.26 45.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.005 -172.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -86.23 85.54 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.608 0.718 . . . . 0.45 110.624 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 105' ' ' GLU . 21.1 m -74.81 -25.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.897 -1.047 . . . . 1.79 112.174 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.622 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 9.0 m-20 -78.96 -13.59 59.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 121.116 -0.234 . . . . 1.64 110.756 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttt 59.72 29.9 19.47 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 108.691 -0.855 . . . . 2.31 108.691 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.622 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 17.9 p-10 -105.73 9.35 33.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.134 -0.939 . . . . 0.78 111.308 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.462 ' C ' ' HZ2' ' A' ' 90' ' ' TRP . . . 64.54 20.66 66.07 Favored Glycine 0 CA--C 1.493 -1.336 0 CA-C-O 121.584 0.547 . . . . 0.5 112.657 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.746 HD11 ' HB3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -156.49 143.11 18.53 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.343 -0.984 . . . . 2.0 108.343 -173.105 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.593 ' N ' HD13 ' A' ' 100' ' ' LEU . 88.0 mt -104.57 126.5 51.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.975 0.417 . . . . 1.06 111.943 -171.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.86 -176.78 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.94 -0.573 . . . . 1.39 109.772 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.518 ' CG ' ' HZ1' ' A' ' 50' ' ' LYS . 14.5 t0 -57.75 -42.76 84.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.777 -0.647 . . . . 1.69 110.414 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -72.99 -43.97 61.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.508 -0.769 . . . . 2.29 110.822 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.465 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 52.3 mt-10 -63.37 -42.83 98.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.171 -0.468 . . . . 0.39 110.784 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.537 ' CD1' HD13 ' A' ' 67' ' ' ILE . 44.9 t80 -65.84 -35.87 81.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.35 110.094 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.69 89.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.938 -0.574 . . . . 1.1 110.321 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -62.29 -45.8 91.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.161 -0.472 . . . . 2.42 110.832 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.74 -58.06 8.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.989 0.423 . . . . 1.08 111.001 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -33.96 72.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.91 111.564 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -69.51 -46.97 65.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.566 -0.288 . . . . 0.93 110.309 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.08 -47.63 83.83 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.955 0.407 . . . . 1.06 110.608 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.9 mt -57.83 -52.23 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 1.27 111.101 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.66 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.66 -30.44 69.13 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.343 -0.39 . . . . 2.57 110.413 -176.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.658 HG13 ' HB2' ' A' ' 120' ' ' HIS . 3.1 t -61.49 -43.83 97.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.763 0.316 . . . . 1.64 110.361 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 25.7 mmmt -63.11 -37.48 87.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 1.69 110.869 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.8 tp -70.14 -30.52 67.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.606 -0.27 . . . . 2.3 111.01 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 29.9 mm-40 -66.01 -26.39 67.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 2.05 110.216 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.35 21.8 8.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.935 -0.65 . . . . 0.68 112.227 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.658 ' HB2' HG13 ' A' ' 115' ' ' VAL . 96.2 m-70 -104.91 165.97 10.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 1.32 110.443 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -108.74 127.01 53.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.143 -0.48 . . . . 2.69 110.06 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.64 146.72 80.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 1.74 110.08 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.54 -10.16 25.25 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.134 2.556 . . . . 1.47 113.548 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.33 19.33 10.98 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.214 -0.448 . . . . 1.78 111.124 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -133.09 175.08 9.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.844 -0.616 . . . . 1.93 110.232 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.62 90.51 50.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.452 -0.944 . . . . 2.5 108.452 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.75 151.57 69.15 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.479 2.12 . . . . 1.12 112.027 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.55 -25.91 61.31 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.191 2.594 . . . . 1.24 112.807 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -89.12 19.58 4.16 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.884 -0.326 . . . . 1.23 111.658 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.532 HD21 HG21 ' A' ' 45' ' ' VAL . 31.5 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 1.88 110.664 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ASP . . . . . 0.487 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 7.7 t70 . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.892 -0.41 . . . . 1.41 109.892 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.629 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.7 Cg_exo -76.82 -2.39 12.61 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.538 2.825 . . . . 0.79 113.924 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.537 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 10.7 m-85 -106.78 -9.97 16.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.126 0.489 . . . . 0.56 110.477 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 28.0 p . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.805 -0.634 . . . . 1.89 110.798 -177.598 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.073 -0.411 . . . . 10.82 112.073 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.83 143.18 36.58 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.673 2.249 . . . . 11.16 111.845 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.4 tp 72.04 110.47 0.06 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.93 0.769 . . . . 9.47 111.194 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.57 -110.96 0.33 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.59 -0.732 . . . . 6.48 111.528 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 p -148.49 -26.79 0.32 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.648 0.261 . . . . 5.98 111.169 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.41 92.9 7.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.348 0.594 . . . . 3.92 110.579 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -118.94 126.35 51.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.275 -0.875 . . . . 4.94 109.494 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.0 t -116.98 116.22 51.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.49 -0.323 . . . . 2.63 110.255 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.85 104.18 8.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.033 0.444 . . . . 2.4 110.385 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.472 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 20.9 t90 -71.25 112.89 7.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.347 -0.842 . . . . 1.16 109.115 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.96 -41.36 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 1.94 112.04 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG22 HD22 ' A' ' 108' ' ' LEU . 11.0 t -79.93 -1.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.363 0.602 . . . . 1.14 110.708 -174.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.13 76.95 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.673 -0.775 . . . . 0.78 112.562 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.54 -28.46 28.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.863 0.363 . . . . 3.71 110.952 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -124.18 34.7 4.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.172 0.987 . . . . 2.39 109.227 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 17.8 ttpt -78.78 -44.29 1.88 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 114.066 -1.425 . . . . 1.9 112.281 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.421 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 83.2 Cg_exo -49.15 -24.26 7.67 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.632 2.222 . . . . 0.99 113.67 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -69.89 -45.45 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.696 -0.483 . . . . 1.03 109.696 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.44 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 5.9 m-85 -73.49 -22.95 60.01 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.916 -0.584 . . . . 1.15 109.96 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.421 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -69.61 -44.59 70.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.48 0.657 . . . . 0.73 110.32 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -60.31 -45.58 92.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.279 -0.873 . . . . 1.86 109.765 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.516 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 77.3 mt -64.83 -39.92 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.669 . . . . 1.11 110.455 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.423 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 58.1 t80 -52.88 -50.72 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.5 111.306 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.421 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 45.1 m-85 -76.77 -22.4 53.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.275 -0.421 . . . . 1.23 112.071 -177.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.9 p -88.73 8.24 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.677 -0.409 . . . . 1.3 111.337 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 85.1 mt -104.88 1.34 28.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 1.79 110.589 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m 69.14 87.06 0.12 Allowed Pre-proline 0 N--CA 1.467 0.379 0 O-C-N 123.902 0.751 . . . . 1.51 110.586 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.578 ' HA ' HG22 ' A' ' 67' ' ' ILE . 1.2 Cg_endo -84.61 163.84 12.4 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.174 2.583 . . . . 1.1 112.755 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.85 102.57 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 2.4 110.087 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 m120 68.87 23.23 6.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 2.02 110.358 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.16 65.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.771 -0.728 . . . . 0.9 112.428 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.611 ' HD3' ' CB ' ' A' ' 100' ' ' LEU . 14.8 ttmm -133.4 126.78 32.0 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.982 -0.748 . . . . 1.52 108.982 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.578 HG22 ' HA ' ' A' ' 62' ' ' PRO . 39.0 pt -87.36 151.18 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.094 -0.642 . . . . 1.09 110.473 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 80.5 p -90.42 177.43 6.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.192 -0.458 . . . . 1.84 110.613 -176.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.15 -16.78 67.21 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.695 -0.764 . . . . 0.33 112.088 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -69.65 -59.37 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.049 0.452 . . . . 1.05 110.381 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -43.64 98.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.733 . . . . 1.79 110.162 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.54 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.65 -47.32 86.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.075 -0.966 . . . . 1.02 111.35 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.27 -34.59 76.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.157 -0.312 . . . . 1.83 110.157 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.2 mtpt -58.04 -46.92 84.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 2.96 110.502 174.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -64.11 -44.72 91.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.885 -0.598 . . . . 2.16 110.254 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.595 ' HB3' HD23 ' A' ' 86' ' ' LEU . 94.5 mtp -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.589 . . . . 1.27 112.209 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.21 -24.82 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.944 -0.703 . . . . 1.99 110.664 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -75.5 -12.03 60.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.71 110.476 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -72.86 -14.93 61.6 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.49 -0.559 . . . . 1.25 109.49 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 68.25 29.96 5.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.133 -0.939 . . . . 3.08 111.455 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.423 ' HB2' HD21 ' A' ' 86' ' ' LEU . 80.7 mt -104.56 154.88 38.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.537 -0.301 . . . . 1.94 110.651 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.489 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 40.4 Cg_endo -68.37 155.59 68.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.843 2.362 . . . . 0.59 112.558 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -66.06 -25.18 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.486 -0.325 . . . . 2.32 111.283 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.3 m -63.35 -52.69 60.71 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.937 0.399 . . . . 1.77 110.675 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 89' ' ' ILE . 84.8 t -62.76 -46.08 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.09 -0.505 . . . . 1.13 109.806 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.595 HD23 ' HB3' ' A' ' 76' ' ' MET . 83.0 mt -59.94 -37.7 80.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 1.26 111.4 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.12 87.94 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.25 112.685 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 20.5 ptmt -66.54 -33.27 75.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.494 -0.482 . . . . 2.34 109.789 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.635 HG13 ' O ' ' A' ' 85' ' ' VAL . 83.8 mt -57.47 -50.04 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.722 -0.473 . . . . 1.15 109.722 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 34.1 t-105 -58.89 -49.92 75.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.545 -0.752 . . . . 0.57 111.133 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.515 ' HB3' ' HZ2' ' A' ' 91' ' ' LYS . 8.0 mtpm? -65.41 -20.27 66.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.184 0.438 . . . . 3.03 112.184 -174.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.662 HD13 ' HA ' ' A' ' 124' ' ' ALA . 29.7 mt -93.58 -35.63 12.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.863 0.363 . . . . 1.75 111.384 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.57 -16.39 36.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.054 -0.521 . . . . 1.0 112.058 -172.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.631 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 40.3 t0 -79.13 80.56 5.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.692 0.758 . . . . 0.45 109.83 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.496 HG22 ' HG2' ' A' ' 132' ' ' PRO . 96.2 t -58.78 -44.55 90.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.583 -1.189 . . . . 1.79 112.207 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.425 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 33.8 m-20 -70.63 -24.52 62.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.399 -0.364 . . . . 1.64 110.089 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 57.12 51.48 10.31 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.608 -0.886 . . . . 2.31 108.608 -169.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.631 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 18.2 p-10 -125.5 8.4 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.928 -1.033 . . . . 0.78 112.146 -167.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.82 -0.13 62.65 Favored Glycine 0 CA--C 1.507 -0.406 0 C-N-CA 120.441 -0.885 . . . . 0.5 112.785 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.611 ' CB ' ' HD3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -118.83 163.49 16.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.012 -0.736 . . . . 2.0 109.012 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 mt -115.69 110.02 18.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.423 -0.584 . . . . 1.06 109.423 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -76.43 -173.95 2.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.559 -0.746 . . . . 1.39 109.274 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -55.85 -44.91 78.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.694 -0.685 . . . . 1.69 111.239 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -81.63 -31.25 32.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.638 -0.71 . . . . 2.29 110.743 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.59 -47.43 66.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.39 110.338 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -65.92 -35.1 79.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.35 109.942 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.44 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -57.3 -49.79 74.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.002 -0.544 . . . . 1.1 110.693 174.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.472 ' HG ' ' HZ2' ' A' ' 44' ' ' TRP . 12.9 mt -60.5 -43.95 96.5 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.59 -0.277 . . . . 2.42 111.509 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.419 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.34 -56.74 17.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 1.08 111.238 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -33.68 73.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.91 111.28 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.605 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.8 t60 -62.86 -50.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.929 -0.578 . . . . 0.93 110.733 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.615 HD11 HG21 ' A' ' 89' ' ' ILE . 49.2 mt -63.17 -36.83 84.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.673 0.273 . . . . 1.06 110.447 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 109' ' ' ALA . 89.7 mt -56.95 -48.53 81.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.117 -0.492 . . . . 1.27 110.644 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.638 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 34.6 pttt -74.6 -24.1 58.82 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 120.678 -0.409 . . . . 2.57 110.879 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 111' ' ' HIS . 76.6 t -62.25 -39.71 85.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.498 -0.556 . . . . 1.64 109.498 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.871 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 2.4 mmmp? -67.19 -37.45 83.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 1.69 109.957 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -64.68 -38.69 91.85 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 2.3 110.161 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.638 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 7.1 mm-40 -66.98 -9.0 34.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.152 -0.476 . . . . 2.05 110.55 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.82 35.19 5.69 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.961 -0.638 . . . . 0.68 112.417 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.493 ' HB2' HG11 ' A' ' 115' ' ' VAL . 99.5 m-70 -121.78 -176.98 3.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 1.32 111.283 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -124.7 160.61 28.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 2.69 109.805 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.871 ' HG ' ' HD3' ' A' ' 116' ' ' LYS . 26.6 mt -104.51 115.33 62.99 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.252 -0.647 . . . . 1.74 109.252 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.09 2.88 7.91 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.256 2.637 . . . . 1.47 113.333 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.662 ' HA ' HD13 ' A' ' 92' ' ' LEU . . . 63.81 19.22 11.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.935 -0.575 . . . . 1.78 111.243 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -111.24 147.11 35.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.874 -0.603 . . . . 1.93 109.788 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.458 ' HG ' ' HB ' ' A' ' 131' ' ' VAL . 17.0 tp -125.05 94.23 44.19 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.325 -0.398 . . . . 2.5 110.382 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 25.7 Cg_exo -62.94 152.07 81.16 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.194 2.596 . . . . 1.12 112.11 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.09 -26.9 43.59 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.371 2.714 . . . . 1.24 113.822 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -99.85 5.84 45.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.781 -0.368 . . . . 1.23 111.129 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.455 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 3.8 mm? -101.99 -28.67 12.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.704 -0.48 . . . . 1.88 109.704 171.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.458 ' HB ' ' HG ' ' A' ' 126' ' ' LEU . 7.6 p -92.81 132.76 30.44 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.653 -0.703 . . . . 2.17 109.937 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.496 ' HG2' HG22 ' A' ' 95' ' ' VAL . 76.4 Cg_exo -49.2 135.19 31.02 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.525 2.15 . . . . 1.66 111.58 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.66 2.21 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.155 2.57 . . . . 2.34 113.196 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 m -80.81 -1.63 43.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.443 -0.344 . . . . 2.7 111.381 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -106.17 15.47 26.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 3.61 110.951 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -100.41 134.97 42.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.319 -0.4 . . . . 4.47 111.243 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -90.2 173.61 8.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.915 -0.584 . . . . 5.59 110.391 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.13 99.06 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.792 0.329 . . . . 7.32 110.222 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.691 -0.671 . . . . 6.66 109.328 176.906 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 109.978 -0.378 . . . . 11.14 109.978 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -78.8 92.23 4.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.593 0.235 . . . . 8.71 110.942 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.46 ' HD1' ' H ' ' B' ' 147' ' ' SER . 36.2 p90 43.41 -164.76 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.422 1.089 . . . . 7.77 113.285 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -155.89 20.73 0.38 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.83 -0.623 . . . . 5.92 109.84 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.46 ' H ' ' HD1' ' B' ' 145' ' ' TYR . 4.0 m -92.61 121.36 33.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.528 -0.76 . . . . 4.46 111.945 -170.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.1 t -140.38 13.0 2.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.712 -0.848 . . . . 2.55 108.712 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.52 150.99 49.95 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.991 -1.004 . . . . 1.41 111.327 -172.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.71 0.15 5.27 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 123.527 2.818 . . . . 0.79 113.892 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.35 -45.51 6.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 0.56 111.038 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 70.1 p -89.65 25.28 2.06 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.181 0.438 . . . . 1.89 112.181 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.3 1.49 47.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.443 -0.344 . . . . 3.32 111.537 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 35.4 mttp . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.197 -0.906 . . . . 7.37 111.16 -179.35 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.631 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 112.156 -0.378 . . . . 10.82 112.156 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -95.0 16.14 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.478 2.786 . . . . 11.16 113.46 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 tp -123.0 -44.28 2.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.921 0.391 . . . . 9.47 111.193 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.58 156.07 15.84 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.458 -0.877 . . . . 6.48 112.315 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 p -89.13 177.94 6.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.775 0.322 . . . . 5.98 110.921 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -100.45 134.57 43.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.374 0.607 . . . . 3.92 110.942 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -106.94 122.11 45.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.396 -0.82 . . . . 4.94 109.838 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 p -107.47 146.17 13.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 120.876 0.37 . . . . 2.63 111.045 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.06 130.7 40.89 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.274 -0.639 . . . . 2.4 109.274 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.472 ' CZ3' ' HG3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -77.95 112.66 15.08 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.33 -0.619 . . . . 1.16 109.33 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.65 -36.67 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 1.94 110.75 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.409 HG22 HD22 ' A' ' 108' ' ' LEU . 39.6 t -76.94 -17.44 14.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.744 -0.662 . . . . 1.14 110.496 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -66.21 -14.86 62.35 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.78 112.989 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -73.77 -25.55 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 3.71 109.912 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -131.1 33.23 4.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.714 0.768 . . . . 2.39 109.342 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.509 ' HB2' ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -79.46 -46.38 1.59 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.338 -0.846 . . . . 1.9 111.304 -177.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.62 -24.66 37.9 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.418 2.079 . . . . 0.99 112.715 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -46.69 64.21 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.447 0.641 . . . . 1.03 110.204 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.413 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.1 m-85 -75.1 -21.99 58.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 1.15 109.329 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.61 -38.85 64.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.422 -0.808 . . . . 0.73 109.16 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -54.02 -52.69 60.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.29 -0.868 . . . . 1.86 109.591 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.455 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.4 mt -62.3 -41.48 91.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.658 -0.701 . . . . 1.11 110.766 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -52.47 -42.82 64.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.616 -0.72 . . . . 0.5 111.476 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.712 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 4.7 m-85 -83.18 -22.44 33.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.935 0.346 . . . . 1.23 111.935 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.08 -7.62 58.29 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.546 -0.462 . . . . 1.3 111.161 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.569 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.1 mt -102.73 15.47 29.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 1.79 110.877 -177.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m 61.19 78.4 0.32 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.51 111.127 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.712 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 94.2 Cg_endo -85.75 119.44 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.532 2.155 . . . . 1.1 112.241 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.57 132.86 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.93 -0.396 . . . . 2.4 109.93 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 p30 48.39 25.37 0.88 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.926 0.89 . . . . 2.02 112.604 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.86 15.24 78.02 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.981 -0.628 . . . . 0.9 113.449 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.664 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 10.0 ttmm -141.54 126.26 18.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.543 -0.539 . . . . 1.52 109.543 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.53 HG22 ' HA ' ' A' ' 62' ' ' PRO . 44.7 pt -94.04 146.06 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 121.709 -0.619 . . . . 1.09 111.191 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.769 ' HA ' HD22 ' A' ' 100' ' ' LEU . 9.7 t -76.74 157.69 31.5 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.001 -0.545 . . . . 1.84 110.115 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -16.84 38.46 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.156 -0.929 . . . . 0.33 114.232 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.426 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -61.83 -52.97 61.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.377 0.588 . . . . 1.05 110.903 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.569 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 18.6 m-80 -65.81 -43.21 89.36 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.101 0.477 . . . . 1.79 110.07 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.71 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.19 -49.19 78.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.297 -0.865 . . . . 1.02 110.792 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.705 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 84.0 tttt -61.56 -40.37 94.49 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.25 -0.432 . . . . 1.83 110.391 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.639 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.8 mtpt -64.8 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.927 -0.579 . . . . 2.96 111.6 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -70.67 -41.96 71.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.838 0.828 . . . . 2.16 109.465 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.763 ' HB3' HD21 ' A' ' 86' ' ' LEU . 69.7 mtp -65.86 -31.47 72.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.139 -0.937 . . . . 1.27 111.222 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 74' ' ' LYS . 4.4 p -76.51 -27.5 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.599 -0.441 . . . . 1.99 110.759 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.639 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 84.2 mttt -64.02 -28.14 69.59 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.299 -0.56 . . . . 2.71 110.11 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 15.2 m -66.8 -26.78 67.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.562 -0.745 . . . . 1.25 111.071 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 79' ' ' SER . 95.8 mttt 71.74 22.45 3.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.861 -0.609 . . . . 3.08 112.213 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -86.03 158.38 55.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.111 -0.7 . . . . 1.94 109.111 172.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.516 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 2.0 Cg_endo -76.05 160.9 36.31 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.434 2.09 . . . . 0.59 111.705 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -62.63 -23.04 66.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 2.32 110.253 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -58.82 -53.67 55.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.725 -0.671 . . . . 1.77 110.217 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 89' ' ' ILE . 54.4 t -72.65 -42.72 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 1.13 110.373 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.763 HD21 ' HB3' ' A' ' 76' ' ' MET . 67.3 mt -60.12 -39.26 85.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 1.26 110.489 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.95 79.72 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.856 -0.687 . . . . 0.25 111.859 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -51.49 -51.4 55.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.755 0.312 . . . . 2.34 110.735 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.7 mt -62.36 -49.08 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.615 -0.721 . . . . 1.15 110.748 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.447 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 51.3 t-105 -57.79 -50.29 73.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.235 -0.439 . . . . 0.57 111.764 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -81.08 -14.7 57.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.57 -0.452 . . . . 3.03 112.005 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.732 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -94.69 -27.39 15.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.926 0.393 . . . . 1.75 110.26 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.17 -42.33 12.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.157 -0.474 . . . . 1.0 111.609 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.642 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.0 t70 -77.52 71.78 4.02 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.589 -0.893 . . . . 0.45 108.589 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.68 -22.74 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.033 -0.985 . . . . 1.79 110.706 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.12 -23.66 51.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.69 -0.686 . . . . 1.64 109.936 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.4 mttt 57.78 49.25 12.48 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.173 -0.921 . . . . 2.31 111.483 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.668 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.6 p-10 -117.26 9.25 13.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.282 -0.872 . . . . 0.78 110.743 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.12 17.64 66.02 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.233 -0.747 . . . . 0.5 111.233 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.769 HD22 ' HA ' ' A' ' 68' ' ' THR . 33.2 mt -139.24 140.58 37.75 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.353 -0.924 . . . . 2.0 109.309 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.3 mt -110.43 114.95 28.78 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.022 0.439 . . . . 1.06 111.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.98 170.71 9.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.308 -0.997 . . . . 1.39 108.308 165.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.72 -27.27 69.15 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.558 . . . . 1.69 110.035 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.27 -52.74 44.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.391 0.615 . . . . 2.29 110.625 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.65 -35.36 77.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.39 110.898 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.72 -32.23 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.35 110.204 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.413 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -64.64 -44.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.679 -0.692 . . . . 1.1 110.212 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 95.4 mt -58.23 -47.46 83.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 2.42 110.365 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.462 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -53.54 -56.56 16.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.006 -0.543 . . . . 1.08 111.42 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -63.46 -35.65 81.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.91 111.53 -176.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.25 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.93 110.557 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 115' ' ' VAL . 86.8 mt -76.31 -30.5 57.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 1.06 111.042 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 109' ' ' ALA . 82.7 mt -75.53 -41.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.061 -1.088 . . . . 1.27 108.061 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.567 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 29.9 ttmt -68.12 -40.71 82.45 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.056 -1.429 . . . . 2.57 110.718 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.522 HG22 ' HB2' ' A' ' 120' ' ' HIS . 2.0 p -64.54 -37.55 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.115 -0.328 . . . . 1.64 110.115 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 28.7 mmmt -66.97 -42.74 84.62 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.73 -0.213 . . . . 1.69 110.513 173.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.89 -37.9 86.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 2.3 111.23 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.567 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 31.4 mm-40 -71.73 -5.02 30.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 2.05 111.239 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.11 36.23 6.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 0.68 112.584 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.538 ' HD2' ' HB2' ' A' ' 118' ' ' GLU . 63.8 m-70 -118.44 170.34 9.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.59 -0.522 . . . . 1.32 109.59 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -115.48 132.65 56.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.948 0.404 . . . . 2.69 111.319 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.529 HD13 ' O ' ' A' ' 122' ' ' LEU . 1.7 pp -95.27 139.37 21.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.519 -0.549 . . . . 1.74 109.519 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.89 11.62 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.633 2.222 . . . . 1.47 113.348 -175.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.732 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 58.74 28.8 17.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.228 0.537 . . . . 1.78 110.419 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -130.51 164.84 23.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.551 -0.75 . . . . 1.93 109.79 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.748 HD13 ' HB ' ' A' ' 131' ' ' VAL . 0.2 OUTLIER -125.37 88.66 53.84 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 109.514 -0.551 . . . . 2.5 109.514 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.528 ' HB2' HD22 ' A' ' 130' ' ' LEU . 55.2 Cg_exo -52.54 150.49 21.15 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.786 2.99 . . . . 1.12 113.586 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -52.98 -30.32 48.13 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.386 2.724 . . . . 1.24 113.82 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -94.47 9.05 39.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.206 -0.597 . . . . 1.23 111.309 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.528 HD22 ' HB2' ' A' ' 127' ' ' PRO . 3.8 mm? -110.05 -27.55 9.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 1.88 110.742 171.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.748 ' HB ' HD13 ' A' ' 126' ' ' LEU . 3.4 p -82.3 118.56 72.37 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-O 121.509 0.671 . . . . 2.17 111.759 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.6 177.93 6.88 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.074 2.516 . . . . 1.66 112.089 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.835 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 21.5 Cg_exo -66.13 -3.7 9.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.922 2.415 . . . . 2.34 113.051 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.59 -29.36 69.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.87 -0.604 . . . . 2.7 112.006 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.404 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 42.0 tptt -120.04 1.6 10.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.345 0.498 . . . . 3.61 112.345 -175.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.835 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 18.1 ptp180 -99.26 143.06 29.95 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.882 -0.511 . . . . 4.47 110.343 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -58.89 135.79 57.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.991 0.424 . . . . 5.59 111.325 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -106.38 124.22 49.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.096 -0.502 . . . . 7.32 109.651 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.246 0.917 0 N-CA-C 109.581 -0.525 . . . . 6.66 109.581 173.687 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 110.33 -0.248 . . . . 11.14 110.33 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -56.27 -74.22 0.05 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.81 0.693 . . . . 8.71 112.319 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.46 99.6 5.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 122.154 0.978 . . . . 7.77 111.743 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -101.75 75.45 1.56 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.936 -1.135 . . . . 5.92 107.936 170.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 71.1 m -78.6 66.38 4.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.458 -0.792 . . . . 4.46 112.945 -169.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 6.2 p -112.86 18.4 18.21 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.777 -0.823 . . . . 2.55 108.777 167.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -104.99 140.44 21.08 Favored Pre-proline 0 C--O 1.235 0.328 0 CA-C-N 114.974 -1.012 . . . . 1.41 110.5 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.705 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 61.5 Cg_endo -72.07 0.4 7.3 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 123.445 2.763 . . . . 0.79 113.763 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.647 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 36.3 m-85 -95.74 -30.1 13.9 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.16 -0.338 . . . . 0.56 111.256 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 20.5 p -81.74 102.09 10.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 1.89 112.277 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 76.3 -36.11 0.27 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.016 0.926 . . . . 3.32 113.134 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.425 ' N ' ' HD3' ' B' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.233 -0.889 . . . . 7.37 111.067 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.648 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 111.494 -0.643 . . . . 10.82 111.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.97 112.65 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.6 2.2 . . . . 11.16 111.578 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.1 mt 63.96 81.6 0.2 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 123.912 0.757 . . . . 9.47 110.833 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.54 -158.54 31.29 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.846 -0.692 . . . . 6.48 112.142 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -76.17 166.68 23.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.124 0.488 . . . . 5.98 110.985 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -83.62 108.84 16.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 3.92 110.419 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -87.72 135.21 33.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.896 -0.409 . . . . 4.94 109.896 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.71 127.83 74.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.197 0.522 . . . . 2.63 111.503 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 129' ' ' HIS . 59.2 mm-40 -83.34 85.17 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.686 -0.688 . . . . 2.4 110.673 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -80.81 95.7 6.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.843 -0.799 . . . . 1.16 108.843 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -62.68 -17.22 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.726 -0.67 . . . . 1.94 112.678 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 t -73.22 -26.8 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.87 0.367 . . . . 1.14 110.697 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.04 9.58 52.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.139 -0.553 . . . . 0.78 112.91 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -86.54 -25.65 24.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.749 0.309 . . . . 3.71 111.062 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.44 36.26 1.33 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 2.39 110.152 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.498 ' HA ' ' HD2' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -65.16 -43.49 66.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.095 -0.957 . . . . 1.9 112.121 -174.208 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.425 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 73.2 Cg_exo -52.68 -22.46 17.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.448 2.099 . . . . 0.99 114.197 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 m -72.65 -47.04 50.77 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.231 0.539 . . . . 1.03 110.231 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.498 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 8.5 m-85 -71.74 -22.5 61.61 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.529 -0.915 . . . . 1.15 108.529 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.484 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 15.0 t70 -69.4 -41.29 76.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.788 -1.096 . . . . 0.73 109.801 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.26 -53.8 53.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.987 -0.551 . . . . 1.86 109.594 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.475 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.6 mt -54.47 -43.21 62.76 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 CA-C-N 115.851 -0.613 . . . . 1.11 109.979 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 73.4 t80 -55.15 -55.05 35.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.482 -0.781 . . . . 0.5 111.55 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.577 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 38.4 m-85 -71.57 -21.18 61.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.217 0.451 . . . . 1.23 112.217 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -82.92 0.86 42.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.759 -0.376 . . . . 1.3 111.046 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 81.9 mt -104.67 6.38 34.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.79 110.372 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m 66.34 86.84 0.13 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.308 -0.86 . . . . 1.51 111.569 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.577 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -83.28 117.81 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.11 2.54 . . . . 1.1 112.192 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.5 t -90.15 118.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 2.4 109.586 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 63.19 23.23 13.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.808 -0.633 . . . . 2.02 110.711 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.87 12.55 66.09 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.872 -0.68 . . . . 0.9 113.05 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.633 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 11.4 ttmt -138.43 142.92 39.5 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.798 -0.445 . . . . 1.52 109.798 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.597 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 49.8 pt -100.32 153.11 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 1.09 111.097 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.634 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 15.5 p -88.74 160.89 17.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.48 -0.782 . . . . 1.84 110.938 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.24 -8.65 31.72 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.649 -0.786 . . . . 0.33 113.172 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.12 -58.17 5.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.914 0.388 . . . . 1.05 110.996 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.597 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.0 OUTLIER -74.76 -31.27 61.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.376 -0.374 . . . . 1.79 110.587 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.543 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.2 -50.99 70.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 1.02 110.112 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -64.09 -33.07 74.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.197 -0.456 . . . . 1.83 110.137 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.55 -45.11 85.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 2.96 110.168 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.7 -51.76 67.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.979 -0.749 . . . . 2.16 108.979 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.684 ' HB3' HD23 ' A' ' 86' ' ' LEU . 77.8 mtp -60.48 -32.1 71.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.542 -0.754 . . . . 1.27 112.335 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -81.72 -20.46 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 O-C-N 121.927 -0.483 . . . . 1.99 110.811 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.54 -23.66 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.135 -0.32 . . . . 2.71 110.135 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -64.41 -23.4 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 1.25 110.083 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 67.95 33.41 4.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.447 -0.797 . . . . 3.08 111.531 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.477 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.7 mt -96.76 158.56 33.35 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.021 -0.536 . . . . 1.94 109.661 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.457 ' HG2' HG23 ' A' ' 85' ' ' VAL . 38.3 Cg_endo -68.52 146.83 69.2 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.358 2.039 . . . . 0.59 112.229 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -58.72 -29.46 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.933 -0.576 . . . . 2.32 111.723 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.42 -52.93 63.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 1.77 110.375 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' HG13 ' A' ' 89' ' ' ILE . 75.6 t -68.04 -42.02 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.56 -0.745 . . . . 1.13 110.169 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.684 HD23 ' HB3' ' A' ' 76' ' ' MET . 83.9 mt -58.46 -46.63 86.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 1.26 111.458 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.449 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -63.32 -41.85 99.37 Favored Glycine 0 C--O 1.235 0.205 0 C-N-CA 120.827 -0.701 . . . . 0.25 111.483 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.586 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 39.9 ttmt -56.64 -46.77 80.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.219 -0.491 . . . . 2.34 110.298 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 85' ' ' VAL . 77.0 mt -63.02 -40.81 90.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 1.15 110.884 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 45.0 t-105 -61.85 -51.67 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.614 -0.266 . . . . 0.57 110.512 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.05 -21.14 66.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.427 -0.351 . . . . 3.03 111.799 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 77.7 mt -85.51 -54.02 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.947 0.403 . . . . 1.75 111.135 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.15 -34.07 72.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.31 -0.859 . . . . 1.0 111.711 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.61 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.0 t0 -87.58 93.24 9.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.363 0.601 . . . . 0.45 109.836 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.629 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 2.7 m -74.12 -29.94 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 1.79 111.843 -174.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.61 -25.39 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.034 -0.53 . . . . 1.64 109.985 -178.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.4 mttt 60.15 32.15 20.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.892 -1.049 . . . . 2.31 108.541 -171.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.511 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.4 p-10 -94.69 10.19 35.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.663 -1.153 . . . . 0.78 110.983 -172.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.16 20.58 62.99 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.369 -0.693 . . . . 0.5 111.369 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.634 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 14.9 mt -141.52 145.51 35.25 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.84 -0.68 . . . . 2.0 110.028 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.0 mt -115.56 118.18 32.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.866 0.365 . . . . 1.06 111.103 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.14 174.42 5.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.41 -0.959 . . . . 1.39 108.41 168.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -63.35 -32.62 74.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.959 -0.386 . . . . 1.69 109.959 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.98 -50.72 54.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 2.29 110.432 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.54 -44.15 97.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.39 110.69 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -69.82 -25.09 63.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.35 111.081 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.77 31.93 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.599 -0.889 . . . . 1.1 108.599 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.1 -36.5 79.88 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.347 -1.297 . . . . 2.42 110.057 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.46 33.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 1.08 110.712 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -59.51 -30.71 68.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.349 -0.387 . . . . 0.91 110.568 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.415 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 32.2 t60 -69.01 -39.17 79.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.93 110.552 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.658 ' O ' HG11 ' A' ' 115' ' ' VAL . 95.5 mt -71.66 -40.77 69.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.257 0.551 . . . . 1.06 110.318 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.583 HD12 ' HG2' ' A' ' 76' ' ' MET . 84.2 mt -58.29 -51.27 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 1.27 110.722 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.8 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 12.0 ptmm? -75.67 -24.34 56.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.58 -0.448 . . . . 2.57 111.121 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.658 HG11 ' O ' ' A' ' 112' ' ' LEU . 1.4 p -66.46 -34.28 69.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 120.024 -0.67 . . . . 1.64 109.246 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.408 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 27.8 mmmt -66.94 -43.67 82.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.25 -0.432 . . . . 1.69 110.001 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.25 -38.73 80.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 2.3 111.894 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.8 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 3.7 mm-40 -73.86 -7.15 51.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.695 -0.229 . . . . 2.05 110.825 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.46 10.48 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.518 -0.849 . . . . 0.68 113.123 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.498 ' HB2' HG22 ' A' ' 115' ' ' VAL . 90.9 m-70 -105.84 172.96 6.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.885 0.374 . . . . 1.32 110.315 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.408 ' CD ' ' HZ3' ' A' ' 116' ' ' LYS . 7.4 tp10 -124.67 134.56 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.377 -0.601 . . . . 2.69 109.377 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.19 140.77 28.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.915 0.388 . . . . 1.74 110.26 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.47 1.23 7.65 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.387 2.724 . . . . 1.47 113.652 -172.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.14 22.72 12.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.164 0.507 . . . . 1.78 110.864 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.47 171.99 12.38 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.241 -0.651 . . . . 1.93 109.241 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.422 ' CD2' ' HB3' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -125.61 89.07 53.18 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.834 0.349 . . . . 2.5 110.603 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 32.5 Cg_endo -66.34 155.96 67.44 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.952 2.435 . . . . 1.12 111.865 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.3 -34.19 39.51 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.599 2.866 . . . . 1.24 114.298 -176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.446 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 37.6 p-80 -88.32 14.4 9.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.612 -0.435 . . . . 1.23 111.931 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.3 mt -129.88 -32.25 1.88 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 1.88 111.185 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.404 ' CA ' HD11 ' A' ' 126' ' ' LEU . 6.1 p -69.92 126.96 92.73 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 121.015 0.436 . . . . 2.17 111.445 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 131' ' ' VAL . 37.9 Cg_exo -61.75 155.23 55.4 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.449 2.766 . . . . 1.66 112.733 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.33 -7.03 14.63 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.398 2.732 . . . . 2.34 113.506 -176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 p -86.63 1.56 51.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.501 -0.318 . . . . 2.7 111.635 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.629 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 20.6 tptp -118.94 17.66 13.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.101 0.477 . . . . 3.61 110.636 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -71.86 151.6 43.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 4.47 111.024 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.47 ' NE ' ' HA ' ' A' ' 137' ' ' ARG . 4.6 mmp_? -98.42 136.6 38.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.261 -0.427 . . . . 5.59 110.326 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -132.46 143.34 49.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.464 -0.334 . . . . 7.32 110.292 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.737 -0.649 . . . . 6.66 109.595 169.998 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.588 0.233 . . . . 11.14 110.619 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -85.26 137.82 32.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 8.71 110.608 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.409 ' CE2' ' HB2' ' B' ' 147' ' ' SER . 3.6 p90 -117.53 0.65 12.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.168 -0.469 . . . . 7.77 110.727 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 63.41 23.43 13.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.456 -0.793 . . . . 5.92 112.854 172.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' SER . . . . . 0.449 ' HB3' ' HA ' ' B' ' 153' ' ' ALA . 69.5 m -81.33 82.87 7.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.332 0.587 . . . . 4.46 110.266 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.6 m -123.87 1.77 8.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.158 -0.928 . . . . 2.55 109.0 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -92.67 156.46 41.02 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 114.683 -1.144 . . . . 1.41 110.872 -177.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_exo -70.86 -2.18 10.56 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.219 2.613 . . . . 0.79 113.48 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.449 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 40.1 m-85 -102.54 -23.31 13.9 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.244 -0.285 . . . . 0.56 111.376 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 t -151.93 116.22 5.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.458 0.647 . . . . 1.89 111.155 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . 0.449 ' HA ' ' HB3' ' B' ' 147' ' ' SER . . . -141.61 113.22 7.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.917 -0.583 . . . . 3.32 110.779 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.776 -0.631 . . . . 7.37 109.676 177.407 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.61 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.016 -0.434 . . . . 10.82 112.016 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.72 121.82 5.22 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.635 2.223 . . . . 11.16 112.109 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.56 -66.72 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.84 -0.618 . . . . 9.47 110.471 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.77 88.91 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.605 -0.807 . . . . 6.48 112.053 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.2 t -154.96 151.97 29.13 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.173 -0.676 . . . . 5.98 109.173 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.08 120.63 23.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 3.92 110.421 176.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.02 109.38 19.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.798 -0.637 . . . . 4.94 109.799 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 t -77.07 138.93 19.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.249 -0.887 . . . . 2.63 110.672 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.03 128.82 37.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.79 -0.641 . . . . 2.4 109.938 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -71.57 113.64 8.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.561 . . . . 1.16 110.031 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.44 -42.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 1.94 111.826 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.02 -5.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.072 -0.513 . . . . 1.14 111.042 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.37 -15.85 75.2 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.248 -1.141 . . . . 0.78 110.248 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -80.28 -29.86 38.3 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.735 -0.733 . . . . 3.71 111.226 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -124.39 34.64 4.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.723 . . . . 2.39 109.824 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.422 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 22.1 ttpp -79.11 -43.98 1.72 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.79 -1.095 . . . . 1.9 112.031 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.422 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 12.4 Cg_exo -39.15 -40.72 1.8 Allowed 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 123.43 2.753 . . . . 0.99 115.015 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.4 m -69.47 -43.96 72.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.995 0.426 . . . . 1.03 110.515 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -71.24 -22.16 62.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.224 -0.658 . . . . 1.15 109.224 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.93 -41.2 71.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.872 . . . . 0.73 109.595 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.71 -45.32 93.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 1.86 109.713 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.527 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 63.9 mt -58.7 -43.52 87.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 1.11 110.454 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -54.38 -38.46 66.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.533 -0.758 . . . . 0.5 111.011 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.572 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 49.1 m-85 -98.83 7.84 45.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.004 0.742 . . . . 1.23 113.004 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 56' ' ' ILE . 2.6 p -109.9 -3.02 16.85 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.791 -0.364 . . . . 1.3 110.935 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 3.8 pp -118.13 18.56 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.398 -0.365 . . . . 1.79 111.343 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 m 74.85 90.82 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.051 -0.977 . . . . 1.51 111.939 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.757 ' HA ' HG22 ' A' ' 67' ' ' ILE . 97.0 Cg_endo -92.95 125.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.947 2.431 . . . . 1.1 111.976 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.21 113.0 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 2.4 109.691 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.0 p30 48.48 26.95 1.28 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.072 0.949 . . . . 2.02 113.029 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 11.34 58.05 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.916 -0.659 . . . . 0.9 113.345 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.613 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 8.6 ttmm -140.46 126.56 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.927 -0.768 . . . . 1.52 108.927 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.757 HG22 ' HA ' ' A' ' 62' ' ' PRO . 36.7 pt -95.97 141.49 15.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.128 -0.629 . . . . 1.09 111.141 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.741 ' HA ' HD23 ' A' ' 100' ' ' LEU . 3.6 t -79.88 158.54 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.711 -0.677 . . . . 1.84 110.75 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.84 -23.14 21.27 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.496 -0.775 . . . . 0.33 113.414 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.19 -55.93 27.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 1.05 111.113 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.5 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 42.2 m-80 -78.25 -28.91 47.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.379 . . . . 1.79 110.634 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.641 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.85 -52.88 61.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 1.02 110.09 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.581 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 86.1 tttt -61.69 -35.43 77.98 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.559 -0.291 . . . . 1.83 110.432 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.5 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 26.2 ttpp -54.39 -46.16 73.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.228 0.537 . . . . 2.96 110.457 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HB2' HD22 ' A' ' 60' ' ' LEU . 13.9 tp10 -67.6 -41.44 84.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 2.16 110.234 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.793 ' HB3' HD21 ' A' ' 86' ' ' LEU . 72.8 mtp -67.66 -28.41 67.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.897 -0.592 . . . . 1.27 112.012 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.51 -16.17 11.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 O-C-N 121.857 -0.527 . . . . 1.99 110.638 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 99.0 mttt -75.59 -22.47 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.254 0.549 . . . . 2.71 109.626 168.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -73.78 -11.99 60.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.691 -0.686 . . . . 1.25 111.331 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt 63.92 37.14 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.153 -0.476 . . . . 3.08 111.697 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.546 ' HB2' HD22 ' A' ' 86' ' ' LEU . 84.1 mt -106.16 153.15 40.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 1.94 110.696 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.451 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 43.7 Cg_endo -67.8 152.65 77.23 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.164 2.576 . . . . 0.59 112.604 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -57.35 -34.63 69.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.863 -0.608 . . . . 2.32 111.942 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.7 m -58.05 -54.13 50.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.14 0.495 . . . . 1.77 111.365 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.41 HG21 ' HG2' ' A' ' 82' ' ' PRO . 60.6 t -67.11 -38.95 82.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 1.13 110.402 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.793 HD21 ' HB3' ' A' ' 76' ' ' MET . 88.9 mt -59.59 -46.61 88.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 1.26 110.795 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.17 -42.6 97.24 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.263 -0.494 . . . . 0.25 112.079 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.471 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 66.5 mttm -55.6 -53.6 54.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.843 0.354 . . . . 2.34 110.279 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.49 -36.71 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 1.15 110.364 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.461 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 74.4 t-105 -61.11 -56.45 20.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.57 111.182 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.71 -0.88 28.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.057 0.392 . . . . 3.03 112.057 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 74.9 mt -94.37 -46.95 6.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.031 0.443 . . . . 1.75 110.523 169.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.538 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -72.05 -36.21 69.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.531 -0.758 . . . . 1.0 111.175 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.4 t0 -86.71 70.42 10.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.896 0.855 . . . . 0.45 109.947 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.647 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 15.8 m -68.7 -15.63 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.542 -1.208 . . . . 1.79 110.826 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -18.27 40.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.724 -1.126 . . . . 1.64 110.171 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 61.58 35.66 17.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.089 -0.96 . . . . 2.31 111.144 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.672 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.3 p-10 -116.64 7.99 13.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.916 -0.584 . . . . 0.78 111.64 -172.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.16 10.53 59.62 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.326 -0.71 . . . . 0.5 111.326 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.741 HD23 ' HA ' ' A' ' 68' ' ' THR . 87.1 mt -133.68 141.19 47.48 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.726 -0.737 . . . . 2.0 109.182 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.1 mt -109.99 113.13 25.59 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.984 0.421 . . . . 1.06 111.022 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.58 172.26 7.65 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.963 -0.754 . . . . 1.39 108.963 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.2 -32.27 72.03 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.825 -0.35 . . . . 1.69 110.701 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -66.35 -51.52 56.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.884 0.374 . . . . 2.29 110.497 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -62.39 -41.5 98.69 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.925 -0.58 . . . . 0.39 110.645 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.404 ' CZ ' HD23 ' A' ' 60' ' ' LEU . 66.3 t80 -70.53 -23.82 62.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.749 -0.659 . . . . 0.35 110.96 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.79 32.89 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.579 -0.897 . . . . 1.1 108.579 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.538 HD23 ' HA ' ' A' ' 93' ' ' ALA . 29.6 tp -59.41 -39.79 84.58 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.627 -1.17 . . . . 2.42 109.772 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -59.07 -55.44 35.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.011 -0.54 . . . . 1.08 111.189 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -33.63 75.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.287 -0.415 . . . . 0.91 111.426 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.413 ' O ' HG23 ' A' ' 115' ' ' VAL . 16.7 t60 -63.5 -44.04 95.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.93 109.932 177.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.71 -39.2 90.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 1.06 110.655 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.2 mt -60.14 -53.51 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.63 . . . . 1.27 111.385 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.465 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 16.0 pttp -70.9 -26.84 63.4 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 120.584 -0.446 . . . . 2.57 110.209 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.662 HG12 ' HB2' ' A' ' 120' ' ' HIS . 2.6 t -56.6 -48.76 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.665 -0.495 . . . . 1.64 109.665 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -62.29 -46.15 90.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.223 -0.444 . . . . 1.69 111.051 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.434 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 8.9 mp -59.36 -38.22 79.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 2.3 111.822 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 12.2 mm-40 -81.92 6.63 15.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.529 -0.305 . . . . 2.05 111.799 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 27.84 27.9 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.915 -0.66 . . . . 0.68 112.913 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.662 ' HB2' HG12 ' A' ' 115' ' ' VAL . 90.6 m-70 -109.69 119.59 39.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.776 -0.453 . . . . 1.32 109.776 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -83.25 106.37 14.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.995 0.426 . . . . 2.69 110.845 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 122' ' ' LEU . 3.1 pp -68.66 146.98 97.95 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 1.74 110.34 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.5 Cg_endo -83.21 -1.86 10.47 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.911 2.408 . . . . 1.47 112.671 -173.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.83 19.24 11.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.774 -0.648 . . . . 1.78 111.322 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -115.63 165.99 12.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.142 -1.058 . . . . 1.93 108.142 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 29.0 tp -118.34 95.35 48.48 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 120.481 -0.487 . . . . 2.5 110.628 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.406 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 18.1 Cg_endo -61.66 150.37 85.89 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.767 2.312 . . . . 1.12 112.255 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 52.0 Cg_exo -55.74 -25.44 51.37 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.713 2.942 . . . . 1.24 113.578 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -86.27 3.92 41.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.68 0.252 . . . . 1.23 111.68 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.7 mt -116.55 -30.67 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.352 -0.217 . . . . 1.88 111.486 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -76.39 127.4 84.76 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.762 0.315 . . . . 2.17 110.768 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.26 136.59 5.54 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.425 2.75 . . . . 1.66 112.944 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.31 -16.15 52.72 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.757 2.305 . . . . 2.34 112.346 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.9 m -84.3 -8.73 58.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.654 . . . . 2.7 111.203 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.647 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 7.3 tppt? -118.08 10.31 12.96 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.051 0.453 . . . . 3.61 111.066 -176.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.36 144.85 38.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 4.47 110.221 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -128.22 132.23 48.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.217 0.532 . . . . 5.59 111.671 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -132.26 121.3 23.38 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.774 -0.824 . . . . 7.32 108.774 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 . . . . . 0 C--O 1.245 0.82 0 N-CA-C 108.448 -0.945 . . . . 6.66 108.448 -178.164 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.479 1.025 0 CA-C-O 120.72 0.295 . . . . 11.14 110.305 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -161.09 -172.9 3.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.213 -0.449 . . . . 8.71 110.111 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -130.65 151.48 51.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.214 -0.448 . . . . 7.77 110.09 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -73.03 127.43 32.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.156 0.503 . . . . 5.92 110.903 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 35.1 t -138.92 7.39 2.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.416 -0.811 . . . . 4.46 109.497 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 3.3 m -87.79 -36.84 17.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.75 -0.659 . . . . 2.55 110.155 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -106.7 112.39 63.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.423 -0.808 . . . . 1.41 110.121 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.581 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.8 Cg_exo -76.51 -2.35 12.55 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.566 2.844 . . . . 0.79 113.488 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.471 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 15.4 m-85 -98.18 -9.68 25.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.188 0.518 . . . . 0.56 110.077 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 66.2 p -68.59 -7.17 30.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 1.89 111.138 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.4 4.03 33.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.599 . . . . 3.32 111.571 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . 0.442 ' HD2' ' N ' ' B' ' 154' ' ' LYS . 10.8 mptt . . . . . 0 C--O 1.247 0.961 0 O-C-N 123.732 0.645 . . . . 7.37 111.138 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.629 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.855 0 N-CA-C 112.111 -0.396 . . . . 10.82 112.111 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.57 -19.85 41.79 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.971 2.447 . . . . 11.16 112.232 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 tp 72.19 119.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.956 0.785 . . . . 9.47 111.043 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.99 -174.73 13.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.676 -0.773 . . . . 6.48 112.169 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.5 t 63.34 42.54 6.79 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.061 0.458 . . . . 5.98 110.798 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.08 112.18 23.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 3.92 110.025 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.78 116.99 10.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 4.94 111.532 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.7 p -88.64 129.81 39.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.808 -0.633 . . . . 2.63 109.588 173.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -105.35 108.1 19.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.254 0.549 . . . . 2.4 110.692 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -81.38 102.55 10.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.937 -0.574 . . . . 1.16 109.553 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.76 -23.09 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.427 -0.806 . . . . 1.94 112.625 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG23 HD23 ' A' ' 108' ' ' LEU . 21.2 t -82.27 -10.72 12.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.07 0.462 . . . . 1.14 110.708 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.09 -23.83 69.92 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.118 -0.563 . . . . 0.78 113.176 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -73.89 -23.38 59.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.913 0.387 . . . . 3.71 111.549 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -134.13 32.95 3.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.965 0.888 . . . . 2.39 109.648 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 11.3 ttpp -82.99 -44.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.232 -0.895 . . . . 1.9 110.841 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 50' ' ' LYS . 84.6 Cg_exo -49.37 -28.0 14.67 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.533 2.155 . . . . 0.99 113.574 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 m -69.28 -47.08 65.62 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.349 0.595 . . . . 1.03 109.987 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -75.85 -20.63 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.723 -0.843 . . . . 1.15 108.723 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -70.03 -42.04 73.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.885 -1.052 . . . . 0.73 109.431 178.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.31 -41.01 97.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.62 . . . . 1.86 109.808 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.3 -34.78 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.395 0.616 . . . . 1.11 110.283 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.94 -48.13 83.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.228 -0.896 . . . . 0.5 111.021 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.465 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 64.9 m-85 -73.81 -22.49 59.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.039 0.385 . . . . 1.23 112.039 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -85.24 1.73 46.95 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.508 -0.477 . . . . 1.3 111.16 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.9 mt -106.42 3.29 27.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.79 110.473 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.3 m 67.08 80.98 0.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.47 -0.786 . . . . 1.51 111.068 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.465 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 83.3 Cg_endo -88.63 111.23 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.804 2.336 . . . . 1.1 112.567 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.07 121.9 39.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.139 -0.482 . . . . 2.4 109.971 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.29 23.59 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.48 0.488 . . . . 2.02 110.846 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.58 22.79 59.49 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.9 112.528 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -137.71 142.14 41.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.625 0.25 . . . . 1.52 110.487 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.652 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 42.9 pt -104.78 132.83 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.215 -0.661 . . . . 1.09 109.215 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -73.39 162.42 29.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.119 -0.491 . . . . 1.84 109.841 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.461 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -63.08 -11.54 39.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.967 -0.635 . . . . 0.33 114.08 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.73 -63.25 1.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.489 0.644 . . . . 1.05 111.006 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.652 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 2.7 p30 -71.73 -29.42 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 1.79 110.9 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.14 -51.05 70.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.337 -0.392 . . . . 1.02 110.502 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -61.78 -34.74 76.43 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.938 -0.393 . . . . 1.83 109.938 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.553 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 36.1 ttmt -57.87 -45.8 85.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 2.96 110.994 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.842 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -65.87 -36.37 83.24 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.286 0.565 . . . . 2.16 110.007 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.53 ' HB3' HD22 ' A' ' 86' ' ' LEU . 90.7 mtp -67.75 -34.29 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 1.27 111.36 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.2 m -81.49 -15.38 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.872 -0.331 . . . . 1.99 110.822 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.842 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 50.2 mtpt -72.79 -28.95 62.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.922 -0.769 . . . . 2.71 108.922 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.0 m -68.51 -29.73 68.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.963 -1.017 . . . . 1.25 110.306 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 70.6 26.3 4.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.372 -0.831 . . . . 3.08 112.48 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.07 159.87 67.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.269 -0.641 . . . . 1.94 109.269 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.86 142.22 92.64 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.659 2.24 . . . . 0.59 112.32 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.76 -31.05 58.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.859 -0.61 . . . . 2.32 111.763 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p -63.54 -51.33 65.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.947 0.403 . . . . 1.77 111.139 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.53 ' O ' HG13 ' A' ' 89' ' ' ILE . 98.2 t -66.83 -41.5 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 1.13 110.317 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.53 HD22 ' HB3' ' A' ' 76' ' ' MET . 75.2 mt -58.09 -43.07 86.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 1.26 110.797 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' A' ' 91' ' ' LYS . . . -61.03 -43.84 98.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.042 -0.599 . . . . 0.25 111.939 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.569 ' HE3' HD11 ' A' ' 122' ' ' LEU . 53.5 mtmt -57.21 -42.63 81.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.39 . . . . 2.34 110.437 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.0 mt -64.76 -42.21 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.615 . . . . 1.15 109.972 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.506 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 75.2 t-105 -62.09 -51.78 66.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.28 -0.873 . . . . 0.57 111.185 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.443 ' HG2' ' O ' ' A' ' 87' ' ' GLY . 31.0 mmmt -70.14 -18.15 63.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 3.03 111.907 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.842 HD12 ' HA ' ' A' ' 124' ' ' ALA . 92.7 mt -90.71 -45.58 8.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 1.75 111.501 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.91 63.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 1.0 111.301 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.654 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.9 t70 -95.55 95.24 8.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.496 0.665 . . . . 0.45 110.77 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 m -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.095 -0.957 . . . . 1.79 111.806 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.652 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 23.5 m-20 -76.36 -25.28 54.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.121 -0.49 . . . . 1.64 110.837 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttt 62.16 34.29 16.33 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 124.124 0.89 . . . . 2.31 109.434 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -129.64 8.19 5.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.349 -0.387 . . . . 0.78 111.949 -173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.41 12.47 76.94 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.686 -0.768 . . . . 0.5 113.247 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.47 126.98 55.9 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.586 -0.361 . . . . 2.0 110.138 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 36.2 mt -102.93 112.86 25.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 1.06 111.323 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.78 170.12 11.64 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.495 -0.928 . . . . 1.39 108.495 167.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.73 -30.6 71.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.926 0.393 . . . . 1.69 110.67 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.441 ' OE1' ' HD2' ' A' ' 133' ' ' PRO . 16.8 mt-10 -67.26 -46.92 72.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.061 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -65.19 -41.47 94.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.274 -0.875 . . . . 0.39 110.952 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.519 ' CD1' HD12 ' A' ' 67' ' ' ILE . 47.3 t80 -65.84 -33.23 75.37 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.017 -0.538 . . . . 0.35 110.094 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.17 95.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 1.1 110.192 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.412 HD23 HG23 ' A' ' 46' ' ' VAL . 92.0 mt -62.53 -41.68 99.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 2.42 110.633 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.465 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.13 -55.46 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 1.08 111.089 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -37.19 84.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.91 110.913 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.491 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.7 t60 -58.29 -50.06 74.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.416 . . . . 0.93 110.832 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.99 -29.57 70.72 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.883 0.373 . . . . 1.06 111.265 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 109' ' ' ALA . 85.0 mt -75.18 -42.51 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.537 0.684 . . . . 1.27 109.468 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -65.24 -36.12 83.15 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.821 -1.081 . . . . 2.57 110.79 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 111' ' ' HIS . 68.6 t -60.87 -54.2 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.748 0.309 . . . . 1.64 110.455 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.523 ' HG2' HG11 ' A' ' 85' ' ' VAL . 40.7 tptt -55.35 -48.25 74.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.403 -0.362 . . . . 1.69 111.619 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.48 -40.05 81.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 2.3 112.03 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.97 7.78 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.037 0.384 . . . . 2.05 112.037 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.47 35.54 6.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.552 -0.832 . . . . 0.68 112.966 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -121.83 -168.99 1.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.449 -0.442 . . . . 1.32 110.066 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -139.55 150.44 45.08 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.213 -0.662 . . . . 2.69 109.213 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.569 HD11 ' HE3' ' A' ' 88' ' ' LYS . 0.9 OUTLIER -104.01 129.39 25.3 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.667 -0.494 . . . . 1.74 109.667 178.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 6.64 2.19 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.271 2.647 . . . . 1.47 113.832 -169.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.842 ' HA ' HD12 ' A' ' 92' ' ' LEU . . . 58.77 28.67 17.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.389 -0.369 . . . . 1.78 111.416 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -112.34 171.25 7.63 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.043 0.449 . . . . 1.93 110.084 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.523 HD23 HG22 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -124.66 86.67 55.47 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.38 -0.97 . . . . 2.5 108.38 168.545 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -48.68 141.08 21.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.999 2.466 . . . . 1.12 112.126 173.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.24 -31.27 75.61 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.94 2.427 . . . . 1.24 112.664 -177.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -91.51 12.94 19.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.755 -0.378 . . . . 1.23 111.43 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.3 mt -116.49 5.45 13.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 1.88 110.847 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.523 HG22 HD23 ' A' ' 126' ' ' LEU . 56.0 t -85.15 119.59 72.6 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 2.17 111.025 -177.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.41 142.37 90.47 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.101 2.534 . . . . 1.66 112.244 177.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.441 ' HD2' ' OE1' ' A' ' 104' ' ' GLU . 41.6 Cg_endo -67.45 -9.56 25.73 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.286 2.657 . . . . 2.34 113.103 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.1 m -76.97 -1.7 30.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.462 -0.336 . . . . 2.7 111.807 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.448 ' HZ1' ' HA ' ' A' ' 96' ' ' ASP . 32.8 tptt -114.39 13.41 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 3.61 110.292 179.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -71.52 134.2 46.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.101 0.476 . . . . 4.47 112.261 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -121.37 131.39 54.15 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.454 -0.943 . . . . 5.59 108.454 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -63.81 113.07 3.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.107 0.48 . . . . 7.32 111.078 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.072 -0.967 . . . . 6.66 109.806 -177.909 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 60.2 t80 . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.665 -0.495 . . . . 11.14 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -128.63 161.26 30.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.206 -0.452 . . . . 8.71 110.408 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 46.4 p90 46.16 -169.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.621 1.201 . . . . 7.77 112.522 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.61 139.03 33.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.091 -0.504 . . . . 5.92 110.239 -174.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 63.5 p -131.1 77.73 1.8 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.03 0.443 . . . . 4.46 111.207 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 69.1 p -117.42 9.05 13.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.647 0.737 . . . . 2.55 109.051 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 9.5 t70 -111.8 116.6 49.74 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.814 -1.084 . . . . 1.41 110.075 -174.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.9 Cg_exo -74.85 -2.01 11.93 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.471 2.781 . . . . 0.79 113.627 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.514 ' CE1' ' HB3' ' A' ' 86' ' ' LEU . 20.0 m-85 -99.17 -12.86 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.441 . . . . 0.56 110.359 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 77.5 p -86.41 -169.17 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.847 -0.615 . . . . 1.89 110.584 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -129.24 134.84 48.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.416 -0.216 . . . . 3.32 110.416 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 22.9 tptm . . . . . 0 C--O 1.245 0.83 0 CA-C-O 118.515 -0.755 . . . . 7.37 110.556 -174.484 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.654 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.674 -0.57 . . . . 10.82 111.674 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.87 -0.75 9.77 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.694 2.262 . . . . 11.16 113.108 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.7 mt -116.55 113.97 23.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.513 0.197 . . . . 9.47 110.589 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.96 106.22 2.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.642 -0.789 . . . . 6.48 111.958 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.4 t -133.41 119.53 19.76 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.903 -0.406 . . . . 5.98 109.903 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -77.02 93.88 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.353 . . . . 3.92 111.013 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.92 96.02 10.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.706 0.765 . . . . 4.94 109.24 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 31.6 m -76.76 123.25 32.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.433 -0.803 . . . . 2.63 111.484 -175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -91.34 121.67 33.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 2.4 109.639 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.576 ' HZ3' ' HD3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -74.17 101.6 4.01 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.067 -0.716 . . . . 1.16 109.067 178.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.652 HG21 HD22 ' A' ' 130' ' ' LEU . 21.2 m -62.71 -14.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 1.94 112.398 -172.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.498 ' HB ' ' CZ3' ' A' ' 44' ' ' TRP . 15.7 t -90.75 -11.07 9.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.482 . . . . 1.14 110.252 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.553 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -70.39 -10.42 66.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.171 -0.538 . . . . 0.78 112.673 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -75.67 -27.75 58.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.045 0.45 . . . . 3.71 110.435 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.8 34.0 4.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.961 0.886 . . . . 2.39 109.332 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.576 ' HD3' ' HZ3' ' A' ' 44' ' ' TRP . 0.7 OUTLIER -70.17 -52.45 12.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.861 -1.063 . . . . 1.9 111.825 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.09 -24.48 58.43 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.041 1.827 . . . . 0.99 113.667 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -69.07 -45.76 69.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.682 -0.69 . . . . 1.03 109.895 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.472 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 6.7 m-85 -74.18 -21.59 59.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.677 -0.692 . . . . 1.15 109.385 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.73 110.208 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.28 -44.19 95.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.86 110.046 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.472 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 61.0 mt -68.82 -36.79 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 1.11 110.546 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 53' ' ' TYR . 51.8 t80 -59.31 -52.32 66.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.5 110.931 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.641 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 33.5 m-85 -76.81 -11.4 59.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.57 0.582 . . . . 1.23 112.57 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 p -93.5 2.98 56.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 1.3 110.812 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 82.2 mt -101.11 1.32 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.005 -0.543 . . . . 1.79 110.386 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m 69.45 85.07 0.13 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 115.496 -0.775 . . . . 1.51 111.103 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.641 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.8 Cg_endo -86.28 150.66 9.25 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.145 2.563 . . . . 1.1 112.539 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.36 119.8 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 2.4 110.532 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.46 27.0 16.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.747 -0.66 . . . . 2.02 111.267 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.28 4.9 83.34 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.734 -0.745 . . . . 0.9 112.65 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 58.1 mttm -123.32 148.48 45.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.35 -0.241 . . . . 1.52 110.35 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.698 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 40.9 pt -112.45 128.52 69.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.723 -0.473 . . . . 1.09 109.723 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.494 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 8.2 t -70.97 161.74 30.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.029 -0.532 . . . . 1.84 110.252 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -7.02 10.02 Favored Glycine 0 C--O 1.223 -0.534 0 CA-C-N 115.624 -0.716 . . . . 0.33 113.992 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 -64.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.479 0.64 . . . . 1.05 110.816 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.698 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 4.0 p30 -68.52 -34.06 75.21 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.848 0.356 . . . . 1.79 110.555 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.594 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -59.2 -52.6 64.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.012 -0.54 . . . . 1.02 110.54 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.776 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.3 tttt -62.11 -35.51 78.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.535 -0.302 . . . . 1.83 110.658 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.401 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 40.1 ttpt -53.77 -49.97 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.962 0.41 . . . . 2.96 110.468 177.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -66.52 -38.28 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.003 0.43 . . . . 2.16 110.54 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.799 ' HB3' HD21 ' A' ' 86' ' ' LEU . 93.0 mtp -64.99 -38.22 90.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 1.27 111.356 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.41 -16.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 1.99 110.668 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 68.1 mttm -85.74 -12.53 50.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.072 0.463 . . . . 2.71 110.327 172.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -77.54 -4.92 48.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.689 -0.687 . . . . 1.25 110.135 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.97 22.02 8.7 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.597 -0.729 . . . . 3.08 112.135 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.558 ' HB2' HD22 ' A' ' 86' ' ' LEU . 87.8 mt -93.84 153.92 40.93 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 1.94 110.36 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.449 ' HG2' HG21 ' A' ' 85' ' ' VAL . 57.0 Cg_endo -72.41 160.52 46.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.835 2.357 . . . . 0.59 112.526 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -55.45 -34.46 64.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.761 -0.654 . . . . 2.32 111.092 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -57.39 -59.2 5.49 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.863 -0.608 . . . . 1.77 111.288 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.449 HG21 ' HG2' ' A' ' 82' ' ' PRO . 65.9 t -64.5 -45.15 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.572 -0.74 . . . . 1.13 110.657 -177.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 76' ' ' MET . 86.1 mt -60.65 -42.76 97.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.815 0.34 . . . . 1.26 110.864 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.487 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -61.37 -46.29 94.69 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.002 -0.544 . . . . 0.25 112.642 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.442 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 19.3 ptmt -72.17 -35.22 68.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.37 -0.532 . . . . 2.34 110.917 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.431 HG23 HD11 ' A' ' 112' ' ' LEU . 46.8 mt -60.65 -41.08 86.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.996 -0.372 . . . . 1.15 109.996 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.4 ' CD1' ' HB3' ' B' ' 149' ' ' ASP . 49.6 t-105 -64.25 -48.9 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.57 110.541 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -58.5 -24.78 61.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.929 -0.578 . . . . 3.03 111.878 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 31.8 mt -92.41 -52.16 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.353 . . . . 1.75 111.281 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.03 73.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.539 -0.755 . . . . 1.0 112.097 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.621 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 44.3 t0 -86.93 94.75 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.455 0.645 . . . . 0.45 109.358 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.427 HG13 ' HE2' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -81.42 -26.91 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.323 -0.853 . . . . 1.79 111.381 -171.039 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.605 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -80.3 -10.71 59.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 1.64 109.402 174.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.554 ' HZ1' ' HH ' ' B' ' 145' ' ' TYR . 0.4 OUTLIER 45.92 46.42 12.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.081 0.863 . . . . 2.31 109.873 -172.661 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -109.49 5.33 23.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.78 111.676 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 84.77 -4.88 84.03 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.307 -0.717 . . . . 0.5 111.307 174.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.667 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mp -122.41 142.89 50.05 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.151 -0.524 . . . . 2.0 110.153 177.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.53 115.22 28.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.89 -0.782 . . . . 1.06 108.89 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 175.79 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.848 -0.797 . . . . 1.39 108.848 167.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -56.67 -40.39 75.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.221 0.534 . . . . 1.69 110.735 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.52 -33.18 62.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 2.29 110.631 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.34 -41.72 69.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.39 110.373 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -67.54 -32.27 72.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.807 -0.633 . . . . 0.35 109.439 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.472 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -60.83 -46.75 89.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 1.1 110.86 173.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 82.5 mt -61.84 -42.75 99.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.375 -0.375 . . . . 2.42 110.635 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.487 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.36 -57.17 13.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 1.08 110.901 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.47 -34.22 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.91 111.197 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.418 ' O ' HG22 ' A' ' 115' ' ' VAL . 59.3 t60 -65.41 -46.2 80.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.93 110.179 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 79.9 mt -60.43 -40.8 92.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.91 0.386 . . . . 1.06 110.264 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 109' ' ' ALA . 83.8 mt -61.13 -54.38 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.38 -0.827 . . . . 1.27 111.065 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.661 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 14.8 ptpt -67.37 -33.85 76.08 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.051 -0.659 . . . . 2.57 111.23 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.418 HG22 ' O ' ' A' ' 111' ' ' HIS . 39.9 t -58.92 -50.4 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.127 -0.323 . . . . 1.64 110.127 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 42.5 tptt -53.96 -48.81 69.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.884 0.374 . . . . 1.69 111.096 172.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.405 HD12 ' HA ' ' A' ' 117' ' ' LEU . 4.0 mm? -67.01 -20.16 65.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.389 0.515 . . . . 2.3 112.389 -177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.661 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.1 mt-10 -76.59 -6.22 51.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.83 0.348 . . . . 2.05 110.626 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.75 27.51 14.27 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.178 -0.769 . . . . 0.68 111.178 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -113.27 -176.98 3.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 1.32 109.865 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.4 ' CD ' ' HZ3' ' A' ' 116' ' ' LYS . 8.6 tp10 -123.94 142.31 51.26 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.612 -0.885 . . . . 2.69 108.612 172.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -85.07 141.24 37.39 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.449 -0.341 . . . . 1.74 110.321 -179.092 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 39.3 Cg_exo -58.54 -16.44 29.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.438 2.759 . . . . 1.47 114.197 -170.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.34 18.03 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.701 0.626 . . . . 1.78 110.992 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -135.58 173.63 11.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.717 -0.674 . . . . 1.93 109.548 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.54 95.76 44.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.608 -0.516 . . . . 2.5 109.608 174.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 51.2 Cg_exo -54.1 147.47 43.91 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.221 2.614 . . . . 1.12 112.847 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 41.9 Cg_exo -58.42 -25.19 72.42 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.196 2.597 . . . . 1.24 112.763 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.416 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 7.4 p-80 -85.79 3.34 41.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.458 -0.337 . . . . 1.23 111.03 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.652 HD22 HG21 ' A' ' 45' ' ' VAL . 31.2 mt -118.56 -28.76 5.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 1.88 111.385 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.0 m -66.51 132.56 94.23 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 120.739 -0.384 . . . . 2.17 110.549 178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.87 160.06 35.07 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.321 2.681 . . . . 1.66 112.589 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.6 -25.46 50.18 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.121 2.548 . . . . 2.34 112.777 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.8 t -71.95 -7.46 48.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.808 0.337 . . . . 2.7 111.276 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HE2' HG13 ' A' ' 95' ' ' VAL . 26.1 mmmt -111.43 5.53 19.69 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.997 0.369 . . . . 3.61 111.997 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -58.02 114.05 2.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.224 0.535 . . . . 4.47 111.899 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -119.34 164.75 15.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.315 -0.857 . . . . 5.59 108.831 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -117.42 115.79 25.9 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.102 -0.639 . . . . 7.32 109.665 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.437 -0.792 . . . . 6.66 110.795 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.368 0.127 . . . . 11.14 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -88.72 149.25 23.57 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.865 0.364 . . . . 8.71 110.956 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . 0.554 ' HH ' ' HZ1' ' A' ' 97' ' ' LYS . 37.3 p90 -130.35 -174.43 3.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.001 -0.545 . . . . 7.77 110.626 -179.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 129.83 41.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.109 0.48 . . . . 5.92 112.277 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 10.0 m -95.13 153.11 17.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.526 -0.761 . . . . 4.46 109.87 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 5.6 p -104.29 27.87 7.39 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.989 0.366 . . . . 2.55 111.989 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.9 p30 -83.81 145.63 47.52 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.163 0.506 . . . . 1.41 110.906 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.776 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 14.3 Cg_exo -69.57 0.49 5.43 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.666 2.911 . . . . 0.79 113.69 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.487 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 28.5 m-85 -97.47 -45.93 6.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.006 0.431 . . . . 0.56 110.312 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 76.4 p -118.24 95.91 5.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.561 0.696 . . . . 1.89 110.35 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.76 -30.55 56.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.46 -0.791 . . . . 3.32 111.885 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 C--O 1.252 1.185 0 O-C-N 123.452 0.47 . . . . 7.37 110.054 -175.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.621 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.959 -0.456 . . . . 10.82 111.959 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.33 -23.27 15.51 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.782 2.321 . . . . 11.16 112.241 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.42 39.62 1.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.003 -0.544 . . . . 9.47 110.917 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.95 66.37 3.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.84 -0.695 . . . . 6.48 111.476 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.4 m -90.37 -7.12 54.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.901 0.382 . . . . 5.98 110.983 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -75.83 134.45 40.37 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.946 -0.391 . . . . 3.92 109.946 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -83.45 144.85 29.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.417 -0.356 . . . . 4.94 110.184 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.77 136.2 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.902 0.382 . . . . 2.63 111.099 -174.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -85.26 148.91 25.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.39 0.614 . . . . 2.4 111.082 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -92.63 140.17 29.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.119 -0.946 . . . . 1.16 112.349 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.49 -7.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.888 0.851 . . . . 1.94 109.035 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 t -96.83 -11.93 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.887 -1.051 . . . . 1.14 109.802 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.67 -23.68 69.09 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.773 -0.649 . . . . 0.78 112.996 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -74.35 -27.32 60.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.999 0.428 . . . . 3.71 110.67 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.39 31.39 5.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 2.39 109.637 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.457 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -75.81 -56.44 1.73 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.51 -0.314 . . . . 1.9 111.692 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.471 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 51.0 Cg_endo -66.94 -14.75 44.87 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.707 1.605 . . . . 0.99 112.569 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.41 -46.59 63.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.548 0.689 . . . . 1.03 109.177 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -80.82 -20.8 41.65 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.453 -0.794 . . . . 1.15 109.922 178.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 11.2 t70 -66.29 -44.55 83.18 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.212 -0.662 . . . . 0.73 109.212 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.93 -50.89 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.86 110.229 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.51 -38.81 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.062 -0.517 . . . . 1.11 110.338 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.486 ' HE1' HG12 ' A' ' 67' ' ' ILE . 65.2 t80 -56.72 -47.56 79.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.317 -0.856 . . . . 0.5 111.134 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -76.09 -22.36 55.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.27 0.471 . . . . 1.23 112.27 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.45 -6.71 57.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.6 -0.44 . . . . 1.3 111.032 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.14 0.73 38.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 1.79 111.228 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m 69.65 88.15 0.1 Allowed Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 123.84 0.713 . . . . 1.51 111.201 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.0 136.27 5.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.809 2.34 . . . . 1.1 112.438 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.3 m -107.71 115.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.113 0.482 . . . . 2.4 110.828 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 58.0 28.33 16.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.717 -0.674 . . . . 2.02 112.016 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.88 -2.4 69.4 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.94 -0.648 . . . . 0.9 113.352 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.505 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 57.3 mttm -127.11 142.25 51.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.501 -0.411 . . . . 1.52 110.546 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.486 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -99.06 138.67 22.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.201 -0.666 . . . . 1.09 109.201 170.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.714 ' HA ' HD23 ' A' ' 100' ' ' LEU . 1.1 p -71.53 164.55 25.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.254 -0.43 . . . . 1.84 111.067 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.56 -25.25 41.97 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 115.719 -0.673 . . . . 0.33 113.175 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.26 -42.91 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 1.05 111.074 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.725 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 25.6 m-80 -76.72 -43.03 39.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.14 0.495 . . . . 1.79 110.234 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.527 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.98 -41.15 86.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.022 -0.99 . . . . 1.02 110.516 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.682 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.6 tttt -70.59 -35.93 73.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.009 -0.541 . . . . 1.83 110.122 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.725 ' HE2' ' HA ' ' A' ' 71' ' ' ASN . 52.3 mtmt -54.45 -46.37 73.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.906 0.384 . . . . 2.96 110.203 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.76 -52.54 63.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.693 -0.685 . . . . 2.16 110.176 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.527 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 32.8 mtt -56.23 -41.96 76.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.128 0.49 . . . . 1.27 112.01 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 73' ' ' LYS . 99.6 t -68.74 -31.17 49.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.707 -0.678 . . . . 1.99 110.72 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 98.4 mttt -71.53 -28.15 63.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.88 0.371 . . . . 2.71 110.348 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 m -74.17 -15.07 61.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 1.25 111.122 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 73.15 24.38 2.47 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.821 0.674 . . . . 3.08 112.821 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.664 ' HB2' HD21 ' A' ' 86' ' ' LEU . 3.9 mm? -87.84 158.15 50.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.655 -0.418 . . . . 1.94 110.271 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.487 ' HG2' HG23 ' A' ' 85' ' ' VAL . 73.5 Cg_endo -76.31 157.21 37.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.125 2.55 . . . . 0.59 113.274 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -53.69 -42.99 68.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.661 -0.7 . . . . 2.32 111.703 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 p -55.78 -56.88 15.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.235 0.54 . . . . 1.77 111.785 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.487 HG23 ' HG2' ' A' ' 82' ' ' PRO . 87.9 t -62.39 -45.15 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.81 -0.632 . . . . 1.13 111.171 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.664 HD21 ' HB2' ' A' ' 81' ' ' LEU . 70.3 mt -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 1.26 110.376 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.94 -48.07 79.61 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.02 -0.536 . . . . 0.25 112.48 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.426 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 40.9 pttt -74.05 -33.68 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 2.34 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 85' ' ' VAL . 43.5 mt -60.66 -41.44 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.851 -0.425 . . . . 1.15 109.851 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -60.88 -48.75 80.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.57 110.377 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -67.84 -14.03 62.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.055 0.391 . . . . 3.03 112.055 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 61.5 mt -93.31 -51.18 5.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.331 . . . . 1.75 110.79 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.03 -33.66 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.775 . . . . 1.0 111.544 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.599 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 37.6 t0 -84.32 86.26 7.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.672 0.748 . . . . 0.45 109.494 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.802 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 3.5 m -68.66 -30.62 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.562 -1.199 . . . . 1.79 112.405 -175.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.44 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 2.7 m-20 -72.78 -24.34 60.92 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 116.514 -0.312 . . . . 1.64 110.265 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 mttt 58.37 40.33 24.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.277 -1.008 . . . . 2.31 108.277 -167.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.589 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 p-10 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.995 -1.002 . . . . 0.78 111.22 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.65 22.16 65.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.72 . . . . 0.5 111.793 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.714 HD23 ' HA ' ' A' ' 68' ' ' THR . 15.3 mt -140.67 143.95 35.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.503 -0.555 . . . . 2.0 109.503 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.401 HD23 ' HB3' ' A' ' 105' ' ' GLU . 71.0 mt -121.56 114.2 20.86 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.451 0.469 . . . . 1.06 109.973 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.404 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -79.19 -177.57 5.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.971 -0.752 . . . . 1.39 108.971 169.71 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.65 -30.85 69.03 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.985 -0.286 . . . . 1.69 111.385 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.36 -58.05 3.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.075 -0.343 . . . . 2.29 110.075 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.401 ' HB3' HD23 ' A' ' 101' ' ' LEU . 38.6 mt-10 -56.94 -39.71 75.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.323 0.582 . . . . 0.39 110.653 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.75 -29.43 66.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.549 -0.751 . . . . 0.35 110.945 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.47 -42.23 30.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.918 0.866 . . . . 1.1 108.925 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.505 -1.225 . . . . 2.42 110.044 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.18 -52.02 67.32 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.965 -0.561 . . . . 1.08 110.754 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -27.09 68.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.91 111.668 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.487 ' O ' HG22 ' A' ' 115' ' ' VAL . 21.9 t60 -67.19 -47.18 71.7 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 0.93 109.841 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.6 mt -62.48 -41.88 99.09 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.996 0.427 . . . . 1.06 110.234 176.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.503 HD13 ' HE1' ' A' ' 76' ' ' MET . 73.6 mt -61.22 -50.77 79.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 1.27 111.313 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.439 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 45.4 pttt -73.48 -21.42 60.44 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 120.336 -0.545 . . . . 2.57 110.236 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 111' ' ' HIS . 2.8 t -58.96 -46.45 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.638 -0.504 . . . . 1.64 109.638 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.487 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 13.1 mmmm -72.73 -31.98 65.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.397 -0.365 . . . . 1.69 111.249 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.409 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 37.0 tp -65.41 -42.0 93.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 2.3 111.317 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.439 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 80.8 mm-40 -69.98 -26.01 63.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.027 0.441 . . . . 2.05 110.619 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.33 34.48 3.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.653 -0.784 . . . . 0.68 112.65 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.66 177.24 4.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.962 -0.384 . . . . 1.32 109.962 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.79 149.41 24.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.832 0.349 . . . . 2.69 111.631 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 122' ' ' LEU . 1.4 pp -124.91 130.67 24.14 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.117 -0.697 . . . . 1.74 109.117 167.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 -13.62 20.19 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.689 2.26 . . . . 1.47 113.726 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.6 18.94 9.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.586 -0.734 . . . . 1.78 110.571 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -106.14 170.17 8.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.332 -0.849 . . . . 1.93 108.904 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.1 tp -123.15 96.83 44.02 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.651 -0.419 . . . . 2.5 110.758 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -75.21 152.67 40.1 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.899 2.4 . . . . 1.12 112.125 177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.3 -39.69 62.42 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.537 2.825 . . . . 1.24 114.237 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -81.02 13.92 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 1.23 111.716 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.4 mt -122.53 5.14 9.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.281 -0.418 . . . . 1.88 110.217 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.8 t -95.73 106.51 27.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 2.17 110.171 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.65 161.43 45.29 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.801 2.334 . . . . 1.66 112.962 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.57 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 30.6 Cg_endo -64.05 2.9 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.188 2.592 . . . . 2.34 113.274 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.8 t -73.5 -27.64 61.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.912 0.387 . . . . 2.7 110.184 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.802 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 4.2 mmmp? -92.08 8.0 39.78 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 112.647 0.61 . . . . 3.61 112.647 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.57 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 14.4 ptp180 -100.14 124.07 45.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.103 0.477 . . . . 4.47 110.386 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.0 ttm-85 -126.1 115.7 20.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.606 -0.725 . . . . 5.59 109.256 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -133.69 140.98 47.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.16 0.505 . . . . 7.32 111.321 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.484 ' CD ' ' H ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 117.951 -1.023 . . . . 6.66 111.375 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.984 -0.376 . . . . 11.14 109.984 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -64.37 -41.29 96.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.45 -0.341 . . . . 8.71 111.409 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -156.6 151.25 25.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 7.77 110.271 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.49 75.84 0.95 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.226 0.536 . . . . 5.92 110.499 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 24.4 m -156.74 94.01 1.42 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 4.46 109.753 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.3 p -120.14 -3.53 10.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.255 0.465 . . . . 2.55 112.255 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -133.86 152.98 79.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.676 0.274 . . . . 1.41 110.382 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.682 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -72.75 -1.59 10.61 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.464 2.776 . . . . 0.79 113.936 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.447 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 25.2 m-85 -100.31 -20.31 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.101 0.476 . . . . 0.56 110.91 -175.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 34.1 p -83.32 -2.75 56.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.8 -0.637 . . . . 1.89 110.57 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.8 90.1 2.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.773 -0.649 . . . . 3.32 110.541 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.555 -0.748 . . . . 7.37 111.605 176.051 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.599 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.33 -0.708 . . . . 10.82 111.33 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.11 -69.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.816 2.344 . . . . 11.16 112.14 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.9 tp 65.23 -77.68 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.829 0.706 . . . . 9.47 111.732 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.75 79.41 1.12 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.272 -0.489 . . . . 6.48 113.145 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.9 m -94.77 69.61 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.248 -0.649 . . . . 5.98 109.248 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.42 133.2 39.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 3.92 111.185 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.21 109.99 4.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.519 -0.764 . . . . 4.94 111.174 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 p -104.52 115.54 46.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.215 -0.661 . . . . 2.63 109.215 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.48 132.1 34.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.395 0.616 . . . . 2.4 111.392 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.456 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.6 t90 -76.79 123.22 25.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.303 -0.862 . . . . 1.16 109.895 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.85 -35.34 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 1.94 111.786 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.9 -21.0 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.145 -0.48 . . . . 1.14 111.174 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.452 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -68.67 -5.93 47.58 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.084 -0.579 . . . . 0.78 112.98 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -74.64 -28.25 60.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.089 0.471 . . . . 3.71 110.867 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -135.02 33.16 3.15 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.53 -0.915 . . . . 2.39 108.53 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.599 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 82.3 tttt -84.33 -44.71 0.74 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 114.946 -1.025 . . . . 1.9 113.409 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.599 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 19.7 Cg_endo -56.18 -23.84 47.11 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.426 2.084 . . . . 0.99 113.132 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 m -69.9 -41.21 74.99 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.273 -0.876 . . . . 1.03 110.378 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.59 -21.95 60.18 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.362 -0.607 . . . . 1.15 109.362 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.419 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 3.6 t70 -66.3 -45.18 81.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.443 0.64 . . . . 0.73 109.75 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -59.59 -40.8 88.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.072 -0.967 . . . . 1.86 109.902 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.603 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 65.9 mt -70.29 -37.89 72.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.071 0.462 . . . . 1.11 110.731 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -61.54 -51.09 70.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.142 -0.481 . . . . 0.5 111.235 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -82.24 14.18 3.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.231 0.456 . . . . 1.23 112.231 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -118.5 3.58 11.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 1.3 110.467 172.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 72.5 mt -106.35 11.97 30.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.919 -0.582 . . . . 1.79 110.513 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t 66.35 80.77 0.22 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.371 -0.831 . . . . 1.51 111.325 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.77 128.67 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.313 2.008 . . . . 1.1 111.526 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.0 t -106.81 107.79 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.398 -0.364 . . . . 2.4 110.191 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.3 m120 68.61 29.22 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.478 -0.783 . . . . 2.02 110.52 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.24 -3.62 72.93 Favored Glycine 0 C--O 1.23 -0.142 0 CA-C-N 115.655 -0.702 . . . . 0.9 113.333 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -122.03 140.36 52.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.407 -0.22 . . . . 1.52 110.407 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -101.13 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.835 -0.802 . . . . 1.09 108.835 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.72 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 72.0 p -80.75 164.94 22.38 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.483 -0.487 . . . . 1.84 110.207 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.38 -20.73 52.02 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 120.999 -0.62 . . . . 0.33 112.802 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 -43.84 81.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.907 0.384 . . . . 1.05 111.308 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -76.3 -44.21 37.94 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.524 0.678 . . . . 1.79 109.767 -176.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.674 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.72 -50.82 72.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.771 -1.104 . . . . 1.02 110.182 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.565 ' O ' HG21 ' A' ' 77' ' ' VAL . 76.3 tttt -56.73 -40.62 76.03 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.1 -0.5 . . . . 1.83 110.539 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.9 ttpt -51.88 -49.25 63.34 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.003 0.43 . . . . 2.96 110.218 177.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.27 -39.88 89.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.89 -0.595 . . . . 2.16 110.517 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.723 ' HB3' HD22 ' A' ' 86' ' ' LEU . 66.4 mtp -67.26 -27.01 66.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.001 -0.545 . . . . 1.27 110.451 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 73' ' ' LYS . 77.7 t -70.94 -38.05 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 1.99 109.97 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -66.44 -21.87 66.21 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 2.71 110.885 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.4 t -73.88 -17.28 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.25 -0.432 . . . . 1.25 111.069 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 65.65 24.22 11.62 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.581 0.585 . . . . 3.08 112.581 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.544 ' HB2' HD23 ' A' ' 86' ' ' LEU . 69.3 mt -85.59 151.61 56.01 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.574 -0.45 . . . . 1.94 110.219 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.468 ' HG2' HG22 ' A' ' 85' ' ' VAL . 33.1 Cg_endo -65.34 149.7 87.99 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.771 2.314 . . . . 0.59 111.918 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -53.13 -35.55 59.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.317 -0.401 . . . . 2.32 111.621 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 m -61.97 -45.05 95.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.348 -0.387 . . . . 1.77 111.017 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.626 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 86.6 t -73.37 -39.19 54.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.971 0.415 . . . . 1.13 110.332 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.723 HD22 ' HB3' ' A' ' 76' ' ' MET . 84.4 mt -59.58 -48.76 80.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 1.26 110.563 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.57 -41.15 99.83 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.727 -0.669 . . . . 0.25 112.415 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 0.4 OUTLIER -66.67 -38.78 87.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.359 -0.536 . . . . 2.34 110.084 -179.013 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.81 -39.6 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 110.085 -0.339 . . . . 1.15 110.085 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -62.26 -51.56 67.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.57 110.445 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.465 ' HB3' ' HZ2' ' A' ' 91' ' ' LYS . 7.6 mtpm? -67.39 -12.44 60.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 3.03 112.159 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.3 mt -93.97 -49.77 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 1.75 111.21 174.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.518 ' HA ' HD22 ' A' ' 108' ' ' LEU . . . -72.34 -32.27 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 1.0 111.705 -173.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.64 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 28.1 t70 -88.3 83.73 6.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.45 109.861 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.14 -28.9 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.206 -0.906 . . . . 1.79 111.497 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.545 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 57.5 m-20 -74.21 -19.9 60.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 121.002 -0.279 . . . . 1.64 110.271 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mttt 58.75 27.81 16.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.898 0.856 . . . . 2.31 109.097 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.596 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 19.6 p-10 -98.69 9.7 42.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.347 -1.297 . . . . 0.78 111.366 -169.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.94 9.23 52.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.93 -0.653 . . . . 0.5 111.522 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.72 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 15.5 mt -131.18 136.86 48.66 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.998 -0.601 . . . . 2.0 110.046 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 47.8 mt -105.83 112.59 25.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 1.06 110.414 178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.11 -178.11 3.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.89 -0.595 . . . . 1.39 109.55 170.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -56.8 -42.94 80.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.12 0.486 . . . . 1.69 110.339 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.456 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 19.2 mm-40 -66.08 -54.77 21.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.922 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -60.37 -39.19 86.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.39 111.202 -175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 -25.47 59.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.35 110.959 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.77 -42.41 40.96 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.533 -0.914 . . . . 1.1 108.533 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 93' ' ' ALA . 22.8 tp -63.56 -37.62 88.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.608 -1.178 . . . . 2.42 109.845 174.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.74 -56.63 19.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.187 -0.46 . . . . 1.08 110.972 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.73 -31.13 72.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.33 -0.396 . . . . 0.91 111.242 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.464 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.0 t60 -66.93 -40.91 87.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.477 -0.329 . . . . 0.93 110.319 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.581 ' O ' HG13 ' A' ' 115' ' ' VAL . 94.7 mt -70.6 -39.4 73.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.159 0.504 . . . . 1.06 110.058 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 65.7 mt -56.45 -53.7 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.844 . . . . 1.27 111.177 177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.52 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 28.3 pttt -76.42 -25.05 54.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.293 -0.412 . . . . 2.57 111.042 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 112' ' ' LEU . 1.2 p -68.68 -38.88 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.245 -0.65 . . . . 1.64 109.245 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -66.53 -39.53 88.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.163 -0.472 . . . . 1.69 110.082 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.51 -39.76 92.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.879 -0.6 . . . . 2.3 111.149 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 71.3 mt-10 -71.55 -9.48 58.27 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.42 -0.354 . . . . 2.05 111.023 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.92 16.84 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.612 -0.804 . . . . 0.68 112.59 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.538 ' HB2' HG22 ' A' ' 115' ' ' VAL . 83.7 m-70 -99.49 121.16 40.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.336 -0.616 . . . . 1.32 109.336 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -81.07 100.6 9.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.911 0.386 . . . . 2.69 110.411 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.4 ' O ' HD13 ' A' ' 122' ' ' LEU . 2.6 pp -61.09 133.47 92.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 1.74 109.81 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.26 4.84 3.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.952 2.434 . . . . 1.47 113.56 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.59 27.63 14.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.172 0.511 . . . . 1.78 110.854 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.68 163.49 16.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.926 -0.579 . . . . 1.93 109.97 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -126.56 85.65 59.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.128 -0.942 . . . . 2.5 109.124 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -62.55 145.62 95.39 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.18 1.92 . . . . 1.12 111.612 174.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.39 -32.33 14.76 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.494 2.796 . . . . 1.24 114.277 -175.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -81.28 3.88 22.47 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.032 0.382 . . . . 1.23 112.032 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.83 -9.15 11.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.59 0.233 . . . . 1.88 111.128 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.66 121.8 77.22 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 2.17 111.151 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.403 ' HB3' ' HB3' ' A' ' 104' ' ' GLU . 44.6 Cg_exo -57.97 139.99 92.32 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.81 2.34 . . . . 1.66 112.286 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.41 3.09 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.329 2.686 . . . . 2.34 113.807 -178.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.4 t -72.05 -33.39 67.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 2.7 110.66 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 15.3 tptm -92.32 14.18 17.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.438 -0.346 . . . . 3.61 111.663 -172.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -75.55 111.75 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.964 -0.384 . . . . 4.47 109.964 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -90.83 149.06 22.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.119 0.485 . . . . 5.59 111.098 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -127.97 100.35 5.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.733 -0.84 . . . . 7.32 108.733 173.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.526 -0.75 . . . . 6.66 110.35 -177.206 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.879 0.371 . . . . 11.14 110.801 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 16.9 m120 69.39 -168.64 0.17 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.133 -0.94 . . . . 8.71 111.257 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -95.12 147.05 23.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.058 -0.519 . . . . 7.77 110.712 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.45 102.51 12.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.776 -0.647 . . . . 5.92 109.968 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.4 t -99.1 144.83 27.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.254 -0.43 . . . . 4.46 109.993 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 12.9 t -124.92 -7.18 7.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.163 -0.472 . . . . 2.55 109.784 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.436 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 6.3 t70 -117.98 117.61 35.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 1.41 110.373 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.5 Cg_exo -74.61 -2.02 11.88 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.43 2.754 . . . . 0.79 113.825 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.471 ' HZ ' ' SD ' ' A' ' 76' ' ' MET . 10.1 m-85 -105.13 -25.23 12.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.84 0.352 . . . . 0.56 110.771 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.3 p -79.79 21.75 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.485 . . . . 1.89 111.775 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -80.75 -5.89 57.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 3.32 110.791 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.563 -0.732 . . . . 7.37 110.132 177.294 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.64 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 111.638 -0.585 . . . . 10.82 111.638 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.68 -162.24 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 123.286 2.657 . . . . 11.16 112.335 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 5.4 mp -93.72 147.81 22.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.025 -0.534 . . . . 9.47 109.655 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.44 119.17 0.65 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.288 -0.958 . . . . 6.48 112.54 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.6 m -155.4 104.07 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.087 -0.338 . . . . 5.98 110.087 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.1 92.22 5.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.127 0.965 . . . . 3.92 110.339 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -124.22 95.02 4.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.93 -1.032 . . . . 4.94 109.116 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.5 t -98.46 92.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.028 0.442 . . . . 2.63 110.315 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -104.23 110.5 22.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.896 -0.593 . . . . 2.4 110.246 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -72.99 102.05 3.38 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.089 -0.708 . . . . 1.16 109.089 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.17 -17.33 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.708 -0.678 . . . . 1.94 112.56 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 t -89.25 -7.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.313 0.578 . . . . 1.14 110.049 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -20.82 78.51 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.723 -0.751 . . . . 0.78 112.852 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 mtmm -75.0 -29.37 60.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.137 0.494 . . . . 3.71 109.703 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.49 33.36 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.447 -0.797 . . . . 2.39 109.992 -172.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.43 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 18.5 ttpp -83.88 -48.96 0.69 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.87 -0.604 . . . . 1.9 111.401 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.43 ' HD3' ' HB3' ' A' ' 50' ' ' LYS . 84.8 Cg_exo -50.13 -29.29 21.88 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.654 2.236 . . . . 0.99 114.359 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.6 m -70.78 -46.5 62.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.318 0.58 . . . . 1.03 110.209 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -73.94 -20.07 60.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.353 -0.61 . . . . 1.15 109.353 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.506 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 14.4 t70 -68.94 -42.34 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.24 -0.891 . . . . 0.73 109.467 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.64 -41.84 95.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 1.86 110.135 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.3 mt -61.98 -39.4 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.104 0.478 . . . . 1.11 110.029 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -57.11 -52.88 63.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.855 . . . . 0.5 111.584 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.653 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 63.8 m-85 -74.9 -21.25 59.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.123 0.416 . . . . 1.23 112.123 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.7 p -83.25 2.31 36.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.411 . . . . 1.3 111.374 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.21 9.28 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.64 0.257 . . . . 1.79 110.485 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m 66.72 87.37 0.12 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.321 -0.854 . . . . 1.51 111.095 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.653 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -81.08 132.51 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.776 2.317 . . . . 1.1 112.044 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.95 123.63 67.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.832 -0.622 . . . . 2.4 110.464 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 65.43 23.2 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.655 -0.702 . . . . 2.02 110.817 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.79 -0.62 79.94 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.886 -0.673 . . . . 0.9 112.628 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.664 ' HB2' HD13 ' A' ' 100' ' ' LEU . 44.6 mttm -123.5 164.82 18.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.999 -0.371 . . . . 1.52 109.999 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.678 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 48.2 pt -111.5 130.24 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.925 -0.71 . . . . 1.09 109.302 167.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -71.25 154.89 41.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.973 -0.558 . . . . 1.84 110.674 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.4 -9.01 2.01 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.9 -0.591 . . . . 0.33 113.981 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.75 -67.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.14 0.47 . . . . 1.05 110.581 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.836 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 4.3 p30 -69.32 -28.25 66.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.79 110.62 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.595 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.68 -49.09 78.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 1.02 110.333 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 42.8 tttp -64.54 -36.81 85.43 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.905 0.383 . . . . 1.83 110.22 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.836 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 28.5 mtpp -54.85 -42.15 71.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.632 . . . . 2.96 110.82 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -71.16 -38.86 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.661 . . . . 2.16 110.123 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.736 ' HB3' HD23 ' A' ' 86' ' ' LEU . 87.5 mtp -68.17 -28.08 66.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.481 -0.781 . . . . 1.27 111.41 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -81.11 -22.69 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.362 -0.535 . . . . 1.99 110.28 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.527 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 44.2 mttp -66.49 -28.93 68.95 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.304 -0.558 . . . . 2.71 109.666 170.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -67.03 -17.56 64.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.569 -0.741 . . . . 1.25 110.797 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mttp 67.28 22.83 9.5 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.839 -0.619 . . . . 3.08 111.582 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.558 ' HB2' HD21 ' A' ' 86' ' ' LEU . 84.5 mt -89.4 155.76 48.59 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.657 -0.498 . . . . 1.94 109.657 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.513 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 35.4 Cg_endo -66.53 147.26 81.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.564 2.176 . . . . 0.59 112.232 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.29 -36.9 69.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.652 -0.704 . . . . 2.32 111.276 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.2 m -60.02 -48.51 81.41 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.838 -0.619 . . . . 1.77 111.214 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.543 ' O ' HG13 ' A' ' 89' ' ' ILE . 78.7 t -67.6 -38.31 80.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 1.13 110.162 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.736 HD23 ' HB3' ' A' ' 76' ' ' MET . 81.8 mt -57.49 -42.27 82.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 1.26 110.556 175.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.422 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.67 -41.21 98.86 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.953 -0.567 . . . . 0.25 112.132 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.03 -47.74 81.74 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.23 -0.188 . . . . 2.34 110.84 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 85' ' ' VAL . 69.3 mt -53.35 -45.55 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 123.339 0.4 . . . . 1.15 110.365 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.451 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 32.0 t-105 -59.71 -52.68 64.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.731 -0.668 . . . . 0.57 110.963 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.93 -13.55 61.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.308 0.484 . . . . 3.03 112.308 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.49 -39.77 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.142 0.496 . . . . 1.75 110.648 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 105' ' ' GLU . . . -78.53 -36.18 45.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.605 -0.725 . . . . 1.0 111.56 -176.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.432 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 44.0 t0 -83.56 70.61 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.869 0.842 . . . . 0.45 109.467 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.45 ' CG1' HD13 ' A' ' 126' ' ' LEU . 15.0 m -77.32 -16.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.944 -1.025 . . . . 1.79 109.619 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.56 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . 2.1 t70 -86.23 -20.72 28.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.186 -1.37 . . . . 1.64 109.295 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttt 60.77 40.34 16.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.667 -1.152 . . . . 2.31 111.359 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 7.2 p-10 -114.27 9.21 16.96 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.505 -0.478 . . . . 0.78 111.299 -174.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.6 -2.41 67.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 120.843 -0.694 . . . . 0.5 111.992 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.664 HD13 ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -120.71 134.02 55.31 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.752 -0.832 . . . . 2.0 108.752 -176.729 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.47 HD13 ' HB1' ' A' ' 72' ' ' ALA . 62.3 mt -83.23 108.6 16.57 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 118.743 -1.183 . . . . 1.06 108.012 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.88 171.22 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.711 -1.218 . . . . 1.39 107.711 171.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -57.6 -42.01 82.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.996 0.362 . . . . 1.69 111.212 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.8 -42.21 77.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.291 0.567 . . . . 2.29 110.28 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.56 ' OE2' ' HB3' ' A' ' 96' ' ' ASP . 25.4 mt-10 -66.89 -38.63 86.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.516 -0.765 . . . . 0.39 110.627 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 38.9 t80 -73.1 -25.06 60.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.35 110.625 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 -41.57 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.244 -1.021 . . . . 1.1 108.244 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 93' ' ' ALA . 40.7 tp -65.25 -35.52 81.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.449 -1.25 . . . . 2.42 109.826 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -55.88 29.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.133 -0.485 . . . . 1.08 110.84 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.541 HD21 HD12 ' A' ' 113' ' ' ILE . 13.8 m120 -61.62 -28.16 69.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.91 110.928 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.519 ' O ' HG22 ' A' ' 115' ' ' VAL . 61.7 t60 -63.95 -48.01 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 0.93 110.585 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.471 ' HB3' HD21 ' A' ' 122' ' ' LEU . 36.4 mt -66.24 -33.39 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.792 -0.448 . . . . 1.06 109.792 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.541 HD12 HD21 ' A' ' 110' ' ' ASN . 88.2 mt -60.49 -51.39 73.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.83 -0.623 . . . . 1.27 111.511 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.495 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.28 -41.02 86.14 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 120.601 -0.439 . . . . 2.57 110.444 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.519 HG22 ' O ' ' A' ' 111' ' ' HIS . 69.4 t -54.62 -47.83 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.027 0.442 . . . . 1.64 109.867 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 44.4 tptt -57.8 -56.58 20.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.54 -0.755 . . . . 1.69 111.306 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.89 -31.81 72.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 2.3 111.73 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.495 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 44.4 mt-10 -80.5 4.29 18.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 2.05 111.353 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.07 33.17 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.699 . . . . 0.68 113.467 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.51 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 97.7 m-70 -131.5 173.55 10.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.778 0.289 . . . . 1.32 110.444 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -120.0 155.13 33.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.269 -0.423 . . . . 2.69 111.163 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' A' ' 112' ' ' LEU . 21.9 mt -93.47 128.16 43.48 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.946 -0.57 . . . . 1.74 109.582 176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.49 -6.81 19.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.792 2.328 . . . . 1.47 113.57 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.89 9.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 1.78 112.404 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -127.6 174.61 8.92 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.661 -0.496 . . . . 1.93 109.661 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.45 HD13 ' CG1' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -124.36 88.96 52.6 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.696 -0.483 . . . . 2.5 109.696 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 32.5 Cg_endo -66.57 150.34 83.97 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.859 2.373 . . . . 1.12 112.256 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 32.3 Cg_exo -58.25 -21.4 52.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.218 2.612 . . . . 1.24 113.856 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -96.94 13.14 29.86 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.487 -0.485 . . . . 1.23 111.576 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 mt -121.74 5.5 9.99 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 1.88 111.418 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.8 m -81.53 126.69 75.47 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-O 121.125 0.488 . . . . 2.17 110.846 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.02 164.21 36.55 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.743 2.296 . . . . 1.66 112.347 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -56.17 -31.12 82.43 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.978 2.452 . . . . 2.34 113.15 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 t -78.95 9.37 4.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.794 0.331 . . . . 2.7 111.034 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 17.6 tptm -109.41 15.73 22.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.446 0.641 . . . . 3.61 110.291 175.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.512 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 4.5 mmp_? -81.54 119.31 23.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.239 0.542 . . . . 4.47 110.543 175.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -80.83 132.02 35.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.703 -0.68 . . . . 5.59 110.482 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -115.06 112.34 22.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.662 -0.496 . . . . 7.32 109.662 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.548 -0.739 . . . . 6.66 110.714 -179.762 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 58.8 t80 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.1 0.476 . . . . 11.14 109.857 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -106.48 -154.79 0.53 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.301 -0.629 . . . . 8.71 109.301 175.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -129.84 148.98 51.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.589 -0.523 . . . . 7.77 109.589 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -107.33 175.15 5.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.736 0.303 . . . . 5.92 110.344 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -90.86 124.89 35.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.287 0.565 . . . . 4.46 111.859 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 13.3 t -122.55 13.48 10.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.342 -0.845 . . . . 2.55 109.25 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.2 p30 -80.38 152.39 73.16 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.235 -0.893 . . . . 1.41 111.388 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.597 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 30.7 Cg_exo -63.24 0.22 1.86 Allowed 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 124.118 3.212 . . . . 0.79 114.114 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.461 ' HZ ' ' SD ' ' A' ' 76' ' ' MET . 28.9 m-85 -100.4 -49.8 4.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.925 0.393 . . . . 0.56 110.813 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 30.6 p -87.09 -13.73 43.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.054 -0.521 . . . . 1.89 111.706 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.91 104.52 9.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.129 -0.487 . . . . 3.32 111.299 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 66.3 mttm . . . . . 0 C--O 1.253 1.263 0 CA-C-N 115.289 -0.868 . . . . 7.37 111.361 177.7 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.62 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.116 -0.394 . . . . 10.82 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.7 -17.43 23.11 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.887 2.391 . . . . 11.16 113.003 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.4 tp -123.77 120.48 32.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.859 -0.423 . . . . 9.47 109.859 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.92 -38.18 1.9 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.552 -0.832 . . . . 6.48 112.788 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.8 t 71.65 -69.97 0.17 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.32 0.648 . . . . 5.98 110.508 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -108.25 121.39 44.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.25 -0.432 . . . . 3.92 110.064 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.69 138.05 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.206 0.527 . . . . 4.94 109.961 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.55 137.67 28.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.702 -0.681 . . . . 2.63 111.975 -171.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -92.05 117.93 30.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.633 -0.712 . . . . 2.4 109.612 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -72.27 101.01 2.74 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.542 -1.281 . . . . 1.16 107.542 171.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.532 HG21 HD21 ' A' ' 130' ' ' LEU . 16.5 m -57.82 -20.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.989 0.737 . . . . 1.94 112.989 -169.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.6 t -92.45 -25.81 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 1.14 110.723 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.433 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -69.84 -23.58 76.82 Favored Glycine 0 CA--C 1.516 0.101 0 C-N-CA 121.167 -0.54 . . . . 0.78 113.0 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -73.91 -20.48 60.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.583 0.706 . . . . 3.71 109.907 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -134.48 34.38 3.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.413 1.101 . . . . 2.39 108.683 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.518 ' HZ1' ' CG ' ' A' ' 103' ' ' ASP . 16.1 ttpp -79.57 -42.1 1.53 Allowed Pre-proline 0 C--O 1.215 -0.718 0 CA-C-N 114.637 -1.165 . . . . 1.9 111.19 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.456 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 42.9 Cg_exo -44.0 -29.37 2.63 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.909 2.406 . . . . 0.99 114.419 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -70.19 -46.54 64.4 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.461 0.648 . . . . 1.03 109.792 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -74.75 -17.03 60.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.604 -0.725 . . . . 1.15 109.567 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.456 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 10.7 t70 -72.86 -44.61 61.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.158 -0.928 . . . . 0.73 109.442 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.64 -42.86 97.78 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.712 -0.676 . . . . 1.86 109.671 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.419 ' O ' HD13 ' A' ' 60' ' ' LEU . 60.7 mt -61.01 -42.44 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 1.11 109.788 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -53.74 -35.08 60.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 0.5 110.975 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.596 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 39.2 m-85 -84.83 -22.86 29.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.57 0.581 . . . . 1.23 112.57 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 p -77.26 -11.27 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.3 -0.56 . . . . 1.3 110.446 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.515 HD12 ' OE1' ' A' ' 75' ' ' GLU . 10.1 mp -99.76 7.04 45.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.959 -0.564 . . . . 1.79 111.321 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m 64.92 88.12 0.11 Allowed Pre-proline 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 1.51 110.793 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 90.4 Cg_endo -84.28 102.6 0.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.213 1.942 . . . . 1.1 112.151 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.85 110.35 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.79 -0.641 . . . . 2.4 110.918 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 65.38 26.5 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.799 . . . . 2.02 111.052 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.85 19.86 64.64 Favored Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 121.176 -0.535 . . . . 0.9 112.269 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.746 ' HB3' HD11 ' A' ' 100' ' ' LEU . 52.7 mttm -139.9 155.53 47.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.866 -0.42 . . . . 1.52 109.866 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.537 HD13 ' CD1' ' A' ' 106' ' ' PHE . 38.1 pt -131.35 131.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.196 0.522 . . . . 1.09 110.247 171.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 p -66.98 161.89 23.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.683 -0.69 . . . . 1.84 111.061 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.17 -16.8 62.81 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 121.304 -0.474 . . . . 0.33 113.696 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.69 -51.45 68.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.104 0.478 . . . . 1.05 110.829 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 18.2 m-80 -68.38 -43.05 78.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 1.79 109.954 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.563 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.22 -53.65 55.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.241 -0.891 . . . . 1.02 111.425 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.629 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.7 tttt -61.59 -35.73 78.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 1.83 110.296 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 16.7 ttpp -51.66 -47.26 63.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 2.96 110.344 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.515 ' OE1' HD12 ' A' ' 60' ' ' LEU . 3.4 tp10 -65.97 -38.08 87.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.454 0.645 . . . . 2.16 110.155 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.751 ' HB3' HD21 ' A' ' 86' ' ' LEU . 76.4 mtp -71.56 -31.27 66.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.423 -0.808 . . . . 1.27 111.486 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.56 -24.05 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.913 -0.315 . . . . 1.99 110.46 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -70.87 -28.29 64.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.24 0.543 . . . . 2.71 109.904 172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.5 m -66.48 -19.31 65.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.203 -0.908 . . . . 1.25 111.058 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 62.43 36.3 14.31 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.871 -0.604 . . . . 3.08 111.407 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.645 ' HB2' HD22 ' A' ' 86' ' ' LEU . 85.9 mt -97.13 161.17 27.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.894 -0.41 . . . . 1.94 109.894 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 81' ' ' LEU . 36.5 Cg_endo -67.19 143.08 63.36 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.463 2.109 . . . . 0.59 112.136 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -56.32 -31.47 63.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.849 -0.614 . . . . 2.32 111.604 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p -59.68 -54.7 43.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 1.77 111.373 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.42 ' O ' HG13 ' A' ' 89' ' ' ILE . 59.9 t -66.1 -41.94 90.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 1.13 110.187 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.751 HD21 ' HB3' ' A' ' 76' ' ' MET . 90.6 mt -55.68 -52.71 62.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.16 -0.473 . . . . 1.26 111.113 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.53 -39.26 96.17 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 121.155 -0.545 . . . . 0.25 112.116 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.497 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 25.6 ttmm -61.27 -44.13 97.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 2.34 110.419 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 85' ' ' VAL . 84.5 mt -62.85 -39.78 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 1.15 110.614 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.462 ' HZ2' ' C ' ' A' ' 99' ' ' GLY . 57.7 t-105 -60.43 -49.05 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.57 110.327 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -65.67 -16.22 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 3.03 112.16 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 34.2 mt -92.37 -44.39 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.147 0.499 . . . . 1.75 111.497 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.69 -27.26 45.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.588 -0.733 . . . . 1.0 112.005 -172.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.612 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.0 t0 -86.23 85.54 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.608 0.718 . . . . 0.45 110.624 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.429 HG21 ' HG2' ' A' ' 105' ' ' GLU . 21.1 m -74.81 -25.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.897 -1.047 . . . . 1.79 112.174 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.622 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 9.0 m-20 -78.96 -13.59 59.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 121.116 -0.234 . . . . 1.64 110.756 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttt 59.72 29.9 19.47 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 108.691 -0.855 . . . . 2.31 108.691 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.622 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 17.9 p-10 -105.73 9.35 33.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.134 -0.939 . . . . 0.78 111.308 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.462 ' C ' ' HZ2' ' A' ' 90' ' ' TRP . . . 64.54 20.66 66.07 Favored Glycine 0 CA--C 1.493 -1.336 0 CA-C-O 121.584 0.547 . . . . 0.5 112.657 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.746 HD11 ' HB3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -156.49 143.11 18.53 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.343 -0.984 . . . . 2.0 108.343 -173.105 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.593 ' N ' HD13 ' A' ' 100' ' ' LEU . 88.0 mt -104.57 126.5 51.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.975 0.417 . . . . 1.06 111.943 -171.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.86 -176.78 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.94 -0.573 . . . . 1.39 109.772 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.518 ' CG ' ' HZ1' ' A' ' 50' ' ' LYS . 14.5 t0 -57.75 -42.76 84.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.777 -0.647 . . . . 1.69 110.414 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.464 ' OE2' ' HD2' ' A' ' 133' ' ' PRO . 18.8 mt-10 -72.99 -43.97 61.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.508 -0.769 . . . . 2.29 110.822 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.465 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 52.3 mt-10 -63.37 -42.83 98.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.171 -0.468 . . . . 0.39 110.784 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.537 ' CD1' HD13 ' A' ' 67' ' ' ILE . 44.9 t80 -65.84 -35.87 81.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.35 110.094 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.69 89.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.938 -0.574 . . . . 1.1 110.321 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 78.6 mt -62.29 -45.8 91.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.161 -0.472 . . . . 2.42 110.832 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.74 -58.06 8.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.989 0.423 . . . . 1.08 111.001 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -33.96 72.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.91 111.564 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -69.51 -46.97 65.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.566 -0.288 . . . . 0.93 110.309 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.08 -47.63 83.83 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.955 0.407 . . . . 1.06 110.608 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.9 mt -57.83 -52.23 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 1.27 111.101 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.66 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.66 -30.44 69.13 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.343 -0.39 . . . . 2.57 110.413 -176.102 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.658 HG13 ' HB2' ' A' ' 120' ' ' HIS . 3.1 t -61.49 -43.83 97.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.763 0.316 . . . . 1.64 110.361 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.404 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 25.7 mmmt -63.11 -37.48 87.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 1.69 110.869 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.8 tp -70.14 -30.52 67.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.606 -0.27 . . . . 2.3 111.01 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 29.9 mm-40 -66.01 -26.39 67.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 2.05 110.216 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.35 21.8 8.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.935 -0.65 . . . . 0.68 112.227 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.658 ' HB2' HG13 ' A' ' 115' ' ' VAL . 96.2 m-70 -104.91 165.97 10.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 1.32 110.443 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -108.74 127.01 53.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.143 -0.48 . . . . 2.69 110.06 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.64 146.72 80.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 1.74 110.08 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.54 -10.16 25.25 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.134 2.556 . . . . 1.47 113.548 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.33 19.33 10.98 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.214 -0.448 . . . . 1.78 111.124 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -133.09 175.08 9.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.844 -0.616 . . . . 1.93 110.232 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.62 90.51 50.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.452 -0.944 . . . . 2.5 108.452 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.75 151.57 69.15 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.479 2.12 . . . . 1.12 112.027 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.55 -25.91 61.31 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.191 2.594 . . . . 1.24 112.807 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -89.12 19.58 4.16 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.884 -0.326 . . . . 1.23 111.658 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.532 HD21 HG21 ' A' ' 45' ' ' VAL . 31.5 mt -130.47 4.75 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 1.88 110.664 173.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.99 119.62 73.68 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.253 -0.431 . . . . 2.17 110.567 -177.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.429 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 17.7 Cg_endo -60.06 148.77 87.99 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.064 2.509 . . . . 1.66 113.004 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.464 ' HD2' ' OE2' ' A' ' 104' ' ' GLU . 52.7 Cg_exo -56.45 -22.73 43.78 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.469 2.779 . . . . 2.34 113.11 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.0 t -67.59 -8.33 33.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.981 -0.554 . . . . 2.7 111.449 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -117.36 21.95 12.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.997 0.427 . . . . 3.61 111.526 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -106.46 147.2 29.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 4.47 110.581 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -66.7 108.29 2.44 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.022 -0.733 . . . . 5.59 109.022 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -114.59 99.66 7.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.408 0.623 . . . . 7.32 110.826 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.247 0.955 0 CA-C-N 115.175 -0.92 . . . . 6.66 109.596 -177.849 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 88.1 t80 . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.764 0.316 . . . . 11.14 111.573 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -64.42 -26.37 68.42 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.922 0.712 . . . . 8.71 112.922 -168.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -107.34 4.98 27.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.724 -0.216 . . . . 7.77 111.572 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 50.01 -152.98 0.15 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.256 -0.429 . . . . 5.92 111.233 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.0 m -155.93 115.39 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.636 -0.505 . . . . 4.46 109.636 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 12.1 t -140.35 -3.85 1.33 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.846 0.355 . . . . 2.55 111.504 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ASP . . . . . 0.487 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 7.7 t70 -127.81 127.69 23.94 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.265 -0.425 . . . . 1.41 109.892 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.629 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.7 Cg_exo -76.82 -2.39 12.61 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.538 2.825 . . . . 0.79 113.924 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.537 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 10.7 m-85 -106.78 -9.97 16.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.126 0.489 . . . . 0.56 110.477 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 28.0 p -129.25 -176.38 3.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.805 -0.634 . . . . 1.89 110.798 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.47 -163.4 0.26 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.883 -0.598 . . . . 3.32 111.289 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.39 -0.814 . . . . 7.37 110.181 -179.724 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.612 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 20.9 t90 . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 109.115 -0.698 . . . . 0.96 109.115 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.96 -41.36 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 1.33 112.04 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.52 HG21 HD23 ' A' ' 108' ' ' LEU . 11.0 t -79.93 -1.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.363 0.602 . . . . 0.53 110.708 -174.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.13 76.95 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.673 -0.775 . . . . 0.78 112.562 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.54 -28.46 28.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.863 0.363 . . . . 3.22 110.952 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -124.18 34.7 4.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.172 0.987 . . . . 2.39 109.227 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 17.8 ttpt -78.78 -44.29 1.88 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 114.066 -1.425 . . . . 1.17 112.281 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 83.2 Cg_exo -49.15 -24.26 7.67 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.632 2.222 . . . . 0.65 113.67 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -69.89 -45.45 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.696 -0.483 . . . . 0.45 109.696 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.455 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 5.9 m-85 -73.49 -22.95 60.01 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.916 -0.584 . . . . 0.7 109.96 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -69.61 -44.59 70.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.48 0.657 . . . . 0.73 110.32 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -60.31 -45.58 92.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.279 -0.873 . . . . 1.86 109.765 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 77.3 mt -64.83 -39.92 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.669 . . . . 0.32 110.455 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.415 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 58.1 t80 -52.88 -50.72 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.39 111.306 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 45.1 m-85 -76.77 -22.4 53.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.275 -0.421 . . . . 0.91 112.071 -177.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.9 p -88.73 8.24 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.677 -0.409 . . . . 0.58 111.337 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 85.1 mt -104.88 1.34 28.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 1.17 110.589 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m 69.14 87.06 0.12 Allowed Pre-proline 0 N--CA 1.467 0.379 0 O-C-N 123.902 0.751 . . . . 1.14 110.586 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HA ' HG22 ' A' ' 67' ' ' ILE . 1.2 Cg_endo -84.61 163.84 12.4 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.174 2.583 . . . . 1.1 112.755 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.85 102.57 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 1.66 110.087 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 68.87 23.23 6.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 1.98 110.358 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.16 65.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.771 -0.728 . . . . 0.83 112.428 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.618 ' HD3' ' CB ' ' A' ' 100' ' ' LEU . 14.8 ttmm -133.4 126.78 32.0 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.982 -0.748 . . . . 0.97 108.982 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 62' ' ' PRO . 39.0 pt -87.36 151.18 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.094 -0.642 . . . . 0.37 110.473 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.405 ' HA ' HD13 ' A' ' 100' ' ' LEU . 80.5 p -90.42 177.43 6.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.192 -0.458 . . . . 1.31 110.613 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.15 -16.78 67.21 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.695 -0.764 . . . . 0.33 112.088 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -69.65 -59.37 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.049 0.452 . . . . 0.27 110.381 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -43.64 98.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.733 . . . . 1.79 110.162 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.65 -47.32 86.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.075 -0.966 . . . . 0.32 111.35 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.27 -34.59 76.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.157 -0.312 . . . . 1.36 110.157 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.2 mtpt -58.04 -46.92 84.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 2.48 110.502 174.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -64.11 -44.72 91.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.885 -0.598 . . . . 2.16 110.254 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.611 ' HB3' HD22 ' A' ' 86' ' ' LEU . 94.5 mtp -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.589 . . . . 0.51 112.209 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.21 -24.82 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.944 -0.703 . . . . 1.34 110.664 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -75.5 -12.03 60.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.2 110.476 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -72.86 -14.93 61.6 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.49 -0.559 . . . . 0.91 109.49 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 68.25 29.96 5.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.133 -0.939 . . . . 2.37 111.455 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HB2' HD21 ' A' ' 86' ' ' LEU . 80.7 mt -104.56 154.88 38.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.537 -0.301 . . . . 1.35 110.651 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 40.4 Cg_endo -68.37 155.59 68.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.843 2.362 . . . . 0.44 112.558 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -66.06 -25.18 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.486 -0.325 . . . . 1.94 111.283 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.3 m -63.35 -52.69 60.71 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.937 0.399 . . . . 1.04 110.675 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 89' ' ' ILE . 84.8 t -62.76 -46.08 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.41 109.806 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.0 mt -59.94 -37.7 80.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.44 111.4 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.12 87.94 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.23 112.685 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 20.5 ptmt -66.54 -33.27 75.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.494 -0.482 . . . . 1.71 109.789 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.633 HG13 ' O ' ' A' ' 85' ' ' VAL . 83.8 mt -57.47 -50.04 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.722 -0.473 . . . . 0.4 109.722 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 34.1 t-105 -58.89 -49.92 75.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.545 -0.752 . . . . 0.46 111.133 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -65.41 -20.27 66.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.184 0.438 . . . . 2.4 112.184 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' A' ' 124' ' ' ALA . 29.7 mt -93.58 -35.63 12.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.863 0.363 . . . . 1.08 111.384 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.57 -16.39 36.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.054 -0.521 . . . . 0.3 112.058 -172.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -79.13 80.56 5.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.692 0.758 . . . . 0.45 109.83 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.78 -44.55 90.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.583 -1.189 . . . . 1.28 112.207 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 33.8 m-20 -70.63 -24.52 62.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.399 -0.364 . . . . 1.12 110.089 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 57.12 51.48 10.31 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.608 -0.886 . . . . 1.68 108.608 -169.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.591 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 18.2 p-10 -125.5 8.4 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.928 -1.033 . . . . 0.71 112.146 -167.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.82 -0.13 62.65 Favored Glycine 0 CA--C 1.507 -0.406 0 C-N-CA 120.441 -0.885 . . . . 0.39 112.785 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.618 ' CB ' ' HD3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -118.83 163.49 16.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.012 -0.736 . . . . 1.37 109.012 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 mt -115.69 110.02 18.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.423 -0.584 . . . . 0.34 109.423 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -76.43 -173.95 2.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.559 -0.746 . . . . 1.39 109.274 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -55.85 -44.91 78.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.694 -0.685 . . . . 1.69 111.239 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -81.63 -31.25 32.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.638 -0.71 . . . . 2.29 110.743 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.59 -47.43 66.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.39 110.338 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -65.92 -35.1 79.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.29 109.942 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -57.3 -49.79 74.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.002 -0.544 . . . . 0.34 110.693 174.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.52 HD23 HG21 ' A' ' 46' ' ' VAL . 12.9 mt -60.5 -43.95 96.5 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.59 -0.277 . . . . 1.74 111.509 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.34 -56.74 17.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.27 111.238 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -61.04 -33.68 73.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.7 111.28 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.614 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.8 t60 -62.86 -50.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.929 -0.578 . . . . 0.75 110.733 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.622 HD12 HG23 ' A' ' 89' ' ' ILE . 49.2 mt -63.17 -36.83 84.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.673 0.273 . . . . 0.27 110.447 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 109' ' ' ALA . 89.7 mt -56.95 -48.53 81.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.117 -0.492 . . . . 0.46 110.644 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 34.6 pttt -74.6 -24.1 58.82 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 120.678 -0.409 . . . . 1.81 110.879 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 111' ' ' HIS . 76.6 t -62.25 -39.71 85.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.498 -0.556 . . . . 0.91 109.498 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.893 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 2.4 mmmp? -67.19 -37.45 83.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 1.06 109.957 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.413 ' O ' HD13 ' A' ' 117' ' ' LEU . 1.5 tm? -64.68 -38.69 91.85 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 1.59 110.161 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 7.1 mm-40 -66.98 -9.0 34.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.152 -0.476 . . . . 2.05 110.55 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.82 35.19 5.69 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.961 -0.638 . . . . 0.68 112.417 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.541 ' HB2' HG12 ' A' ' 115' ' ' VAL . 57.6 m80 -121.78 -176.98 3.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 1.16 111.283 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -124.7 160.61 28.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 2.69 109.805 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.893 ' HG ' ' HD3' ' A' ' 116' ' ' LYS . 26.6 mt -104.51 115.33 62.99 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.252 -0.647 . . . . 1.21 109.252 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.09 2.88 7.91 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.256 2.637 . . . . 1.28 113.333 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.81 19.22 11.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.935 -0.575 . . . . 1.06 111.243 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -111.24 147.11 35.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.874 -0.603 . . . . 1.93 109.788 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 tp -125.05 94.23 44.19 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.325 -0.398 . . . . 1.85 110.382 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 25.7 Cg_exo -62.94 152.07 81.16 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.194 2.596 . . . . 0.9 112.11 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.09 -26.9 43.59 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.371 2.714 . . . . 1.02 113.822 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -99.85 5.84 45.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.781 -0.368 . . . . 1.14 111.129 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.45 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 3.8 mm? . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.704 -0.48 . . . . 1.34 109.704 171.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.267 0.556 . . . . 1.25 111.327 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.71 0.15 5.27 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 123.527 2.818 . . . . 0.49 113.892 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.35 -45.51 6.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 0.56 111.038 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 70.1 p . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 112.181 0.438 . . . . 1.89 112.181 -174.434 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.478 ' CZ3' ' HG3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 109.33 -0.619 . . . . 0.96 109.33 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.65 -36.67 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 1.33 110.75 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.433 HG21 HD23 ' A' ' 108' ' ' LEU . 39.6 t -76.94 -17.44 14.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.744 -0.662 . . . . 0.53 110.496 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -66.21 -14.86 62.35 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.78 112.989 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -73.77 -25.55 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 3.22 109.912 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -131.1 33.23 4.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.714 0.768 . . . . 2.39 109.342 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HB2' ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -79.46 -46.38 1.59 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.338 -0.846 . . . . 1.17 111.304 -177.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.62 -24.66 37.9 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.418 2.079 . . . . 0.65 112.715 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -46.69 64.21 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.447 0.641 . . . . 0.45 110.204 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.1 m-85 -75.1 -21.99 58.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.7 109.329 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.61 -38.85 64.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.422 -0.808 . . . . 0.73 109.16 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -54.02 -52.69 60.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.29 -0.868 . . . . 1.86 109.591 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.467 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.4 mt -62.3 -41.48 91.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.658 -0.701 . . . . 0.32 110.766 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -52.47 -42.82 64.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.616 -0.72 . . . . 0.39 111.476 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 4.7 m-85 -83.18 -22.44 33.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.935 0.346 . . . . 0.91 111.935 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.08 -7.62 58.29 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.546 -0.462 . . . . 0.58 111.161 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.1 mt -102.73 15.47 29.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 1.17 110.877 -177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m 61.19 78.4 0.32 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.14 111.127 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.723 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 94.2 Cg_endo -85.75 119.44 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.532 2.155 . . . . 1.1 112.241 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.57 132.86 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.93 -0.396 . . . . 1.66 109.93 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 48.39 25.37 0.88 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.926 0.89 . . . . 1.98 112.604 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.86 15.24 78.02 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.981 -0.628 . . . . 0.83 113.449 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.683 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 10.0 ttmm -141.54 126.26 18.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.543 -0.539 . . . . 0.97 109.543 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 62' ' ' PRO . 44.7 pt -94.04 146.06 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 121.709 -0.619 . . . . 0.37 111.191 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.815 ' HA ' HD23 ' A' ' 100' ' ' LEU . 9.7 t -76.74 157.69 31.5 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.001 -0.545 . . . . 1.31 110.115 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -16.84 38.46 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.156 -0.929 . . . . 0.33 114.232 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -61.83 -52.97 61.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.377 0.588 . . . . 0.27 110.903 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 18.6 m-80 -65.81 -43.21 89.36 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.101 0.477 . . . . 1.79 110.07 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.716 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.19 -49.19 78.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.297 -0.865 . . . . 0.32 110.792 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.732 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 84.0 tttt -61.56 -40.37 94.49 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.25 -0.432 . . . . 1.36 110.391 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.651 ' HA ' HG12 ' A' ' 77' ' ' VAL . 27.8 mtpt -64.8 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.927 -0.579 . . . . 2.48 111.6 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -70.67 -41.96 71.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.838 0.828 . . . . 2.16 109.465 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.766 ' HB3' HD22 ' A' ' 86' ' ' LEU . 69.7 mtp -65.86 -31.47 72.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.139 -0.937 . . . . 0.51 111.222 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.651 HG12 ' HA ' ' A' ' 74' ' ' LYS . 4.4 p -76.51 -27.5 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.599 -0.441 . . . . 1.34 110.759 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 84.2 mttt -64.02 -28.14 69.59 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.299 -0.56 . . . . 2.2 110.11 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 15.2 m -66.8 -26.78 67.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.562 -0.745 . . . . 0.91 111.071 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 79' ' ' SER . 95.8 mttt 71.74 22.45 3.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.861 -0.609 . . . . 2.37 112.213 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 81' ' ' LEU . 4.0 mm? -86.03 158.38 55.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.111 -0.7 . . . . 1.35 109.111 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.531 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 2.0 Cg_endo -76.05 160.9 36.31 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.434 2.09 . . . . 0.44 111.705 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.63 -23.04 66.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 1.94 110.253 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -58.82 -53.67 55.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.725 -0.671 . . . . 1.04 110.217 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 89' ' ' ILE . 54.4 t -72.65 -42.72 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.41 110.373 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.766 HD22 ' HB3' ' A' ' 76' ' ' MET . 67.3 mt -60.12 -39.26 85.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 0.44 110.489 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.95 79.72 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.856 -0.687 . . . . 0.23 111.859 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -51.49 -51.4 55.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.755 0.312 . . . . 1.71 110.735 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.7 mt -62.36 -49.08 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.615 -0.721 . . . . 0.4 110.748 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.466 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 51.3 t-105 -57.79 -50.29 73.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.235 -0.439 . . . . 0.46 111.764 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -81.08 -14.7 57.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.57 -0.452 . . . . 2.4 112.005 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -94.69 -27.39 15.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.926 0.393 . . . . 1.08 110.26 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.17 -42.33 12.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.157 -0.474 . . . . 0.3 111.609 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.52 71.78 4.02 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.589 -0.893 . . . . 0.45 108.589 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.68 -22.74 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.033 -0.985 . . . . 1.28 110.706 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.12 -23.66 51.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.69 -0.686 . . . . 1.12 109.936 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.4 mttt 57.78 49.25 12.48 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.173 -0.921 . . . . 1.68 111.483 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.687 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.6 p-10 -117.26 9.25 13.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.282 -0.872 . . . . 0.71 110.743 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.12 17.64 66.02 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.233 -0.747 . . . . 0.39 111.233 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.815 HD23 ' HA ' ' A' ' 68' ' ' THR . 33.2 mt -139.24 140.58 37.75 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.353 -0.924 . . . . 1.37 109.309 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.3 mt -110.43 114.95 28.78 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.022 0.439 . . . . 0.34 111.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.98 170.71 9.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.308 -0.997 . . . . 1.39 108.308 165.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.72 -27.27 69.15 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.558 . . . . 1.69 110.035 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.27 -52.74 44.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.391 0.615 . . . . 2.29 110.625 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.65 -35.36 77.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.39 110.898 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.72 -32.23 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.29 110.204 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.42 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -64.64 -44.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.679 -0.692 . . . . 0.34 110.212 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 95.4 mt -58.23 -47.46 83.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 1.74 110.365 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -53.54 -56.56 16.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.006 -0.543 . . . . 0.27 111.42 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -63.46 -35.65 81.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.7 111.53 -176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.25 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.75 110.557 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 115' ' ' VAL . 86.8 mt -76.31 -30.5 57.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 0.27 111.042 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 109' ' ' ALA . 82.7 mt -75.53 -41.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.061 -1.088 . . . . 0.46 108.061 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 29.9 ttmt -68.12 -40.71 82.45 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.056 -1.429 . . . . 1.81 110.718 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 120' ' ' HIS . 2.0 p -64.54 -37.55 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.115 -0.328 . . . . 0.91 110.115 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 28.7 mmmt -66.97 -42.74 84.62 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.73 -0.213 . . . . 1.06 110.513 173.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.89 -37.9 86.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 1.59 111.23 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 31.4 mm-40 -71.73 -5.02 30.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 2.05 111.239 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.11 36.23 6.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 0.68 112.584 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.568 ' HB2' HG22 ' A' ' 115' ' ' VAL . 66.2 m80 -118.44 170.34 9.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.59 -0.522 . . . . 1.16 109.59 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -115.48 132.65 56.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.948 0.404 . . . . 2.69 111.319 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 122' ' ' LEU . 1.7 pp -95.27 139.37 21.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.519 -0.549 . . . . 1.21 109.519 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.89 11.62 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.633 2.222 . . . . 1.28 113.348 -175.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.756 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 58.74 28.8 17.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.228 0.537 . . . . 1.06 110.419 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -130.51 164.84 23.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.551 -0.75 . . . . 1.93 109.79 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.734 HD23 HD12 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -125.37 88.66 53.84 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 109.514 -0.551 . . . . 1.85 109.514 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.537 ' HB2' HD23 ' A' ' 130' ' ' LEU . 55.2 Cg_exo -52.54 150.49 21.15 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.786 2.99 . . . . 0.9 113.586 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 73.4 Cg_exo -52.98 -30.32 48.13 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.386 2.724 . . . . 1.02 113.82 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -94.47 9.05 39.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.206 -0.597 . . . . 1.14 111.309 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 127' ' ' PRO . 3.8 mm? . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 1.34 110.742 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.49 0.662 . . . . 1.25 110.5 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.732 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 61.5 Cg_endo -72.07 0.4 7.3 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 123.445 2.763 . . . . 0.49 113.763 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.646 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 36.3 m-85 -95.74 -30.1 13.9 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.16 -0.338 . . . . 0.56 111.256 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 20.5 p . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 1.89 112.277 -175.085 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.2 t90 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.843 -0.799 . . . . 0.96 108.843 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -62.68 -17.22 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.726 -0.67 . . . . 1.33 112.678 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 t -73.22 -26.8 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.87 0.367 . . . . 0.53 110.697 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.04 9.58 52.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.139 -0.553 . . . . 0.78 112.91 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -86.54 -25.65 24.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.749 0.309 . . . . 3.22 111.062 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.44 36.26 1.33 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 2.39 110.152 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HA ' ' HD2' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -65.16 -43.49 66.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.095 -0.957 . . . . 1.17 112.121 -174.208 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 73.2 Cg_exo -52.68 -22.46 17.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.448 2.099 . . . . 0.65 114.197 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 m -72.65 -47.04 50.77 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.231 0.539 . . . . 0.45 110.231 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.521 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 8.5 m-85 -71.74 -22.5 61.61 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.529 -0.915 . . . . 0.7 108.529 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.532 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 15.0 t70 -69.4 -41.29 76.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.788 -1.096 . . . . 0.73 109.801 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.26 -53.8 53.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.987 -0.551 . . . . 1.86 109.594 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.6 mt -54.47 -43.21 62.76 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 CA-C-N 115.851 -0.613 . . . . 0.32 109.979 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.476 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 73.4 t80 -55.15 -55.05 35.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.482 -0.781 . . . . 0.39 111.55 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.614 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 38.4 m-85 -71.57 -21.18 61.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.217 0.451 . . . . 0.91 112.217 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -82.92 0.86 42.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.759 -0.376 . . . . 0.58 111.046 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 81.9 mt -104.67 6.38 34.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.17 110.372 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m 66.34 86.84 0.13 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.308 -0.86 . . . . 1.14 111.569 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -83.28 117.81 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.11 2.54 . . . . 1.1 112.192 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.5 t -90.15 118.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 1.66 109.586 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 63.19 23.23 13.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.808 -0.633 . . . . 1.98 110.711 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.87 12.55 66.09 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.872 -0.68 . . . . 0.83 113.05 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.652 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 11.4 ttmt -138.43 142.92 39.5 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.798 -0.445 . . . . 0.97 109.798 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.611 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 49.8 pt -100.32 153.11 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 0.37 111.097 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.643 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 15.5 p -88.74 160.89 17.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.48 -0.782 . . . . 1.31 110.938 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 72' ' ' ALA . . . -64.24 -8.65 31.72 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.649 -0.786 . . . . 0.33 113.172 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.12 -58.17 5.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.914 0.388 . . . . 0.27 110.996 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.611 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.0 OUTLIER -74.76 -31.27 61.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.376 -0.374 . . . . 1.79 110.587 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.2 -50.99 70.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.32 110.112 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -64.09 -33.07 74.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.197 -0.456 . . . . 1.36 110.137 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.55 -45.11 85.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 2.48 110.168 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.7 -51.76 67.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.979 -0.749 . . . . 2.16 108.979 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.705 ' HB3' HD22 ' A' ' 86' ' ' LEU . 77.8 mtp -60.48 -32.1 71.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.542 -0.754 . . . . 0.51 112.335 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -81.72 -20.46 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 O-C-N 121.927 -0.483 . . . . 1.34 110.811 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.54 -23.66 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.135 -0.32 . . . . 2.2 110.135 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -64.41 -23.4 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.91 110.083 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 67.95 33.41 4.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.447 -0.797 . . . . 2.37 111.531 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.7 mt -96.76 158.56 33.35 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.021 -0.536 . . . . 1.35 109.661 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HG2' HG23 ' A' ' 85' ' ' VAL . 38.3 Cg_endo -68.52 146.83 69.2 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.358 2.039 . . . . 0.44 112.229 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -58.72 -29.46 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.933 -0.576 . . . . 1.94 111.723 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.42 -52.93 63.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 1.04 110.375 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 89' ' ' ILE . 75.6 t -68.04 -42.02 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.56 -0.745 . . . . 0.41 110.169 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.705 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.9 mt -58.46 -46.63 86.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.44 111.458 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.461 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -63.32 -41.85 99.37 Favored Glycine 0 C--O 1.235 0.205 0 C-N-CA 120.827 -0.701 . . . . 0.23 111.483 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.585 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 39.9 ttmt -56.64 -46.77 80.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.219 -0.491 . . . . 1.71 110.298 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 85' ' ' VAL . 77.0 mt -63.02 -40.81 90.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 0.4 110.884 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.432 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 45.0 t-105 -61.85 -51.67 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.614 -0.266 . . . . 0.46 110.512 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.05 -21.14 66.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.427 -0.351 . . . . 2.4 111.799 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 77.7 mt -85.51 -54.02 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.947 0.403 . . . . 1.08 111.135 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.15 -34.07 72.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.31 -0.859 . . . . 0.3 111.711 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -87.58 93.24 9.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.363 0.601 . . . . 0.45 109.836 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 95' ' ' VAL . 2.7 m -74.12 -29.94 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 1.28 111.843 -174.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.61 -25.39 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.034 -0.53 . . . . 1.12 109.985 -178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.4 mttt 60.15 32.15 20.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.892 -1.049 . . . . 1.68 108.541 -171.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.534 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.4 p-10 -94.69 10.19 35.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.663 -1.153 . . . . 0.71 110.983 -172.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.16 20.58 62.99 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.369 -0.693 . . . . 0.39 111.369 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 14.9 mt -141.52 145.51 35.25 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.84 -0.68 . . . . 1.37 110.028 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.0 mt -115.56 118.18 32.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.866 0.365 . . . . 0.34 111.103 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.14 174.42 5.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.41 -0.959 . . . . 1.39 108.41 168.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -63.35 -32.62 74.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.959 -0.386 . . . . 1.69 109.959 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.98 -50.72 54.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 2.29 110.432 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.54 -44.15 97.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.39 110.69 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -69.82 -25.09 63.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.29 111.081 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.77 31.93 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.599 -0.889 . . . . 0.34 108.599 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.1 -36.5 79.88 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.347 -1.297 . . . . 1.74 110.057 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.46 33.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.27 110.712 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.51 -30.71 68.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.349 -0.387 . . . . 0.7 110.568 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.438 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 32.2 t60 -69.01 -39.17 79.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.75 110.552 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 115' ' ' VAL . 95.5 mt -71.66 -40.77 69.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.257 0.551 . . . . 0.27 110.318 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.588 HD11 ' HG2' ' A' ' 76' ' ' MET . 84.2 mt -58.29 -51.27 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 0.46 110.722 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.81 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 12.0 ptmm? -75.67 -24.34 56.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.58 -0.448 . . . . 1.81 111.121 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 112' ' ' LEU . 1.4 p -66.46 -34.28 69.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 120.024 -0.67 . . . . 0.91 109.246 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 27.8 mmmt -66.94 -43.67 82.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.25 -0.432 . . . . 1.06 110.001 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.25 -38.73 80.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 1.59 111.894 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.81 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 3.7 mm-40 -73.86 -7.15 51.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.695 -0.229 . . . . 2.05 110.825 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.46 10.48 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.518 -0.849 . . . . 0.68 113.123 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.509 ' HB2' HG22 ' A' ' 115' ' ' VAL . 77.6 m80 -105.84 172.96 6.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.885 0.374 . . . . 1.16 110.315 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 116' ' ' LYS . 7.4 tp10 -124.67 134.56 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.377 -0.601 . . . . 2.69 109.377 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.19 140.77 28.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.915 0.388 . . . . 1.21 110.26 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.47 1.23 7.65 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.387 2.724 . . . . 1.28 113.652 -172.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.14 22.72 12.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.164 0.507 . . . . 1.06 110.864 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.47 171.99 12.38 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.241 -0.651 . . . . 1.93 109.241 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 0.5 OUTLIER -125.61 89.07 53.18 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.834 0.349 . . . . 1.85 110.603 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 32.5 Cg_endo -66.34 155.96 67.44 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.952 2.435 . . . . 0.9 111.865 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 75.5 Cg_exo -50.3 -34.19 39.51 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.599 2.866 . . . . 1.02 114.298 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -88.32 14.4 9.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.612 -0.435 . . . . 1.14 111.931 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.3 mt . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 1.34 111.185 177.294 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 5.1 p-10 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.007 0.432 . . . . 1.25 110.872 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 14.9 Cg_exo -70.86 -2.18 10.56 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.219 2.613 . . . . 0.49 113.48 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.461 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 40.1 m-85 -102.54 -23.31 13.9 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.244 -0.285 . . . . 0.56 111.376 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.458 0.647 . . . . 1.89 111.155 175.532 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 110.031 -0.359 . . . . 0.96 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.44 -42.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 1.33 111.826 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.02 -5.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.072 -0.513 . . . . 0.53 111.042 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.37 -15.85 75.2 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.248 -1.141 . . . . 0.78 110.248 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -80.28 -29.86 38.3 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.735 -0.733 . . . . 3.22 111.226 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -124.39 34.64 4.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.723 . . . . 2.39 109.824 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 22.1 ttpp -79.11 -43.98 1.72 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.79 -1.095 . . . . 1.17 112.031 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 12.4 Cg_exo -39.15 -40.72 1.8 Allowed 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 123.43 2.753 . . . . 0.65 115.015 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 56' ' ' ILE . 67.4 m -69.47 -43.96 72.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.995 0.426 . . . . 0.45 110.515 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -71.24 -22.16 62.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.224 -0.658 . . . . 0.7 109.224 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.93 -41.2 71.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.872 . . . . 0.73 109.595 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.71 -45.32 93.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 1.86 109.713 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 63.9 mt -58.7 -43.52 87.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 0.32 110.454 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -54.38 -38.46 66.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.533 -0.758 . . . . 0.39 111.011 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.567 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 49.1 m-85 -98.83 7.84 45.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.004 0.742 . . . . 0.91 113.004 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 56' ' ' ILE . 2.6 p -109.9 -3.02 16.85 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.791 -0.364 . . . . 0.58 110.935 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 3.8 pp -118.13 18.56 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.398 -0.365 . . . . 1.17 111.343 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 m 74.85 90.82 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.051 -0.977 . . . . 1.14 111.939 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.766 ' HA ' HG22 ' A' ' 67' ' ' ILE . 97.0 Cg_endo -92.95 125.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.947 2.431 . . . . 1.1 111.976 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.21 113.0 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 1.66 109.691 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 48.48 26.95 1.28 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.072 0.949 . . . . 1.98 113.029 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 11.34 58.05 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.916 -0.659 . . . . 0.83 113.345 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 8.6 ttmm -140.46 126.56 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.927 -0.768 . . . . 0.97 108.927 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 62' ' ' PRO . 36.7 pt -95.97 141.49 15.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.128 -0.629 . . . . 0.37 111.141 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.77 ' HA ' HD23 ' A' ' 100' ' ' LEU . 3.6 t -79.88 158.54 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.711 -0.677 . . . . 1.31 110.75 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.84 -23.14 21.27 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.496 -0.775 . . . . 0.33 113.414 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.19 -55.93 27.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 0.27 111.113 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.522 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 42.2 m-80 -78.25 -28.91 47.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.379 . . . . 1.79 110.634 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.649 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.85 -52.88 61.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 0.32 110.09 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.616 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 86.1 tttt -61.69 -35.43 77.98 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.559 -0.291 . . . . 1.36 110.432 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 26.2 ttpp -54.39 -46.16 73.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.228 0.537 . . . . 2.48 110.457 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -67.6 -41.44 84.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 2.16 110.234 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.785 ' HB3' HD22 ' A' ' 86' ' ' LEU . 72.8 mtp -67.66 -28.41 67.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.897 -0.592 . . . . 0.51 112.012 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.51 -16.17 11.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 O-C-N 121.857 -0.527 . . . . 1.34 110.638 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 99.0 mttt -75.59 -22.47 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.254 0.549 . . . . 2.2 109.626 168.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -73.78 -11.99 60.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.691 -0.686 . . . . 0.91 111.331 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt 63.92 37.14 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.153 -0.476 . . . . 2.37 111.697 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 86' ' ' LEU . 84.1 mt -106.16 153.15 40.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 1.35 110.696 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 43.7 Cg_endo -67.8 152.65 77.23 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.164 2.576 . . . . 0.44 112.604 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -57.35 -34.63 69.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.863 -0.608 . . . . 1.94 111.942 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.7 m -58.05 -54.13 50.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.14 0.495 . . . . 1.04 111.365 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.459 HG23 ' HG2' ' A' ' 82' ' ' PRO . 60.6 t -67.11 -38.95 82.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.41 110.402 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 76' ' ' MET . 88.9 mt -59.59 -46.61 88.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.44 110.795 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.17 -42.6 97.24 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.263 -0.494 . . . . 0.23 112.079 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 66.5 mttm -55.6 -53.6 54.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.843 0.354 . . . . 1.71 110.279 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.49 -36.71 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 0.4 110.364 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.468 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 74.4 t-105 -61.11 -56.45 20.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.46 111.182 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.71 -0.88 28.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.057 0.392 . . . . 2.4 112.057 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 74.9 mt -94.37 -46.95 6.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.031 0.443 . . . . 1.08 110.523 169.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.57 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -72.05 -36.21 69.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.531 -0.758 . . . . 0.3 111.175 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -86.71 70.42 10.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.896 0.855 . . . . 0.45 109.947 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.7 -15.63 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.542 -1.208 . . . . 1.28 110.826 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -18.27 40.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.724 -1.126 . . . . 1.12 110.171 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 61.58 35.66 17.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.089 -0.96 . . . . 1.68 111.144 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.693 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.3 p-10 -116.64 7.99 13.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.916 -0.584 . . . . 0.71 111.64 -172.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.16 10.53 59.62 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.326 -0.71 . . . . 0.39 111.326 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.77 HD23 ' HA ' ' A' ' 68' ' ' THR . 87.1 mt -133.68 141.19 47.48 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.726 -0.737 . . . . 1.37 109.182 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.1 mt -109.99 113.13 25.59 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.984 0.421 . . . . 0.34 111.022 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.58 172.26 7.65 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.963 -0.754 . . . . 1.39 108.963 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.2 -32.27 72.03 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.825 -0.35 . . . . 1.69 110.701 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -66.35 -51.52 56.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.884 0.374 . . . . 2.29 110.497 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -62.39 -41.5 98.69 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.925 -0.58 . . . . 0.39 110.645 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 66.3 t80 -70.53 -23.82 62.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.749 -0.659 . . . . 0.29 110.96 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.79 32.89 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.579 -0.897 . . . . 0.34 108.579 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 93' ' ' ALA . 29.6 tp -59.41 -39.79 84.58 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.627 -1.17 . . . . 1.74 109.772 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -59.07 -55.44 35.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.011 -0.54 . . . . 0.27 111.189 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -33.63 75.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.287 -0.415 . . . . 0.7 111.426 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -63.5 -44.04 95.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.75 109.932 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.71 -39.2 90.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.27 110.655 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.2 mt -60.14 -53.51 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.63 . . . . 0.46 111.385 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 16.0 pttp -70.9 -26.84 63.4 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 120.584 -0.446 . . . . 1.81 110.209 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.707 HG13 ' HB2' ' A' ' 120' ' ' HIS . 2.6 t -56.6 -48.76 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.665 -0.495 . . . . 0.91 109.665 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -62.29 -46.15 90.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.223 -0.444 . . . . 1.06 111.051 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 8.9 mp -59.36 -38.22 79.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 1.59 111.822 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 12.2 mm-40 -81.92 6.63 15.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.529 -0.305 . . . . 2.05 111.799 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 27.84 27.9 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.915 -0.66 . . . . 0.68 112.913 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.707 ' HB2' HG13 ' A' ' 115' ' ' VAL . 52.6 m80 -109.69 119.59 39.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.776 -0.453 . . . . 1.16 109.776 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -83.25 106.37 14.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.995 0.426 . . . . 2.69 110.845 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 122' ' ' LEU . 3.1 pp -68.66 146.98 97.95 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 1.21 110.34 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.5 Cg_endo -83.21 -1.86 10.47 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.911 2.408 . . . . 1.28 112.671 -173.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.83 19.24 11.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.774 -0.648 . . . . 1.06 111.322 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -115.63 165.99 12.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.142 -1.058 . . . . 1.93 108.142 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 29.0 tp -118.34 95.35 48.48 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 120.481 -0.487 . . . . 1.85 110.628 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 18.1 Cg_endo -61.66 150.37 85.89 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.767 2.312 . . . . 0.9 112.255 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 52.0 Cg_exo -55.74 -25.44 51.37 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.713 2.942 . . . . 1.02 113.578 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -86.27 3.92 41.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.68 0.252 . . . . 1.14 111.68 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--N 1.329 -0.296 0 O-C-N 122.352 -0.217 . . . . 1.34 111.486 177.501 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.787 0.327 . . . . 1.25 110.121 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.616 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.8 Cg_exo -76.51 -2.35 12.55 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.566 2.844 . . . . 0.49 113.488 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.468 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 15.4 m-85 -98.18 -9.68 25.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.188 0.518 . . . . 0.56 110.077 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 1.89 111.138 175.794 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.553 -0.536 . . . . 0.96 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.76 -23.09 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.427 -0.806 . . . . 1.33 112.625 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG21 HD23 ' A' ' 108' ' ' LEU . 21.2 t -82.27 -10.72 12.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.07 0.462 . . . . 0.53 110.708 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.09 -23.83 69.92 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.118 -0.563 . . . . 0.78 113.176 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -73.89 -23.38 59.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.913 0.387 . . . . 3.22 111.549 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -134.13 32.95 3.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.965 0.888 . . . . 2.39 109.648 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 11.3 ttpp -82.99 -44.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.232 -0.895 . . . . 1.17 110.841 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 84.6 Cg_exo -49.37 -28.0 14.67 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.533 2.155 . . . . 0.65 113.574 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 m -69.28 -47.08 65.62 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.349 0.595 . . . . 0.45 109.987 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -75.85 -20.63 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.723 -0.843 . . . . 0.7 108.723 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 14.7 t70 -70.03 -42.04 73.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.885 -1.052 . . . . 0.73 109.431 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.31 -41.01 97.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.62 . . . . 1.86 109.808 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.3 -34.78 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.395 0.616 . . . . 0.32 110.283 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.94 -48.13 83.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.228 -0.896 . . . . 0.39 111.021 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.477 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 64.9 m-85 -73.81 -22.49 59.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.039 0.385 . . . . 0.91 112.039 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -85.24 1.73 46.95 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.508 -0.477 . . . . 0.58 111.16 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.9 mt -106.42 3.29 27.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.17 110.473 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.3 m 67.08 80.98 0.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.47 -0.786 . . . . 1.14 111.068 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 83.3 Cg_endo -88.63 111.23 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.804 2.336 . . . . 1.1 112.567 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.07 121.9 39.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.139 -0.482 . . . . 1.66 109.971 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 65.29 23.59 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.48 0.488 . . . . 1.98 110.846 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.58 22.79 59.49 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.83 112.528 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -137.71 142.14 41.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.625 0.25 . . . . 0.97 110.487 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.656 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 42.9 pt -104.78 132.83 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.215 -0.661 . . . . 0.37 109.215 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -73.39 162.42 29.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.119 -0.491 . . . . 1.31 109.841 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.485 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -63.08 -11.54 39.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.967 -0.635 . . . . 0.33 114.08 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.73 -63.25 1.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.489 0.644 . . . . 0.27 111.006 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.656 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 2.7 p30 -71.73 -29.42 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 1.79 110.9 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.14 -51.05 70.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.337 -0.392 . . . . 0.32 110.502 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -61.78 -34.74 76.43 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.938 -0.393 . . . . 1.36 109.938 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.551 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 36.1 ttmt -57.87 -45.8 85.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 2.48 110.994 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.862 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -65.87 -36.37 83.24 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.286 0.565 . . . . 2.16 110.007 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.529 ' HB3' HD22 ' A' ' 86' ' ' LEU . 90.7 mtp -67.75 -34.29 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.51 111.36 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.2 m -81.49 -15.38 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.872 -0.331 . . . . 1.34 110.822 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.862 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 50.2 mtpt -72.79 -28.95 62.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.922 -0.769 . . . . 2.2 108.922 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.0 m -68.51 -29.73 68.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.963 -1.017 . . . . 0.91 110.306 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 70.6 26.3 4.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.372 -0.831 . . . . 2.37 112.48 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.07 159.87 67.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.269 -0.641 . . . . 1.35 109.269 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.86 142.22 92.64 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.659 2.24 . . . . 0.44 112.32 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.76 -31.05 58.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.859 -0.61 . . . . 1.94 111.763 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p -63.54 -51.33 65.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.947 0.403 . . . . 1.04 111.139 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.536 HG11 ' HG2' ' A' ' 116' ' ' LYS . 98.2 t -66.83 -41.5 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 0.41 110.317 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.531 ' HB3' ' CE1' ' B' ' 151' ' ' PHE . 75.2 mt -58.09 -43.07 86.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 0.44 110.797 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 91' ' ' LYS . . . -61.03 -43.84 98.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.042 -0.599 . . . . 0.23 111.939 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.542 ' HE3' HD11 ' A' ' 122' ' ' LEU . 53.5 mtmt -57.21 -42.63 81.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.39 . . . . 1.71 110.437 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.0 mt -64.76 -42.21 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.615 . . . . 0.4 109.972 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.596 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 75.2 t-105 -62.09 -51.78 66.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.28 -0.873 . . . . 0.46 111.185 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 87' ' ' GLY . 31.0 mmmt -70.14 -18.15 63.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 2.4 111.907 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.863 HD11 ' HA ' ' A' ' 124' ' ' ALA . 92.7 mt -90.71 -45.58 8.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 1.08 111.501 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.91 63.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 0.3 111.301 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -95.55 95.24 8.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.496 0.665 . . . . 0.45 110.77 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 m -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.095 -0.957 . . . . 1.28 111.806 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 23.5 m-20 -76.36 -25.28 54.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.121 -0.49 . . . . 1.12 110.837 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttt 62.16 34.29 16.33 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 124.124 0.89 . . . . 1.68 109.434 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 13.7 p-10 -129.64 8.19 5.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.349 -0.387 . . . . 0.71 111.949 -173.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.41 12.47 76.94 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.686 -0.768 . . . . 0.39 113.247 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.47 126.98 55.9 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.586 -0.361 . . . . 1.37 110.138 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.435 HD22 ' HB3' ' A' ' 105' ' ' GLU . 36.2 mt -102.93 112.86 25.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.34 111.323 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.78 170.12 11.64 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.495 -0.928 . . . . 1.39 108.495 167.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.73 -30.6 71.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.926 0.393 . . . . 1.69 110.67 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -67.26 -46.92 72.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.061 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 101' ' ' LEU . 47.9 mt-10 -65.19 -41.47 94.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.274 -0.875 . . . . 0.39 110.952 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.528 ' CD1' HD11 ' A' ' 67' ' ' ILE . 47.3 t80 -65.84 -33.23 75.37 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.017 -0.538 . . . . 0.29 110.094 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.17 95.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.34 110.192 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 46' ' ' VAL . 92.0 mt -62.53 -41.68 99.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 1.74 110.633 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.13 -55.46 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.27 111.089 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -62.37 -37.19 84.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.7 110.913 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.51 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.7 t60 -58.29 -50.06 74.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.416 . . . . 0.75 110.832 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.99 -29.57 70.72 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.883 0.373 . . . . 0.27 111.265 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 109' ' ' ALA . 85.0 mt -75.18 -42.51 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.537 0.684 . . . . 0.46 109.468 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -65.24 -36.12 83.15 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.821 -1.081 . . . . 1.81 110.79 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 111' ' ' HIS . 68.6 t -60.87 -54.2 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.748 0.309 . . . . 0.91 110.455 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.536 ' HG2' HG11 ' A' ' 85' ' ' VAL . 40.7 tptt -55.35 -48.25 74.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.403 -0.362 . . . . 1.06 111.619 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.48 -40.05 81.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 1.59 112.03 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.97 7.78 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.037 0.384 . . . . 2.05 112.037 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.47 35.54 6.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.552 -0.832 . . . . 0.68 112.966 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -121.83 -168.99 1.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.449 -0.442 . . . . 1.16 110.066 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -139.55 150.44 45.08 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.213 -0.662 . . . . 2.69 109.213 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.542 HD11 ' HE3' ' A' ' 88' ' ' LYS . 0.9 OUTLIER -104.01 129.39 25.3 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.667 -0.494 . . . . 1.21 109.667 178.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 6.64 2.19 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.271 2.647 . . . . 1.28 113.832 -169.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.863 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 58.77 28.67 17.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.389 -0.369 . . . . 1.06 111.416 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -112.34 171.25 7.63 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.043 0.449 . . . . 1.93 110.084 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.66 86.67 55.47 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.38 -0.97 . . . . 1.85 108.38 168.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 80.7 Cg_exo -48.68 141.08 21.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.999 2.466 . . . . 0.9 112.126 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 52.1 Cg_exo -55.24 -31.27 75.61 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.94 2.427 . . . . 1.02 112.664 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -91.51 12.94 19.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.755 -0.378 . . . . 1.14 111.43 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.3 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 1.34 110.847 173.123 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 9.5 t70 . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 110.075 -0.343 . . . . 1.25 110.075 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.9 Cg_exo -74.85 -2.01 11.93 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.471 2.781 . . . . 0.49 113.627 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.596 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 20.0 m-85 -99.17 -12.86 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.441 . . . . 0.56 110.359 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.847 -0.615 . . . . 1.89 110.584 177.27 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.585 ' HZ3' ' HD3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.067 -0.716 . . . . 0.96 109.067 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.672 HG22 HD21 ' A' ' 130' ' ' LEU . 21.2 m -62.71 -14.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 1.33 112.398 -172.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.509 ' HB ' ' CZ3' ' A' ' 44' ' ' TRP . 15.7 t -90.75 -11.07 9.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.482 . . . . 0.53 110.252 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.568 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -70.39 -10.42 66.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.171 -0.538 . . . . 0.78 112.673 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -75.67 -27.75 58.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.045 0.45 . . . . 3.22 110.435 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.8 34.0 4.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.961 0.886 . . . . 2.39 109.332 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HD3' ' HZ3' ' A' ' 44' ' ' TRP . 0.7 OUTLIER -70.17 -52.45 12.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.861 -1.063 . . . . 1.17 111.825 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.09 -24.48 58.43 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.041 1.827 . . . . 0.65 113.667 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -69.07 -45.76 69.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.682 -0.69 . . . . 0.45 109.895 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 6.7 m-85 -74.18 -21.59 59.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.677 -0.692 . . . . 0.7 109.385 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.73 110.208 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.28 -44.19 95.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.86 110.046 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 61.0 mt -68.82 -36.79 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.32 110.546 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' TYR . 51.8 t80 -59.31 -52.32 66.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.39 110.931 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.683 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 33.5 m-85 -76.81 -11.4 59.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.57 0.582 . . . . 0.91 112.57 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 p -93.5 2.98 56.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.58 110.812 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 82.2 mt -101.11 1.32 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.005 -0.543 . . . . 1.17 110.386 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m 69.45 85.07 0.13 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 115.496 -0.775 . . . . 1.14 111.103 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.683 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.8 Cg_endo -86.28 150.66 9.25 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.145 2.563 . . . . 1.1 112.539 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.36 119.8 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 1.66 110.532 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 60.46 27.0 16.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.747 -0.66 . . . . 1.98 111.267 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.28 4.9 83.34 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.734 -0.745 . . . . 0.83 112.65 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.699 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 58.1 mttm -123.32 148.48 45.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.35 -0.241 . . . . 0.97 110.35 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.701 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 40.9 pt -112.45 128.52 69.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.723 -0.473 . . . . 0.37 109.723 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.521 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 8.2 t -70.97 161.74 30.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.029 -0.532 . . . . 1.31 110.252 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -7.02 10.02 Favored Glycine 0 C--O 1.223 -0.534 0 CA-C-N 115.624 -0.716 . . . . 0.33 113.992 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 -64.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.479 0.64 . . . . 0.27 110.816 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.701 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 4.0 p30 -68.52 -34.06 75.21 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.848 0.356 . . . . 1.79 110.555 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -59.2 -52.6 64.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.012 -0.54 . . . . 0.32 110.54 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.814 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.3 tttt -62.11 -35.51 78.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.535 -0.302 . . . . 1.36 110.658 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -53.77 -49.97 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.962 0.41 . . . . 2.48 110.468 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -66.52 -38.28 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.003 0.43 . . . . 2.16 110.54 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.824 ' HB3' HD22 ' A' ' 86' ' ' LEU . 93.0 mtp -64.99 -38.22 90.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 0.51 111.356 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.41 -16.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 1.34 110.668 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.74 -12.53 50.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.072 0.463 . . . . 2.2 110.327 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -77.54 -4.92 48.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.689 -0.687 . . . . 0.91 110.135 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.97 22.02 8.7 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.597 -0.729 . . . . 2.37 112.135 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' HD21 ' A' ' 86' ' ' LEU . 87.8 mt -93.84 153.92 40.93 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 1.35 110.36 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 85' ' ' VAL . 57.0 Cg_endo -72.41 160.52 46.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.835 2.357 . . . . 0.44 112.526 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -55.45 -34.46 64.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.761 -0.654 . . . . 1.94 111.092 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -57.39 -59.2 5.49 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.863 -0.608 . . . . 1.04 111.288 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.508 HG23 ' HG2' ' A' ' 82' ' ' PRO . 65.9 t -64.5 -45.15 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.572 -0.74 . . . . 0.41 110.657 -177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.824 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.1 mt -60.65 -42.76 97.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.815 0.34 . . . . 0.44 110.864 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -61.37 -46.29 94.69 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.002 -0.544 . . . . 0.23 112.642 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 19.3 ptmt -72.17 -35.22 68.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.37 -0.532 . . . . 1.71 110.917 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.471 HG23 HD12 ' A' ' 112' ' ' LEU . 46.8 mt -60.65 -41.08 86.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.996 -0.372 . . . . 0.4 109.996 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' B' ' 149' ' ' ASP . 49.6 t-105 -64.25 -48.9 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.46 110.541 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -58.5 -24.78 61.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.929 -0.578 . . . . 2.4 111.878 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 31.8 mt -92.41 -52.16 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.353 . . . . 1.08 111.281 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.03 73.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.539 -0.755 . . . . 0.3 112.097 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -86.93 94.75 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.455 0.645 . . . . 0.45 109.358 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.91 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.323 -0.853 . . . . 1.28 111.381 -171.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -10.71 59.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 1.12 109.402 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 45.92 46.42 12.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.081 0.863 . . . . 1.68 109.873 -172.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -109.49 5.33 23.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.71 111.676 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.491 ' C ' HD12 ' A' ' 100' ' ' LEU . . . 84.77 -4.88 84.03 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.307 -0.717 . . . . 0.39 111.307 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mp -122.41 142.89 50.05 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.151 -0.524 . . . . 1.37 110.153 177.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.53 115.22 28.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.89 -0.782 . . . . 0.34 108.89 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 175.79 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.848 -0.797 . . . . 1.39 108.848 167.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -56.67 -40.39 75.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.221 0.534 . . . . 1.69 110.735 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.52 -33.18 62.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 2.29 110.631 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.34 -41.72 69.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.39 110.373 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -67.54 -32.27 72.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.807 -0.633 . . . . 0.29 109.439 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -60.83 -46.75 89.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 0.34 110.86 173.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 82.5 mt -61.84 -42.75 99.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.375 -0.375 . . . . 1.74 110.635 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.36 -57.17 13.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.27 110.901 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -61.47 -34.22 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.7 111.197 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.415 ' O ' HG23 ' A' ' 115' ' ' VAL . 59.3 t60 -65.41 -46.2 80.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.75 110.179 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.471 HD12 HG23 ' A' ' 89' ' ' ILE . 79.9 mt -60.43 -40.8 92.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.91 0.386 . . . . 0.27 110.264 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 109' ' ' ALA . 83.8 mt -61.13 -54.38 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.38 -0.827 . . . . 0.46 111.065 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.667 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 14.8 ptpt -67.37 -33.85 76.08 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.051 -0.659 . . . . 1.81 111.23 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 111' ' ' HIS . 39.9 t -58.92 -50.4 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.127 -0.323 . . . . 0.91 110.127 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -53.96 -48.81 69.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.884 0.374 . . . . 1.06 111.096 172.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.01 -20.16 65.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.389 0.515 . . . . 1.59 112.389 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.667 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.1 mt-10 -76.59 -6.22 51.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.83 0.348 . . . . 2.05 110.626 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.75 27.51 14.27 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.178 -0.769 . . . . 0.68 111.178 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -113.27 -176.98 3.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 1.16 109.865 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -123.94 142.31 51.26 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.612 -0.885 . . . . 2.69 108.612 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -85.07 141.24 37.39 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.449 -0.341 . . . . 1.21 110.321 -179.092 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 39.3 Cg_exo -58.54 -16.44 29.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.438 2.759 . . . . 1.28 114.197 -170.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.34 18.03 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.701 0.626 . . . . 1.06 110.992 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -135.58 173.63 11.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.717 -0.674 . . . . 1.93 109.548 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.54 95.76 44.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.608 -0.516 . . . . 1.85 109.608 174.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 51.2 Cg_exo -54.1 147.47 43.91 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.221 2.614 . . . . 0.9 112.847 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 41.9 Cg_exo -58.42 -25.19 72.42 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.196 2.597 . . . . 1.02 112.763 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -85.79 3.34 41.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.458 -0.337 . . . . 1.14 111.03 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.672 HD21 HG22 ' A' ' 45' ' ' VAL . 31.2 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 1.34 111.385 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.9 p30 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.163 0.506 . . . . 1.25 110.906 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.814 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 14.3 Cg_exo -69.57 0.49 5.43 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.666 2.911 . . . . 0.49 113.69 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.495 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 28.5 m-85 -97.47 -45.93 6.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.006 0.431 . . . . 0.56 110.312 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 76.4 p . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 121.561 0.696 . . . . 1.89 110.35 -179.745 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 112.349 0.5 . . . . 0.96 112.349 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.49 -7.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.888 0.851 . . . . 1.33 109.035 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 t -96.83 -11.93 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.887 -1.051 . . . . 0.53 109.802 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.67 -23.68 69.09 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.773 -0.649 . . . . 0.78 112.996 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -74.35 -27.32 60.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.999 0.428 . . . . 3.22 110.67 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.39 31.39 5.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 2.39 109.637 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -75.81 -56.44 1.73 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.51 -0.314 . . . . 1.17 111.692 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.555 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 51.0 Cg_endo -66.94 -14.75 44.87 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.707 1.605 . . . . 0.65 112.569 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.41 -46.59 63.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.548 0.689 . . . . 0.45 109.177 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 13.5 m-85 -80.82 -20.8 41.65 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.453 -0.794 . . . . 0.7 109.922 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 11.2 t70 -66.29 -44.55 83.18 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.212 -0.662 . . . . 0.73 109.212 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.93 -50.89 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.86 110.229 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.51 -38.81 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.062 -0.517 . . . . 0.32 110.338 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.49 ' HE1' HG12 ' A' ' 67' ' ' ILE . 65.2 t80 -56.72 -47.56 79.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.317 -0.856 . . . . 0.39 111.134 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -76.09 -22.36 55.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.27 0.471 . . . . 0.91 112.27 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.45 -6.71 57.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.6 -0.44 . . . . 0.58 111.032 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.14 0.73 38.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 1.17 111.228 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m 69.65 88.15 0.1 Allowed Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 123.84 0.713 . . . . 1.14 111.201 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.0 136.27 5.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.809 2.34 . . . . 1.1 112.438 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.3 m -107.71 115.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.113 0.482 . . . . 1.66 110.828 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 58.0 28.33 16.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.717 -0.674 . . . . 1.98 112.016 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.88 -2.4 69.4 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.94 -0.648 . . . . 0.83 113.352 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 57.3 mttm -127.11 142.25 51.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.501 -0.411 . . . . 0.97 110.546 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.49 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -99.06 138.67 22.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.201 -0.666 . . . . 0.37 109.201 170.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.752 ' HA ' HD23 ' A' ' 100' ' ' LEU . 1.1 p -71.53 164.55 25.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.254 -0.43 . . . . 1.31 111.067 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.56 -25.25 41.97 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 115.719 -0.673 . . . . 0.33 113.175 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.26 -42.91 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.27 111.074 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.756 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 25.6 m-80 -76.72 -43.03 39.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.14 0.495 . . . . 1.79 110.234 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.54 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.98 -41.15 86.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.022 -0.99 . . . . 0.32 110.516 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.723 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.6 tttt -70.59 -35.93 73.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.009 -0.541 . . . . 1.36 110.122 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.756 ' HE2' ' HA ' ' A' ' 71' ' ' ASN . 52.3 mtmt -54.45 -46.37 73.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.906 0.384 . . . . 2.48 110.203 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.76 -52.54 63.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.693 -0.685 . . . . 2.16 110.176 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.54 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 32.8 mtt -56.23 -41.96 76.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.128 0.49 . . . . 0.51 112.01 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 73' ' ' LYS . 99.6 t -68.74 -31.17 49.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.707 -0.678 . . . . 1.34 110.72 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 98.4 mttt -71.53 -28.15 63.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.88 0.371 . . . . 2.2 110.348 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 m -74.17 -15.07 61.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.91 111.122 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 73.15 24.38 2.47 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.821 0.674 . . . . 2.37 112.821 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.685 ' HB2' HD21 ' A' ' 86' ' ' LEU . 3.9 mm? -87.84 158.15 50.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.655 -0.418 . . . . 1.35 110.271 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HG2' HG23 ' A' ' 85' ' ' VAL . 73.5 Cg_endo -76.31 157.21 37.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.125 2.55 . . . . 0.44 113.274 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -53.69 -42.99 68.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.661 -0.7 . . . . 1.94 111.703 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 p -55.78 -56.88 15.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.235 0.54 . . . . 1.04 111.785 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 82' ' ' PRO . 87.9 t -62.39 -45.15 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.81 -0.632 . . . . 0.41 111.171 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 81' ' ' LEU . 70.3 mt -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.44 110.376 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.94 -48.07 79.61 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.02 -0.536 . . . . 0.23 112.48 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 40.9 pttt -74.05 -33.68 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 1.71 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.434 HG23 HD12 ' A' ' 112' ' ' LEU . 43.5 mt -60.66 -41.44 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.851 -0.425 . . . . 0.4 109.851 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -60.88 -48.75 80.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.46 110.377 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -67.84 -14.03 62.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.055 0.391 . . . . 2.4 112.055 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 61.5 mt -93.31 -51.18 5.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.331 . . . . 1.08 110.79 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.03 -33.66 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.775 . . . . 0.3 111.544 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -84.32 86.26 7.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.672 0.748 . . . . 0.45 109.494 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.66 -30.62 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.562 -1.199 . . . . 1.28 112.405 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.433 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 2.7 m-20 -72.78 -24.34 60.92 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 116.514 -0.312 . . . . 1.12 110.265 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 mttt 58.37 40.33 24.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.277 -1.008 . . . . 1.68 108.277 -167.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.602 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 p-10 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.995 -1.002 . . . . 0.71 111.22 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.65 22.16 65.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.72 . . . . 0.39 111.793 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 68' ' ' THR . 15.3 mt -140.67 143.95 35.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.503 -0.555 . . . . 1.37 109.503 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.495 HD22 ' HB3' ' A' ' 105' ' ' GLU . 71.0 mt -121.56 114.2 20.86 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.451 0.469 . . . . 0.34 109.973 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -79.19 -177.57 5.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.971 -0.752 . . . . 1.39 108.971 169.71 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.65 -30.85 69.03 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.985 -0.286 . . . . 1.69 111.385 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.36 -58.05 3.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.075 -0.343 . . . . 2.29 110.075 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.495 ' HB3' HD22 ' A' ' 101' ' ' LEU . 38.6 mt-10 -56.94 -39.71 75.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.323 0.582 . . . . 0.39 110.653 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.75 -29.43 66.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.549 -0.751 . . . . 0.29 110.945 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.47 -42.23 30.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.918 0.866 . . . . 0.34 108.925 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.505 -1.225 . . . . 1.74 110.044 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.18 -52.02 67.32 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.965 -0.561 . . . . 0.27 110.754 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -61.97 -27.09 68.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.7 111.668 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.474 ' O ' HG23 ' A' ' 115' ' ' VAL . 21.9 t60 -67.19 -47.18 71.7 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 0.75 109.841 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.434 HD12 HG23 ' A' ' 89' ' ' ILE . 87.6 mt -62.48 -41.88 99.09 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.996 0.427 . . . . 0.27 110.234 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 109' ' ' ALA . 73.6 mt -61.22 -50.77 79.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.46 111.313 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 45.4 pttt -73.48 -21.42 60.44 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 120.336 -0.545 . . . . 1.81 110.236 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 111' ' ' HIS . 2.8 t -58.96 -46.45 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.638 -0.504 . . . . 0.91 109.638 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 13.1 mmmm -72.73 -31.98 65.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.397 -0.365 . . . . 1.06 111.249 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.43 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 37.0 tp -65.41 -42.0 93.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 1.59 111.317 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 80.8 mm-40 -69.98 -26.01 63.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.027 0.441 . . . . 2.05 110.619 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.33 34.48 3.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.653 -0.784 . . . . 0.68 112.65 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.66 177.24 4.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.962 -0.384 . . . . 1.16 109.962 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.79 149.41 24.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.832 0.349 . . . . 2.69 111.631 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 122' ' ' LEU . 1.4 pp -124.91 130.67 24.14 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.117 -0.697 . . . . 1.21 109.117 167.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 -13.62 20.19 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.689 2.26 . . . . 1.28 113.726 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.6 18.94 9.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.586 -0.734 . . . . 1.06 110.571 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -106.14 170.17 8.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.332 -0.849 . . . . 1.93 108.904 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.1 tp -123.15 96.83 44.02 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.651 -0.419 . . . . 1.85 110.758 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 60.2 Cg_endo -75.21 152.67 40.1 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.899 2.4 . . . . 0.9 112.125 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 77.1 Cg_exo -51.3 -39.69 62.42 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.537 2.825 . . . . 1.02 114.237 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -81.02 13.92 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 1.14 111.716 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.281 -0.418 . . . . 1.34 110.217 173.776 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.676 0.274 . . . . 1.25 110.382 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.723 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -72.75 -1.59 10.61 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.464 2.776 . . . . 0.49 113.936 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.447 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 25.2 m-85 -100.31 -20.31 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.101 0.476 . . . . 0.56 110.91 -175.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.8 -0.637 . . . . 1.89 110.57 175.791 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.459 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.6 t90 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.895 -0.409 . . . . 0.96 109.895 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.85 -35.34 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 1.33 111.786 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.9 -21.0 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.145 -0.48 . . . . 0.53 111.174 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -68.67 -5.93 47.58 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.084 -0.579 . . . . 0.78 112.98 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -74.64 -28.25 60.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.089 0.471 . . . . 3.22 110.867 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -135.02 33.16 3.15 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.53 -0.915 . . . . 2.39 108.53 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 82.3 tttt -84.33 -44.71 0.74 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 114.946 -1.025 . . . . 1.17 113.409 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 19.7 Cg_endo -56.18 -23.84 47.11 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.426 2.084 . . . . 0.65 113.132 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 m -69.9 -41.21 74.99 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.273 -0.876 . . . . 0.45 110.378 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.59 -21.95 60.18 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.362 -0.607 . . . . 0.7 109.362 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 3.6 t70 -66.3 -45.18 81.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.443 0.64 . . . . 0.73 109.75 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -59.59 -40.8 88.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.072 -0.967 . . . . 1.86 109.902 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 65.9 mt -70.29 -37.89 72.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.071 0.462 . . . . 0.32 110.731 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -61.54 -51.09 70.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.142 -0.481 . . . . 0.39 111.235 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -82.24 14.18 3.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.231 0.456 . . . . 0.91 112.231 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -118.5 3.58 11.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 0.58 110.467 172.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 72.5 mt -106.35 11.97 30.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.919 -0.582 . . . . 1.17 110.513 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t 66.35 80.77 0.22 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.371 -0.831 . . . . 1.14 111.325 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.77 128.67 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.313 2.008 . . . . 1.1 111.526 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.0 t -106.81 107.79 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.398 -0.364 . . . . 1.66 110.191 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 68.61 29.22 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.478 -0.783 . . . . 1.98 110.52 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.24 -3.62 72.93 Favored Glycine 0 C--O 1.23 -0.142 0 CA-C-N 115.655 -0.702 . . . . 0.83 113.333 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -122.03 140.36 52.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.407 -0.22 . . . . 0.97 110.407 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -101.13 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.835 -0.802 . . . . 0.37 108.835 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.73 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 72.0 p -80.75 164.94 22.38 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.483 -0.487 . . . . 1.31 110.207 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.38 -20.73 52.02 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 120.999 -0.62 . . . . 0.33 112.802 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 -43.84 81.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.907 0.384 . . . . 0.27 111.308 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -76.3 -44.21 37.94 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.524 0.678 . . . . 1.79 109.767 -176.218 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.68 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.72 -50.82 72.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.771 -1.104 . . . . 0.32 110.182 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 77' ' ' VAL . 76.3 tttt -56.73 -40.62 76.03 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.1 -0.5 . . . . 1.36 110.539 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 35.9 ttpt -51.88 -49.25 63.34 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.003 0.43 . . . . 2.48 110.218 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.27 -39.88 89.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.89 -0.595 . . . . 2.16 110.517 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.741 ' HB3' HD22 ' A' ' 86' ' ' LEU . 66.4 mtp -67.26 -27.01 66.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.001 -0.545 . . . . 0.51 110.451 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 73' ' ' LYS . 77.7 t -70.94 -38.05 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 1.34 109.97 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -66.44 -21.87 66.21 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 2.2 110.885 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.4 t -73.88 -17.28 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.25 -0.432 . . . . 0.91 111.069 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 65.65 24.22 11.62 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.581 0.585 . . . . 2.37 112.581 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 86' ' ' LEU . 69.3 mt -85.59 151.61 56.01 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.574 -0.45 . . . . 1.35 110.219 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.481 ' HG2' HG23 ' A' ' 85' ' ' VAL . 33.1 Cg_endo -65.34 149.7 87.99 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.771 2.314 . . . . 0.44 111.918 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -53.13 -35.55 59.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.317 -0.401 . . . . 1.94 111.621 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 m -61.97 -45.05 95.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.348 -0.387 . . . . 1.04 111.017 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.639 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 86.6 t -73.37 -39.19 54.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.971 0.415 . . . . 0.41 110.332 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 76' ' ' MET . 84.4 mt -59.58 -48.76 80.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 0.44 110.563 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.57 -41.15 99.83 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.727 -0.669 . . . . 0.23 112.415 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 0.4 OUTLIER -66.67 -38.78 87.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.359 -0.536 . . . . 1.71 110.084 -179.013 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.81 -39.6 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 110.085 -0.339 . . . . 0.4 110.085 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -62.26 -51.56 67.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.46 110.445 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -67.39 -12.44 60.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 2.4 112.159 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.3 mt -93.97 -49.77 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 1.08 111.21 174.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.532 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -72.34 -32.27 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.3 111.705 -173.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -88.3 83.73 6.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.45 109.861 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.14 -28.9 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.206 -0.906 . . . . 1.28 111.497 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.555 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 57.5 m-20 -74.21 -19.9 60.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 121.002 -0.279 . . . . 1.12 110.271 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mttt 58.75 27.81 16.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.898 0.856 . . . . 1.68 109.097 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.596 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.6 p-10 -98.69 9.7 42.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.347 -1.297 . . . . 0.71 111.366 -169.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.94 9.23 52.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.93 -0.653 . . . . 0.39 111.522 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.73 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 15.5 mt -131.18 136.86 48.66 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.998 -0.601 . . . . 1.37 110.046 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 105' ' ' GLU . 47.8 mt -105.83 112.59 25.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 0.34 110.414 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.11 -178.11 3.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.89 -0.595 . . . . 1.39 109.55 170.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -56.8 -42.94 80.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.12 0.486 . . . . 1.69 110.339 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.459 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 19.2 mm-40 -66.08 -54.77 21.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.922 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HB3' HD22 ' A' ' 101' ' ' LEU . 48.0 mt-10 -60.37 -39.19 86.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.39 111.202 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 -25.47 59.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.29 110.959 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.77 -42.41 40.96 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.533 -0.914 . . . . 0.34 108.533 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 93' ' ' ALA . 22.8 tp -63.56 -37.62 88.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.608 -1.178 . . . . 1.74 109.845 174.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.74 -56.63 19.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.187 -0.46 . . . . 0.27 110.972 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.73 -31.13 72.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.33 -0.396 . . . . 0.7 111.242 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.486 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.0 t60 -66.93 -40.91 87.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.477 -0.329 . . . . 0.75 110.319 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 115' ' ' VAL . 94.7 mt -70.6 -39.4 73.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.159 0.504 . . . . 0.27 110.058 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.42 HD11 ' HG2' ' A' ' 76' ' ' MET . 65.7 mt -56.45 -53.7 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.844 . . . . 0.46 111.177 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 28.3 pttt -76.42 -25.05 54.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.293 -0.412 . . . . 1.81 111.042 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 112' ' ' LEU . 1.2 p -68.68 -38.88 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.245 -0.65 . . . . 0.91 109.245 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -66.53 -39.53 88.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.163 -0.472 . . . . 1.06 110.082 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.51 -39.76 92.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.879 -0.6 . . . . 1.59 111.149 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 71.3 mt-10 -71.55 -9.48 58.27 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.42 -0.354 . . . . 2.05 111.023 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.92 16.84 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.612 -0.804 . . . . 0.68 112.59 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.557 ' HB2' HG22 ' A' ' 115' ' ' VAL . 36.0 m80 -99.49 121.16 40.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.336 -0.616 . . . . 1.16 109.336 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -81.07 100.6 9.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.911 0.386 . . . . 2.69 110.411 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 122' ' ' LEU . 2.6 pp -61.09 133.47 92.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 1.21 109.81 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.26 4.84 3.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.952 2.434 . . . . 1.28 113.56 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.59 27.63 14.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.172 0.511 . . . . 1.06 110.854 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.68 163.49 16.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.926 -0.579 . . . . 1.93 109.97 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -126.56 85.65 59.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.128 -0.942 . . . . 1.85 109.124 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 11.1 Cg_endo -62.55 145.62 95.39 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.18 1.92 . . . . 0.9 111.612 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 84.8 Cg_exo -47.39 -32.33 14.76 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.494 2.796 . . . . 1.02 114.277 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -81.28 3.88 22.47 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.032 0.382 . . . . 1.14 112.032 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.59 0.233 . . . . 1.34 111.128 176.344 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.526 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 6.3 t70 . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.198 0.523 . . . . 1.25 110.373 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.5 Cg_exo -74.61 -2.02 11.88 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.43 2.754 . . . . 0.49 113.825 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.469 ' HZ ' ' SD ' ' A' ' 76' ' ' MET . 10.1 m-85 -105.13 -25.23 12.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.84 0.352 . . . . 0.56 110.771 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.485 . . . . 1.89 111.775 -177.967 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.1 t90 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.089 -0.708 . . . . 0.96 109.089 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.17 -17.33 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.708 -0.678 . . . . 1.33 112.56 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 t -89.25 -7.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.313 0.578 . . . . 0.53 110.049 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -20.82 78.51 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.723 -0.751 . . . . 0.78 112.852 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 48' ' ' LYS . 2.1 mtmm -75.0 -29.37 60.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.137 0.494 . . . . 3.22 109.703 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.49 33.36 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.447 -0.797 . . . . 2.39 109.992 -172.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 18.5 ttpp -83.88 -48.96 0.69 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.87 -0.604 . . . . 1.17 111.401 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 84.8 Cg_exo -50.13 -29.29 21.88 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.654 2.236 . . . . 0.65 114.359 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.6 m -70.78 -46.5 62.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.318 0.58 . . . . 0.45 110.209 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.429 ' HB3' HD21 ' A' ' 110' ' ' ASN . 12.7 m-85 -73.94 -20.07 60.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.353 -0.61 . . . . 0.7 109.353 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.506 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 14.4 t70 -68.94 -42.34 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.24 -0.891 . . . . 0.73 109.467 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.64 -41.84 95.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 1.86 110.135 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.3 mt -61.98 -39.4 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.104 0.478 . . . . 0.32 110.029 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -57.11 -52.88 63.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.855 . . . . 0.39 111.584 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.689 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 63.8 m-85 -74.9 -21.25 59.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.123 0.416 . . . . 0.91 112.123 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.7 p -83.25 2.31 36.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.411 . . . . 0.58 111.374 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.21 9.28 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.64 0.257 . . . . 1.17 110.485 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m 66.72 87.37 0.12 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.321 -0.854 . . . . 1.14 111.095 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.689 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -81.08 132.51 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.776 2.317 . . . . 1.1 112.044 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.95 123.63 67.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.832 -0.622 . . . . 1.66 110.464 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 65.43 23.2 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.655 -0.702 . . . . 1.98 110.817 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.79 -0.62 79.94 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.886 -0.673 . . . . 0.83 112.628 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.687 ' HB2' HD12 ' A' ' 100' ' ' LEU . 44.6 mttm -123.5 164.82 18.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.999 -0.371 . . . . 0.97 109.999 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.685 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 48.2 pt -111.5 130.24 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.925 -0.71 . . . . 0.37 109.302 167.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -71.25 154.89 41.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.973 -0.558 . . . . 1.31 110.674 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.4 -9.01 2.01 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.9 -0.591 . . . . 0.33 113.981 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.75 -67.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.14 0.47 . . . . 0.27 110.581 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.855 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 4.3 p30 -69.32 -28.25 66.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.79 110.62 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.6 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.68 -49.09 78.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.32 110.333 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.631 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 42.8 tttp -64.54 -36.81 85.43 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.905 0.383 . . . . 1.36 110.22 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.855 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 28.5 mtpp -54.85 -42.15 71.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.632 . . . . 2.48 110.82 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -71.16 -38.86 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.661 . . . . 2.16 110.123 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.764 ' HB3' HD22 ' A' ' 86' ' ' LEU . 87.5 mtp -68.17 -28.08 66.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.481 -0.781 . . . . 0.51 111.41 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -81.11 -22.69 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.362 -0.535 . . . . 1.34 110.28 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 44.2 mttp -66.49 -28.93 68.95 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.304 -0.558 . . . . 2.2 109.666 170.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -67.03 -17.56 64.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.569 -0.741 . . . . 0.91 110.797 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mttp 67.28 22.83 9.5 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.839 -0.619 . . . . 2.37 111.582 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.582 ' HB2' HD21 ' A' ' 86' ' ' LEU . 84.5 mt -89.4 155.76 48.59 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.657 -0.498 . . . . 1.35 109.657 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.525 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 35.4 Cg_endo -66.53 147.26 81.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.564 2.176 . . . . 0.44 112.232 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.29 -36.9 69.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.652 -0.704 . . . . 1.94 111.276 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.2 m -60.02 -48.51 81.41 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.838 -0.619 . . . . 1.04 111.214 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.563 HG11 ' HE2' ' A' ' 116' ' ' LYS . 78.7 t -67.6 -38.31 80.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.41 110.162 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.764 HD22 ' HB3' ' A' ' 76' ' ' MET . 81.8 mt -57.49 -42.27 82.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.44 110.556 175.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.43 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.67 -41.21 98.86 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.953 -0.567 . . . . 0.23 112.132 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.03 -47.74 81.74 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.23 -0.188 . . . . 1.71 110.84 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 85' ' ' VAL . 69.3 mt -53.35 -45.55 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 123.339 0.4 . . . . 0.4 110.365 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.535 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 32.0 t-105 -59.71 -52.68 64.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.731 -0.668 . . . . 0.46 110.963 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.93 -13.55 61.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.308 0.484 . . . . 2.4 112.308 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.49 -39.77 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.142 0.496 . . . . 1.08 110.648 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.529 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.53 -36.18 45.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.605 -0.725 . . . . 0.3 111.56 -176.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 44.0 t0 -83.56 70.61 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.869 0.842 . . . . 0.45 109.467 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.468 ' CG1' HD11 ' A' ' 126' ' ' LEU . 15.0 m -77.32 -16.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.944 -1.025 . . . . 1.28 109.619 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.569 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . 2.1 t70 -86.23 -20.72 28.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.186 -1.37 . . . . 1.12 109.295 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttt 60.77 40.34 16.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.667 -1.152 . . . . 1.68 111.359 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.62 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 7.2 p-10 -114.27 9.21 16.96 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.505 -0.478 . . . . 0.71 111.299 -174.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.6 -2.41 67.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 120.843 -0.694 . . . . 0.39 111.992 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -120.71 134.02 55.31 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.752 -0.832 . . . . 1.37 108.752 -176.729 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 62.3 mt -83.23 108.6 16.57 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 118.743 -1.183 . . . . 0.34 108.012 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 2.6 m-20 -71.88 171.22 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.711 -1.218 . . . . 1.39 107.711 171.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -57.6 -42.01 82.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.996 0.362 . . . . 1.69 111.212 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.8 -42.21 77.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.291 0.567 . . . . 2.29 110.28 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.569 ' OE2' ' HB3' ' A' ' 96' ' ' ASP . 25.4 mt-10 -66.89 -38.63 86.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.516 -0.765 . . . . 0.39 110.627 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 38.9 t80 -73.1 -25.06 60.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.29 110.625 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 -41.57 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.244 -1.021 . . . . 0.34 108.244 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 93' ' ' ALA . 40.7 tp -65.25 -35.52 81.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.449 -1.25 . . . . 1.74 109.826 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -55.88 29.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.133 -0.485 . . . . 0.27 110.84 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.511 ' HA ' HD12 ' A' ' 113' ' ' ILE . 91.0 m-20 -61.62 -28.16 69.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.7 110.928 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.514 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.7 t60 -63.95 -48.01 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 0.75 110.585 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 mt -66.24 -33.39 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.792 -0.448 . . . . 0.27 109.792 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 110' ' ' ASN . 88.2 mt -60.49 -51.39 73.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.83 -0.623 . . . . 0.46 111.511 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.28 -41.02 86.14 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 120.601 -0.439 . . . . 1.81 110.444 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 111' ' ' HIS . 69.4 t -54.62 -47.83 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.027 0.442 . . . . 0.91 109.867 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.563 ' HE2' HG11 ' A' ' 85' ' ' VAL . 44.4 tptt -57.8 -56.58 20.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.54 -0.755 . . . . 1.06 111.306 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.89 -31.81 72.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 1.59 111.73 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 44.4 mt-10 -80.5 4.29 18.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 2.05 111.353 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.07 33.17 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.699 . . . . 0.68 113.467 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 97.7 m-70 -131.5 173.55 10.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.778 0.289 . . . . 1.16 110.444 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -120.0 155.13 33.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.269 -0.423 . . . . 2.69 111.163 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.9 mt -93.47 128.16 43.48 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.946 -0.57 . . . . 1.21 109.582 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.49 -6.81 19.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.792 2.328 . . . . 1.28 113.57 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.89 9.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 1.06 112.404 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -127.6 174.61 8.92 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.661 -0.496 . . . . 1.93 109.661 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.468 HD11 ' CG1' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -124.36 88.96 52.6 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.696 -0.483 . . . . 1.85 109.696 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 32.5 Cg_endo -66.57 150.34 83.97 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.859 2.373 . . . . 0.9 112.256 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 32.3 Cg_exo -58.25 -21.4 52.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.218 2.612 . . . . 1.02 113.856 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -96.94 13.14 29.86 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.487 -0.485 . . . . 1.14 111.576 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 mt . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 1.34 111.418 177.06 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.2 p30 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.056 0.455 . . . . 1.25 111.388 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.631 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 30.7 Cg_exo -63.24 0.22 1.86 Allowed 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 124.118 3.212 . . . . 0.49 114.114 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.535 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 28.9 m-85 -100.4 -49.8 4.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.925 0.393 . . . . 0.56 110.813 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 116.054 -0.521 . . . . 1.89 111.706 -177.072 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.4 t90 . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 107.542 -1.281 . . . . 0.96 107.542 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 130' ' ' LEU . 16.5 m -57.82 -20.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.989 0.737 . . . . 1.33 112.989 -169.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 108' ' ' LEU . 33.6 t -92.45 -25.81 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 0.53 110.723 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -69.84 -23.58 76.82 Favored Glycine 0 CA--C 1.516 0.101 0 C-N-CA 121.167 -0.54 . . . . 0.78 113.0 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -73.91 -20.48 60.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.583 0.706 . . . . 3.22 109.907 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -134.48 34.38 3.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.413 1.101 . . . . 2.39 108.683 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.507 ' HZ3' ' CG ' ' A' ' 103' ' ' ASP . 16.1 ttpp -79.57 -42.1 1.53 Allowed Pre-proline 0 C--O 1.215 -0.718 0 CA-C-N 114.637 -1.165 . . . . 1.17 111.19 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.578 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 42.9 Cg_exo -44.0 -29.37 2.63 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.909 2.406 . . . . 0.65 114.419 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -70.19 -46.54 64.4 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.461 0.648 . . . . 0.45 109.792 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -74.75 -17.03 60.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.604 -0.725 . . . . 0.7 109.567 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.578 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 10.7 t70 -72.86 -44.61 61.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.158 -0.928 . . . . 0.73 109.442 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.64 -42.86 97.78 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.712 -0.676 . . . . 1.86 109.671 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' HD13 ' A' ' 60' ' ' LEU . 60.7 mt -61.01 -42.44 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 0.32 109.788 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -53.74 -35.08 60.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 0.39 110.975 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.596 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 39.2 m-85 -84.83 -22.86 29.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.57 0.581 . . . . 0.91 112.57 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 p -77.26 -11.27 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.3 -0.56 . . . . 0.58 110.446 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.523 HD11 ' OE1' ' A' ' 75' ' ' GLU . 10.1 mp -99.76 7.04 45.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.959 -0.564 . . . . 1.17 111.321 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m 64.92 88.12 0.11 Allowed Pre-proline 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 1.14 110.793 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 90.4 Cg_endo -84.28 102.6 0.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.213 1.942 . . . . 1.1 112.151 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.85 110.35 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.79 -0.641 . . . . 1.66 110.918 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 65.38 26.5 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.799 . . . . 1.98 111.052 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.85 19.86 64.64 Favored Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 121.176 -0.535 . . . . 0.83 112.269 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.79 ' HB3' HD11 ' A' ' 100' ' ' LEU . 52.7 mttm -139.9 155.53 47.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.866 -0.42 . . . . 0.97 109.866 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 106' ' ' PHE . 38.1 pt -131.35 131.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.196 0.522 . . . . 0.37 110.247 171.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 p -66.98 161.89 23.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.683 -0.69 . . . . 1.31 111.061 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.17 -16.8 62.81 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 121.304 -0.474 . . . . 0.33 113.696 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.69 -51.45 68.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.104 0.478 . . . . 0.27 110.829 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.577 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 18.2 m-80 -68.38 -43.05 78.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 1.79 109.954 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.22 -53.65 55.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.241 -0.891 . . . . 0.32 111.425 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.667 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.7 tttt -61.59 -35.73 78.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 1.36 110.296 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 16.7 ttpp -51.66 -47.26 63.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 2.48 110.344 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' OE1' HD11 ' A' ' 60' ' ' LEU . 3.4 tp10 -65.97 -38.08 87.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.454 0.645 . . . . 2.16 110.155 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.779 ' HB3' HD22 ' A' ' 86' ' ' LEU . 76.4 mtp -71.56 -31.27 66.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.423 -0.808 . . . . 0.51 111.486 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.56 -24.05 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.913 -0.315 . . . . 1.34 110.46 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 27.0 mtpp -70.87 -28.29 64.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.24 0.543 . . . . 2.2 109.904 172.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.5 m -66.48 -19.31 65.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.203 -0.908 . . . . 0.91 111.058 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 62.43 36.3 14.31 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.871 -0.604 . . . . 2.37 111.407 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 86' ' ' LEU . 85.9 mt -97.13 161.17 27.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.894 -0.41 . . . . 1.35 109.894 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 81' ' ' LEU . 36.5 Cg_endo -67.19 143.08 63.36 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.463 2.109 . . . . 0.44 112.136 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -56.32 -31.47 63.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.849 -0.614 . . . . 1.94 111.604 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p -59.68 -54.7 43.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 1.04 111.373 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 89' ' ' ILE . 59.9 t -66.1 -41.94 90.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 0.41 110.187 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 76' ' ' MET . 90.6 mt -55.68 -52.71 62.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.16 -0.473 . . . . 0.44 111.113 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.549 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.53 -39.26 96.17 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 121.155 -0.545 . . . . 0.23 112.116 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 25.6 ttmm -61.27 -44.13 97.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 1.71 110.419 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 85' ' ' VAL . 84.5 mt -62.85 -39.78 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.4 110.614 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.458 ' HZ2' ' C ' ' A' ' 99' ' ' GLY . 57.7 t-105 -60.43 -49.05 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.46 110.327 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -65.67 -16.22 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 2.4 112.16 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 34.2 mt -92.37 -44.39 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.147 0.499 . . . . 1.08 111.497 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.69 -27.26 45.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.588 -0.733 . . . . 0.3 112.005 -172.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -86.23 85.54 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.608 0.718 . . . . 0.45 110.624 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 105' ' ' GLU . 21.1 m -74.81 -25.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.897 -1.047 . . . . 1.28 112.174 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.631 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 9.0 m-20 -78.96 -13.59 59.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 121.116 -0.234 . . . . 1.12 110.756 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttt 59.72 29.9 19.47 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 108.691 -0.855 . . . . 1.68 108.691 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.631 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 17.9 p-10 -105.73 9.35 33.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.134 -0.939 . . . . 0.71 111.308 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.458 ' C ' ' HZ2' ' A' ' 90' ' ' TRP . . . 64.54 20.66 66.07 Favored Glycine 0 CA--C 1.493 -1.336 0 CA-C-O 121.584 0.547 . . . . 0.39 112.657 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -156.49 143.11 18.53 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.343 -0.984 . . . . 1.37 108.343 -173.105 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 100' ' ' LEU . 88.0 mt -104.57 126.5 51.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.975 0.417 . . . . 0.34 111.943 -171.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.86 -176.78 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.94 -0.573 . . . . 1.39 109.772 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.507 ' CG ' ' HZ3' ' A' ' 50' ' ' LYS . 14.5 t0 -57.75 -42.76 84.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.777 -0.647 . . . . 1.69 110.414 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -72.99 -43.97 61.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.508 -0.769 . . . . 2.29 110.822 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 52.3 mt-10 -63.37 -42.83 98.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.171 -0.468 . . . . 0.39 110.784 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.546 ' CD1' HD11 ' A' ' 67' ' ' ILE . 44.9 t80 -65.84 -35.87 81.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.29 110.094 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.69 89.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.34 110.321 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 46' ' ' VAL . 78.6 mt -62.29 -45.8 91.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.161 -0.472 . . . . 1.74 110.832 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.74 -58.06 8.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.989 0.423 . . . . 0.27 111.001 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -33.96 72.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.7 111.564 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -69.51 -46.97 65.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.566 -0.288 . . . . 0.75 110.309 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.08 -47.63 83.83 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.955 0.407 . . . . 0.27 110.608 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.9 mt -57.83 -52.23 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.46 111.101 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.676 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.66 -30.44 69.13 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.343 -0.39 . . . . 1.81 110.413 -176.102 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 120' ' ' HIS . 3.1 t -61.49 -43.83 97.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.763 0.316 . . . . 0.91 110.361 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 25.7 mmmt -63.11 -37.48 87.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 1.06 110.869 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.8 tp -70.14 -30.52 67.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.606 -0.27 . . . . 1.59 111.01 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 29.9 mm-40 -66.01 -26.39 67.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 2.05 110.216 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.35 21.8 8.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.935 -0.65 . . . . 0.68 112.227 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.67 ' HB2' HG13 ' A' ' 115' ' ' VAL . 71.9 m80 -104.91 165.97 10.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 1.16 110.443 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -108.74 127.01 53.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.143 -0.48 . . . . 2.69 110.06 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.64 146.72 80.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 1.21 110.08 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.54 -10.16 25.25 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.134 2.556 . . . . 1.28 113.548 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.33 19.33 10.98 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.214 -0.448 . . . . 1.06 111.124 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -133.09 175.08 9.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.844 -0.616 . . . . 1.93 110.232 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.62 90.51 50.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.452 -0.944 . . . . 1.85 108.452 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.75 151.57 69.15 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.479 2.12 . . . . 0.9 112.027 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.55 -25.91 61.31 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.191 2.594 . . . . 1.02 112.807 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -89.12 19.58 4.16 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.884 -0.326 . . . . 1.14 111.658 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.531 HD21 HG22 ' A' ' 45' ' ' VAL . 31.5 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 1.34 110.664 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 7.7 t70 . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.892 -0.41 . . . . 1.25 109.892 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.667 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.7 Cg_exo -76.82 -2.39 12.61 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.538 2.825 . . . . 0.49 113.924 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.549 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 10.7 m-85 -106.78 -9.97 16.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.126 0.489 . . . . 0.56 110.477 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 28.0 p . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.805 -0.634 . . . . 1.89 110.798 -177.598 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.073 -0.411 . . . . 10.47 112.073 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.83 143.18 36.58 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.673 2.249 . . . . 10.45 111.845 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.4 tp 72.04 110.47 0.06 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.93 0.769 . . . . 9.09 111.194 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.57 -110.96 0.33 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.59 -0.732 . . . . 6.24 111.528 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 p -148.49 -26.79 0.32 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.648 0.261 . . . . 5.98 111.169 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.41 92.9 7.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.348 0.594 . . . . 3.92 110.579 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -118.94 126.35 51.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.275 -0.875 . . . . 4.94 109.494 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.0 t -116.98 116.22 51.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.49 -0.323 . . . . 1.99 110.255 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.85 104.18 8.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.033 0.444 . . . . 2.4 110.385 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 20.9 t90 -71.25 112.89 7.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.347 -0.842 . . . . 0.96 109.115 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.96 -41.36 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 1.33 112.04 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.52 HG21 HD23 ' A' ' 108' ' ' LEU . 11.0 t -79.93 -1.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.363 0.602 . . . . 0.53 110.708 -174.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.13 76.95 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.673 -0.775 . . . . 0.78 112.562 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.54 -28.46 28.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.863 0.363 . . . . 3.22 110.952 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -124.18 34.7 4.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.172 0.987 . . . . 2.39 109.227 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 17.8 ttpt -78.78 -44.29 1.88 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 114.066 -1.425 . . . . 1.17 112.281 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 83.2 Cg_exo -49.15 -24.26 7.67 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.632 2.222 . . . . 0.65 113.67 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -69.89 -45.45 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.696 -0.483 . . . . 0.45 109.696 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.455 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 5.9 m-85 -73.49 -22.95 60.01 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.916 -0.584 . . . . 0.7 109.96 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -69.61 -44.59 70.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.48 0.657 . . . . 0.73 110.32 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -60.31 -45.58 92.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.279 -0.873 . . . . 1.86 109.765 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 77.3 mt -64.83 -39.92 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.669 . . . . 0.32 110.455 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 58.1 t80 -52.88 -50.72 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.39 111.306 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 45.1 m-85 -76.77 -22.4 53.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.275 -0.421 . . . . 0.91 112.071 -177.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.9 p -88.73 8.24 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.677 -0.409 . . . . 0.58 111.337 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 85.1 mt -104.88 1.34 28.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 1.17 110.589 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m 69.14 87.06 0.12 Allowed Pre-proline 0 N--CA 1.467 0.379 0 O-C-N 123.902 0.751 . . . . 1.14 110.586 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HA ' HG22 ' A' ' 67' ' ' ILE . 1.2 Cg_endo -84.61 163.84 12.4 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.174 2.583 . . . . 1.1 112.755 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.85 102.57 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 1.66 110.087 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.9 m-20 68.87 23.23 6.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 1.98 110.358 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.16 65.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.771 -0.728 . . . . 0.83 112.428 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.618 ' HD3' ' CB ' ' A' ' 100' ' ' LEU . 14.8 ttmm -133.4 126.78 32.0 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.982 -0.748 . . . . 0.97 108.982 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 62' ' ' PRO . 39.0 pt -87.36 151.18 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.094 -0.642 . . . . 0.37 110.473 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.405 ' HA ' HD13 ' A' ' 100' ' ' LEU . 80.5 p -90.42 177.43 6.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.192 -0.458 . . . . 1.31 110.613 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.15 -16.78 67.21 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.695 -0.764 . . . . 0.33 112.088 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -69.65 -59.37 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.049 0.452 . . . . 0.27 110.381 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -43.64 98.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.733 . . . . 1.79 110.162 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.65 -47.32 86.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.075 -0.966 . . . . 0.32 111.35 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.27 -34.59 76.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.157 -0.312 . . . . 1.36 110.157 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.2 mtpt -58.04 -46.92 84.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 2.48 110.502 174.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -64.11 -44.72 91.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.885 -0.598 . . . . 2.16 110.254 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.611 ' HB3' HD22 ' A' ' 86' ' ' LEU . 94.5 mtp -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.589 . . . . 0.51 112.209 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.21 -24.82 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.944 -0.703 . . . . 1.34 110.664 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -75.5 -12.03 60.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.2 110.476 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -72.86 -14.93 61.6 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.49 -0.559 . . . . 0.91 109.49 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 68.25 29.96 5.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.133 -0.939 . . . . 2.37 111.455 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HB2' HD21 ' A' ' 86' ' ' LEU . 80.7 mt -104.56 154.88 38.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.537 -0.301 . . . . 1.35 110.651 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 40.4 Cg_endo -68.37 155.59 68.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.843 2.362 . . . . 0.44 112.558 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -66.06 -25.18 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.486 -0.325 . . . . 1.94 111.283 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.3 m -63.35 -52.69 60.71 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.937 0.399 . . . . 1.04 110.675 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 89' ' ' ILE . 84.8 t -62.76 -46.08 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.41 109.806 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.0 mt -59.94 -37.7 80.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.44 111.4 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.12 87.94 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.23 112.685 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 20.5 ptmt -66.54 -33.27 75.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.494 -0.482 . . . . 1.71 109.789 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.633 HG13 ' O ' ' A' ' 85' ' ' VAL . 83.8 mt -57.47 -50.04 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.722 -0.473 . . . . 0.4 109.722 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 34.1 t-105 -58.89 -49.92 75.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.545 -0.752 . . . . 0.46 111.133 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -65.41 -20.27 66.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.184 0.438 . . . . 2.4 112.184 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' A' ' 124' ' ' ALA . 29.7 mt -93.58 -35.63 12.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.863 0.363 . . . . 1.08 111.384 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.57 -16.39 36.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.054 -0.521 . . . . 0.3 112.058 -172.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.631 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 40.3 t0 -79.13 80.56 5.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.692 0.758 . . . . 0.45 109.83 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.486 HG21 ' HG2' ' A' ' 132' ' ' PRO . 96.2 t -58.78 -44.55 90.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.583 -1.189 . . . . 1.28 112.207 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 33.8 m-20 -70.63 -24.52 62.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.399 -0.364 . . . . 1.12 110.089 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 57.12 51.48 10.31 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.608 -0.886 . . . . 1.68 108.608 -169.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.631 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 18.2 p-10 -125.5 8.4 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.928 -1.033 . . . . 0.71 112.146 -167.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.82 -0.13 62.65 Favored Glycine 0 CA--C 1.507 -0.406 0 C-N-CA 120.441 -0.885 . . . . 0.39 112.785 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.618 ' CB ' ' HD3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -118.83 163.49 16.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.012 -0.736 . . . . 1.37 109.012 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 mt -115.69 110.02 18.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.423 -0.584 . . . . 0.34 109.423 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -76.43 -173.95 2.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.559 -0.746 . . . . 1.39 109.274 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -55.85 -44.91 78.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.694 -0.685 . . . . 1.69 111.239 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -81.63 -31.25 32.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.638 -0.71 . . . . 2.29 110.743 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.59 -47.43 66.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.39 110.338 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -65.92 -35.1 79.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.29 109.942 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -57.3 -49.79 74.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.002 -0.544 . . . . 0.34 110.693 174.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.52 HD23 HG21 ' A' ' 46' ' ' VAL . 12.9 mt -60.5 -43.95 96.5 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.59 -0.277 . . . . 1.74 111.509 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.34 -56.74 17.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.27 111.238 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -61.04 -33.68 73.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.7 111.28 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.614 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.8 t60 -62.86 -50.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.929 -0.578 . . . . 0.75 110.733 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.622 HD12 HG23 ' A' ' 89' ' ' ILE . 49.2 mt -63.17 -36.83 84.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.673 0.273 . . . . 0.27 110.447 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 109' ' ' ALA . 89.7 mt -56.95 -48.53 81.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.117 -0.492 . . . . 0.46 110.644 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 34.6 pttt -74.6 -24.1 58.82 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 120.678 -0.409 . . . . 1.81 110.879 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 111' ' ' HIS . 76.6 t -62.25 -39.71 85.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.498 -0.556 . . . . 0.91 109.498 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.893 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 2.4 mmmp? -67.19 -37.45 83.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 1.06 109.957 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.413 ' O ' HD13 ' A' ' 117' ' ' LEU . 1.5 tm? -64.68 -38.69 91.85 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 1.59 110.161 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 7.1 mm-40 -66.98 -9.0 34.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.152 -0.476 . . . . 2.05 110.55 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.82 35.19 5.69 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.961 -0.638 . . . . 0.68 112.417 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.541 ' HB2' HG12 ' A' ' 115' ' ' VAL . 57.6 m80 -121.78 -176.98 3.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 1.16 111.283 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -124.7 160.61 28.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 2.69 109.805 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.893 ' HG ' ' HD3' ' A' ' 116' ' ' LYS . 26.6 mt -104.51 115.33 62.99 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.252 -0.647 . . . . 1.21 109.252 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.09 2.88 7.91 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.256 2.637 . . . . 1.28 113.333 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.81 19.22 11.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.935 -0.575 . . . . 1.06 111.243 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -111.24 147.11 35.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.874 -0.603 . . . . 1.93 109.788 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.471 ' HG ' ' HB ' ' A' ' 131' ' ' VAL . 17.0 tp -125.05 94.23 44.19 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.325 -0.398 . . . . 1.85 110.382 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 25.7 Cg_exo -62.94 152.07 81.16 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.194 2.596 . . . . 0.9 112.11 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.09 -26.9 43.59 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.371 2.714 . . . . 1.02 113.822 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -99.85 5.84 45.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.781 -0.368 . . . . 1.14 111.129 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.45 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 3.8 mm? -101.99 -28.67 12.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.704 -0.48 . . . . 1.34 109.704 171.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.471 ' HB ' ' HG ' ' A' ' 126' ' ' LEU . 7.6 p -92.81 132.76 30.44 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.653 -0.703 . . . . 1.57 109.937 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.486 ' HG2' HG21 ' A' ' 95' ' ' VAL . 76.4 Cg_exo -49.2 135.19 31.02 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.525 2.15 . . . . 1.35 111.58 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.66 2.21 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.155 2.57 . . . . 2.05 113.196 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 m -80.81 -1.63 43.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.443 -0.344 . . . . 2.66 111.381 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -106.17 15.47 26.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 3.1 110.951 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -100.41 134.97 42.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.319 -0.4 . . . . 3.86 111.243 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 137' ' ' ARG . 1.1 ptp180 -90.2 173.61 8.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.915 -0.584 . . . . 5.0 110.391 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.13 99.06 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.792 0.329 . . . . 6.63 110.222 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.691 -0.671 . . . . 6.66 109.328 176.906 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 109.978 -0.378 . . . . 10.53 109.978 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -78.8 92.23 4.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.593 0.235 . . . . 8.22 110.942 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.485 ' HD1' ' H ' ' B' ' 147' ' ' SER . 36.2 p90 43.41 -164.76 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.422 1.089 . . . . 7.43 113.285 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -155.89 20.73 0.38 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.83 -0.623 . . . . 5.92 109.84 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.485 ' H ' ' HD1' ' B' ' 145' ' ' TYR . 4.0 m -92.61 121.36 33.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.528 -0.76 . . . . 4.34 111.945 -170.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.1 t -140.38 13.0 2.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.712 -0.848 . . . . 2.12 108.712 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.52 150.99 49.95 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.991 -1.004 . . . . 1.25 111.327 -172.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.71 0.15 5.27 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 123.527 2.818 . . . . 0.49 113.892 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.35 -45.51 6.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 0.56 111.038 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 70.1 p -89.65 25.28 2.06 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.181 0.438 . . . . 1.89 112.181 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.3 1.49 47.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.443 -0.344 . . . . 3.11 111.537 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 35.4 mttp . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.197 -0.906 . . . . 6.99 111.16 -179.35 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.631 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 112.156 -0.378 . . . . 10.47 112.156 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -95.0 16.14 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.478 2.786 . . . . 10.45 113.46 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 tp -123.0 -44.28 2.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.921 0.391 . . . . 9.09 111.193 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.58 156.07 15.84 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.458 -0.877 . . . . 6.24 112.315 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 p -89.13 177.94 6.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.775 0.322 . . . . 5.98 110.921 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -100.45 134.57 43.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.374 0.607 . . . . 3.92 110.942 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -106.94 122.11 45.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.396 -0.82 . . . . 4.94 109.838 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 p -107.47 146.17 13.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 120.876 0.37 . . . . 1.99 111.045 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.06 130.7 40.89 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.274 -0.639 . . . . 2.4 109.274 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.478 ' CZ3' ' HG3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -77.95 112.66 15.08 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.33 -0.619 . . . . 0.96 109.33 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.65 -36.67 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 1.33 110.75 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.433 HG21 HD23 ' A' ' 108' ' ' LEU . 39.6 t -76.94 -17.44 14.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.744 -0.662 . . . . 0.53 110.496 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -66.21 -14.86 62.35 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.78 112.989 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -73.77 -25.55 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 3.22 109.912 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -131.1 33.23 4.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.714 0.768 . . . . 2.39 109.342 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HB2' ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -79.46 -46.38 1.59 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.338 -0.846 . . . . 1.17 111.304 -177.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.62 -24.66 37.9 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.418 2.079 . . . . 0.65 112.715 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -46.69 64.21 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.447 0.641 . . . . 0.45 110.204 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.1 m-85 -75.1 -21.99 58.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.7 109.329 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.61 -38.85 64.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.422 -0.808 . . . . 0.73 109.16 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -54.02 -52.69 60.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.29 -0.868 . . . . 1.86 109.591 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.467 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.4 mt -62.3 -41.48 91.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.658 -0.701 . . . . 0.32 110.766 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -52.47 -42.82 64.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.616 -0.72 . . . . 0.39 111.476 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 4.7 m-85 -83.18 -22.44 33.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.935 0.346 . . . . 0.91 111.935 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.08 -7.62 58.29 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.546 -0.462 . . . . 0.58 111.161 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.1 mt -102.73 15.47 29.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 1.17 110.877 -177.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m 61.19 78.4 0.32 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.14 111.127 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.723 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 94.2 Cg_endo -85.75 119.44 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.532 2.155 . . . . 1.1 112.241 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.57 132.86 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.93 -0.396 . . . . 1.66 109.93 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 48.39 25.37 0.88 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.926 0.89 . . . . 1.98 112.604 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.86 15.24 78.02 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.981 -0.628 . . . . 0.83 113.449 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.683 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 10.0 ttmm -141.54 126.26 18.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.543 -0.539 . . . . 0.97 109.543 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 62' ' ' PRO . 44.7 pt -94.04 146.06 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 121.709 -0.619 . . . . 0.37 111.191 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.815 ' HA ' HD23 ' A' ' 100' ' ' LEU . 9.7 t -76.74 157.69 31.5 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.001 -0.545 . . . . 1.31 110.115 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -16.84 38.46 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.156 -0.929 . . . . 0.33 114.232 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -61.83 -52.97 61.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.377 0.588 . . . . 0.27 110.903 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 18.6 m-80 -65.81 -43.21 89.36 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.101 0.477 . . . . 1.79 110.07 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.716 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.19 -49.19 78.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.297 -0.865 . . . . 0.32 110.792 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.732 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 84.0 tttt -61.56 -40.37 94.49 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.25 -0.432 . . . . 1.36 110.391 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.651 ' HA ' HG12 ' A' ' 77' ' ' VAL . 27.8 mtpt -64.8 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.927 -0.579 . . . . 2.48 111.6 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -70.67 -41.96 71.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.838 0.828 . . . . 2.16 109.465 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.766 ' HB3' HD22 ' A' ' 86' ' ' LEU . 69.7 mtp -65.86 -31.47 72.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.139 -0.937 . . . . 0.51 111.222 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.651 HG12 ' HA ' ' A' ' 74' ' ' LYS . 4.4 p -76.51 -27.5 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.599 -0.441 . . . . 1.34 110.759 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 84.2 mttt -64.02 -28.14 69.59 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.299 -0.56 . . . . 2.2 110.11 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 15.2 m -66.8 -26.78 67.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.562 -0.745 . . . . 0.91 111.071 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 79' ' ' SER . 95.8 mttt 71.74 22.45 3.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.861 -0.609 . . . . 2.37 112.213 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 81' ' ' LEU . 4.0 mm? -86.03 158.38 55.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.111 -0.7 . . . . 1.35 109.111 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.531 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 2.0 Cg_endo -76.05 160.9 36.31 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.434 2.09 . . . . 0.44 111.705 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -62.63 -23.04 66.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 1.94 110.253 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -58.82 -53.67 55.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.725 -0.671 . . . . 1.04 110.217 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 89' ' ' ILE . 54.4 t -72.65 -42.72 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.41 110.373 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.766 HD22 ' HB3' ' A' ' 76' ' ' MET . 67.3 mt -60.12 -39.26 85.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 0.44 110.489 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.95 79.72 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.856 -0.687 . . . . 0.23 111.859 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -51.49 -51.4 55.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.755 0.312 . . . . 1.71 110.735 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.7 mt -62.36 -49.08 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.615 -0.721 . . . . 0.4 110.748 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.466 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 51.3 t-105 -57.79 -50.29 73.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.235 -0.439 . . . . 0.46 111.764 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -81.08 -14.7 57.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.57 -0.452 . . . . 2.4 112.005 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -94.69 -27.39 15.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.926 0.393 . . . . 1.08 110.26 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.17 -42.33 12.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.157 -0.474 . . . . 0.3 111.609 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.642 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.0 t70 -77.52 71.78 4.02 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.589 -0.893 . . . . 0.45 108.589 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.68 -22.74 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.033 -0.985 . . . . 1.28 110.706 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.12 -23.66 51.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.69 -0.686 . . . . 1.12 109.936 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.4 mttt 57.78 49.25 12.48 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.173 -0.921 . . . . 1.68 111.483 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.687 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.6 p-10 -117.26 9.25 13.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.282 -0.872 . . . . 0.71 110.743 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.12 17.64 66.02 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.233 -0.747 . . . . 0.39 111.233 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.815 HD23 ' HA ' ' A' ' 68' ' ' THR . 33.2 mt -139.24 140.58 37.75 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.353 -0.924 . . . . 1.37 109.309 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.3 mt -110.43 114.95 28.78 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.022 0.439 . . . . 0.34 111.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.98 170.71 9.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.308 -0.997 . . . . 1.39 108.308 165.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.72 -27.27 69.15 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.558 . . . . 1.69 110.035 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.27 -52.74 44.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.391 0.615 . . . . 2.29 110.625 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.65 -35.36 77.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.39 110.898 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.72 -32.23 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.29 110.204 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.42 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -64.64 -44.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.679 -0.692 . . . . 0.34 110.212 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 95.4 mt -58.23 -47.46 83.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 1.74 110.365 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -53.54 -56.56 16.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.006 -0.543 . . . . 0.27 111.42 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -63.46 -35.65 81.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.7 111.53 -176.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.25 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.75 110.557 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 115' ' ' VAL . 86.8 mt -76.31 -30.5 57.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 0.27 111.042 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 109' ' ' ALA . 82.7 mt -75.53 -41.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.061 -1.088 . . . . 0.46 108.061 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 29.9 ttmt -68.12 -40.71 82.45 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.056 -1.429 . . . . 1.81 110.718 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 120' ' ' HIS . 2.0 p -64.54 -37.55 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.115 -0.328 . . . . 0.91 110.115 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 28.7 mmmt -66.97 -42.74 84.62 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.73 -0.213 . . . . 1.06 110.513 173.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.89 -37.9 86.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 1.59 111.23 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 31.4 mm-40 -71.73 -5.02 30.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 2.05 111.239 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.11 36.23 6.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 0.68 112.584 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.568 ' HB2' HG22 ' A' ' 115' ' ' VAL . 66.2 m80 -118.44 170.34 9.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.59 -0.522 . . . . 1.16 109.59 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -115.48 132.65 56.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.948 0.404 . . . . 2.69 111.319 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 122' ' ' LEU . 1.7 pp -95.27 139.37 21.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.519 -0.549 . . . . 1.21 109.519 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.89 11.62 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.633 2.222 . . . . 1.28 113.348 -175.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.756 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 58.74 28.8 17.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.228 0.537 . . . . 1.06 110.419 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -130.51 164.84 23.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.551 -0.75 . . . . 1.93 109.79 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.761 HD12 ' HB ' ' A' ' 131' ' ' VAL . 0.2 OUTLIER -125.37 88.66 53.84 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 109.514 -0.551 . . . . 1.85 109.514 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.537 ' HB2' HD23 ' A' ' 130' ' ' LEU . 55.2 Cg_exo -52.54 150.49 21.15 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.786 2.99 . . . . 0.9 113.586 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 73.4 Cg_exo -52.98 -30.32 48.13 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.386 2.724 . . . . 1.02 113.82 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 33.2 p80 -94.47 9.05 39.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.206 -0.597 . . . . 1.14 111.309 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 127' ' ' PRO . 3.8 mm? -110.05 -27.55 9.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 1.34 110.742 171.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.761 ' HB ' HD12 ' A' ' 126' ' ' LEU . 3.4 p -82.3 118.56 72.37 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-O 121.509 0.671 . . . . 1.57 111.759 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.6 177.93 6.88 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.074 2.516 . . . . 1.35 112.089 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.917 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 21.5 Cg_exo -66.13 -3.7 9.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.922 2.415 . . . . 2.05 113.051 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.59 -29.36 69.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.87 -0.604 . . . . 2.66 112.006 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -120.04 1.6 10.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.345 0.498 . . . . 3.1 112.345 -175.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.917 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 18.1 ptp180 -99.26 143.06 29.95 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.882 -0.511 . . . . 3.86 110.343 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -58.89 135.79 57.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.991 0.424 . . . . 5.0 111.325 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -106.38 124.22 49.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.096 -0.502 . . . . 6.63 109.651 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.246 0.917 0 N-CA-C 109.581 -0.525 . . . . 6.66 109.581 173.687 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 110.33 -0.248 . . . . 10.53 110.33 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -56.27 -74.22 0.05 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.81 0.693 . . . . 8.22 112.319 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.46 99.6 5.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 122.154 0.978 . . . . 7.43 111.743 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -101.75 75.45 1.56 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.936 -1.135 . . . . 5.92 107.936 170.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 71.1 m -78.6 66.38 4.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.458 -0.792 . . . . 4.34 112.945 -169.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 6.2 p -112.86 18.4 18.21 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.777 -0.823 . . . . 2.12 108.777 167.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -104.99 140.44 21.08 Favored Pre-proline 0 C--O 1.235 0.328 0 CA-C-N 114.974 -1.012 . . . . 1.25 110.5 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.732 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 61.5 Cg_endo -72.07 0.4 7.3 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 123.445 2.763 . . . . 0.49 113.763 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.646 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 36.3 m-85 -95.74 -30.1 13.9 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.16 -0.338 . . . . 0.56 111.256 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 20.5 p -81.74 102.09 10.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 1.89 112.277 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 76.3 -36.11 0.27 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.016 0.926 . . . . 3.11 113.134 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.415 ' N ' ' HD3' ' B' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.233 -0.889 . . . . 6.99 111.067 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.648 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 111.494 -0.643 . . . . 10.47 111.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.97 112.65 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.6 2.2 . . . . 10.45 111.578 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.1 mt 63.96 81.6 0.2 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 123.912 0.757 . . . . 9.09 110.833 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.54 -158.54 31.29 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.846 -0.692 . . . . 6.24 112.142 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -76.17 166.68 23.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.124 0.488 . . . . 5.98 110.985 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -83.62 108.84 16.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 3.92 110.419 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -87.72 135.21 33.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.896 -0.409 . . . . 4.94 109.896 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.71 127.83 74.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.197 0.522 . . . . 1.99 111.503 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 129' ' ' HIS . 59.2 mm-40 -83.34 85.17 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.686 -0.688 . . . . 2.4 110.673 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -80.81 95.7 6.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.843 -0.799 . . . . 0.96 108.843 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -62.68 -17.22 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.726 -0.67 . . . . 1.33 112.678 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 t -73.22 -26.8 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.87 0.367 . . . . 0.53 110.697 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.04 9.58 52.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.139 -0.553 . . . . 0.78 112.91 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -86.54 -25.65 24.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.749 0.309 . . . . 3.22 111.062 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.44 36.26 1.33 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 2.39 110.152 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HA ' ' HD2' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -65.16 -43.49 66.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.095 -0.957 . . . . 1.17 112.121 -174.208 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 73.2 Cg_exo -52.68 -22.46 17.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.448 2.099 . . . . 0.65 114.197 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 m -72.65 -47.04 50.77 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.231 0.539 . . . . 0.45 110.231 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.521 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 8.5 m-85 -71.74 -22.5 61.61 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.529 -0.915 . . . . 0.7 108.529 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.532 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 15.0 t70 -69.4 -41.29 76.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.788 -1.096 . . . . 0.73 109.801 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.26 -53.8 53.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.987 -0.551 . . . . 1.86 109.594 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.6 mt -54.47 -43.21 62.76 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 CA-C-N 115.851 -0.613 . . . . 0.32 109.979 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.476 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 73.4 t80 -55.15 -55.05 35.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.482 -0.781 . . . . 0.39 111.55 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.614 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 38.4 m-85 -71.57 -21.18 61.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.217 0.451 . . . . 0.91 112.217 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -82.92 0.86 42.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.759 -0.376 . . . . 0.58 111.046 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 81.9 mt -104.67 6.38 34.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.17 110.372 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m 66.34 86.84 0.13 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.308 -0.86 . . . . 1.14 111.569 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -83.28 117.81 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.11 2.54 . . . . 1.1 112.192 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.5 t -90.15 118.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 1.66 109.586 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 63.19 23.23 13.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.808 -0.633 . . . . 1.98 110.711 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.87 12.55 66.09 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.872 -0.68 . . . . 0.83 113.05 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.652 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 11.4 ttmt -138.43 142.92 39.5 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.798 -0.445 . . . . 0.97 109.798 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.611 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 49.8 pt -100.32 153.11 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 0.37 111.097 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.643 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 15.5 p -88.74 160.89 17.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.48 -0.782 . . . . 1.31 110.938 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 72' ' ' ALA . . . -64.24 -8.65 31.72 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.649 -0.786 . . . . 0.33 113.172 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.12 -58.17 5.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.914 0.388 . . . . 0.27 110.996 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.611 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.0 OUTLIER -74.76 -31.27 61.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.376 -0.374 . . . . 1.79 110.587 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.2 -50.99 70.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.32 110.112 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -64.09 -33.07 74.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.197 -0.456 . . . . 1.36 110.137 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.55 -45.11 85.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 2.48 110.168 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.7 -51.76 67.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.979 -0.749 . . . . 2.16 108.979 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.705 ' HB3' HD22 ' A' ' 86' ' ' LEU . 77.8 mtp -60.48 -32.1 71.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.542 -0.754 . . . . 0.51 112.335 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -81.72 -20.46 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 O-C-N 121.927 -0.483 . . . . 1.34 110.811 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.54 -23.66 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.135 -0.32 . . . . 2.2 110.135 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -64.41 -23.4 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.91 110.083 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 67.95 33.41 4.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.447 -0.797 . . . . 2.37 111.531 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.7 mt -96.76 158.56 33.35 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.021 -0.536 . . . . 1.35 109.661 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HG2' HG23 ' A' ' 85' ' ' VAL . 38.3 Cg_endo -68.52 146.83 69.2 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.358 2.039 . . . . 0.44 112.229 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -58.72 -29.46 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.933 -0.576 . . . . 1.94 111.723 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.42 -52.93 63.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 1.04 110.375 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 89' ' ' ILE . 75.6 t -68.04 -42.02 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.56 -0.745 . . . . 0.41 110.169 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.705 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.9 mt -58.46 -46.63 86.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.44 111.458 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.461 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -63.32 -41.85 99.37 Favored Glycine 0 C--O 1.235 0.205 0 C-N-CA 120.827 -0.701 . . . . 0.23 111.483 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.585 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 39.9 ttmt -56.64 -46.77 80.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.219 -0.491 . . . . 1.71 110.298 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 85' ' ' VAL . 77.0 mt -63.02 -40.81 90.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 0.4 110.884 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.432 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 45.0 t-105 -61.85 -51.67 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.614 -0.266 . . . . 0.46 110.512 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.05 -21.14 66.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.427 -0.351 . . . . 2.4 111.799 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 77.7 mt -85.51 -54.02 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.947 0.403 . . . . 1.08 111.135 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.15 -34.07 72.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.31 -0.859 . . . . 0.3 111.711 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.61 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.0 t0 -87.58 93.24 9.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.363 0.601 . . . . 0.45 109.836 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.641 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 2.7 m -74.12 -29.94 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 1.28 111.843 -174.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.61 -25.39 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.034 -0.53 . . . . 1.12 109.985 -178.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.4 mttt 60.15 32.15 20.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.892 -1.049 . . . . 1.68 108.541 -171.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.534 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.4 p-10 -94.69 10.19 35.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.663 -1.153 . . . . 0.71 110.983 -172.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.16 20.58 62.99 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.369 -0.693 . . . . 0.39 111.369 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 14.9 mt -141.52 145.51 35.25 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.84 -0.68 . . . . 1.37 110.028 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.0 mt -115.56 118.18 32.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.866 0.365 . . . . 0.34 111.103 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.14 174.42 5.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.41 -0.959 . . . . 1.39 108.41 168.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -63.35 -32.62 74.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.959 -0.386 . . . . 1.69 109.959 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.98 -50.72 54.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 2.29 110.432 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.54 -44.15 97.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.39 110.69 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -69.82 -25.09 63.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.29 111.081 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.77 31.93 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.599 -0.889 . . . . 0.34 108.599 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.1 -36.5 79.88 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.347 -1.297 . . . . 1.74 110.057 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.46 33.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.27 110.712 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.51 -30.71 68.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.349 -0.387 . . . . 0.7 110.568 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.438 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 32.2 t60 -69.01 -39.17 79.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.75 110.552 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 115' ' ' VAL . 95.5 mt -71.66 -40.77 69.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.257 0.551 . . . . 0.27 110.318 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.588 HD11 ' HG2' ' A' ' 76' ' ' MET . 84.2 mt -58.29 -51.27 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 0.46 110.722 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.81 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 12.0 ptmm? -75.67 -24.34 56.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.58 -0.448 . . . . 1.81 111.121 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 112' ' ' LEU . 1.4 p -66.46 -34.28 69.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 120.024 -0.67 . . . . 0.91 109.246 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 27.8 mmmt -66.94 -43.67 82.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.25 -0.432 . . . . 1.06 110.001 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.25 -38.73 80.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 1.59 111.894 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.81 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 3.7 mm-40 -73.86 -7.15 51.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.695 -0.229 . . . . 2.05 110.825 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.46 10.48 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.518 -0.849 . . . . 0.68 113.123 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.509 ' HB2' HG22 ' A' ' 115' ' ' VAL . 77.6 m80 -105.84 172.96 6.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.885 0.374 . . . . 1.16 110.315 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 116' ' ' LYS . 7.4 tp10 -124.67 134.56 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.377 -0.601 . . . . 2.69 109.377 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.19 140.77 28.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.915 0.388 . . . . 1.21 110.26 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.47 1.23 7.65 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.387 2.724 . . . . 1.28 113.652 -172.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.14 22.72 12.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.164 0.507 . . . . 1.06 110.864 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.47 171.99 12.38 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.241 -0.651 . . . . 1.93 109.241 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 0.5 OUTLIER -125.61 89.07 53.18 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.834 0.349 . . . . 1.85 110.603 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 32.5 Cg_endo -66.34 155.96 67.44 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.952 2.435 . . . . 0.9 111.865 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 75.5 Cg_exo -50.3 -34.19 39.51 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.599 2.866 . . . . 1.02 114.298 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 37.6 p-80 -88.32 14.4 9.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.612 -0.435 . . . . 1.14 111.931 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.3 mt -129.88 -32.25 1.88 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 1.34 111.185 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.421 ' CA ' HD12 ' A' ' 126' ' ' LEU . 6.1 p -69.92 126.96 92.73 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 121.015 0.436 . . . . 1.57 111.445 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 37.9 Cg_exo -61.75 155.23 55.4 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.449 2.766 . . . . 1.35 112.733 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 22.5 Cg_exo -65.33 -7.03 14.63 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.398 2.732 . . . . 2.05 113.506 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 p -86.63 1.56 51.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.501 -0.318 . . . . 2.66 111.635 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.641 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 20.6 tptp -118.94 17.66 13.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.101 0.477 . . . . 3.1 110.636 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -71.86 151.6 43.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 3.86 111.024 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.479 ' NE ' ' HA ' ' A' ' 137' ' ' ARG . 4.6 mmp_? -98.42 136.6 38.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.261 -0.427 . . . . 5.0 110.326 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -132.46 143.34 49.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.464 -0.334 . . . . 6.63 110.292 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.737 -0.649 . . . . 6.66 109.595 169.998 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.588 0.233 . . . . 10.53 110.619 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -85.26 137.82 32.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 8.22 110.608 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 145' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' B' ' 147' ' ' SER . 3.6 p90 -117.53 0.65 12.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.168 -0.469 . . . . 7.43 110.727 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 63.41 23.43 13.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.456 -0.793 . . . . 5.92 112.854 172.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 147' ' ' SER . . . . . 0.472 ' HB3' ' HA ' ' B' ' 153' ' ' ALA . 69.5 m -81.33 82.87 7.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.332 0.587 . . . . 4.34 110.266 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.6 m -123.87 1.77 8.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.158 -0.928 . . . . 2.12 109.0 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 5.1 p-10 -92.67 156.46 41.02 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 114.683 -1.144 . . . . 1.25 110.872 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 14.9 Cg_exo -70.86 -2.18 10.56 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.219 2.613 . . . . 0.49 113.48 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.461 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 40.1 m-85 -102.54 -23.31 13.9 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.244 -0.285 . . . . 0.56 111.376 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 t -151.93 116.22 5.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.458 0.647 . . . . 1.89 111.155 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 153' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' B' ' 147' ' ' SER . . . -141.61 113.22 7.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.917 -0.583 . . . . 3.11 110.779 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.776 -0.631 . . . . 6.99 109.676 177.407 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.61 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.016 -0.434 . . . . 10.47 112.016 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.72 121.82 5.22 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.635 2.223 . . . . 10.45 112.109 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.56 -66.72 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.84 -0.618 . . . . 9.09 110.471 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.77 88.91 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.605 -0.807 . . . . 6.24 112.053 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.2 t -154.96 151.97 29.13 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.173 -0.676 . . . . 5.98 109.173 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.08 120.63 23.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 3.92 110.421 176.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.02 109.38 19.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.798 -0.637 . . . . 4.94 109.799 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 t -77.07 138.93 19.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.249 -0.887 . . . . 1.99 110.672 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.03 128.82 37.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.79 -0.641 . . . . 2.4 109.938 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -71.57 113.64 8.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.561 . . . . 0.96 110.031 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.44 -42.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 1.33 111.826 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.02 -5.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.072 -0.513 . . . . 0.53 111.042 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.37 -15.85 75.2 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.248 -1.141 . . . . 0.78 110.248 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -80.28 -29.86 38.3 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.735 -0.733 . . . . 3.22 111.226 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -124.39 34.64 4.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.723 . . . . 2.39 109.824 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 22.1 ttpp -79.11 -43.98 1.72 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.79 -1.095 . . . . 1.17 112.031 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 12.4 Cg_exo -39.15 -40.72 1.8 Allowed 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 123.43 2.753 . . . . 0.65 115.015 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 56' ' ' ILE . 67.4 m -69.47 -43.96 72.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.995 0.426 . . . . 0.45 110.515 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -71.24 -22.16 62.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.224 -0.658 . . . . 0.7 109.224 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.93 -41.2 71.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.872 . . . . 0.73 109.595 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.71 -45.32 93.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 1.86 109.713 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 63.9 mt -58.7 -43.52 87.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 0.32 110.454 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -54.38 -38.46 66.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.533 -0.758 . . . . 0.39 111.011 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.567 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 49.1 m-85 -98.83 7.84 45.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.004 0.742 . . . . 0.91 113.004 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 56' ' ' ILE . 2.6 p -109.9 -3.02 16.85 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.791 -0.364 . . . . 0.58 110.935 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 3.8 pp -118.13 18.56 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.398 -0.365 . . . . 1.17 111.343 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 m 74.85 90.82 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.051 -0.977 . . . . 1.14 111.939 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.766 ' HA ' HG22 ' A' ' 67' ' ' ILE . 97.0 Cg_endo -92.95 125.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.947 2.431 . . . . 1.1 111.976 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.21 113.0 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 1.66 109.691 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 48.48 26.95 1.28 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.072 0.949 . . . . 1.98 113.029 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 11.34 58.05 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.916 -0.659 . . . . 0.83 113.345 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 8.6 ttmm -140.46 126.56 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.927 -0.768 . . . . 0.97 108.927 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 62' ' ' PRO . 36.7 pt -95.97 141.49 15.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.128 -0.629 . . . . 0.37 111.141 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.77 ' HA ' HD23 ' A' ' 100' ' ' LEU . 3.6 t -79.88 158.54 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.711 -0.677 . . . . 1.31 110.75 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.84 -23.14 21.27 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.496 -0.775 . . . . 0.33 113.414 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.19 -55.93 27.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 0.27 111.113 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.522 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 42.2 m-80 -78.25 -28.91 47.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.379 . . . . 1.79 110.634 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.649 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.85 -52.88 61.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 0.32 110.09 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.616 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 86.1 tttt -61.69 -35.43 77.98 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.559 -0.291 . . . . 1.36 110.432 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 26.2 ttpp -54.39 -46.16 73.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.228 0.537 . . . . 2.48 110.457 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -67.6 -41.44 84.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 2.16 110.234 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.785 ' HB3' HD22 ' A' ' 86' ' ' LEU . 72.8 mtp -67.66 -28.41 67.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.897 -0.592 . . . . 0.51 112.012 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.51 -16.17 11.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 O-C-N 121.857 -0.527 . . . . 1.34 110.638 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 99.0 mttt -75.59 -22.47 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.254 0.549 . . . . 2.2 109.626 168.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -73.78 -11.99 60.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.691 -0.686 . . . . 0.91 111.331 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt 63.92 37.14 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.153 -0.476 . . . . 2.37 111.697 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 86' ' ' LEU . 84.1 mt -106.16 153.15 40.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 1.35 110.696 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 43.7 Cg_endo -67.8 152.65 77.23 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.164 2.576 . . . . 0.44 112.604 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -57.35 -34.63 69.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.863 -0.608 . . . . 1.94 111.942 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.7 m -58.05 -54.13 50.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.14 0.495 . . . . 1.04 111.365 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.459 HG23 ' HG2' ' A' ' 82' ' ' PRO . 60.6 t -67.11 -38.95 82.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.41 110.402 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 76' ' ' MET . 88.9 mt -59.59 -46.61 88.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.44 110.795 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.17 -42.6 97.24 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.263 -0.494 . . . . 0.23 112.079 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 66.5 mttm -55.6 -53.6 54.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.843 0.354 . . . . 1.71 110.279 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.49 -36.71 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 0.4 110.364 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.468 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 74.4 t-105 -61.11 -56.45 20.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.46 111.182 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.71 -0.88 28.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.057 0.392 . . . . 2.4 112.057 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 74.9 mt -94.37 -46.95 6.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.031 0.443 . . . . 1.08 110.523 169.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.57 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -72.05 -36.21 69.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.531 -0.758 . . . . 0.3 111.175 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.4 t0 -86.71 70.42 10.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.896 0.855 . . . . 0.45 109.947 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.675 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 15.8 m -68.7 -15.63 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.542 -1.208 . . . . 1.28 110.826 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -18.27 40.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.724 -1.126 . . . . 1.12 110.171 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 61.58 35.66 17.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.089 -0.96 . . . . 1.68 111.144 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.693 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.3 p-10 -116.64 7.99 13.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.916 -0.584 . . . . 0.71 111.64 -172.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.16 10.53 59.62 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.326 -0.71 . . . . 0.39 111.326 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.77 HD23 ' HA ' ' A' ' 68' ' ' THR . 87.1 mt -133.68 141.19 47.48 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.726 -0.737 . . . . 1.37 109.182 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.1 mt -109.99 113.13 25.59 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.984 0.421 . . . . 0.34 111.022 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.58 172.26 7.65 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.963 -0.754 . . . . 1.39 108.963 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.2 -32.27 72.03 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.825 -0.35 . . . . 1.69 110.701 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -66.35 -51.52 56.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.884 0.374 . . . . 2.29 110.497 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -62.39 -41.5 98.69 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.925 -0.58 . . . . 0.39 110.645 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 66.3 t80 -70.53 -23.82 62.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.749 -0.659 . . . . 0.29 110.96 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.79 32.89 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.579 -0.897 . . . . 0.34 108.579 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 93' ' ' ALA . 29.6 tp -59.41 -39.79 84.58 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.627 -1.17 . . . . 1.74 109.772 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -59.07 -55.44 35.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.011 -0.54 . . . . 0.27 111.189 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -33.63 75.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.287 -0.415 . . . . 0.7 111.426 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -63.5 -44.04 95.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.75 109.932 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.71 -39.2 90.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.27 110.655 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.2 mt -60.14 -53.51 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.63 . . . . 0.46 111.385 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 16.0 pttp -70.9 -26.84 63.4 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 120.584 -0.446 . . . . 1.81 110.209 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.707 HG13 ' HB2' ' A' ' 120' ' ' HIS . 2.6 t -56.6 -48.76 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.665 -0.495 . . . . 0.91 109.665 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -62.29 -46.15 90.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.223 -0.444 . . . . 1.06 111.051 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 8.9 mp -59.36 -38.22 79.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 1.59 111.822 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 12.2 mm-40 -81.92 6.63 15.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.529 -0.305 . . . . 2.05 111.799 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 27.84 27.9 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.915 -0.66 . . . . 0.68 112.913 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.707 ' HB2' HG13 ' A' ' 115' ' ' VAL . 52.6 m80 -109.69 119.59 39.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.776 -0.453 . . . . 1.16 109.776 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -83.25 106.37 14.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.995 0.426 . . . . 2.69 110.845 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.49 HD12 ' O ' ' A' ' 122' ' ' LEU . 3.1 pp -68.66 146.98 97.95 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 1.21 110.34 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.5 Cg_endo -83.21 -1.86 10.47 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.911 2.408 . . . . 1.28 112.671 -173.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.83 19.24 11.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.774 -0.648 . . . . 1.06 111.322 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -115.63 165.99 12.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.142 -1.058 . . . . 1.93 108.142 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 29.0 tp -118.34 95.35 48.48 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 120.481 -0.487 . . . . 1.85 110.628 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 18.1 Cg_endo -61.66 150.37 85.89 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.767 2.312 . . . . 0.9 112.255 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 52.0 Cg_exo -55.74 -25.44 51.37 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.713 2.942 . . . . 1.02 113.578 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -86.27 3.92 41.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.68 0.252 . . . . 1.14 111.68 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.7 mt -116.55 -30.67 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.352 -0.217 . . . . 1.34 111.486 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -76.39 127.4 84.76 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.762 0.315 . . . . 1.57 110.768 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.26 136.59 5.54 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.425 2.75 . . . . 1.35 112.944 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.31 -16.15 52.72 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.757 2.305 . . . . 2.05 112.346 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.9 m -84.3 -8.73 58.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.654 . . . . 2.66 111.203 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.675 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 7.3 tppt? -118.08 10.31 12.96 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.051 0.453 . . . . 3.1 111.066 -176.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.36 144.85 38.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 3.86 110.221 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -128.22 132.23 48.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.217 0.532 . . . . 5.0 111.671 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -132.26 121.3 23.38 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.774 -0.824 . . . . 6.63 108.774 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 . . . . . 0 C--O 1.245 0.82 0 N-CA-C 108.448 -0.945 . . . . 6.66 108.448 -178.164 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.479 1.025 0 CA-C-O 120.72 0.295 . . . . 10.53 110.305 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -161.09 -172.9 3.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.213 -0.449 . . . . 8.22 110.111 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -130.65 151.48 51.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.214 -0.448 . . . . 7.43 110.09 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -73.03 127.43 32.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.156 0.503 . . . . 5.92 110.903 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 35.1 t -138.92 7.39 2.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.416 -0.811 . . . . 4.34 109.497 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 3.3 m -87.79 -36.84 17.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.75 -0.659 . . . . 2.12 110.155 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -106.7 112.39 63.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.423 -0.808 . . . . 1.25 110.121 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.616 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.8 Cg_exo -76.51 -2.35 12.55 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.566 2.844 . . . . 0.49 113.488 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.468 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 15.4 m-85 -98.18 -9.68 25.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.188 0.518 . . . . 0.56 110.077 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 66.2 p -68.59 -7.17 30.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 1.89 111.138 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.4 4.03 33.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.599 . . . . 3.11 111.571 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' B' ' 154' ' ' LYS . 10.8 mptt . . . . . 0 C--O 1.247 0.961 0 O-C-N 123.732 0.645 . . . . 6.99 111.138 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.629 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.855 0 N-CA-C 112.111 -0.396 . . . . 10.47 112.111 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.57 -19.85 41.79 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.971 2.447 . . . . 10.45 112.232 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 tp 72.19 119.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.956 0.785 . . . . 9.09 111.043 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.99 -174.73 13.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.676 -0.773 . . . . 6.24 112.169 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.5 t 63.34 42.54 6.79 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.061 0.458 . . . . 5.98 110.798 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.08 112.18 23.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 3.92 110.025 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.78 116.99 10.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 4.94 111.532 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.7 p -88.64 129.81 39.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.808 -0.633 . . . . 1.99 109.588 173.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -105.35 108.1 19.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.254 0.549 . . . . 2.4 110.692 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -81.38 102.55 10.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.937 -0.574 . . . . 0.96 109.553 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.76 -23.09 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.427 -0.806 . . . . 1.33 112.625 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG21 HD23 ' A' ' 108' ' ' LEU . 21.2 t -82.27 -10.72 12.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.07 0.462 . . . . 0.53 110.708 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.09 -23.83 69.92 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.118 -0.563 . . . . 0.78 113.176 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -73.89 -23.38 59.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.913 0.387 . . . . 3.22 111.549 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -134.13 32.95 3.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.965 0.888 . . . . 2.39 109.648 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 11.3 ttpp -82.99 -44.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.232 -0.895 . . . . 1.17 110.841 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 84.6 Cg_exo -49.37 -28.0 14.67 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.533 2.155 . . . . 0.65 113.574 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 m -69.28 -47.08 65.62 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.349 0.595 . . . . 0.45 109.987 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -75.85 -20.63 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.723 -0.843 . . . . 0.7 108.723 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 14.7 t70 -70.03 -42.04 73.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.885 -1.052 . . . . 0.73 109.431 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.31 -41.01 97.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.62 . . . . 1.86 109.808 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.3 -34.78 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.395 0.616 . . . . 0.32 110.283 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.94 -48.13 83.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.228 -0.896 . . . . 0.39 111.021 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.477 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 64.9 m-85 -73.81 -22.49 59.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.039 0.385 . . . . 0.91 112.039 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -85.24 1.73 46.95 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.508 -0.477 . . . . 0.58 111.16 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.9 mt -106.42 3.29 27.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.17 110.473 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.3 m 67.08 80.98 0.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.47 -0.786 . . . . 1.14 111.068 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 83.3 Cg_endo -88.63 111.23 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.804 2.336 . . . . 1.1 112.567 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.07 121.9 39.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.139 -0.482 . . . . 1.66 109.971 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 65.29 23.59 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.48 0.488 . . . . 1.98 110.846 -178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.58 22.79 59.49 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.83 112.528 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -137.71 142.14 41.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.625 0.25 . . . . 0.97 110.487 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.656 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 42.9 pt -104.78 132.83 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.215 -0.661 . . . . 0.37 109.215 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -73.39 162.42 29.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.119 -0.491 . . . . 1.31 109.841 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.485 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -63.08 -11.54 39.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.967 -0.635 . . . . 0.33 114.08 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.73 -63.25 1.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.489 0.644 . . . . 0.27 111.006 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.656 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 2.7 p30 -71.73 -29.42 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 1.79 110.9 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.14 -51.05 70.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.337 -0.392 . . . . 0.32 110.502 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -61.78 -34.74 76.43 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.938 -0.393 . . . . 1.36 109.938 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.551 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 36.1 ttmt -57.87 -45.8 85.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 2.48 110.994 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.862 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -65.87 -36.37 83.24 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.286 0.565 . . . . 2.16 110.007 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.529 ' HB3' HD22 ' A' ' 86' ' ' LEU . 90.7 mtp -67.75 -34.29 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.51 111.36 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.2 m -81.49 -15.38 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.872 -0.331 . . . . 1.34 110.822 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.862 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 50.2 mtpt -72.79 -28.95 62.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.922 -0.769 . . . . 2.2 108.922 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.0 m -68.51 -29.73 68.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.963 -1.017 . . . . 0.91 110.306 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 70.6 26.3 4.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.372 -0.831 . . . . 2.37 112.48 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.07 159.87 67.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.269 -0.641 . . . . 1.35 109.269 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.86 142.22 92.64 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.659 2.24 . . . . 0.44 112.32 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.76 -31.05 58.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.859 -0.61 . . . . 1.94 111.763 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p -63.54 -51.33 65.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.947 0.403 . . . . 1.04 111.139 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.536 HG11 ' HG2' ' A' ' 116' ' ' LYS . 98.2 t -66.83 -41.5 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 0.41 110.317 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.531 ' HB3' ' CE1' ' B' ' 151' ' ' PHE . 75.2 mt -58.09 -43.07 86.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 0.44 110.797 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 91' ' ' LYS . . . -61.03 -43.84 98.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.042 -0.599 . . . . 0.23 111.939 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.542 ' HE3' HD11 ' A' ' 122' ' ' LEU . 53.5 mtmt -57.21 -42.63 81.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.39 . . . . 1.71 110.437 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.0 mt -64.76 -42.21 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.615 . . . . 0.4 109.972 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.596 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 75.2 t-105 -62.09 -51.78 66.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.28 -0.873 . . . . 0.46 111.185 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 87' ' ' GLY . 31.0 mmmt -70.14 -18.15 63.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 2.4 111.907 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.863 HD11 ' HA ' ' A' ' 124' ' ' ALA . 92.7 mt -90.71 -45.58 8.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 1.08 111.501 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.91 63.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 0.3 111.301 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.654 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.9 t70 -95.55 95.24 8.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.496 0.665 . . . . 0.45 110.77 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' A' ' 132' ' ' PRO . 3.7 m -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.095 -0.957 . . . . 1.28 111.806 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.652 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 23.5 m-20 -76.36 -25.28 54.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.121 -0.49 . . . . 1.12 110.837 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttt 62.16 34.29 16.33 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 124.124 0.89 . . . . 1.68 109.434 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 13.7 p-10 -129.64 8.19 5.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.349 -0.387 . . . . 0.71 111.949 -173.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.41 12.47 76.94 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.686 -0.768 . . . . 0.39 113.247 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.47 126.98 55.9 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.586 -0.361 . . . . 1.37 110.138 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.435 HD22 ' HB3' ' A' ' 105' ' ' GLU . 36.2 mt -102.93 112.86 25.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.34 111.323 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.78 170.12 11.64 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.495 -0.928 . . . . 1.39 108.495 167.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.73 -30.6 71.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.926 0.393 . . . . 1.69 110.67 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.437 ' OE1' ' HD2' ' A' ' 133' ' ' PRO . 16.8 mt-10 -67.26 -46.92 72.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.061 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 101' ' ' LEU . 47.9 mt-10 -65.19 -41.47 94.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.274 -0.875 . . . . 0.39 110.952 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.528 ' CD1' HD11 ' A' ' 67' ' ' ILE . 47.3 t80 -65.84 -33.23 75.37 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.017 -0.538 . . . . 0.29 110.094 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.17 95.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.34 110.192 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 46' ' ' VAL . 92.0 mt -62.53 -41.68 99.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 1.74 110.633 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.13 -55.46 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.27 111.089 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -62.37 -37.19 84.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.7 110.913 -178.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.51 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.7 t60 -58.29 -50.06 74.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.416 . . . . 0.75 110.832 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.99 -29.57 70.72 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.883 0.373 . . . . 0.27 111.265 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 109' ' ' ALA . 85.0 mt -75.18 -42.51 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.537 0.684 . . . . 0.46 109.468 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -65.24 -36.12 83.15 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.821 -1.081 . . . . 1.81 110.79 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 111' ' ' HIS . 68.6 t -60.87 -54.2 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.748 0.309 . . . . 0.91 110.455 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.536 ' HG2' HG11 ' A' ' 85' ' ' VAL . 40.7 tptt -55.35 -48.25 74.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.403 -0.362 . . . . 1.06 111.619 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.48 -40.05 81.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 1.59 112.03 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.97 7.78 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.037 0.384 . . . . 2.05 112.037 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.47 35.54 6.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.552 -0.832 . . . . 0.68 112.966 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -121.83 -168.99 1.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.449 -0.442 . . . . 1.16 110.066 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -139.55 150.44 45.08 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.213 -0.662 . . . . 2.69 109.213 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.542 HD11 ' HE3' ' A' ' 88' ' ' LYS . 0.9 OUTLIER -104.01 129.39 25.3 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.667 -0.494 . . . . 1.21 109.667 178.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 6.64 2.19 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.271 2.647 . . . . 1.28 113.832 -169.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.863 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 58.77 28.67 17.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.389 -0.369 . . . . 1.06 111.416 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -112.34 171.25 7.63 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.043 0.449 . . . . 1.93 110.084 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.582 HD22 HG22 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -124.66 86.67 55.47 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.38 -0.97 . . . . 1.85 108.38 168.545 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 80.7 Cg_exo -48.68 141.08 21.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.999 2.466 . . . . 0.9 112.126 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 52.1 Cg_exo -55.24 -31.27 75.61 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.94 2.427 . . . . 1.02 112.664 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -91.51 12.94 19.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.755 -0.378 . . . . 1.14 111.43 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.3 mt -116.49 5.45 13.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 1.34 110.847 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.582 HG22 HD22 ' A' ' 126' ' ' LEU . 56.0 t -85.15 119.59 72.6 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 1.57 111.025 -177.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.494 ' HD2' HG11 ' A' ' 95' ' ' VAL . 32.7 Cg_exo -62.41 142.37 90.47 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.101 2.534 . . . . 1.35 112.244 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.437 ' HD2' ' OE1' ' A' ' 104' ' ' GLU . 41.6 Cg_endo -67.45 -9.56 25.73 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.286 2.657 . . . . 2.05 113.103 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.1 m -76.97 -1.7 30.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.462 -0.336 . . . . 2.66 111.807 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -114.39 13.41 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 3.1 110.292 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -71.52 134.2 46.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.101 0.476 . . . . 3.86 112.261 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -121.37 131.39 54.15 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.454 -0.943 . . . . 5.0 108.454 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -63.81 113.07 3.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.107 0.48 . . . . 6.63 111.078 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.072 -0.967 . . . . 6.66 109.806 -177.909 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 60.2 t80 . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.665 -0.495 . . . . 10.53 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -128.63 161.26 30.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.206 -0.452 . . . . 8.22 110.408 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 46.4 p90 46.16 -169.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.621 1.201 . . . . 7.43 112.522 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.61 139.03 33.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.091 -0.504 . . . . 5.92 110.239 -174.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 63.5 p -131.1 77.73 1.8 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.03 0.443 . . . . 4.34 111.207 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 69.1 p -117.42 9.05 13.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.647 0.737 . . . . 2.12 109.051 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 9.5 t70 -111.8 116.6 49.74 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.814 -1.084 . . . . 1.25 110.075 -174.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.9 Cg_exo -74.85 -2.01 11.93 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.471 2.781 . . . . 0.49 113.627 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.596 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 20.0 m-85 -99.17 -12.86 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.441 . . . . 0.56 110.359 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 77.5 p -86.41 -169.17 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.847 -0.615 . . . . 1.89 110.584 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -129.24 134.84 48.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.416 -0.216 . . . . 3.11 110.416 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 22.9 tptm . . . . . 0 C--O 1.245 0.83 0 CA-C-O 118.515 -0.755 . . . . 6.99 110.556 -174.484 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.654 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.674 -0.57 . . . . 10.47 111.674 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.87 -0.75 9.77 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.694 2.262 . . . . 10.45 113.108 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.7 mt -116.55 113.97 23.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.513 0.197 . . . . 9.09 110.589 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.96 106.22 2.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.642 -0.789 . . . . 6.24 111.958 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.4 t -133.41 119.53 19.76 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.903 -0.406 . . . . 5.98 109.903 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -77.02 93.88 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.353 . . . . 3.92 111.013 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.92 96.02 10.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.706 0.765 . . . . 4.94 109.24 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 129' ' ' HIS . 31.6 m -76.76 123.25 32.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.433 -0.803 . . . . 1.99 111.484 -175.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -91.34 121.67 33.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 2.4 109.639 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.585 ' HZ3' ' HD3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -74.17 101.6 4.01 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.067 -0.716 . . . . 0.96 109.067 178.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.672 HG22 HD21 ' A' ' 130' ' ' LEU . 21.2 m -62.71 -14.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 1.33 112.398 -172.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.509 ' HB ' ' CZ3' ' A' ' 44' ' ' TRP . 15.7 t -90.75 -11.07 9.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.482 . . . . 0.53 110.252 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.568 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -70.39 -10.42 66.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.171 -0.538 . . . . 0.78 112.673 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -75.67 -27.75 58.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.045 0.45 . . . . 3.22 110.435 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.8 34.0 4.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.961 0.886 . . . . 2.39 109.332 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HD3' ' HZ3' ' A' ' 44' ' ' TRP . 0.7 OUTLIER -70.17 -52.45 12.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.861 -1.063 . . . . 1.17 111.825 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.09 -24.48 58.43 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.041 1.827 . . . . 0.65 113.667 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -69.07 -45.76 69.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.682 -0.69 . . . . 0.45 109.895 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 6.7 m-85 -74.18 -21.59 59.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.677 -0.692 . . . . 0.7 109.385 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.73 110.208 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.28 -44.19 95.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.86 110.046 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 61.0 mt -68.82 -36.79 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.32 110.546 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' TYR . 51.8 t80 -59.31 -52.32 66.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.39 110.931 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.683 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 33.5 m-85 -76.81 -11.4 59.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.57 0.582 . . . . 0.91 112.57 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 p -93.5 2.98 56.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.58 110.812 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 82.2 mt -101.11 1.32 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.005 -0.543 . . . . 1.17 110.386 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m 69.45 85.07 0.13 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 115.496 -0.775 . . . . 1.14 111.103 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.683 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.8 Cg_endo -86.28 150.66 9.25 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.145 2.563 . . . . 1.1 112.539 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.36 119.8 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 1.66 110.532 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 60.46 27.0 16.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.747 -0.66 . . . . 1.98 111.267 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.28 4.9 83.34 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.734 -0.745 . . . . 0.83 112.65 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.699 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 58.1 mttm -123.32 148.48 45.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.35 -0.241 . . . . 0.97 110.35 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.701 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 40.9 pt -112.45 128.52 69.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.723 -0.473 . . . . 0.37 109.723 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.521 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 8.2 t -70.97 161.74 30.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.029 -0.532 . . . . 1.31 110.252 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -7.02 10.02 Favored Glycine 0 C--O 1.223 -0.534 0 CA-C-N 115.624 -0.716 . . . . 0.33 113.992 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 -64.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.479 0.64 . . . . 0.27 110.816 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.701 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 4.0 p30 -68.52 -34.06 75.21 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.848 0.356 . . . . 1.79 110.555 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -59.2 -52.6 64.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.012 -0.54 . . . . 0.32 110.54 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.814 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.3 tttt -62.11 -35.51 78.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.535 -0.302 . . . . 1.36 110.658 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -53.77 -49.97 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.962 0.41 . . . . 2.48 110.468 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -66.52 -38.28 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.003 0.43 . . . . 2.16 110.54 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.824 ' HB3' HD22 ' A' ' 86' ' ' LEU . 93.0 mtp -64.99 -38.22 90.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 0.51 111.356 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.41 -16.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 1.34 110.668 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.74 -12.53 50.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.072 0.463 . . . . 2.2 110.327 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -77.54 -4.92 48.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.689 -0.687 . . . . 0.91 110.135 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.97 22.02 8.7 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.597 -0.729 . . . . 2.37 112.135 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' HD21 ' A' ' 86' ' ' LEU . 87.8 mt -93.84 153.92 40.93 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 1.35 110.36 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 85' ' ' VAL . 57.0 Cg_endo -72.41 160.52 46.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.835 2.357 . . . . 0.44 112.526 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -55.45 -34.46 64.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.761 -0.654 . . . . 1.94 111.092 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -57.39 -59.2 5.49 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.863 -0.608 . . . . 1.04 111.288 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.508 HG23 ' HG2' ' A' ' 82' ' ' PRO . 65.9 t -64.5 -45.15 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.572 -0.74 . . . . 0.41 110.657 -177.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.824 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.1 mt -60.65 -42.76 97.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.815 0.34 . . . . 0.44 110.864 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -61.37 -46.29 94.69 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.002 -0.544 . . . . 0.23 112.642 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 19.3 ptmt -72.17 -35.22 68.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.37 -0.532 . . . . 1.71 110.917 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.471 HG23 HD12 ' A' ' 112' ' ' LEU . 46.8 mt -60.65 -41.08 86.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.996 -0.372 . . . . 0.4 109.996 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' B' ' 149' ' ' ASP . 49.6 t-105 -64.25 -48.9 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.46 110.541 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -58.5 -24.78 61.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.929 -0.578 . . . . 2.4 111.878 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 31.8 mt -92.41 -52.16 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.353 . . . . 1.08 111.281 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.03 73.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.539 -0.755 . . . . 0.3 112.097 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.621 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 44.3 t0 -86.93 94.75 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.455 0.645 . . . . 0.45 109.358 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.427 HG12 ' HE2' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -81.42 -26.91 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.323 -0.853 . . . . 1.28 111.381 -171.039 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.605 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -80.3 -10.71 59.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 1.12 109.402 174.266 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 45.92 46.42 12.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.081 0.863 . . . . 1.68 109.873 -172.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -109.49 5.33 23.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.71 111.676 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.491 ' C ' HD12 ' A' ' 100' ' ' LEU . . . 84.77 -4.88 84.03 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.307 -0.717 . . . . 0.39 111.307 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mp -122.41 142.89 50.05 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.151 -0.524 . . . . 1.37 110.153 177.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.53 115.22 28.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.89 -0.782 . . . . 0.34 108.89 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 175.79 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.848 -0.797 . . . . 1.39 108.848 167.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -56.67 -40.39 75.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.221 0.534 . . . . 1.69 110.735 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.52 -33.18 62.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 2.29 110.631 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.34 -41.72 69.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.39 110.373 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -67.54 -32.27 72.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.807 -0.633 . . . . 0.29 109.439 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -60.83 -46.75 89.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 0.34 110.86 173.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 82.5 mt -61.84 -42.75 99.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.375 -0.375 . . . . 1.74 110.635 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.36 -57.17 13.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.27 110.901 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -61.47 -34.22 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.7 111.197 -178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.415 ' O ' HG23 ' A' ' 115' ' ' VAL . 59.3 t60 -65.41 -46.2 80.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.75 110.179 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.471 HD12 HG23 ' A' ' 89' ' ' ILE . 79.9 mt -60.43 -40.8 92.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.91 0.386 . . . . 0.27 110.264 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 109' ' ' ALA . 83.8 mt -61.13 -54.38 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.38 -0.827 . . . . 0.46 111.065 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.667 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 14.8 ptpt -67.37 -33.85 76.08 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.051 -0.659 . . . . 1.81 111.23 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 111' ' ' HIS . 39.9 t -58.92 -50.4 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.127 -0.323 . . . . 0.91 110.127 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -53.96 -48.81 69.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.884 0.374 . . . . 1.06 111.096 172.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.01 -20.16 65.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.389 0.515 . . . . 1.59 112.389 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.667 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.1 mt-10 -76.59 -6.22 51.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.83 0.348 . . . . 2.05 110.626 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.75 27.51 14.27 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.178 -0.769 . . . . 0.68 111.178 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 24.5 m170 -113.27 -176.98 3.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 1.16 109.865 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -123.94 142.31 51.26 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.612 -0.885 . . . . 2.69 108.612 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -85.07 141.24 37.39 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.449 -0.341 . . . . 1.21 110.321 -179.092 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 39.3 Cg_exo -58.54 -16.44 29.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.438 2.759 . . . . 1.28 114.197 -170.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.34 18.03 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.701 0.626 . . . . 1.06 110.992 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -135.58 173.63 11.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.717 -0.674 . . . . 1.93 109.548 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.54 95.76 44.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.608 -0.516 . . . . 1.85 109.608 174.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 51.2 Cg_exo -54.1 147.47 43.91 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.221 2.614 . . . . 0.9 112.847 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 41.9 Cg_exo -58.42 -25.19 72.42 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.196 2.597 . . . . 1.02 112.763 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.417 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 24.0 p80 -85.79 3.34 41.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.458 -0.337 . . . . 1.14 111.03 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.672 HD21 HG22 ' A' ' 45' ' ' VAL . 31.2 mt -118.56 -28.76 5.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 1.34 111.385 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 128' ' ' PRO . 32.0 m -66.51 132.56 94.23 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 120.739 -0.384 . . . . 1.57 110.549 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.87 160.06 35.07 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.321 2.681 . . . . 1.35 112.589 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.6 -25.46 50.18 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.121 2.548 . . . . 2.05 112.777 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.8 t -71.95 -7.46 48.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.808 0.337 . . . . 2.66 111.276 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HE2' HG12 ' A' ' 95' ' ' VAL . 26.1 mmmt -111.43 5.53 19.69 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.997 0.369 . . . . 3.1 111.997 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -58.02 114.05 2.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.224 0.535 . . . . 3.86 111.899 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -119.34 164.75 15.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.315 -0.857 . . . . 5.0 108.831 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -117.42 115.79 25.9 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.102 -0.639 . . . . 6.63 109.665 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.437 -0.792 . . . . 6.66 110.795 -175.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.368 0.127 . . . . 10.53 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -88.72 149.25 23.57 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.865 0.364 . . . . 8.22 110.956 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -130.35 -174.43 3.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.001 -0.545 . . . . 7.43 110.626 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 129.83 41.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.109 0.48 . . . . 5.92 112.277 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 10.0 m -95.13 153.11 17.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.526 -0.761 . . . . 4.34 109.87 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 5.6 p -104.29 27.87 7.39 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.989 0.366 . . . . 2.12 111.989 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.9 p30 -83.81 145.63 47.52 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.163 0.506 . . . . 1.25 110.906 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.814 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 14.3 Cg_exo -69.57 0.49 5.43 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.666 2.911 . . . . 0.49 113.69 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.495 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 28.5 m-85 -97.47 -45.93 6.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.006 0.431 . . . . 0.56 110.312 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 76.4 p -118.24 95.91 5.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.561 0.696 . . . . 1.89 110.35 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.76 -30.55 56.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.46 -0.791 . . . . 3.11 111.885 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 C--O 1.252 1.185 0 O-C-N 123.452 0.47 . . . . 6.99 110.054 -175.966 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.621 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.959 -0.456 . . . . 10.47 111.959 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.33 -23.27 15.51 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.782 2.321 . . . . 10.45 112.241 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.42 39.62 1.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.003 -0.544 . . . . 9.09 110.917 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.95 66.37 3.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.84 -0.695 . . . . 6.24 111.476 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.4 m -90.37 -7.12 54.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.901 0.382 . . . . 5.98 110.983 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -75.83 134.45 40.37 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.946 -0.391 . . . . 3.92 109.946 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -83.45 144.85 29.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.417 -0.356 . . . . 4.94 110.184 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.77 136.2 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.902 0.382 . . . . 1.99 111.099 -174.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -85.26 148.91 25.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.39 0.614 . . . . 2.4 111.082 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -92.63 140.17 29.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.119 -0.946 . . . . 0.96 112.349 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.49 -7.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.888 0.851 . . . . 1.33 109.035 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 t -96.83 -11.93 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.887 -1.051 . . . . 0.53 109.802 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.67 -23.68 69.09 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.773 -0.649 . . . . 0.78 112.996 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -74.35 -27.32 60.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.999 0.428 . . . . 3.22 110.67 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.39 31.39 5.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 2.39 109.637 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -75.81 -56.44 1.73 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.51 -0.314 . . . . 1.17 111.692 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.555 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 51.0 Cg_endo -66.94 -14.75 44.87 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.707 1.605 . . . . 0.65 112.569 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.41 -46.59 63.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.548 0.689 . . . . 0.45 109.177 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 13.5 m-85 -80.82 -20.8 41.65 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.453 -0.794 . . . . 0.7 109.922 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 11.2 t70 -66.29 -44.55 83.18 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.212 -0.662 . . . . 0.73 109.212 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.93 -50.89 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.86 110.229 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.51 -38.81 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.062 -0.517 . . . . 0.32 110.338 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.49 ' HE1' HG12 ' A' ' 67' ' ' ILE . 65.2 t80 -56.72 -47.56 79.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.317 -0.856 . . . . 0.39 111.134 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -76.09 -22.36 55.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.27 0.471 . . . . 0.91 112.27 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.45 -6.71 57.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.6 -0.44 . . . . 0.58 111.032 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.14 0.73 38.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 1.17 111.228 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m 69.65 88.15 0.1 Allowed Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 123.84 0.713 . . . . 1.14 111.201 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.0 136.27 5.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.809 2.34 . . . . 1.1 112.438 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.3 m -107.71 115.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.113 0.482 . . . . 1.66 110.828 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 58.0 28.33 16.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.717 -0.674 . . . . 1.98 112.016 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.88 -2.4 69.4 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.94 -0.648 . . . . 0.83 113.352 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 57.3 mttm -127.11 142.25 51.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.501 -0.411 . . . . 0.97 110.546 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.49 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -99.06 138.67 22.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.201 -0.666 . . . . 0.37 109.201 170.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.752 ' HA ' HD23 ' A' ' 100' ' ' LEU . 1.1 p -71.53 164.55 25.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.254 -0.43 . . . . 1.31 111.067 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.56 -25.25 41.97 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 115.719 -0.673 . . . . 0.33 113.175 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.26 -42.91 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.27 111.074 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.756 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 25.6 m-80 -76.72 -43.03 39.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.14 0.495 . . . . 1.79 110.234 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.54 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.98 -41.15 86.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.022 -0.99 . . . . 0.32 110.516 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.723 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.6 tttt -70.59 -35.93 73.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.009 -0.541 . . . . 1.36 110.122 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.756 ' HE2' ' HA ' ' A' ' 71' ' ' ASN . 52.3 mtmt -54.45 -46.37 73.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.906 0.384 . . . . 2.48 110.203 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.76 -52.54 63.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.693 -0.685 . . . . 2.16 110.176 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.54 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 32.8 mtt -56.23 -41.96 76.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.128 0.49 . . . . 0.51 112.01 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 73' ' ' LYS . 99.6 t -68.74 -31.17 49.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.707 -0.678 . . . . 1.34 110.72 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 98.4 mttt -71.53 -28.15 63.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.88 0.371 . . . . 2.2 110.348 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 m -74.17 -15.07 61.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.91 111.122 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 73.15 24.38 2.47 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.821 0.674 . . . . 2.37 112.821 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.685 ' HB2' HD21 ' A' ' 86' ' ' LEU . 3.9 mm? -87.84 158.15 50.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.655 -0.418 . . . . 1.35 110.271 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HG2' HG23 ' A' ' 85' ' ' VAL . 73.5 Cg_endo -76.31 157.21 37.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.125 2.55 . . . . 0.44 113.274 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -53.69 -42.99 68.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.661 -0.7 . . . . 1.94 111.703 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 p -55.78 -56.88 15.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.235 0.54 . . . . 1.04 111.785 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 82' ' ' PRO . 87.9 t -62.39 -45.15 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.81 -0.632 . . . . 0.41 111.171 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 81' ' ' LEU . 70.3 mt -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.44 110.376 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.94 -48.07 79.61 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.02 -0.536 . . . . 0.23 112.48 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 40.9 pttt -74.05 -33.68 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 1.71 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.434 HG23 HD12 ' A' ' 112' ' ' LEU . 43.5 mt -60.66 -41.44 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.851 -0.425 . . . . 0.4 109.851 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -60.88 -48.75 80.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.46 110.377 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -67.84 -14.03 62.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.055 0.391 . . . . 2.4 112.055 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 61.5 mt -93.31 -51.18 5.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.331 . . . . 1.08 110.79 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.03 -33.66 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.775 . . . . 0.3 111.544 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.599 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 37.6 t0 -84.32 86.26 7.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.672 0.748 . . . . 0.45 109.494 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.804 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 3.5 m -68.66 -30.62 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.562 -1.199 . . . . 1.28 112.405 -175.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.433 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 2.7 m-20 -72.78 -24.34 60.92 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 116.514 -0.312 . . . . 1.12 110.265 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 mttt 58.37 40.33 24.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.277 -1.008 . . . . 1.68 108.277 -167.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.602 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 p-10 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.995 -1.002 . . . . 0.71 111.22 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.65 22.16 65.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.72 . . . . 0.39 111.793 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 68' ' ' THR . 15.3 mt -140.67 143.95 35.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.503 -0.555 . . . . 1.37 109.503 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.495 HD22 ' HB3' ' A' ' 105' ' ' GLU . 71.0 mt -121.56 114.2 20.86 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.451 0.469 . . . . 0.34 109.973 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -79.19 -177.57 5.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.971 -0.752 . . . . 1.39 108.971 169.71 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.65 -30.85 69.03 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.985 -0.286 . . . . 1.69 111.385 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.36 -58.05 3.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.075 -0.343 . . . . 2.29 110.075 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.495 ' HB3' HD22 ' A' ' 101' ' ' LEU . 38.6 mt-10 -56.94 -39.71 75.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.323 0.582 . . . . 0.39 110.653 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.75 -29.43 66.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.549 -0.751 . . . . 0.29 110.945 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.47 -42.23 30.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.918 0.866 . . . . 0.34 108.925 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.505 -1.225 . . . . 1.74 110.044 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.18 -52.02 67.32 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.965 -0.561 . . . . 0.27 110.754 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -61.97 -27.09 68.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.7 111.668 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.474 ' O ' HG23 ' A' ' 115' ' ' VAL . 21.9 t60 -67.19 -47.18 71.7 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 0.75 109.841 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.434 HD12 HG23 ' A' ' 89' ' ' ILE . 87.6 mt -62.48 -41.88 99.09 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.996 0.427 . . . . 0.27 110.234 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 109' ' ' ALA . 73.6 mt -61.22 -50.77 79.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.46 111.313 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 45.4 pttt -73.48 -21.42 60.44 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 120.336 -0.545 . . . . 1.81 110.236 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 111' ' ' HIS . 2.8 t -58.96 -46.45 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.638 -0.504 . . . . 0.91 109.638 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 13.1 mmmm -72.73 -31.98 65.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.397 -0.365 . . . . 1.06 111.249 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.43 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 37.0 tp -65.41 -42.0 93.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 1.59 111.317 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 80.8 mm-40 -69.98 -26.01 63.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.027 0.441 . . . . 2.05 110.619 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.33 34.48 3.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.653 -0.784 . . . . 0.68 112.65 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.66 177.24 4.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.962 -0.384 . . . . 1.16 109.962 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.79 149.41 24.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.832 0.349 . . . . 2.69 111.631 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 122' ' ' LEU . 1.4 pp -124.91 130.67 24.14 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.117 -0.697 . . . . 1.21 109.117 167.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 -13.62 20.19 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.689 2.26 . . . . 1.28 113.726 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.6 18.94 9.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.586 -0.734 . . . . 1.06 110.571 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -106.14 170.17 8.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.332 -0.849 . . . . 1.93 108.904 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.1 tp -123.15 96.83 44.02 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.651 -0.419 . . . . 1.85 110.758 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 60.2 Cg_endo -75.21 152.67 40.1 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.899 2.4 . . . . 0.9 112.125 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 77.1 Cg_exo -51.3 -39.69 62.42 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.537 2.825 . . . . 1.02 114.237 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -81.02 13.92 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 1.14 111.716 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.4 mt -122.53 5.14 9.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.281 -0.418 . . . . 1.34 110.217 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.8 t -95.73 106.51 27.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 1.57 110.171 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.65 161.43 45.29 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.801 2.334 . . . . 1.35 112.962 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.589 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 30.6 Cg_endo -64.05 2.9 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.188 2.592 . . . . 2.05 113.274 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.8 t -73.5 -27.64 61.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.912 0.387 . . . . 2.66 110.184 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.804 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 4.2 mmmp? -92.08 8.0 39.78 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 112.647 0.61 . . . . 3.1 112.647 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 14.4 ptp180 -100.14 124.07 45.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.103 0.477 . . . . 3.86 110.386 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.0 ttm-85 -126.1 115.7 20.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.606 -0.725 . . . . 5.0 109.256 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -133.69 140.98 47.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.16 0.505 . . . . 6.63 111.321 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.563 ' CD ' ' H ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 117.951 -1.023 . . . . 6.66 111.375 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.984 -0.376 . . . . 10.53 109.984 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -64.37 -41.29 96.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.45 -0.341 . . . . 8.22 111.409 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -156.6 151.25 25.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 7.43 110.271 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.49 75.84 0.95 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.226 0.536 . . . . 5.92 110.499 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 24.4 m -156.74 94.01 1.42 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 4.34 109.753 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.3 p -120.14 -3.53 10.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.255 0.465 . . . . 2.12 112.255 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -133.86 152.98 79.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.676 0.274 . . . . 1.25 110.382 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.723 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -72.75 -1.59 10.61 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.464 2.776 . . . . 0.49 113.936 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.447 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 25.2 m-85 -100.31 -20.31 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.101 0.476 . . . . 0.56 110.91 -175.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 34.1 p -83.32 -2.75 56.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.8 -0.637 . . . . 1.89 110.57 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.8 90.1 2.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.773 -0.649 . . . . 3.11 110.541 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.555 -0.748 . . . . 6.99 111.605 176.051 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.599 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.33 -0.708 . . . . 10.47 111.33 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.11 -69.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.816 2.344 . . . . 10.45 112.14 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.9 tp 65.23 -77.68 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.829 0.706 . . . . 9.09 111.732 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.75 79.41 1.12 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.272 -0.489 . . . . 6.24 113.145 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.9 m -94.77 69.61 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.248 -0.649 . . . . 5.98 109.248 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.42 133.2 39.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 3.92 111.185 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.21 109.99 4.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.519 -0.764 . . . . 4.94 111.174 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 p -104.52 115.54 46.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.215 -0.661 . . . . 1.99 109.215 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.48 132.1 34.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.395 0.616 . . . . 2.4 111.392 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.459 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.6 t90 -76.79 123.22 25.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.303 -0.862 . . . . 0.96 109.895 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.85 -35.34 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 1.33 111.786 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.9 -21.0 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.145 -0.48 . . . . 0.53 111.174 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -68.67 -5.93 47.58 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.084 -0.579 . . . . 0.78 112.98 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -74.64 -28.25 60.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.089 0.471 . . . . 3.22 110.867 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -135.02 33.16 3.15 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.53 -0.915 . . . . 2.39 108.53 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 82.3 tttt -84.33 -44.71 0.74 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 114.946 -1.025 . . . . 1.17 113.409 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 19.7 Cg_endo -56.18 -23.84 47.11 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.426 2.084 . . . . 0.65 113.132 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 m -69.9 -41.21 74.99 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.273 -0.876 . . . . 0.45 110.378 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.59 -21.95 60.18 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.362 -0.607 . . . . 0.7 109.362 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 3.6 t70 -66.3 -45.18 81.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.443 0.64 . . . . 0.73 109.75 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -59.59 -40.8 88.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.072 -0.967 . . . . 1.86 109.902 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 65.9 mt -70.29 -37.89 72.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.071 0.462 . . . . 0.32 110.731 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -61.54 -51.09 70.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.142 -0.481 . . . . 0.39 111.235 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -82.24 14.18 3.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.231 0.456 . . . . 0.91 112.231 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -118.5 3.58 11.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 0.58 110.467 172.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 72.5 mt -106.35 11.97 30.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.919 -0.582 . . . . 1.17 110.513 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t 66.35 80.77 0.22 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.371 -0.831 . . . . 1.14 111.325 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.77 128.67 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.313 2.008 . . . . 1.1 111.526 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.0 t -106.81 107.79 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.398 -0.364 . . . . 1.66 110.191 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 68.61 29.22 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.478 -0.783 . . . . 1.98 110.52 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.24 -3.62 72.93 Favored Glycine 0 C--O 1.23 -0.142 0 CA-C-N 115.655 -0.702 . . . . 0.83 113.333 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -122.03 140.36 52.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.407 -0.22 . . . . 0.97 110.407 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -101.13 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.835 -0.802 . . . . 0.37 108.835 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.73 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 72.0 p -80.75 164.94 22.38 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.483 -0.487 . . . . 1.31 110.207 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.38 -20.73 52.02 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 120.999 -0.62 . . . . 0.33 112.802 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 -43.84 81.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.907 0.384 . . . . 0.27 111.308 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -76.3 -44.21 37.94 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.524 0.678 . . . . 1.79 109.767 -176.218 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.68 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.72 -50.82 72.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.771 -1.104 . . . . 0.32 110.182 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 77' ' ' VAL . 76.3 tttt -56.73 -40.62 76.03 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.1 -0.5 . . . . 1.36 110.539 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 35.9 ttpt -51.88 -49.25 63.34 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.003 0.43 . . . . 2.48 110.218 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.27 -39.88 89.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.89 -0.595 . . . . 2.16 110.517 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.741 ' HB3' HD22 ' A' ' 86' ' ' LEU . 66.4 mtp -67.26 -27.01 66.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.001 -0.545 . . . . 0.51 110.451 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 73' ' ' LYS . 77.7 t -70.94 -38.05 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 1.34 109.97 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -66.44 -21.87 66.21 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 2.2 110.885 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.4 t -73.88 -17.28 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.25 -0.432 . . . . 0.91 111.069 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 65.65 24.22 11.62 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.581 0.585 . . . . 2.37 112.581 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 86' ' ' LEU . 69.3 mt -85.59 151.61 56.01 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.574 -0.45 . . . . 1.35 110.219 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.481 ' HG2' HG23 ' A' ' 85' ' ' VAL . 33.1 Cg_endo -65.34 149.7 87.99 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.771 2.314 . . . . 0.44 111.918 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -53.13 -35.55 59.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.317 -0.401 . . . . 1.94 111.621 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 m -61.97 -45.05 95.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.348 -0.387 . . . . 1.04 111.017 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.639 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 86.6 t -73.37 -39.19 54.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.971 0.415 . . . . 0.41 110.332 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 76' ' ' MET . 84.4 mt -59.58 -48.76 80.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 0.44 110.563 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.57 -41.15 99.83 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.727 -0.669 . . . . 0.23 112.415 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 0.4 OUTLIER -66.67 -38.78 87.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.359 -0.536 . . . . 1.71 110.084 -179.013 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.81 -39.6 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 110.085 -0.339 . . . . 0.4 110.085 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -62.26 -51.56 67.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.46 110.445 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -67.39 -12.44 60.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 2.4 112.159 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.3 mt -93.97 -49.77 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 1.08 111.21 174.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.532 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -72.34 -32.27 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.3 111.705 -173.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.64 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 28.1 t70 -88.3 83.73 6.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.45 109.861 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.446 HG11 ' HD2' ' A' ' 132' ' ' PRO . 4.2 m -70.14 -28.9 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.206 -0.906 . . . . 1.28 111.497 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.555 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 57.5 m-20 -74.21 -19.9 60.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 121.002 -0.279 . . . . 1.12 110.271 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mttt 58.75 27.81 16.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.898 0.856 . . . . 1.68 109.097 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.596 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.6 p-10 -98.69 9.7 42.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.347 -1.297 . . . . 0.71 111.366 -169.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.94 9.23 52.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.93 -0.653 . . . . 0.39 111.522 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.73 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 15.5 mt -131.18 136.86 48.66 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.998 -0.601 . . . . 1.37 110.046 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 105' ' ' GLU . 47.8 mt -105.83 112.59 25.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 0.34 110.414 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.11 -178.11 3.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.89 -0.595 . . . . 1.39 109.55 170.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -56.8 -42.94 80.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.12 0.486 . . . . 1.69 110.339 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.459 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 19.2 mm-40 -66.08 -54.77 21.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.922 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HB3' HD22 ' A' ' 101' ' ' LEU . 48.0 mt-10 -60.37 -39.19 86.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.39 111.202 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 -25.47 59.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.29 110.959 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.77 -42.41 40.96 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.533 -0.914 . . . . 0.34 108.533 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 93' ' ' ALA . 22.8 tp -63.56 -37.62 88.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.608 -1.178 . . . . 1.74 109.845 174.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.74 -56.63 19.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.187 -0.46 . . . . 0.27 110.972 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -62.73 -31.13 72.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.33 -0.396 . . . . 0.7 111.242 -178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.486 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.0 t60 -66.93 -40.91 87.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.477 -0.329 . . . . 0.75 110.319 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 115' ' ' VAL . 94.7 mt -70.6 -39.4 73.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.159 0.504 . . . . 0.27 110.058 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.42 HD11 ' HG2' ' A' ' 76' ' ' MET . 65.7 mt -56.45 -53.7 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.844 . . . . 0.46 111.177 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 28.3 pttt -76.42 -25.05 54.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.293 -0.412 . . . . 1.81 111.042 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 112' ' ' LEU . 1.2 p -68.68 -38.88 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.245 -0.65 . . . . 0.91 109.245 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -66.53 -39.53 88.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.163 -0.472 . . . . 1.06 110.082 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.51 -39.76 92.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.879 -0.6 . . . . 1.59 111.149 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 71.3 mt-10 -71.55 -9.48 58.27 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.42 -0.354 . . . . 2.05 111.023 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.92 16.84 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.612 -0.804 . . . . 0.68 112.59 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.557 ' HB2' HG22 ' A' ' 115' ' ' VAL . 36.0 m80 -99.49 121.16 40.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.336 -0.616 . . . . 1.16 109.336 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -81.07 100.6 9.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.911 0.386 . . . . 2.69 110.411 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.406 HD12 ' O ' ' A' ' 122' ' ' LEU . 2.6 pp -61.09 133.47 92.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 1.21 109.81 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.26 4.84 3.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.952 2.434 . . . . 1.28 113.56 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.59 27.63 14.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.172 0.511 . . . . 1.06 110.854 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.68 163.49 16.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.926 -0.579 . . . . 1.93 109.97 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -126.56 85.65 59.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.128 -0.942 . . . . 1.85 109.124 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 11.1 Cg_endo -62.55 145.62 95.39 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.18 1.92 . . . . 0.9 111.612 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 84.8 Cg_exo -47.39 -32.33 14.76 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.494 2.796 . . . . 1.02 114.277 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -81.28 3.88 22.47 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.032 0.382 . . . . 1.14 112.032 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.83 -9.15 11.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.59 0.233 . . . . 1.34 111.128 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.66 121.8 77.22 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 1.57 111.151 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.446 ' HD2' HG11 ' A' ' 95' ' ' VAL . 44.6 Cg_exo -57.97 139.99 92.32 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.81 2.34 . . . . 1.35 112.286 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 24.7 Cg_exo -63.41 3.09 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.329 2.686 . . . . 2.05 113.807 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.4 t -72.05 -33.39 67.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 2.66 110.66 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 15.3 tptm -92.32 14.18 17.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.438 -0.346 . . . . 3.1 111.663 -172.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -75.55 111.75 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.964 -0.384 . . . . 3.86 109.964 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -90.83 149.06 22.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.119 0.485 . . . . 5.0 111.098 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -127.97 100.35 5.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.733 -0.84 . . . . 6.63 108.733 173.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.526 -0.75 . . . . 6.66 110.35 -177.206 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.879 0.371 . . . . 10.53 110.801 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 16.9 m120 69.39 -168.64 0.17 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.133 -0.94 . . . . 8.22 111.257 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -95.12 147.05 23.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.058 -0.519 . . . . 7.43 110.712 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.45 102.51 12.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.776 -0.647 . . . . 5.92 109.968 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.4 t -99.1 144.83 27.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.254 -0.43 . . . . 4.34 109.993 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 12.9 t -124.92 -7.18 7.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.163 -0.472 . . . . 2.12 109.784 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.526 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 6.3 t70 -117.98 117.61 35.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 1.25 110.373 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.5 Cg_exo -74.61 -2.02 11.88 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.43 2.754 . . . . 0.49 113.825 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.469 ' HZ ' ' SD ' ' A' ' 76' ' ' MET . 10.1 m-85 -105.13 -25.23 12.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.84 0.352 . . . . 0.56 110.771 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.3 p -79.79 21.75 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.485 . . . . 1.89 111.775 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -80.75 -5.89 57.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 3.11 110.791 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.563 -0.732 . . . . 6.99 110.132 177.294 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.64 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 111.638 -0.585 . . . . 10.47 111.638 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.68 -162.24 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 123.286 2.657 . . . . 10.45 112.335 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.422 HD12 ' N ' ' A' ' 37' ' ' LEU . 5.4 mp -93.72 147.81 22.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.025 -0.534 . . . . 9.09 109.655 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.44 119.17 0.65 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.288 -0.958 . . . . 6.24 112.54 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.6 m -155.4 104.07 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.087 -0.338 . . . . 5.98 110.087 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.1 92.22 5.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.127 0.965 . . . . 3.92 110.339 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -124.22 95.02 4.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.93 -1.032 . . . . 4.94 109.116 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.5 t -98.46 92.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.028 0.442 . . . . 1.99 110.315 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -104.23 110.5 22.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.896 -0.593 . . . . 2.4 110.246 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -72.99 102.05 3.38 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.089 -0.708 . . . . 0.96 109.089 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.17 -17.33 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.708 -0.678 . . . . 1.33 112.56 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 t -89.25 -7.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.313 0.578 . . . . 0.53 110.049 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -20.82 78.51 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.723 -0.751 . . . . 0.78 112.852 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 48' ' ' LYS . 2.1 mtmm -75.0 -29.37 60.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.137 0.494 . . . . 3.22 109.703 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.49 33.36 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.447 -0.797 . . . . 2.39 109.992 -172.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 18.5 ttpp -83.88 -48.96 0.69 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.87 -0.604 . . . . 1.17 111.401 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 84.8 Cg_exo -50.13 -29.29 21.88 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.654 2.236 . . . . 0.65 114.359 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.6 m -70.78 -46.5 62.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.318 0.58 . . . . 0.45 110.209 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.429 ' HB3' HD21 ' A' ' 110' ' ' ASN . 12.7 m-85 -73.94 -20.07 60.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.353 -0.61 . . . . 0.7 109.353 177.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.506 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 14.4 t70 -68.94 -42.34 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.24 -0.891 . . . . 0.73 109.467 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.64 -41.84 95.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 1.86 110.135 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.3 mt -61.98 -39.4 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.104 0.478 . . . . 0.32 110.029 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -57.11 -52.88 63.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.855 . . . . 0.39 111.584 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.689 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 63.8 m-85 -74.9 -21.25 59.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.123 0.416 . . . . 0.91 112.123 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.7 p -83.25 2.31 36.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.411 . . . . 0.58 111.374 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.21 9.28 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.64 0.257 . . . . 1.17 110.485 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m 66.72 87.37 0.12 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.321 -0.854 . . . . 1.14 111.095 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.689 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -81.08 132.51 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.776 2.317 . . . . 1.1 112.044 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.95 123.63 67.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.832 -0.622 . . . . 1.66 110.464 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 65.43 23.2 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.655 -0.702 . . . . 1.98 110.817 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.79 -0.62 79.94 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.886 -0.673 . . . . 0.83 112.628 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.687 ' HB2' HD12 ' A' ' 100' ' ' LEU . 44.6 mttm -123.5 164.82 18.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.999 -0.371 . . . . 0.97 109.999 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.685 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 48.2 pt -111.5 130.24 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.925 -0.71 . . . . 0.37 109.302 167.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -71.25 154.89 41.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.973 -0.558 . . . . 1.31 110.674 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.4 -9.01 2.01 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.9 -0.591 . . . . 0.33 113.981 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.75 -67.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.14 0.47 . . . . 0.27 110.581 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.855 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 4.3 p30 -69.32 -28.25 66.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.79 110.62 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.6 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.68 -49.09 78.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.32 110.333 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.631 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 42.8 tttp -64.54 -36.81 85.43 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.905 0.383 . . . . 1.36 110.22 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.855 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 28.5 mtpp -54.85 -42.15 71.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.632 . . . . 2.48 110.82 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -71.16 -38.86 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.661 . . . . 2.16 110.123 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.764 ' HB3' HD22 ' A' ' 86' ' ' LEU . 87.5 mtp -68.17 -28.08 66.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.481 -0.781 . . . . 0.51 111.41 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -81.11 -22.69 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.362 -0.535 . . . . 1.34 110.28 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 44.2 mttp -66.49 -28.93 68.95 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.304 -0.558 . . . . 2.2 109.666 170.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -67.03 -17.56 64.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.569 -0.741 . . . . 0.91 110.797 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mttp 67.28 22.83 9.5 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.839 -0.619 . . . . 2.37 111.582 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.582 ' HB2' HD21 ' A' ' 86' ' ' LEU . 84.5 mt -89.4 155.76 48.59 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.657 -0.498 . . . . 1.35 109.657 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.525 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 35.4 Cg_endo -66.53 147.26 81.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.564 2.176 . . . . 0.44 112.232 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.29 -36.9 69.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.652 -0.704 . . . . 1.94 111.276 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.2 m -60.02 -48.51 81.41 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.838 -0.619 . . . . 1.04 111.214 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.563 HG11 ' HE2' ' A' ' 116' ' ' LYS . 78.7 t -67.6 -38.31 80.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.41 110.162 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.764 HD22 ' HB3' ' A' ' 76' ' ' MET . 81.8 mt -57.49 -42.27 82.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.44 110.556 175.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.43 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.67 -41.21 98.86 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.953 -0.567 . . . . 0.23 112.132 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.03 -47.74 81.74 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.23 -0.188 . . . . 1.71 110.84 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 85' ' ' VAL . 69.3 mt -53.35 -45.55 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 123.339 0.4 . . . . 0.4 110.365 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.535 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 32.0 t-105 -59.71 -52.68 64.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.731 -0.668 . . . . 0.46 110.963 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.93 -13.55 61.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.308 0.484 . . . . 2.4 112.308 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.49 -39.77 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.142 0.496 . . . . 1.08 110.648 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.529 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.53 -36.18 45.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.605 -0.725 . . . . 0.3 111.56 -176.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 44.0 t0 -83.56 70.61 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.869 0.842 . . . . 0.45 109.467 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.468 ' CG1' HD11 ' A' ' 126' ' ' LEU . 15.0 m -77.32 -16.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.944 -1.025 . . . . 1.28 109.619 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.569 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . 2.1 t70 -86.23 -20.72 28.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.186 -1.37 . . . . 1.12 109.295 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttt 60.77 40.34 16.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.667 -1.152 . . . . 1.68 111.359 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.62 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 7.2 p-10 -114.27 9.21 16.96 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.505 -0.478 . . . . 0.71 111.299 -174.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.6 -2.41 67.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 120.843 -0.694 . . . . 0.39 111.992 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -120.71 134.02 55.31 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.752 -0.832 . . . . 1.37 108.752 -176.729 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 62.3 mt -83.23 108.6 16.57 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 118.743 -1.183 . . . . 0.34 108.012 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 2.6 m-20 -71.88 171.22 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.711 -1.218 . . . . 1.39 107.711 171.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -57.6 -42.01 82.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.996 0.362 . . . . 1.69 111.212 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' OE1' ' HB2' ' A' ' 132' ' ' PRO . 8.0 mt-10 -68.8 -42.21 77.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.291 0.567 . . . . 2.29 110.28 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.569 ' OE2' ' HB3' ' A' ' 96' ' ' ASP . 25.4 mt-10 -66.89 -38.63 86.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.516 -0.765 . . . . 0.39 110.627 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 38.9 t80 -73.1 -25.06 60.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.29 110.625 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 -41.57 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.244 -1.021 . . . . 0.34 108.244 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 93' ' ' ALA . 40.7 tp -65.25 -35.52 81.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.449 -1.25 . . . . 1.74 109.826 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -55.88 29.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.133 -0.485 . . . . 0.27 110.84 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.511 ' HA ' HD12 ' A' ' 113' ' ' ILE . 91.0 m-20 -61.62 -28.16 69.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.7 110.928 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.514 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.7 t60 -63.95 -48.01 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 0.75 110.585 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 mt -66.24 -33.39 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.792 -0.448 . . . . 0.27 109.792 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 110' ' ' ASN . 88.2 mt -60.49 -51.39 73.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.83 -0.623 . . . . 0.46 111.511 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.28 -41.02 86.14 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 120.601 -0.439 . . . . 1.81 110.444 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 111' ' ' HIS . 69.4 t -54.62 -47.83 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.027 0.442 . . . . 0.91 109.867 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.563 ' HE2' HG11 ' A' ' 85' ' ' VAL . 44.4 tptt -57.8 -56.58 20.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.54 -0.755 . . . . 1.06 111.306 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.89 -31.81 72.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 1.59 111.73 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 44.4 mt-10 -80.5 4.29 18.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 2.05 111.353 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.07 33.17 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.699 . . . . 0.68 113.467 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 97.7 m-70 -131.5 173.55 10.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.778 0.289 . . . . 1.16 110.444 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -120.0 155.13 33.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.269 -0.423 . . . . 2.69 111.163 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.9 mt -93.47 128.16 43.48 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.946 -0.57 . . . . 1.21 109.582 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.49 -6.81 19.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.792 2.328 . . . . 1.28 113.57 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.89 9.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 1.06 112.404 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -127.6 174.61 8.92 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.661 -0.496 . . . . 1.93 109.661 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.468 HD11 ' CG1' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -124.36 88.96 52.6 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.696 -0.483 . . . . 1.85 109.696 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 32.5 Cg_endo -66.57 150.34 83.97 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.859 2.373 . . . . 0.9 112.256 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 32.3 Cg_exo -58.25 -21.4 52.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.218 2.612 . . . . 1.02 113.856 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -96.94 13.14 29.86 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.487 -0.485 . . . . 1.14 111.576 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 mt -121.74 5.5 9.99 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 1.34 111.418 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.8 m -81.53 126.69 75.47 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-O 121.125 0.488 . . . . 1.57 110.846 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HB2' ' OE1' ' A' ' 104' ' ' GLU . 56.5 Cg_endo -71.02 164.21 36.55 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.743 2.296 . . . . 1.35 112.347 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -56.17 -31.12 82.43 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.978 2.452 . . . . 2.05 113.15 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 t -78.95 9.37 4.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.794 0.331 . . . . 2.66 111.034 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 17.6 tptm -109.41 15.73 22.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.446 0.641 . . . . 3.1 110.291 175.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.512 ' NE ' ' HA ' ' A' ' 136' ' ' ARG . 4.5 mmp_? -81.54 119.31 23.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.239 0.542 . . . . 3.86 110.543 175.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -80.83 132.02 35.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.703 -0.68 . . . . 5.0 110.482 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -115.06 112.34 22.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.662 -0.496 . . . . 6.63 109.662 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.548 -0.739 . . . . 6.66 110.714 -179.762 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 58.8 t80 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.1 0.476 . . . . 10.53 109.857 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -106.48 -154.79 0.53 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.301 -0.629 . . . . 8.22 109.301 175.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -129.84 148.98 51.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.589 -0.523 . . . . 7.43 109.589 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -107.33 175.15 5.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.736 0.303 . . . . 5.92 110.344 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -90.86 124.89 35.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.287 0.565 . . . . 4.34 111.859 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 13.3 t -122.55 13.48 10.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.342 -0.845 . . . . 2.12 109.25 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.2 p30 -80.38 152.39 73.16 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.235 -0.893 . . . . 1.25 111.388 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.631 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 30.7 Cg_exo -63.24 0.22 1.86 Allowed 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 124.118 3.212 . . . . 0.49 114.114 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.535 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 28.9 m-85 -100.4 -49.8 4.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.925 0.393 . . . . 0.56 110.813 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 30.6 p -87.09 -13.73 43.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.054 -0.521 . . . . 1.89 111.706 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.91 104.52 9.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.129 -0.487 . . . . 3.11 111.299 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 66.3 mttm . . . . . 0 C--O 1.253 1.263 0 CA-C-N 115.289 -0.868 . . . . 6.99 111.361 177.7 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.62 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.116 -0.394 . . . . 10.47 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.7 -17.43 23.11 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.887 2.391 . . . . 10.45 113.003 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.4 tp -123.77 120.48 32.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.859 -0.423 . . . . 9.09 109.859 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.92 -38.18 1.9 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.552 -0.832 . . . . 6.24 112.788 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.8 t 71.65 -69.97 0.17 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.32 0.648 . . . . 5.98 110.508 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -108.25 121.39 44.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.25 -0.432 . . . . 3.92 110.064 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.69 138.05 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.206 0.527 . . . . 4.94 109.961 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.55 137.67 28.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.702 -0.681 . . . . 1.99 111.975 -171.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -92.05 117.93 30.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.633 -0.712 . . . . 2.4 109.612 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -72.27 101.01 2.74 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.542 -1.281 . . . . 0.96 107.542 171.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 130' ' ' LEU . 16.5 m -57.82 -20.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.989 0.737 . . . . 1.33 112.989 -169.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 108' ' ' LEU . 33.6 t -92.45 -25.81 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 0.53 110.723 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -69.84 -23.58 76.82 Favored Glycine 0 CA--C 1.516 0.101 0 C-N-CA 121.167 -0.54 . . . . 0.78 113.0 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -73.91 -20.48 60.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.583 0.706 . . . . 3.22 109.907 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -134.48 34.38 3.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.413 1.101 . . . . 2.39 108.683 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.507 ' HZ3' ' CG ' ' A' ' 103' ' ' ASP . 16.1 ttpp -79.57 -42.1 1.53 Allowed Pre-proline 0 C--O 1.215 -0.718 0 CA-C-N 114.637 -1.165 . . . . 1.17 111.19 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.578 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 42.9 Cg_exo -44.0 -29.37 2.63 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.909 2.406 . . . . 0.65 114.419 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -70.19 -46.54 64.4 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.461 0.648 . . . . 0.45 109.792 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -74.75 -17.03 60.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.604 -0.725 . . . . 0.7 109.567 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.578 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 10.7 t70 -72.86 -44.61 61.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.158 -0.928 . . . . 0.73 109.442 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.64 -42.86 97.78 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.712 -0.676 . . . . 1.86 109.671 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' HD13 ' A' ' 60' ' ' LEU . 60.7 mt -61.01 -42.44 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 0.32 109.788 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -53.74 -35.08 60.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 0.39 110.975 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.596 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 39.2 m-85 -84.83 -22.86 29.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.57 0.581 . . . . 0.91 112.57 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 p -77.26 -11.27 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.3 -0.56 . . . . 0.58 110.446 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.523 HD11 ' OE1' ' A' ' 75' ' ' GLU . 10.1 mp -99.76 7.04 45.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.959 -0.564 . . . . 1.17 111.321 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m 64.92 88.12 0.11 Allowed Pre-proline 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 1.14 110.793 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 90.4 Cg_endo -84.28 102.6 0.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.213 1.942 . . . . 1.1 112.151 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.85 110.35 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.79 -0.641 . . . . 1.66 110.918 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 65.38 26.5 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.799 . . . . 1.98 111.052 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.85 19.86 64.64 Favored Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 121.176 -0.535 . . . . 0.83 112.269 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.79 ' HB3' HD11 ' A' ' 100' ' ' LEU . 52.7 mttm -139.9 155.53 47.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.866 -0.42 . . . . 0.97 109.866 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 106' ' ' PHE . 38.1 pt -131.35 131.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.196 0.522 . . . . 0.37 110.247 171.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 p -66.98 161.89 23.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.683 -0.69 . . . . 1.31 111.061 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.17 -16.8 62.81 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 121.304 -0.474 . . . . 0.33 113.696 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.69 -51.45 68.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.104 0.478 . . . . 0.27 110.829 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.577 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 18.2 m-80 -68.38 -43.05 78.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 1.79 109.954 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.22 -53.65 55.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.241 -0.891 . . . . 0.32 111.425 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.667 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.7 tttt -61.59 -35.73 78.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 1.36 110.296 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 16.7 ttpp -51.66 -47.26 63.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 2.48 110.344 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' OE1' HD11 ' A' ' 60' ' ' LEU . 3.4 tp10 -65.97 -38.08 87.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.454 0.645 . . . . 2.16 110.155 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.779 ' HB3' HD22 ' A' ' 86' ' ' LEU . 76.4 mtp -71.56 -31.27 66.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.423 -0.808 . . . . 0.51 111.486 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.56 -24.05 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.913 -0.315 . . . . 1.34 110.46 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 27.0 mtpp -70.87 -28.29 64.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.24 0.543 . . . . 2.2 109.904 172.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.5 m -66.48 -19.31 65.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.203 -0.908 . . . . 0.91 111.058 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 62.43 36.3 14.31 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.871 -0.604 . . . . 2.37 111.407 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 86' ' ' LEU . 85.9 mt -97.13 161.17 27.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.894 -0.41 . . . . 1.35 109.894 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 81' ' ' LEU . 36.5 Cg_endo -67.19 143.08 63.36 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.463 2.109 . . . . 0.44 112.136 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -56.32 -31.47 63.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.849 -0.614 . . . . 1.94 111.604 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p -59.68 -54.7 43.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 1.04 111.373 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 89' ' ' ILE . 59.9 t -66.1 -41.94 90.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 0.41 110.187 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 76' ' ' MET . 90.6 mt -55.68 -52.71 62.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.16 -0.473 . . . . 0.44 111.113 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.549 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.53 -39.26 96.17 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 121.155 -0.545 . . . . 0.23 112.116 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 25.6 ttmm -61.27 -44.13 97.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 1.71 110.419 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 85' ' ' VAL . 84.5 mt -62.85 -39.78 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.4 110.614 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.458 ' HZ2' ' C ' ' A' ' 99' ' ' GLY . 57.7 t-105 -60.43 -49.05 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.46 110.327 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -65.67 -16.22 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 2.4 112.16 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 34.2 mt -92.37 -44.39 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.147 0.499 . . . . 1.08 111.497 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.69 -27.26 45.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.588 -0.733 . . . . 0.3 112.005 -172.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.612 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.0 t0 -86.23 85.54 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.608 0.718 . . . . 0.45 110.624 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 105' ' ' GLU . 21.1 m -74.81 -25.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.897 -1.047 . . . . 1.28 112.174 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.631 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 9.0 m-20 -78.96 -13.59 59.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 121.116 -0.234 . . . . 1.12 110.756 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttt 59.72 29.9 19.47 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 108.691 -0.855 . . . . 1.68 108.691 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.631 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 17.9 p-10 -105.73 9.35 33.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.134 -0.939 . . . . 0.71 111.308 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.458 ' C ' ' HZ2' ' A' ' 90' ' ' TRP . . . 64.54 20.66 66.07 Favored Glycine 0 CA--C 1.493 -1.336 0 CA-C-O 121.584 0.547 . . . . 0.39 112.657 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -156.49 143.11 18.53 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.343 -0.984 . . . . 1.37 108.343 -173.105 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 100' ' ' LEU . 88.0 mt -104.57 126.5 51.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.975 0.417 . . . . 0.34 111.943 -171.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.86 -176.78 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.94 -0.573 . . . . 1.39 109.772 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.507 ' CG ' ' HZ3' ' A' ' 50' ' ' LYS . 14.5 t0 -57.75 -42.76 84.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.777 -0.647 . . . . 1.69 110.414 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.475 ' OE2' ' HD2' ' A' ' 133' ' ' PRO . 18.8 mt-10 -72.99 -43.97 61.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.508 -0.769 . . . . 2.29 110.822 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 52.3 mt-10 -63.37 -42.83 98.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.171 -0.468 . . . . 0.39 110.784 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.546 ' CD1' HD11 ' A' ' 67' ' ' ILE . 44.9 t80 -65.84 -35.87 81.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.29 110.094 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.69 89.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.34 110.321 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 46' ' ' VAL . 78.6 mt -62.29 -45.8 91.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.161 -0.472 . . . . 1.74 110.832 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.74 -58.06 8.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.989 0.423 . . . . 0.27 111.001 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -33.96 72.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.7 111.564 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -69.51 -46.97 65.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.566 -0.288 . . . . 0.75 110.309 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.08 -47.63 83.83 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.955 0.407 . . . . 0.27 110.608 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.9 mt -57.83 -52.23 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.46 111.101 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.676 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.66 -30.44 69.13 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.343 -0.39 . . . . 1.81 110.413 -176.102 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 120' ' ' HIS . 3.1 t -61.49 -43.83 97.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.763 0.316 . . . . 0.91 110.361 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 25.7 mmmt -63.11 -37.48 87.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 1.06 110.869 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.8 tp -70.14 -30.52 67.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.606 -0.27 . . . . 1.59 111.01 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 29.9 mm-40 -66.01 -26.39 67.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 2.05 110.216 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.35 21.8 8.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.935 -0.65 . . . . 0.68 112.227 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.67 ' HB2' HG13 ' A' ' 115' ' ' VAL . 71.9 m80 -104.91 165.97 10.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 1.16 110.443 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -108.74 127.01 53.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.143 -0.48 . . . . 2.69 110.06 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.64 146.72 80.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 1.21 110.08 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.54 -10.16 25.25 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.134 2.556 . . . . 1.28 113.548 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.33 19.33 10.98 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.214 -0.448 . . . . 1.06 111.124 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -133.09 175.08 9.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.844 -0.616 . . . . 1.93 110.232 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.62 90.51 50.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.452 -0.944 . . . . 1.85 108.452 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.75 151.57 69.15 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.479 2.12 . . . . 0.9 112.027 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.55 -25.91 61.31 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.191 2.594 . . . . 1.02 112.807 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -89.12 19.58 4.16 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.884 -0.326 . . . . 1.14 111.658 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.531 HD21 HG22 ' A' ' 45' ' ' VAL . 31.5 mt -130.47 4.75 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 1.34 110.664 173.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 48.7 t -83.99 119.62 73.68 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.253 -0.431 . . . . 1.57 110.567 -177.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 17.7 Cg_endo -60.06 148.77 87.99 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.064 2.509 . . . . 1.35 113.004 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 52.7 Cg_exo -56.45 -22.73 43.78 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.469 2.779 . . . . 2.05 113.11 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.0 t -67.59 -8.33 33.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.981 -0.554 . . . . 2.66 111.449 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -117.36 21.95 12.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.997 0.427 . . . . 3.1 111.526 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -106.46 147.2 29.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 3.86 110.581 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -66.7 108.29 2.44 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.022 -0.733 . . . . 5.0 109.022 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -114.59 99.66 7.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.408 0.623 . . . . 6.63 110.826 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.247 0.955 0 CA-C-N 115.175 -0.92 . . . . 6.66 109.596 -177.849 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 88.1 t80 . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.764 0.316 . . . . 10.53 111.573 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -64.42 -26.37 68.42 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.922 0.712 . . . . 8.22 112.922 -168.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -107.34 4.98 27.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.724 -0.216 . . . . 7.43 111.572 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 50.01 -152.98 0.15 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.256 -0.429 . . . . 5.92 111.233 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.0 m -155.93 115.39 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.636 -0.505 . . . . 4.34 109.636 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 12.1 t -140.35 -3.85 1.33 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.846 0.355 . . . . 2.12 111.504 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 7.7 t70 -127.81 127.69 23.94 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.265 -0.425 . . . . 1.25 109.892 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.667 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.7 Cg_exo -76.82 -2.39 12.61 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.538 2.825 . . . . 0.49 113.924 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.549 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 10.7 m-85 -106.78 -9.97 16.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.126 0.489 . . . . 0.56 110.477 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 28.0 p -129.25 -176.38 3.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.805 -0.634 . . . . 1.89 110.798 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.47 -163.4 0.26 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.883 -0.598 . . . . 3.11 111.289 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.39 -0.814 . . . . 6.99 110.181 -179.724 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.612 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.485 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 20.9 t90 . . . . . 0 N--CA 1.444 -0.729 0 N-CA-C 109.115 -0.698 . . . . 0.95999999999999996 109.115 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.96 -41.36 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 1.3300000000000001 112.04 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.52 HG21 HD23 ' A' ' 108' ' ' LEU . 11.0 t -79.93 -1.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.363 0.602 . . . . 0.53000000000000003 110.708 -174.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.13 76.95 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.673 -0.775 . . . . 0.78000000000000003 112.562 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.54 -28.46 28.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.863 0.363 . . . . 3.2200000000000002 110.952 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -124.18 34.7 4.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.172 0.987 . . . . 2.3900000000000001 109.227 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 17.8 ttpt -78.78 -44.29 1.88 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 114.066 -1.425 . . . . 1.1699999999999999 112.281 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 83.2 Cg_exo -49.15 -24.26 7.67 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.632 2.222 . . . . 0.65000000000000002 113.67 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -69.89 -45.45 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.696 -0.483 . . . . 0.45000000000000001 109.696 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.455 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 5.9 m-85 -73.49 -22.95 60.01 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.916 -0.584 . . . . 0.69999999999999996 109.96 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -69.61 -44.59 70.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.48 0.657 . . . . 0.72999999999999998 110.32 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -60.31 -45.58 92.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.279 -0.873 . . . . 1.8600000000000001 109.765 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 77.3 mt -64.83 -39.92 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.669 . . . . 0.32000000000000001 110.455 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.415 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 58.1 t80 -52.88 -50.72 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.39000000000000001 111.306 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 45.1 m-85 -76.77 -22.4 53.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.275 -0.421 . . . . 0.91000000000000003 112.071 -177.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.9 p -88.73 8.24 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.677 -0.409 . . . . 0.57999999999999996 111.337 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 85.1 mt -104.88 1.34 28.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 1.1699999999999999 110.589 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m 69.14 87.06 0.12 Allowed Pre-proline 0 N--CA 1.467 0.379 0 O-C-N 123.902 0.751 . . . . 1.1399999999999999 110.586 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HA ' HG22 ' A' ' 67' ' ' ILE . 1.2 Cg_endo -84.61 163.84 12.4 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.174 2.583 . . . . 1.1000000000000001 112.755 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.85 102.57 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 1.6599999999999999 110.087 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 m120 68.87 23.23 6.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 1.98 110.358 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.16 65.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.771 -0.728 . . . . 0.82999999999999996 112.428 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.618 ' HD3' ' CB ' ' A' ' 100' ' ' LEU . 14.8 ttmm -133.4 126.78 32.0 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.982 -0.748 . . . . 0.96999999999999997 108.982 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 62' ' ' PRO . 39.0 pt -87.36 151.18 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.094 -0.642 . . . . 0.37 110.473 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.405 ' HA ' HD13 ' A' ' 100' ' ' LEU . 80.5 p -90.42 177.43 6.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.192 -0.458 . . . . 1.3100000000000001 110.613 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.15 -16.78 67.21 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.695 -0.764 . . . . 0.33000000000000002 112.088 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -69.65 -59.37 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.049 0.452 . . . . 0.27000000000000002 110.381 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -43.64 98.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.733 . . . . 1.79 110.162 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.65 -47.32 86.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.075 -0.966 . . . . 0.32000000000000001 111.35 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.27 -34.59 76.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.157 -0.312 . . . . 1.3600000000000001 110.157 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.2 mtpt -58.04 -46.92 84.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 2.48 110.502 174.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -64.11 -44.72 91.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.885 -0.598 . . . . 2.1600000000000001 110.254 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.611 ' HB3' HD22 ' A' ' 86' ' ' LEU . 94.5 mtp -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.589 . . . . 0.51000000000000001 112.209 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.21 -24.82 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.944 -0.703 . . . . 1.3400000000000001 110.664 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -75.5 -12.03 60.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.2000000000000002 110.476 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -72.86 -14.93 61.6 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.49 -0.559 . . . . 0.91000000000000003 109.49 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 68.25 29.96 5.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.133 -0.939 . . . . 2.3700000000000001 111.455 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HB2' HD21 ' A' ' 86' ' ' LEU . 80.7 mt -104.56 154.88 38.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.537 -0.301 . . . . 1.3500000000000001 110.651 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 40.4 Cg_endo -68.37 155.59 68.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.843 2.362 . . . . 0.44 112.558 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -66.06 -25.18 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.486 -0.325 . . . . 1.9399999999999999 111.283 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.3 m -63.35 -52.69 60.71 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.937 0.399 . . . . 1.04 110.675 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 89' ' ' ILE . 84.8 t -62.76 -46.08 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.40999999999999998 109.806 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.0 mt -59.94 -37.7 80.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.44 111.4 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.12 87.94 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.23000000000000001 112.685 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 20.5 ptmt -66.54 -33.27 75.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.494 -0.482 . . . . 1.71 109.789 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.633 HG13 ' O ' ' A' ' 85' ' ' VAL . 83.8 mt -57.47 -50.04 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.722 -0.473 . . . . 0.40000000000000002 109.722 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 34.1 t-105 -58.89 -49.92 75.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.545 -0.752 . . . . 0.46000000000000002 111.133 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -65.41 -20.27 66.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.184 0.438 . . . . 2.3999999999999999 112.184 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' A' ' 124' ' ' ALA . 29.7 mt -93.58 -35.63 12.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.863 0.363 . . . . 1.0800000000000001 111.384 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.57 -16.39 36.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.054 -0.521 . . . . 0.29999999999999999 112.058 -172.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -79.13 80.56 5.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.692 0.758 . . . . 0.45000000000000001 109.83 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 96.2 t -58.78 -44.55 90.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.583 -1.189 . . . . 1.28 112.207 -176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 33.8 m-20 -70.63 -24.52 62.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.399 -0.364 . . . . 1.1200000000000001 110.089 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 57.12 51.48 10.31 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.608 -0.886 . . . . 1.6799999999999999 108.608 -169.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.591 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 18.2 p-10 -125.5 8.4 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.928 -1.033 . . . . 0.70999999999999996 112.146 -167.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.82 -0.13 62.65 Favored Glycine 0 CA--C 1.507 -0.406 0 C-N-CA 120.441 -0.885 . . . . 0.39000000000000001 112.785 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.618 ' CB ' ' HD3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -118.83 163.49 16.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.012 -0.736 . . . . 1.3700000000000001 109.012 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 mt -115.69 110.02 18.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.423 -0.584 . . . . 0.34000000000000002 109.423 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -76.43 -173.95 2.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.559 -0.746 . . . . 1.3899999999999999 109.274 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -55.85 -44.91 78.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.694 -0.685 . . . . 1.6899999999999999 111.239 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -81.63 -31.25 32.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.638 -0.71 . . . . 2.29 110.743 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.59 -47.43 66.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.39000000000000001 110.338 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -65.92 -35.1 79.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.28999999999999998 109.942 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -57.3 -49.79 74.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.002 -0.544 . . . . 0.34000000000000002 110.693 174.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.52 HD23 HG21 ' A' ' 46' ' ' VAL . 12.9 mt -60.5 -43.95 96.5 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.59 -0.277 . . . . 1.74 111.509 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.34 -56.74 17.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.27000000000000002 111.238 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -33.68 73.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.69999999999999996 111.28 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.614 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.8 t60 -62.86 -50.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.929 -0.578 . . . . 0.75 110.733 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.622 HD12 HG23 ' A' ' 89' ' ' ILE . 49.2 mt -63.17 -36.83 84.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.673 0.273 . . . . 0.27000000000000002 110.447 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 109' ' ' ALA . 89.7 mt -56.95 -48.53 81.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.117 -0.492 . . . . 0.46000000000000002 110.644 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 34.6 pttt -74.6 -24.1 58.82 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 120.678 -0.409 . . . . 1.8100000000000001 110.879 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 111' ' ' HIS . 76.6 t -62.25 -39.71 85.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.498 -0.556 . . . . 0.91000000000000003 109.498 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.893 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 2.4 mmmp? -67.19 -37.45 83.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 1.0600000000000001 109.957 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.413 ' O ' HD13 ' A' ' 117' ' ' LEU . 1.5 tm? -64.68 -38.69 91.85 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 1.5900000000000001 110.161 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 7.1 mm-40 -66.98 -9.0 34.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.152 -0.476 . . . . 2.0499999999999998 110.55 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.82 35.19 5.69 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.961 -0.638 . . . . 0.68000000000000005 112.417 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.541 ' HB2' HG12 ' A' ' 115' ' ' VAL . 99.5 m-70 -121.78 -176.98 3.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 1.1599999999999999 111.283 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -124.7 160.61 28.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 2.6899999999999999 109.805 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.893 ' HG ' ' HD3' ' A' ' 116' ' ' LYS . 26.6 mt -104.51 115.33 62.99 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.252 -0.647 . . . . 1.21 109.252 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.09 2.88 7.91 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.256 2.637 . . . . 1.28 113.333 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.81 19.22 11.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.935 -0.575 . . . . 1.0600000000000001 111.243 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -111.24 147.11 35.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.874 -0.603 . . . . 1.9299999999999999 109.788 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 17.0 tp -125.05 94.23 44.19 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.325 -0.398 . . . . 1.8500000000000001 110.382 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 25.7 Cg_exo -62.94 152.07 81.16 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.194 2.596 . . . . 0.90000000000000002 112.11 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.09 -26.9 43.59 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.371 2.714 . . . . 1.02 113.822 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -99.85 5.84 45.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.781 -0.368 . . . . 1.1399999999999999 111.129 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.45 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 3.8 mm? . . . . . 0 C--N 1.331 -0.237 0 N-CA-C 109.704 -0.48 . . . . 1.3400000000000001 109.704 171.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 4.4 p30 . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 121.267 0.556 . . . . 1.25 111.327 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.71 0.15 5.27 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 123.527 2.818 . . . . 0.48999999999999999 113.892 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.35 -45.51 6.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 0.56000000000000005 111.038 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 70.1 p . . . . . 0 C--N 1.324 -0.526 0 N-CA-C 112.181 0.438 . . . . 1.8899999999999999 112.181 -174.434 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.478 ' CZ3' ' HG3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 109.33 -0.619 . . . . 0.95999999999999996 109.33 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.65 -36.67 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 1.3300000000000001 110.75 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.433 HG21 HD23 ' A' ' 108' ' ' LEU . 39.6 t -76.94 -17.44 14.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.744 -0.662 . . . . 0.53000000000000003 110.496 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -66.21 -14.86 62.35 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.78000000000000003 112.989 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -73.77 -25.55 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 3.2200000000000002 109.912 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -131.1 33.23 4.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.714 0.768 . . . . 2.3900000000000001 109.342 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HB2' ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -79.46 -46.38 1.59 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.338 -0.846 . . . . 1.1699999999999999 111.304 -177.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.62 -24.66 37.9 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.418 2.079 . . . . 0.65000000000000002 112.715 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -46.69 64.21 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.447 0.641 . . . . 0.45000000000000001 110.204 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.1 m-85 -75.1 -21.99 58.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.69999999999999996 109.329 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.61 -38.85 64.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.422 -0.808 . . . . 0.72999999999999998 109.16 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -54.02 -52.69 60.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.29 -0.868 . . . . 1.8600000000000001 109.591 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.467 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.4 mt -62.3 -41.48 91.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.658 -0.701 . . . . 0.32000000000000001 110.766 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -52.47 -42.82 64.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.616 -0.72 . . . . 0.39000000000000001 111.476 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.723 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 4.7 m-85 -83.18 -22.44 33.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.935 0.346 . . . . 0.91000000000000003 111.935 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.08 -7.62 58.29 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.546 -0.462 . . . . 0.57999999999999996 111.161 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.1 mt -102.73 15.47 29.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 1.1699999999999999 110.877 -177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m 61.19 78.4 0.32 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.1399999999999999 111.127 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.723 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 94.2 Cg_endo -85.75 119.44 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.532 2.155 . . . . 1.1000000000000001 112.241 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.57 132.86 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.93 -0.396 . . . . 1.6599999999999999 109.93 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 p30 48.39 25.37 0.88 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.926 0.89 . . . . 1.98 112.604 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.86 15.24 78.02 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.981 -0.628 . . . . 0.82999999999999996 113.449 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.683 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 10.0 ttmm -141.54 126.26 18.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.543 -0.539 . . . . 0.96999999999999997 109.543 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 62' ' ' PRO . 44.7 pt -94.04 146.06 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 121.709 -0.619 . . . . 0.37 111.191 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.815 ' HA ' HD23 ' A' ' 100' ' ' LEU . 9.7 t -76.74 157.69 31.5 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.001 -0.545 . . . . 1.3100000000000001 110.115 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -16.84 38.46 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.156 -0.929 . . . . 0.33000000000000002 114.232 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -61.83 -52.97 61.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.377 0.588 . . . . 0.27000000000000002 110.903 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 18.6 m-80 -65.81 -43.21 89.36 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.101 0.477 . . . . 1.79 110.07 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.716 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.19 -49.19 78.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.297 -0.865 . . . . 0.32000000000000001 110.792 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.732 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 84.0 tttt -61.56 -40.37 94.49 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.25 -0.432 . . . . 1.3600000000000001 110.391 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.651 ' HA ' HG12 ' A' ' 77' ' ' VAL . 27.8 mtpt -64.8 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.927 -0.579 . . . . 2.48 111.6 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -70.67 -41.96 71.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.838 0.828 . . . . 2.1600000000000001 109.465 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.766 ' HB3' HD22 ' A' ' 86' ' ' LEU . 69.7 mtp -65.86 -31.47 72.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.139 -0.937 . . . . 0.51000000000000001 111.222 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.651 HG12 ' HA ' ' A' ' 74' ' ' LYS . 4.4 p -76.51 -27.5 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.599 -0.441 . . . . 1.3400000000000001 110.759 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 84.2 mttt -64.02 -28.14 69.59 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.299 -0.56 . . . . 2.2000000000000002 110.11 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 15.2 m -66.8 -26.78 67.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.562 -0.745 . . . . 0.91000000000000003 111.071 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 79' ' ' SER . 95.8 mttt 71.74 22.45 3.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.861 -0.609 . . . . 2.3700000000000001 112.213 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 81' ' ' LEU . 4.0 mm? -86.03 158.38 55.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.111 -0.7 . . . . 1.3500000000000001 109.111 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.531 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 2.0 Cg_endo -76.05 160.9 36.31 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.434 2.09 . . . . 0.44 111.705 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -62.63 -23.04 66.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 1.9399999999999999 110.253 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -58.82 -53.67 55.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.725 -0.671 . . . . 1.04 110.217 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 89' ' ' ILE . 54.4 t -72.65 -42.72 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.40999999999999998 110.373 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.766 HD22 ' HB3' ' A' ' 76' ' ' MET . 67.3 mt -60.12 -39.26 85.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 0.44 110.489 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.95 79.72 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.856 -0.687 . . . . 0.23000000000000001 111.859 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -51.49 -51.4 55.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.755 0.312 . . . . 1.71 110.735 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.7 mt -62.36 -49.08 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.615 -0.721 . . . . 0.40000000000000002 110.748 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.466 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 51.3 t-105 -57.79 -50.29 73.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.235 -0.439 . . . . 0.46000000000000002 111.764 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -81.08 -14.7 57.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.57 -0.452 . . . . 2.3999999999999999 112.005 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -94.69 -27.39 15.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.926 0.393 . . . . 1.0800000000000001 110.26 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.17 -42.33 12.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.157 -0.474 . . . . 0.29999999999999999 111.609 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -77.52 71.78 4.02 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.589 -0.893 . . . . 0.45000000000000001 108.589 176.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.68 -22.74 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.033 -0.985 . . . . 1.28 110.706 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.12 -23.66 51.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.69 -0.686 . . . . 1.1200000000000001 109.936 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.4 mttt 57.78 49.25 12.48 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.173 -0.921 . . . . 1.6799999999999999 111.483 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.687 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.6 p-10 -117.26 9.25 13.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.282 -0.872 . . . . 0.70999999999999996 110.743 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.12 17.64 66.02 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.233 -0.747 . . . . 0.39000000000000001 111.233 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.815 HD23 ' HA ' ' A' ' 68' ' ' THR . 33.2 mt -139.24 140.58 37.75 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.353 -0.924 . . . . 1.3700000000000001 109.309 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.3 mt -110.43 114.95 28.78 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.022 0.439 . . . . 0.34000000000000002 111.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.98 170.71 9.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.308 -0.997 . . . . 1.3899999999999999 108.308 165.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.72 -27.27 69.15 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.558 . . . . 1.6899999999999999 110.035 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.27 -52.74 44.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.391 0.615 . . . . 2.29 110.625 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.65 -35.36 77.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.39000000000000001 110.898 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.72 -32.23 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.28999999999999998 110.204 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.42 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -64.64 -44.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.679 -0.692 . . . . 0.34000000000000002 110.212 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 95.4 mt -58.23 -47.46 83.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 1.74 110.365 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -53.54 -56.56 16.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.006 -0.543 . . . . 0.27000000000000002 111.42 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -63.46 -35.65 81.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.69999999999999996 111.53 -176.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.25 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.75 110.557 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 115' ' ' VAL . 86.8 mt -76.31 -30.5 57.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 0.27000000000000002 111.042 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 109' ' ' ALA . 82.7 mt -75.53 -41.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.061 -1.088 . . . . 0.46000000000000002 108.061 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 29.9 ttmt -68.12 -40.71 82.45 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.056 -1.429 . . . . 1.8100000000000001 110.718 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 120' ' ' HIS . 2.0 p -64.54 -37.55 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.115 -0.328 . . . . 0.91000000000000003 110.115 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 28.7 mmmt -66.97 -42.74 84.62 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.73 -0.213 . . . . 1.0600000000000001 110.513 173.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.89 -37.9 86.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 1.5900000000000001 111.23 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 31.4 mm-40 -71.73 -5.02 30.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 2.0499999999999998 111.239 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.11 36.23 6.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 0.68000000000000005 112.584 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.568 ' HB2' HG22 ' A' ' 115' ' ' VAL . 63.8 m-70 -118.44 170.34 9.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.59 -0.522 . . . . 1.1599999999999999 109.59 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -115.48 132.65 56.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.948 0.404 . . . . 2.6899999999999999 111.319 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 122' ' ' LEU . 1.7 pp -95.27 139.37 21.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.519 -0.549 . . . . 1.21 109.519 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.89 11.62 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.633 2.222 . . . . 1.28 113.348 -175.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.756 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 58.74 28.8 17.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.228 0.537 . . . . 1.0600000000000001 110.419 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -130.51 164.84 23.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.551 -0.75 . . . . 1.9299999999999999 109.79 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.734 HD23 HD12 ' A' ' 92' ' ' LEU . 0.2 OUTLIER -125.37 88.66 53.84 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 109.514 -0.551 . . . . 1.8500000000000001 109.514 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.537 ' HB2' HD23 ' A' ' 130' ' ' LEU . 55.2 Cg_exo -52.54 150.49 21.15 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.786 2.99 . . . . 0.90000000000000002 113.586 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 73.4 Cg_exo -52.98 -30.32 48.13 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.386 2.724 . . . . 1.02 113.82 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -94.47 9.05 39.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.206 -0.597 . . . . 1.1399999999999999 111.309 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 127' ' ' PRO . 3.8 mm? . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 1.3400000000000001 110.742 171.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.49 0.662 . . . . 1.25 110.5 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.732 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 61.5 Cg_endo -72.07 0.4 7.3 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 123.445 2.763 . . . . 0.48999999999999999 113.763 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.646 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 36.3 m-85 -95.74 -30.1 13.9 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.16 -0.338 . . . . 0.56000000000000005 111.256 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 20.5 p . . . . . 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 1.8899999999999999 112.277 -175.085 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.2 t90 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.843 -0.799 . . . . 0.95999999999999996 108.843 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -62.68 -17.22 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.726 -0.67 . . . . 1.3300000000000001 112.678 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 t -73.22 -26.8 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.87 0.367 . . . . 0.53000000000000003 110.697 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.04 9.58 52.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.139 -0.553 . . . . 0.78000000000000003 112.91 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -86.54 -25.65 24.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.749 0.309 . . . . 3.2200000000000002 111.062 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.44 36.26 1.33 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 2.3900000000000001 110.152 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HA ' ' HD2' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -65.16 -43.49 66.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.095 -0.957 . . . . 1.1699999999999999 112.121 -174.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 73.2 Cg_exo -52.68 -22.46 17.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.448 2.099 . . . . 0.65000000000000002 114.197 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 m -72.65 -47.04 50.77 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.231 0.539 . . . . 0.45000000000000001 110.231 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.521 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 8.5 m-85 -71.74 -22.5 61.61 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.529 -0.915 . . . . 0.69999999999999996 108.529 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.532 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 15.0 t70 -69.4 -41.29 76.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.788 -1.096 . . . . 0.72999999999999998 109.801 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.26 -53.8 53.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.987 -0.551 . . . . 1.8600000000000001 109.594 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.6 mt -54.47 -43.21 62.76 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 CA-C-N 115.851 -0.613 . . . . 0.32000000000000001 109.979 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.476 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 73.4 t80 -55.15 -55.05 35.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.482 -0.781 . . . . 0.39000000000000001 111.55 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.614 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 38.4 m-85 -71.57 -21.18 61.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.217 0.451 . . . . 0.91000000000000003 112.217 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -82.92 0.86 42.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.759 -0.376 . . . . 0.57999999999999996 111.046 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 81.9 mt -104.67 6.38 34.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.1699999999999999 110.372 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m 66.34 86.84 0.13 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.308 -0.86 . . . . 1.1399999999999999 111.569 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -83.28 117.81 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.11 2.54 . . . . 1.1000000000000001 112.192 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.5 t -90.15 118.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 1.6599999999999999 109.586 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 63.19 23.23 13.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.808 -0.633 . . . . 1.98 110.711 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.87 12.55 66.09 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.872 -0.68 . . . . 0.82999999999999996 113.05 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.652 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 11.4 ttmt -138.43 142.92 39.5 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.798 -0.445 . . . . 0.96999999999999997 109.798 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.611 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 49.8 pt -100.32 153.11 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 0.37 111.097 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.643 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 15.5 p -88.74 160.89 17.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.48 -0.782 . . . . 1.3100000000000001 110.938 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 72' ' ' ALA . . . -64.24 -8.65 31.72 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.649 -0.786 . . . . 0.33000000000000002 113.172 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.12 -58.17 5.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.914 0.388 . . . . 0.27000000000000002 110.996 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.611 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.0 OUTLIER -74.76 -31.27 61.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.376 -0.374 . . . . 1.79 110.587 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.2 -50.99 70.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.32000000000000001 110.112 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -64.09 -33.07 74.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.197 -0.456 . . . . 1.3600000000000001 110.137 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.55 -45.11 85.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 2.48 110.168 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.7 -51.76 67.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.979 -0.749 . . . . 2.1600000000000001 108.979 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.705 ' HB3' HD22 ' A' ' 86' ' ' LEU . 77.8 mtp -60.48 -32.1 71.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.542 -0.754 . . . . 0.51000000000000001 112.335 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -81.72 -20.46 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 O-C-N 121.927 -0.483 . . . . 1.3400000000000001 110.811 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.54 -23.66 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.135 -0.32 . . . . 2.2000000000000002 110.135 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -64.41 -23.4 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.91000000000000003 110.083 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 67.95 33.41 4.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.447 -0.797 . . . . 2.3700000000000001 111.531 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.7 mt -96.76 158.56 33.35 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.021 -0.536 . . . . 1.3500000000000001 109.661 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HG2' HG23 ' A' ' 85' ' ' VAL . 38.3 Cg_endo -68.52 146.83 69.2 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.358 2.039 . . . . 0.44 112.229 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -58.72 -29.46 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.933 -0.576 . . . . 1.9399999999999999 111.723 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.42 -52.93 63.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 1.04 110.375 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 89' ' ' ILE . 75.6 t -68.04 -42.02 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.56 -0.745 . . . . 0.40999999999999998 110.169 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.705 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.9 mt -58.46 -46.63 86.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.44 111.458 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.461 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -63.32 -41.85 99.37 Favored Glycine 0 C--O 1.235 0.205 0 C-N-CA 120.827 -0.701 . . . . 0.23000000000000001 111.483 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.585 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 39.9 ttmt -56.64 -46.77 80.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.219 -0.491 . . . . 1.71 110.298 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 85' ' ' VAL . 77.0 mt -63.02 -40.81 90.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 0.40000000000000002 110.884 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.432 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 45.0 t-105 -61.85 -51.67 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.614 -0.266 . . . . 0.46000000000000002 110.512 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.05 -21.14 66.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.427 -0.351 . . . . 2.3999999999999999 111.799 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 77.7 mt -85.51 -54.02 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.947 0.403 . . . . 1.0800000000000001 111.135 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.15 -34.07 72.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.31 -0.859 . . . . 0.29999999999999999 111.711 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -87.58 93.24 9.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.363 0.601 . . . . 0.45000000000000001 109.836 -179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 95' ' ' VAL . 2.7 m -74.12 -29.94 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 1.28 111.843 -174.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.61 -25.39 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.034 -0.53 . . . . 1.1200000000000001 109.985 -178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.4 mttt 60.15 32.15 20.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.892 -1.049 . . . . 1.6799999999999999 108.541 -171.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.534 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.4 p-10 -94.69 10.19 35.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.663 -1.153 . . . . 0.70999999999999996 110.983 -172.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.16 20.58 62.99 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.369 -0.693 . . . . 0.39000000000000001 111.369 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 14.9 mt -141.52 145.51 35.25 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.84 -0.68 . . . . 1.3700000000000001 110.028 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.0 mt -115.56 118.18 32.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.866 0.365 . . . . 0.34000000000000002 111.103 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.14 174.42 5.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.41 -0.959 . . . . 1.3899999999999999 108.41 168.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -63.35 -32.62 74.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.959 -0.386 . . . . 1.6899999999999999 109.959 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.98 -50.72 54.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 2.29 110.432 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.54 -44.15 97.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.39000000000000001 110.69 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -69.82 -25.09 63.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.28999999999999998 111.081 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.77 31.93 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.599 -0.889 . . . . 0.34000000000000002 108.599 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.1 -36.5 79.88 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.347 -1.297 . . . . 1.74 110.057 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.46 33.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.27000000000000002 110.712 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -59.51 -30.71 68.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.349 -0.387 . . . . 0.69999999999999996 110.568 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.438 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 32.2 t60 -69.01 -39.17 79.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.75 110.552 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 115' ' ' VAL . 95.5 mt -71.66 -40.77 69.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.257 0.551 . . . . 0.27000000000000002 110.318 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.588 HD11 ' HG2' ' A' ' 76' ' ' MET . 84.2 mt -58.29 -51.27 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 0.46000000000000002 110.722 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.81 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 12.0 ptmm? -75.67 -24.34 56.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.58 -0.448 . . . . 1.8100000000000001 111.121 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 112' ' ' LEU . 1.4 p -66.46 -34.28 69.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 120.024 -0.67 . . . . 0.91000000000000003 109.246 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 27.8 mmmt -66.94 -43.67 82.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.25 -0.432 . . . . 1.0600000000000001 110.001 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.25 -38.73 80.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 1.5900000000000001 111.894 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.81 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 3.7 mm-40 -73.86 -7.15 51.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.695 -0.229 . . . . 2.0499999999999998 110.825 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.46 10.48 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.518 -0.849 . . . . 0.68000000000000005 113.123 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.509 ' HB2' HG22 ' A' ' 115' ' ' VAL . 90.9 m-70 -105.84 172.96 6.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.885 0.374 . . . . 1.1599999999999999 110.315 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 116' ' ' LYS . 7.4 tp10 -124.67 134.56 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.377 -0.601 . . . . 2.6899999999999999 109.377 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.19 140.77 28.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.915 0.388 . . . . 1.21 110.26 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.47 1.23 7.65 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.387 2.724 . . . . 1.28 113.652 -172.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.14 22.72 12.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.164 0.507 . . . . 1.0600000000000001 110.864 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.47 171.99 12.38 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.241 -0.651 . . . . 1.9299999999999999 109.241 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 0.5 OUTLIER -125.61 89.07 53.18 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.834 0.349 . . . . 1.8500000000000001 110.603 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 32.5 Cg_endo -66.34 155.96 67.44 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.952 2.435 . . . . 0.90000000000000002 111.865 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 75.5 Cg_exo -50.3 -34.19 39.51 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.599 2.866 . . . . 1.02 114.298 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.6 p-80 -88.32 14.4 9.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.612 -0.435 . . . . 1.1399999999999999 111.931 -176.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.3 mt . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 1.3400000000000001 111.185 177.294 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 5.1 p-10 . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.007 0.432 . . . . 1.25 110.872 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 14.9 Cg_exo -70.86 -2.18 10.56 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.219 2.613 . . . . 0.48999999999999999 113.48 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.461 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 40.1 m-85 -102.54 -23.31 13.9 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.244 -0.285 . . . . 0.56000000000000005 111.376 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 t . . . . . 0 C--N 1.324 -0.502 0 CA-C-O 121.458 0.647 . . . . 1.8899999999999999 111.155 175.532 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 . . . . . 0 N--CA 1.454 -0.229 0 N-CA-C 110.031 -0.359 . . . . 0.95999999999999996 110.031 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.44 -42.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 1.3300000000000001 111.826 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.02 -5.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.072 -0.513 . . . . 0.53000000000000003 111.042 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.37 -15.85 75.2 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.248 -1.141 . . . . 0.78000000000000003 110.248 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -80.28 -29.86 38.3 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.735 -0.733 . . . . 3.2200000000000002 111.226 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -124.39 34.64 4.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.723 . . . . 2.3900000000000001 109.824 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 22.1 ttpp -79.11 -43.98 1.72 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.79 -1.095 . . . . 1.1699999999999999 112.031 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 12.4 Cg_exo -39.15 -40.72 1.8 Allowed 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 123.43 2.753 . . . . 0.65000000000000002 115.015 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 56' ' ' ILE . 67.4 m -69.47 -43.96 72.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.995 0.426 . . . . 0.45000000000000001 110.515 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -71.24 -22.16 62.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.224 -0.658 . . . . 0.69999999999999996 109.224 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.93 -41.2 71.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.872 . . . . 0.72999999999999998 109.595 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.71 -45.32 93.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 1.8600000000000001 109.713 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 63.9 mt -58.7 -43.52 87.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 0.32000000000000001 110.454 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -54.38 -38.46 66.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.533 -0.758 . . . . 0.39000000000000001 111.011 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.567 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 49.1 m-85 -98.83 7.84 45.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.004 0.742 . . . . 0.91000000000000003 113.004 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 56' ' ' ILE . 2.6 p -109.9 -3.02 16.85 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.791 -0.364 . . . . 0.57999999999999996 110.935 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 3.8 pp -118.13 18.56 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.398 -0.365 . . . . 1.1699999999999999 111.343 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 m 74.85 90.82 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.051 -0.977 . . . . 1.1399999999999999 111.939 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.766 ' HA ' HG22 ' A' ' 67' ' ' ILE . 97.0 Cg_endo -92.95 125.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.947 2.431 . . . . 1.1000000000000001 111.976 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.21 113.0 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 1.6599999999999999 109.691 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.0 p30 48.48 26.95 1.28 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.072 0.949 . . . . 1.98 113.029 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 11.34 58.05 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.916 -0.659 . . . . 0.82999999999999996 113.345 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 8.6 ttmm -140.46 126.56 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.927 -0.768 . . . . 0.96999999999999997 108.927 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 62' ' ' PRO . 36.7 pt -95.97 141.49 15.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.128 -0.629 . . . . 0.37 111.141 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.77 ' HA ' HD23 ' A' ' 100' ' ' LEU . 3.6 t -79.88 158.54 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.711 -0.677 . . . . 1.3100000000000001 110.75 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.84 -23.14 21.27 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.496 -0.775 . . . . 0.33000000000000002 113.414 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.19 -55.93 27.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 0.27000000000000002 111.113 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.522 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 42.2 m-80 -78.25 -28.91 47.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.379 . . . . 1.79 110.634 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.649 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.85 -52.88 61.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 0.32000000000000001 110.09 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.616 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 86.1 tttt -61.69 -35.43 77.98 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.559 -0.291 . . . . 1.3600000000000001 110.432 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 26.2 ttpp -54.39 -46.16 73.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.228 0.537 . . . . 2.48 110.457 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -67.6 -41.44 84.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 2.1600000000000001 110.234 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.785 ' HB3' HD22 ' A' ' 86' ' ' LEU . 72.8 mtp -67.66 -28.41 67.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.897 -0.592 . . . . 0.51000000000000001 112.012 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.51 -16.17 11.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 O-C-N 121.857 -0.527 . . . . 1.3400000000000001 110.638 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 99.0 mttt -75.59 -22.47 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.254 0.549 . . . . 2.2000000000000002 109.626 168.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -73.78 -11.99 60.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.691 -0.686 . . . . 0.91000000000000003 111.331 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt 63.92 37.14 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.153 -0.476 . . . . 2.3700000000000001 111.697 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 86' ' ' LEU . 84.1 mt -106.16 153.15 40.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 1.3500000000000001 110.696 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.461 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 43.7 Cg_endo -67.8 152.65 77.23 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.164 2.576 . . . . 0.44 112.604 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -57.35 -34.63 69.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.863 -0.608 . . . . 1.9399999999999999 111.942 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.7 m -58.05 -54.13 50.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.14 0.495 . . . . 1.04 111.365 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.459 HG23 ' HG2' ' A' ' 82' ' ' PRO . 60.6 t -67.11 -38.95 82.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.40999999999999998 110.402 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 76' ' ' MET . 88.9 mt -59.59 -46.61 88.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.44 110.795 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.17 -42.6 97.24 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.263 -0.494 . . . . 0.23000000000000001 112.079 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 66.5 mttm -55.6 -53.6 54.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.843 0.354 . . . . 1.71 110.279 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.49 -36.71 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 0.40000000000000002 110.364 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.468 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 74.4 t-105 -61.11 -56.45 20.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.46000000000000002 111.182 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.71 -0.88 28.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.057 0.392 . . . . 2.3999999999999999 112.057 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 74.9 mt -94.37 -46.95 6.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.031 0.443 . . . . 1.0800000000000001 110.523 169.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.57 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -72.05 -36.21 69.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.531 -0.758 . . . . 0.29999999999999999 111.175 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -86.71 70.42 10.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.896 0.855 . . . . 0.45000000000000001 109.947 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.8 m -68.7 -15.63 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.542 -1.208 . . . . 1.28 110.826 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -18.27 40.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.724 -1.126 . . . . 1.1200000000000001 110.171 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 61.58 35.66 17.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.089 -0.96 . . . . 1.6799999999999999 111.144 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.693 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.3 p-10 -116.64 7.99 13.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.916 -0.584 . . . . 0.70999999999999996 111.64 -172.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.16 10.53 59.62 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.326 -0.71 . . . . 0.39000000000000001 111.326 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.77 HD23 ' HA ' ' A' ' 68' ' ' THR . 87.1 mt -133.68 141.19 47.48 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.726 -0.737 . . . . 1.3700000000000001 109.182 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.1 mt -109.99 113.13 25.59 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.984 0.421 . . . . 0.34000000000000002 111.022 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.58 172.26 7.65 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.963 -0.754 . . . . 1.3899999999999999 108.963 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.2 -32.27 72.03 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.825 -0.35 . . . . 1.6899999999999999 110.701 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -66.35 -51.52 56.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.884 0.374 . . . . 2.29 110.497 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -62.39 -41.5 98.69 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.925 -0.58 . . . . 0.39000000000000001 110.645 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 66.3 t80 -70.53 -23.82 62.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.749 -0.659 . . . . 0.28999999999999998 110.96 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.79 32.89 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.579 -0.897 . . . . 0.34000000000000002 108.579 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 93' ' ' ALA . 29.6 tp -59.41 -39.79 84.58 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.627 -1.17 . . . . 1.74 109.772 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -59.07 -55.44 35.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.011 -0.54 . . . . 0.27000000000000002 111.189 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -33.63 75.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.287 -0.415 . . . . 0.69999999999999996 111.426 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -63.5 -44.04 95.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.75 109.932 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.71 -39.2 90.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.27000000000000002 110.655 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.2 mt -60.14 -53.51 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.63 . . . . 0.46000000000000002 111.385 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 16.0 pttp -70.9 -26.84 63.4 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 120.584 -0.446 . . . . 1.8100000000000001 110.209 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.707 HG13 ' HB2' ' A' ' 120' ' ' HIS . 2.6 t -56.6 -48.76 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.665 -0.495 . . . . 0.91000000000000003 109.665 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -62.29 -46.15 90.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.223 -0.444 . . . . 1.0600000000000001 111.051 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 8.9 mp -59.36 -38.22 79.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 1.5900000000000001 111.822 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 12.2 mm-40 -81.92 6.63 15.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.529 -0.305 . . . . 2.0499999999999998 111.799 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 27.84 27.9 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.915 -0.66 . . . . 0.68000000000000005 112.913 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.707 ' HB2' HG13 ' A' ' 115' ' ' VAL . 90.6 m-70 -109.69 119.59 39.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.776 -0.453 . . . . 1.1599999999999999 109.776 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -83.25 106.37 14.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.995 0.426 . . . . 2.6899999999999999 110.845 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.49 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.1 pp -68.66 146.98 97.95 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 1.21 110.34 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.5 Cg_endo -83.21 -1.86 10.47 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.911 2.408 . . . . 1.28 112.671 -173.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.83 19.24 11.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.774 -0.648 . . . . 1.0600000000000001 111.322 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -115.63 165.99 12.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.142 -1.058 . . . . 1.9299999999999999 108.142 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 29.0 tp -118.34 95.35 48.48 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 120.481 -0.487 . . . . 1.8500000000000001 110.628 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 18.1 Cg_endo -61.66 150.37 85.89 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.767 2.312 . . . . 0.90000000000000002 112.255 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 52.0 Cg_exo -55.74 -25.44 51.37 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.713 2.942 . . . . 1.02 113.578 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -86.27 3.92 41.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.68 0.252 . . . . 1.1399999999999999 111.68 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--N 1.329 -0.296 0 O-C-N 122.352 -0.217 . . . . 1.3400000000000001 111.486 177.501 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t70 . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.787 0.327 . . . . 1.25 110.121 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.616 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.8 Cg_exo -76.51 -2.35 12.55 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.566 2.844 . . . . 0.48999999999999999 113.488 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.468 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 15.4 m-85 -98.18 -9.68 25.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.188 0.518 . . . . 0.56000000000000005 110.077 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 66.2 p . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 1.8899999999999999 111.138 175.794 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 . . . . . 0 N--CA 1.45 -0.456 0 N-CA-C 109.553 -0.536 . . . . 0.95999999999999996 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.76 -23.09 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.427 -0.806 . . . . 1.3300000000000001 112.625 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG21 HD23 ' A' ' 108' ' ' LEU . 21.2 t -82.27 -10.72 12.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.07 0.462 . . . . 0.53000000000000003 110.708 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.09 -23.83 69.92 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.118 -0.563 . . . . 0.78000000000000003 113.176 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -73.89 -23.38 59.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.913 0.387 . . . . 3.2200000000000002 111.549 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -134.13 32.95 3.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.965 0.888 . . . . 2.3900000000000001 109.648 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 11.3 ttpp -82.99 -44.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.232 -0.895 . . . . 1.1699999999999999 110.841 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 84.6 Cg_exo -49.37 -28.0 14.67 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.533 2.155 . . . . 0.65000000000000002 113.574 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 m -69.28 -47.08 65.62 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.349 0.595 . . . . 0.45000000000000001 109.987 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -75.85 -20.63 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.723 -0.843 . . . . 0.69999999999999996 108.723 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 14.7 t70 -70.03 -42.04 73.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.885 -1.052 . . . . 0.72999999999999998 109.431 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.31 -41.01 97.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.62 . . . . 1.8600000000000001 109.808 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.3 -34.78 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.395 0.616 . . . . 0.32000000000000001 110.283 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.94 -48.13 83.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.228 -0.896 . . . . 0.39000000000000001 111.021 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.477 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 64.9 m-85 -73.81 -22.49 59.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.039 0.385 . . . . 0.91000000000000003 112.039 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -85.24 1.73 46.95 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.508 -0.477 . . . . 0.57999999999999996 111.16 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.9 mt -106.42 3.29 27.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.1699999999999999 110.473 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.3 m 67.08 80.98 0.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.47 -0.786 . . . . 1.1399999999999999 111.068 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 83.3 Cg_endo -88.63 111.23 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.804 2.336 . . . . 1.1000000000000001 112.567 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.07 121.9 39.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.139 -0.482 . . . . 1.6599999999999999 109.971 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.29 23.59 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.48 0.488 . . . . 1.98 110.846 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.58 22.79 59.49 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.82999999999999996 112.528 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -137.71 142.14 41.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.625 0.25 . . . . 0.96999999999999997 110.487 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.656 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 42.9 pt -104.78 132.83 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.215 -0.661 . . . . 0.37 109.215 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -73.39 162.42 29.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.119 -0.491 . . . . 1.3100000000000001 109.841 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.485 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -63.08 -11.54 39.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.967 -0.635 . . . . 0.33000000000000002 114.08 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.73 -63.25 1.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.489 0.644 . . . . 0.27000000000000002 111.006 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.656 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 2.7 p30 -71.73 -29.42 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 1.79 110.9 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.14 -51.05 70.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.337 -0.392 . . . . 0.32000000000000001 110.502 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -61.78 -34.74 76.43 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.938 -0.393 . . . . 1.3600000000000001 109.938 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.551 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 36.1 ttmt -57.87 -45.8 85.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 2.48 110.994 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.862 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -65.87 -36.37 83.24 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.286 0.565 . . . . 2.1600000000000001 110.007 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.529 ' HB3' HD22 ' A' ' 86' ' ' LEU . 90.7 mtp -67.75 -34.29 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.51000000000000001 111.36 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.2 m -81.49 -15.38 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.872 -0.331 . . . . 1.3400000000000001 110.822 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.862 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 50.2 mtpt -72.79 -28.95 62.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.922 -0.769 . . . . 2.2000000000000002 108.922 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.0 m -68.51 -29.73 68.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.963 -1.017 . . . . 0.91000000000000003 110.306 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 70.6 26.3 4.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.372 -0.831 . . . . 2.3700000000000001 112.48 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.07 159.87 67.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.269 -0.641 . . . . 1.3500000000000001 109.269 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.86 142.22 92.64 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.659 2.24 . . . . 0.44 112.32 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.76 -31.05 58.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.859 -0.61 . . . . 1.9399999999999999 111.763 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p -63.54 -51.33 65.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.947 0.403 . . . . 1.04 111.139 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.536 HG11 ' HG2' ' A' ' 116' ' ' LYS . 98.2 t -66.83 -41.5 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 0.40999999999999998 110.317 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.531 ' HB3' ' CE1' ' B' ' 151' ' ' PHE . 75.2 mt -58.09 -43.07 86.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 0.44 110.797 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 91' ' ' LYS . . . -61.03 -43.84 98.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.042 -0.599 . . . . 0.23000000000000001 111.939 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.542 ' HE3' HD11 ' A' ' 122' ' ' LEU . 53.5 mtmt -57.21 -42.63 81.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.39 . . . . 1.71 110.437 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.0 mt -64.76 -42.21 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.615 . . . . 0.40000000000000002 109.972 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.596 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 75.2 t-105 -62.09 -51.78 66.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.28 -0.873 . . . . 0.46000000000000002 111.185 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 87' ' ' GLY . 31.0 mmmt -70.14 -18.15 63.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 2.3999999999999999 111.907 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.863 HD11 ' HA ' ' A' ' 124' ' ' ALA . 92.7 mt -90.71 -45.58 8.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 1.0800000000000001 111.501 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.91 63.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 0.29999999999999999 111.301 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -95.55 95.24 8.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.496 0.665 . . . . 0.45000000000000001 110.77 179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 m -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.095 -0.957 . . . . 1.28 111.806 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.426 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 23.5 m-20 -76.36 -25.28 54.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.121 -0.49 . . . . 1.1200000000000001 110.837 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttt 62.16 34.29 16.33 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 124.124 0.89 . . . . 1.6799999999999999 109.434 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 13.7 p-10 -129.64 8.19 5.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.349 -0.387 . . . . 0.70999999999999996 111.949 -173.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.41 12.47 76.94 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.686 -0.768 . . . . 0.39000000000000001 113.247 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.47 126.98 55.9 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.586 -0.361 . . . . 1.3700000000000001 110.138 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.435 HD22 ' HB3' ' A' ' 105' ' ' GLU . 36.2 mt -102.93 112.86 25.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.34000000000000002 111.323 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.78 170.12 11.64 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.495 -0.928 . . . . 1.3899999999999999 108.495 167.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.73 -30.6 71.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.926 0.393 . . . . 1.6899999999999999 110.67 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -67.26 -46.92 72.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.061 177.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 101' ' ' LEU . 47.9 mt-10 -65.19 -41.47 94.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.274 -0.875 . . . . 0.39000000000000001 110.952 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.528 ' CD1' HD11 ' A' ' 67' ' ' ILE . 47.3 t80 -65.84 -33.23 75.37 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.017 -0.538 . . . . 0.28999999999999998 110.094 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.17 95.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.34000000000000002 110.192 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 46' ' ' VAL . 92.0 mt -62.53 -41.68 99.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 1.74 110.633 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.13 -55.46 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.27000000000000002 111.089 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -37.19 84.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.69999999999999996 110.913 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.51 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.7 t60 -58.29 -50.06 74.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.416 . . . . 0.75 110.832 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.99 -29.57 70.72 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.883 0.373 . . . . 0.27000000000000002 111.265 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 109' ' ' ALA . 85.0 mt -75.18 -42.51 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.537 0.684 . . . . 0.46000000000000002 109.468 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -65.24 -36.12 83.15 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.821 -1.081 . . . . 1.8100000000000001 110.79 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 111' ' ' HIS . 68.6 t -60.87 -54.2 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.748 0.309 . . . . 0.91000000000000003 110.455 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.536 ' HG2' HG11 ' A' ' 85' ' ' VAL . 40.7 tptt -55.35 -48.25 74.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.403 -0.362 . . . . 1.0600000000000001 111.619 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.48 -40.05 81.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 1.5900000000000001 112.03 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.97 7.78 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.037 0.384 . . . . 2.0499999999999998 112.037 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.47 35.54 6.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.552 -0.832 . . . . 0.68000000000000005 112.966 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -121.83 -168.99 1.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.449 -0.442 . . . . 1.1599999999999999 110.066 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -139.55 150.44 45.08 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.213 -0.662 . . . . 2.6899999999999999 109.213 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.542 HD11 ' HE3' ' A' ' 88' ' ' LYS . 0.9 OUTLIER -104.01 129.39 25.3 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.667 -0.494 . . . . 1.21 109.667 178.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 6.64 2.19 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.271 2.647 . . . . 1.28 113.832 -169.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.863 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 58.77 28.67 17.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.389 -0.369 . . . . 1.0600000000000001 111.416 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -112.34 171.25 7.63 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.043 0.449 . . . . 1.9299999999999999 110.084 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.66 86.67 55.47 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.38 -0.97 . . . . 1.8500000000000001 108.38 168.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 80.7 Cg_exo -48.68 141.08 21.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.999 2.466 . . . . 0.90000000000000002 112.126 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 52.1 Cg_exo -55.24 -31.27 75.61 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.94 2.427 . . . . 1.02 112.664 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -91.51 12.94 19.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.755 -0.378 . . . . 1.1399999999999999 111.43 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.3 mt . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 1.3400000000000001 110.847 173.123 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 9.5 t70 . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 110.075 -0.343 . . . . 1.25 110.075 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.9 Cg_exo -74.85 -2.01 11.93 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.471 2.781 . . . . 0.48999999999999999 113.627 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.596 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 20.0 m-85 -99.17 -12.86 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.441 . . . . 0.56000000000000005 110.359 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 C--N 1.324 -0.513 0 CA-C-N 115.847 -0.615 . . . . 1.8899999999999999 110.584 177.27 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.585 ' HZ3' ' HD3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.449 0 N-CA-C 109.067 -0.716 . . . . 0.95999999999999996 109.067 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.672 HG22 HD21 ' A' ' 130' ' ' LEU . 21.2 m -62.71 -14.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 1.3300000000000001 112.398 -172.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.509 ' HB ' ' CZ3' ' A' ' 44' ' ' TRP . 15.7 t -90.75 -11.07 9.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.482 . . . . 0.53000000000000003 110.252 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.568 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -70.39 -10.42 66.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.171 -0.538 . . . . 0.78000000000000003 112.673 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -75.67 -27.75 58.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.045 0.45 . . . . 3.2200000000000002 110.435 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.8 34.0 4.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.961 0.886 . . . . 2.3900000000000001 109.332 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HD3' ' HZ3' ' A' ' 44' ' ' TRP . 0.7 OUTLIER -70.17 -52.45 12.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.861 -1.063 . . . . 1.1699999999999999 111.825 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.09 -24.48 58.43 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.041 1.827 . . . . 0.65000000000000002 113.667 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -69.07 -45.76 69.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.682 -0.69 . . . . 0.45000000000000001 109.895 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 6.7 m-85 -74.18 -21.59 59.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.677 -0.692 . . . . 0.69999999999999996 109.385 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.72999999999999998 110.208 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.28 -44.19 95.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.8600000000000001 110.046 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 61.0 mt -68.82 -36.79 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.32000000000000001 110.546 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' TYR . 51.8 t80 -59.31 -52.32 66.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.39000000000000001 110.931 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.683 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 33.5 m-85 -76.81 -11.4 59.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.57 0.582 . . . . 0.91000000000000003 112.57 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 p -93.5 2.98 56.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.57999999999999996 110.812 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 82.2 mt -101.11 1.32 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.005 -0.543 . . . . 1.1699999999999999 110.386 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m 69.45 85.07 0.13 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 115.496 -0.775 . . . . 1.1399999999999999 111.103 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.683 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.8 Cg_endo -86.28 150.66 9.25 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.145 2.563 . . . . 1.1000000000000001 112.539 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.36 119.8 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 1.6599999999999999 110.532 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.46 27.0 16.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.747 -0.66 . . . . 1.98 111.267 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.28 4.9 83.34 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.734 -0.745 . . . . 0.82999999999999996 112.65 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.699 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 58.1 mttm -123.32 148.48 45.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.35 -0.241 . . . . 0.96999999999999997 110.35 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.701 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 40.9 pt -112.45 128.52 69.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.723 -0.473 . . . . 0.37 109.723 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.521 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 8.2 t -70.97 161.74 30.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.029 -0.532 . . . . 1.3100000000000001 110.252 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -7.02 10.02 Favored Glycine 0 C--O 1.223 -0.534 0 CA-C-N 115.624 -0.716 . . . . 0.33000000000000002 113.992 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 -64.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.479 0.64 . . . . 0.27000000000000002 110.816 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.701 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 4.0 p30 -68.52 -34.06 75.21 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.848 0.356 . . . . 1.79 110.555 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -59.2 -52.6 64.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.012 -0.54 . . . . 0.32000000000000001 110.54 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.814 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.3 tttt -62.11 -35.51 78.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.535 -0.302 . . . . 1.3600000000000001 110.658 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -53.77 -49.97 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.962 0.41 . . . . 2.48 110.468 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -66.52 -38.28 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.003 0.43 . . . . 2.1600000000000001 110.54 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.824 ' HB3' HD22 ' A' ' 86' ' ' LEU . 93.0 mtp -64.99 -38.22 90.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 0.51000000000000001 111.356 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.41 -16.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 1.3400000000000001 110.668 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.74 -12.53 50.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.072 0.463 . . . . 2.2000000000000002 110.327 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -77.54 -4.92 48.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.689 -0.687 . . . . 0.91000000000000003 110.135 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.97 22.02 8.7 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.597 -0.729 . . . . 2.3700000000000001 112.135 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' HD21 ' A' ' 86' ' ' LEU . 87.8 mt -93.84 153.92 40.93 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 1.3500000000000001 110.36 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 85' ' ' VAL . 57.0 Cg_endo -72.41 160.52 46.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.835 2.357 . . . . 0.44 112.526 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -55.45 -34.46 64.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.761 -0.654 . . . . 1.9399999999999999 111.092 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -57.39 -59.2 5.49 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.863 -0.608 . . . . 1.04 111.288 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.508 HG23 ' HG2' ' A' ' 82' ' ' PRO . 65.9 t -64.5 -45.15 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.572 -0.74 . . . . 0.40999999999999998 110.657 -177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.824 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.1 mt -60.65 -42.76 97.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.815 0.34 . . . . 0.44 110.864 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -61.37 -46.29 94.69 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.002 -0.544 . . . . 0.23000000000000001 112.642 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 19.3 ptmt -72.17 -35.22 68.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.37 -0.532 . . . . 1.71 110.917 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.471 HG23 HD12 ' A' ' 112' ' ' LEU . 46.8 mt -60.65 -41.08 86.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.996 -0.372 . . . . 0.40000000000000002 109.996 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' B' ' 149' ' ' ASP . 49.6 t-105 -64.25 -48.9 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.46000000000000002 110.541 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -58.5 -24.78 61.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.929 -0.578 . . . . 2.3999999999999999 111.878 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 31.8 mt -92.41 -52.16 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.353 . . . . 1.0800000000000001 111.281 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.03 73.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.539 -0.755 . . . . 0.29999999999999999 112.097 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -86.93 94.75 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.455 0.645 . . . . 0.45000000000000001 109.358 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -81.42 -26.91 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.323 -0.853 . . . . 1.28 111.381 -171.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -80.3 -10.71 59.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 1.1200000000000001 109.402 174.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 45.92 46.42 12.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.081 0.863 . . . . 1.6799999999999999 109.873 -172.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -109.49 5.33 23.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.70999999999999996 111.676 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.491 ' C ' HD12 ' A' ' 100' ' ' LEU . . . 84.77 -4.88 84.03 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.307 -0.717 . . . . 0.39000000000000001 111.307 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mp -122.41 142.89 50.05 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.151 -0.524 . . . . 1.3700000000000001 110.153 177.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.53 115.22 28.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.89 -0.782 . . . . 0.34000000000000002 108.89 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 175.79 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.848 -0.797 . . . . 1.3899999999999999 108.848 167.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -56.67 -40.39 75.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.221 0.534 . . . . 1.6899999999999999 110.735 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.52 -33.18 62.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 2.29 110.631 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.34 -41.72 69.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.39000000000000001 110.373 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -67.54 -32.27 72.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.807 -0.633 . . . . 0.28999999999999998 109.439 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -60.83 -46.75 89.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 0.34000000000000002 110.86 173.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 82.5 mt -61.84 -42.75 99.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.375 -0.375 . . . . 1.74 110.635 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.36 -57.17 13.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.27000000000000002 110.901 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.47 -34.22 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.69999999999999996 111.197 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.415 ' O ' HG23 ' A' ' 115' ' ' VAL . 59.3 t60 -65.41 -46.2 80.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.75 110.179 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.471 HD12 HG23 ' A' ' 89' ' ' ILE . 79.9 mt -60.43 -40.8 92.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.91 0.386 . . . . 0.27000000000000002 110.264 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 109' ' ' ALA . 83.8 mt -61.13 -54.38 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.38 -0.827 . . . . 0.46000000000000002 111.065 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.667 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 14.8 ptpt -67.37 -33.85 76.08 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.051 -0.659 . . . . 1.8100000000000001 111.23 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 111' ' ' HIS . 39.9 t -58.92 -50.4 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.127 -0.323 . . . . 0.91000000000000003 110.127 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -53.96 -48.81 69.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.884 0.374 . . . . 1.0600000000000001 111.096 172.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.01 -20.16 65.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.389 0.515 . . . . 1.5900000000000001 112.389 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.667 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.1 mt-10 -76.59 -6.22 51.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.83 0.348 . . . . 2.0499999999999998 110.626 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.75 27.51 14.27 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.178 -0.769 . . . . 0.68000000000000005 111.178 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -113.27 -176.98 3.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 1.1599999999999999 109.865 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -123.94 142.31 51.26 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.612 -0.885 . . . . 2.6899999999999999 108.612 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -85.07 141.24 37.39 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.449 -0.341 . . . . 1.21 110.321 -179.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 39.3 Cg_exo -58.54 -16.44 29.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.438 2.759 . . . . 1.28 114.197 -170.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.34 18.03 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.701 0.626 . . . . 1.0600000000000001 110.992 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -135.58 173.63 11.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.717 -0.674 . . . . 1.9299999999999999 109.548 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.54 95.76 44.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.608 -0.516 . . . . 1.8500000000000001 109.608 174.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 51.2 Cg_exo -54.1 147.47 43.91 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.221 2.614 . . . . 0.90000000000000002 112.847 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 41.9 Cg_exo -58.42 -25.19 72.42 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.196 2.597 . . . . 1.02 112.763 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.424 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 7.4 p-80 -85.79 3.34 41.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.458 -0.337 . . . . 1.1399999999999999 111.03 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.672 HD21 HG22 ' A' ' 45' ' ' VAL . 31.2 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 1.3400000000000001 111.385 178.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.9 p30 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 121.163 0.506 . . . . 1.25 110.906 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.814 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 14.3 Cg_exo -69.57 0.49 5.43 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.666 2.911 . . . . 0.48999999999999999 113.69 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.495 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 28.5 m-85 -97.47 -45.93 6.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.006 0.431 . . . . 0.56000000000000005 110.312 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 76.4 p . . . . . 0 C--N 1.322 -0.59 0 CA-C-O 121.561 0.696 . . . . 1.8899999999999999 110.35 -179.745 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.45 -0.459 0 N-CA-C 112.349 0.5 . . . . 0.95999999999999996 112.349 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.49 -7.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.888 0.851 . . . . 1.3300000000000001 109.035 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 t -96.83 -11.93 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.887 -1.051 . . . . 0.53000000000000003 109.802 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.67 -23.68 69.09 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.773 -0.649 . . . . 0.78000000000000003 112.996 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -74.35 -27.32 60.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.999 0.428 . . . . 3.2200000000000002 110.67 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.39 31.39 5.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 2.3900000000000001 109.637 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -75.81 -56.44 1.73 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.51 -0.314 . . . . 1.1699999999999999 111.692 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.555 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 51.0 Cg_endo -66.94 -14.75 44.87 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.707 1.605 . . . . 0.65000000000000002 112.569 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.41 -46.59 63.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.548 0.689 . . . . 0.45000000000000001 109.177 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 13.5 m-85 -80.82 -20.8 41.65 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.453 -0.794 . . . . 0.69999999999999996 109.922 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 11.2 t70 -66.29 -44.55 83.18 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.212 -0.662 . . . . 0.72999999999999998 109.212 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.93 -50.89 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.8600000000000001 110.229 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.51 -38.81 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.062 -0.517 . . . . 0.32000000000000001 110.338 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.49 ' HE1' HG12 ' A' ' 67' ' ' ILE . 65.2 t80 -56.72 -47.56 79.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.317 -0.856 . . . . 0.39000000000000001 111.134 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -76.09 -22.36 55.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.27 0.471 . . . . 0.91000000000000003 112.27 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.45 -6.71 57.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.6 -0.44 . . . . 0.57999999999999996 111.032 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.14 0.73 38.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 1.1699999999999999 111.228 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m 69.65 88.15 0.1 Allowed Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 123.84 0.713 . . . . 1.1399999999999999 111.201 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.0 136.27 5.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.809 2.34 . . . . 1.1000000000000001 112.438 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.3 m -107.71 115.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.113 0.482 . . . . 1.6599999999999999 110.828 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 58.0 28.33 16.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.717 -0.674 . . . . 1.98 112.016 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.88 -2.4 69.4 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.94 -0.648 . . . . 0.82999999999999996 113.352 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 57.3 mttm -127.11 142.25 51.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.501 -0.411 . . . . 0.96999999999999997 110.546 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.49 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -99.06 138.67 22.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.201 -0.666 . . . . 0.37 109.201 170.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.752 ' HA ' HD23 ' A' ' 100' ' ' LEU . 1.1 p -71.53 164.55 25.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.254 -0.43 . . . . 1.3100000000000001 111.067 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.56 -25.25 41.97 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 115.719 -0.673 . . . . 0.33000000000000002 113.175 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.26 -42.91 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.27000000000000002 111.074 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.756 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 25.6 m-80 -76.72 -43.03 39.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.14 0.495 . . . . 1.79 110.234 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.54 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.98 -41.15 86.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.022 -0.99 . . . . 0.32000000000000001 110.516 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.723 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.6 tttt -70.59 -35.93 73.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.009 -0.541 . . . . 1.3600000000000001 110.122 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.756 ' HE2' ' HA ' ' A' ' 71' ' ' ASN . 52.3 mtmt -54.45 -46.37 73.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.906 0.384 . . . . 2.48 110.203 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.76 -52.54 63.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.693 -0.685 . . . . 2.1600000000000001 110.176 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.54 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 32.8 mtt -56.23 -41.96 76.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.128 0.49 . . . . 0.51000000000000001 112.01 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 73' ' ' LYS . 99.6 t -68.74 -31.17 49.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.707 -0.678 . . . . 1.3400000000000001 110.72 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 98.4 mttt -71.53 -28.15 63.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.88 0.371 . . . . 2.2000000000000002 110.348 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 m -74.17 -15.07 61.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.91000000000000003 111.122 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 73.15 24.38 2.47 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.821 0.674 . . . . 2.3700000000000001 112.821 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.685 ' HB2' HD21 ' A' ' 86' ' ' LEU . 3.9 mm? -87.84 158.15 50.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.655 -0.418 . . . . 1.3500000000000001 110.271 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HG2' HG23 ' A' ' 85' ' ' VAL . 73.5 Cg_endo -76.31 157.21 37.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.125 2.55 . . . . 0.44 113.274 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -53.69 -42.99 68.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.661 -0.7 . . . . 1.9399999999999999 111.703 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 p -55.78 -56.88 15.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.235 0.54 . . . . 1.04 111.785 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 82' ' ' PRO . 87.9 t -62.39 -45.15 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.81 -0.632 . . . . 0.40999999999999998 111.171 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 81' ' ' LEU . 70.3 mt -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.44 110.376 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.94 -48.07 79.61 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.02 -0.536 . . . . 0.23000000000000001 112.48 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 40.9 pttt -74.05 -33.68 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 1.71 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.434 HG23 HD12 ' A' ' 112' ' ' LEU . 43.5 mt -60.66 -41.44 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.851 -0.425 . . . . 0.40000000000000002 109.851 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -60.88 -48.75 80.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.46000000000000002 110.377 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -67.84 -14.03 62.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.055 0.391 . . . . 2.3999999999999999 112.055 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 61.5 mt -93.31 -51.18 5.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.331 . . . . 1.0800000000000001 110.79 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.03 -33.66 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.775 . . . . 0.29999999999999999 111.544 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -84.32 86.26 7.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.672 0.748 . . . . 0.45000000000000001 109.494 178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.5 m -68.66 -30.62 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.562 -1.199 . . . . 1.28 112.405 -175.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.433 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 2.7 m-20 -72.78 -24.34 60.92 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 116.514 -0.312 . . . . 1.1200000000000001 110.265 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 mttt 58.37 40.33 24.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.277 -1.008 . . . . 1.6799999999999999 108.277 -167.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.602 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 p-10 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.995 -1.002 . . . . 0.70999999999999996 111.22 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.65 22.16 65.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.72 . . . . 0.39000000000000001 111.793 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 68' ' ' THR . 15.3 mt -140.67 143.95 35.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.503 -0.555 . . . . 1.3700000000000001 109.503 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.495 HD22 ' HB3' ' A' ' 105' ' ' GLU . 71.0 mt -121.56 114.2 20.86 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.451 0.469 . . . . 0.34000000000000002 109.973 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -79.19 -177.57 5.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.971 -0.752 . . . . 1.3899999999999999 108.971 169.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.65 -30.85 69.03 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.985 -0.286 . . . . 1.6899999999999999 111.385 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.36 -58.05 3.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.075 -0.343 . . . . 2.29 110.075 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.495 ' HB3' HD22 ' A' ' 101' ' ' LEU . 38.6 mt-10 -56.94 -39.71 75.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.323 0.582 . . . . 0.39000000000000001 110.653 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.75 -29.43 66.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.549 -0.751 . . . . 0.28999999999999998 110.945 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.47 -42.23 30.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.918 0.866 . . . . 0.34000000000000002 108.925 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.505 -1.225 . . . . 1.74 110.044 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.18 -52.02 67.32 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.965 -0.561 . . . . 0.27000000000000002 110.754 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -27.09 68.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.69999999999999996 111.668 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.474 ' O ' HG23 ' A' ' 115' ' ' VAL . 21.9 t60 -67.19 -47.18 71.7 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 0.75 109.841 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.434 HD12 HG23 ' A' ' 89' ' ' ILE . 87.6 mt -62.48 -41.88 99.09 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.996 0.427 . . . . 0.27000000000000002 110.234 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 109' ' ' ALA . 73.6 mt -61.22 -50.77 79.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.46000000000000002 111.313 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 45.4 pttt -73.48 -21.42 60.44 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 120.336 -0.545 . . . . 1.8100000000000001 110.236 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 111' ' ' HIS . 2.8 t -58.96 -46.45 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.638 -0.504 . . . . 0.91000000000000003 109.638 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 13.1 mmmm -72.73 -31.98 65.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.397 -0.365 . . . . 1.0600000000000001 111.249 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.43 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 37.0 tp -65.41 -42.0 93.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 1.5900000000000001 111.317 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 80.8 mm-40 -69.98 -26.01 63.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.027 0.441 . . . . 2.0499999999999998 110.619 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.33 34.48 3.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.653 -0.784 . . . . 0.68000000000000005 112.65 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.66 177.24 4.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.962 -0.384 . . . . 1.1599999999999999 109.962 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.79 149.41 24.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.832 0.349 . . . . 2.6899999999999999 111.631 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 122' ' ' LEU . 1.4 pp -124.91 130.67 24.14 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.117 -0.697 . . . . 1.21 109.117 167.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 -13.62 20.19 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.689 2.26 . . . . 1.28 113.726 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.6 18.94 9.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.586 -0.734 . . . . 1.0600000000000001 110.571 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -106.14 170.17 8.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.332 -0.849 . . . . 1.9299999999999999 108.904 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.1 tp -123.15 96.83 44.02 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.651 -0.419 . . . . 1.8500000000000001 110.758 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 60.2 Cg_endo -75.21 152.67 40.1 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.899 2.4 . . . . 0.90000000000000002 112.125 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 77.1 Cg_exo -51.3 -39.69 62.42 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.537 2.825 . . . . 1.02 114.237 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -81.02 13.92 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 1.1399999999999999 111.716 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 C--N 1.325 -0.48 0 CA-C-N 116.281 -0.418 . . . . 1.3400000000000001 110.217 173.776 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 p30 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.676 0.274 . . . . 1.25 110.382 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.723 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -72.75 -1.59 10.61 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.464 2.776 . . . . 0.48999999999999999 113.936 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.447 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 25.2 m-85 -100.31 -20.31 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.101 0.476 . . . . 0.56000000000000005 110.91 -175.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 C--N 1.319 -0.744 0 CA-C-N 115.8 -0.637 . . . . 1.8899999999999999 110.57 175.791 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.459 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.6 t90 . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.895 -0.409 . . . . 0.95999999999999996 109.895 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.85 -35.34 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 1.3300000000000001 111.786 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.9 -21.0 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.145 -0.48 . . . . 0.53000000000000003 111.174 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -68.67 -5.93 47.58 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.084 -0.579 . . . . 0.78000000000000003 112.98 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -74.64 -28.25 60.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.089 0.471 . . . . 3.2200000000000002 110.867 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -135.02 33.16 3.15 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.53 -0.915 . . . . 2.3900000000000001 108.53 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 82.3 tttt -84.33 -44.71 0.74 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 114.946 -1.025 . . . . 1.1699999999999999 113.409 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 19.7 Cg_endo -56.18 -23.84 47.11 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.426 2.084 . . . . 0.65000000000000002 113.132 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 m -69.9 -41.21 74.99 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.273 -0.876 . . . . 0.45000000000000001 110.378 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.59 -21.95 60.18 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.362 -0.607 . . . . 0.69999999999999996 109.362 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 3.6 t70 -66.3 -45.18 81.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.443 0.64 . . . . 0.72999999999999998 109.75 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -59.59 -40.8 88.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.072 -0.967 . . . . 1.8600000000000001 109.902 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.611 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 65.9 mt -70.29 -37.89 72.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.071 0.462 . . . . 0.32000000000000001 110.731 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -61.54 -51.09 70.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.142 -0.481 . . . . 0.39000000000000001 111.235 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -82.24 14.18 3.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.231 0.456 . . . . 0.91000000000000003 112.231 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -118.5 3.58 11.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 0.57999999999999996 110.467 172.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 72.5 mt -106.35 11.97 30.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.919 -0.582 . . . . 1.1699999999999999 110.513 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t 66.35 80.77 0.22 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.371 -0.831 . . . . 1.1399999999999999 111.325 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.77 128.67 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.313 2.008 . . . . 1.1000000000000001 111.526 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.0 t -106.81 107.79 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.398 -0.364 . . . . 1.6599999999999999 110.191 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.3 m120 68.61 29.22 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.478 -0.783 . . . . 1.98 110.52 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.24 -3.62 72.93 Favored Glycine 0 C--O 1.23 -0.142 0 CA-C-N 115.655 -0.702 . . . . 0.82999999999999996 113.333 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -122.03 140.36 52.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.407 -0.22 . . . . 0.96999999999999997 110.407 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -101.13 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.835 -0.802 . . . . 0.37 108.835 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.73 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 72.0 p -80.75 164.94 22.38 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.483 -0.487 . . . . 1.3100000000000001 110.207 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.38 -20.73 52.02 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 120.999 -0.62 . . . . 0.33000000000000002 112.802 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 -43.84 81.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.907 0.384 . . . . 0.27000000000000002 111.308 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -76.3 -44.21 37.94 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.524 0.678 . . . . 1.79 109.767 -176.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.68 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.72 -50.82 72.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.771 -1.104 . . . . 0.32000000000000001 110.182 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 77' ' ' VAL . 76.3 tttt -56.73 -40.62 76.03 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.1 -0.5 . . . . 1.3600000000000001 110.539 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 35.9 ttpt -51.88 -49.25 63.34 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.003 0.43 . . . . 2.48 110.218 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.27 -39.88 89.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.89 -0.595 . . . . 2.1600000000000001 110.517 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.741 ' HB3' HD22 ' A' ' 86' ' ' LEU . 66.4 mtp -67.26 -27.01 66.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.001 -0.545 . . . . 0.51000000000000001 110.451 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 73' ' ' LYS . 77.7 t -70.94 -38.05 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 1.3400000000000001 109.97 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -66.44 -21.87 66.21 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 2.2000000000000002 110.885 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.4 t -73.88 -17.28 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.25 -0.432 . . . . 0.91000000000000003 111.069 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 65.65 24.22 11.62 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.581 0.585 . . . . 2.3700000000000001 112.581 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 86' ' ' LEU . 69.3 mt -85.59 151.61 56.01 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.574 -0.45 . . . . 1.3500000000000001 110.219 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.481 ' HG2' HG23 ' A' ' 85' ' ' VAL . 33.1 Cg_endo -65.34 149.7 87.99 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.771 2.314 . . . . 0.44 111.918 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -53.13 -35.55 59.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.317 -0.401 . . . . 1.9399999999999999 111.621 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 m -61.97 -45.05 95.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.348 -0.387 . . . . 1.04 111.017 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.639 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 86.6 t -73.37 -39.19 54.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.971 0.415 . . . . 0.40999999999999998 110.332 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 76' ' ' MET . 84.4 mt -59.58 -48.76 80.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 0.44 110.563 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.57 -41.15 99.83 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.727 -0.669 . . . . 0.23000000000000001 112.415 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 0.4 OUTLIER -66.67 -38.78 87.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.359 -0.536 . . . . 1.71 110.084 -179.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.81 -39.6 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 110.085 -0.339 . . . . 0.40000000000000002 110.085 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -62.26 -51.56 67.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.46000000000000002 110.445 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -67.39 -12.44 60.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 2.3999999999999999 112.159 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.3 mt -93.97 -49.77 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 1.0800000000000001 111.21 174.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.532 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -72.34 -32.27 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.29999999999999999 111.705 -173.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -88.3 83.73 6.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.45000000000000001 109.861 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.2 m -70.14 -28.9 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.206 -0.906 . . . . 1.28 111.497 -177.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.555 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 57.5 m-20 -74.21 -19.9 60.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 121.002 -0.279 . . . . 1.1200000000000001 110.271 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mttt 58.75 27.81 16.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.898 0.856 . . . . 1.6799999999999999 109.097 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.596 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.6 p-10 -98.69 9.7 42.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.347 -1.297 . . . . 0.70999999999999996 111.366 -169.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.94 9.23 52.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.93 -0.653 . . . . 0.39000000000000001 111.522 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.73 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 15.5 mt -131.18 136.86 48.66 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.998 -0.601 . . . . 1.3700000000000001 110.046 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 105' ' ' GLU . 47.8 mt -105.83 112.59 25.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 0.34000000000000002 110.414 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.11 -178.11 3.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.89 -0.595 . . . . 1.3899999999999999 109.55 170.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -56.8 -42.94 80.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.12 0.486 . . . . 1.6899999999999999 110.339 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.459 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 19.2 mm-40 -66.08 -54.77 21.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.922 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HB3' HD22 ' A' ' 101' ' ' LEU . 48.0 mt-10 -60.37 -39.19 86.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.39000000000000001 111.202 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 -25.47 59.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.28999999999999998 110.959 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.77 -42.41 40.96 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.533 -0.914 . . . . 0.34000000000000002 108.533 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 93' ' ' ALA . 22.8 tp -63.56 -37.62 88.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.608 -1.178 . . . . 1.74 109.845 174.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.74 -56.63 19.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.187 -0.46 . . . . 0.27000000000000002 110.972 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.73 -31.13 72.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.33 -0.396 . . . . 0.69999999999999996 111.242 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.486 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.0 t60 -66.93 -40.91 87.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.477 -0.329 . . . . 0.75 110.319 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 115' ' ' VAL . 94.7 mt -70.6 -39.4 73.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.159 0.504 . . . . 0.27000000000000002 110.058 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.42 HD11 ' HG2' ' A' ' 76' ' ' MET . 65.7 mt -56.45 -53.7 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.844 . . . . 0.46000000000000002 111.177 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 28.3 pttt -76.42 -25.05 54.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.293 -0.412 . . . . 1.8100000000000001 111.042 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 112' ' ' LEU . 1.2 p -68.68 -38.88 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.245 -0.65 . . . . 0.91000000000000003 109.245 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -66.53 -39.53 88.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.163 -0.472 . . . . 1.0600000000000001 110.082 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.51 -39.76 92.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.879 -0.6 . . . . 1.5900000000000001 111.149 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 71.3 mt-10 -71.55 -9.48 58.27 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.42 -0.354 . . . . 2.0499999999999998 111.023 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.92 16.84 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.612 -0.804 . . . . 0.68000000000000005 112.59 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.557 ' HB2' HG22 ' A' ' 115' ' ' VAL . 83.7 m-70 -99.49 121.16 40.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.336 -0.616 . . . . 1.1599999999999999 109.336 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -81.07 100.6 9.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.911 0.386 . . . . 2.6899999999999999 110.411 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 122' ' ' LEU . 2.6 pp -61.09 133.47 92.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 1.21 109.81 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.26 4.84 3.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.952 2.434 . . . . 1.28 113.56 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.59 27.63 14.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.172 0.511 . . . . 1.0600000000000001 110.854 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.68 163.49 16.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.926 -0.579 . . . . 1.9299999999999999 109.97 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -126.56 85.65 59.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.128 -0.942 . . . . 1.8500000000000001 109.124 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 11.1 Cg_endo -62.55 145.62 95.39 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.18 1.92 . . . . 0.90000000000000002 111.612 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 84.8 Cg_exo -47.39 -32.33 14.76 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.494 2.796 . . . . 1.02 114.277 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -81.28 3.88 22.47 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.032 0.382 . . . . 1.1399999999999999 112.032 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.7 mt . . . . . 0 C--N 1.323 -0.562 0 CA-C-O 120.59 0.233 . . . . 1.3400000000000001 111.128 176.344 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.526 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 6.3 t70 . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.198 0.523 . . . . 1.25 110.373 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.5 Cg_exo -74.61 -2.02 11.88 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.43 2.754 . . . . 0.48999999999999999 113.825 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.469 ' HZ ' ' SD ' ' A' ' 76' ' ' MET . 10.1 m-85 -105.13 -25.23 12.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.84 0.352 . . . . 0.56000000000000005 110.771 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.485 . . . . 1.8899999999999999 111.775 -177.967 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.1 t90 . . . . . 0 N--CA 1.449 -0.486 0 N-CA-C 109.089 -0.708 . . . . 0.95999999999999996 109.089 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.17 -17.33 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.708 -0.678 . . . . 1.3300000000000001 112.56 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 t -89.25 -7.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.313 0.578 . . . . 0.53000000000000003 110.049 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -20.82 78.51 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.723 -0.751 . . . . 0.78000000000000003 112.852 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 48' ' ' LYS . 2.1 mtmm -75.0 -29.37 60.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.137 0.494 . . . . 3.2200000000000002 109.703 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.49 33.36 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.447 -0.797 . . . . 2.3900000000000001 109.992 -172.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 18.5 ttpp -83.88 -48.96 0.69 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.87 -0.604 . . . . 1.1699999999999999 111.401 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 84.8 Cg_exo -50.13 -29.29 21.88 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.654 2.236 . . . . 0.65000000000000002 114.359 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.6 m -70.78 -46.5 62.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.318 0.58 . . . . 0.45000000000000001 110.209 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -73.94 -20.07 60.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.353 -0.61 . . . . 0.69999999999999996 109.353 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.506 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 14.4 t70 -68.94 -42.34 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.24 -0.891 . . . . 0.72999999999999998 109.467 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.64 -41.84 95.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 1.8600000000000001 110.135 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.3 mt -61.98 -39.4 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.104 0.478 . . . . 0.32000000000000001 110.029 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -57.11 -52.88 63.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.855 . . . . 0.39000000000000001 111.584 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.689 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 63.8 m-85 -74.9 -21.25 59.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.123 0.416 . . . . 0.91000000000000003 112.123 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.7 p -83.25 2.31 36.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.411 . . . . 0.57999999999999996 111.374 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.21 9.28 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.64 0.257 . . . . 1.1699999999999999 110.485 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m 66.72 87.37 0.12 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.321 -0.854 . . . . 1.1399999999999999 111.095 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.689 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -81.08 132.51 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.776 2.317 . . . . 1.1000000000000001 112.044 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.95 123.63 67.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.832 -0.622 . . . . 1.6599999999999999 110.464 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 65.43 23.2 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.655 -0.702 . . . . 1.98 110.817 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.79 -0.62 79.94 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.886 -0.673 . . . . 0.82999999999999996 112.628 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.687 ' HB2' HD12 ' A' ' 100' ' ' LEU . 44.6 mttm -123.5 164.82 18.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.999 -0.371 . . . . 0.96999999999999997 109.999 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.685 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 48.2 pt -111.5 130.24 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.925 -0.71 . . . . 0.37 109.302 167.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -71.25 154.89 41.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.973 -0.558 . . . . 1.3100000000000001 110.674 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.4 -9.01 2.01 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.9 -0.591 . . . . 0.33000000000000002 113.981 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.75 -67.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.14 0.47 . . . . 0.27000000000000002 110.581 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.855 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 4.3 p30 -69.32 -28.25 66.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.79 110.62 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.6 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.68 -49.09 78.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.32000000000000001 110.333 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.631 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 42.8 tttp -64.54 -36.81 85.43 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.905 0.383 . . . . 1.3600000000000001 110.22 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.855 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 28.5 mtpp -54.85 -42.15 71.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.632 . . . . 2.48 110.82 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -71.16 -38.86 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.661 . . . . 2.1600000000000001 110.123 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.764 ' HB3' HD22 ' A' ' 86' ' ' LEU . 87.5 mtp -68.17 -28.08 66.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.481 -0.781 . . . . 0.51000000000000001 111.41 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -81.11 -22.69 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.362 -0.535 . . . . 1.3400000000000001 110.28 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 44.2 mttp -66.49 -28.93 68.95 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.304 -0.558 . . . . 2.2000000000000002 109.666 170.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -67.03 -17.56 64.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.569 -0.741 . . . . 0.91000000000000003 110.797 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mttp 67.28 22.83 9.5 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.839 -0.619 . . . . 2.3700000000000001 111.582 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.582 ' HB2' HD21 ' A' ' 86' ' ' LEU . 84.5 mt -89.4 155.76 48.59 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.657 -0.498 . . . . 1.3500000000000001 109.657 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.525 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 35.4 Cg_endo -66.53 147.26 81.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.564 2.176 . . . . 0.44 112.232 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.29 -36.9 69.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.652 -0.704 . . . . 1.9399999999999999 111.276 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.2 m -60.02 -48.51 81.41 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.838 -0.619 . . . . 1.04 111.214 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.563 HG11 ' HE2' ' A' ' 116' ' ' LYS . 78.7 t -67.6 -38.31 80.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.40999999999999998 110.162 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.764 HD22 ' HB3' ' A' ' 76' ' ' MET . 81.8 mt -57.49 -42.27 82.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.44 110.556 175.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.43 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.67 -41.21 98.86 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.953 -0.567 . . . . 0.23000000000000001 112.132 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.03 -47.74 81.74 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.23 -0.188 . . . . 1.71 110.84 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 85' ' ' VAL . 69.3 mt -53.35 -45.55 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 123.339 0.4 . . . . 0.40000000000000002 110.365 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.535 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 32.0 t-105 -59.71 -52.68 64.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.731 -0.668 . . . . 0.46000000000000002 110.963 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.93 -13.55 61.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.308 0.484 . . . . 2.3999999999999999 112.308 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.49 -39.77 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.142 0.496 . . . . 1.0800000000000001 110.648 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.529 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.53 -36.18 45.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.605 -0.725 . . . . 0.29999999999999999 111.56 -176.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 44.0 t0 -83.56 70.61 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.869 0.842 . . . . 0.45000000000000001 109.467 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.468 ' CG1' HD11 ' A' ' 126' ' ' LEU . 15.0 m -77.32 -16.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.944 -1.025 . . . . 1.28 109.619 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.569 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . 2.1 t70 -86.23 -20.72 28.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.186 -1.37 . . . . 1.1200000000000001 109.295 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttt 60.77 40.34 16.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.667 -1.152 . . . . 1.6799999999999999 111.359 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.62 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 7.2 p-10 -114.27 9.21 16.96 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.505 -0.478 . . . . 0.70999999999999996 111.299 -174.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.6 -2.41 67.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 120.843 -0.694 . . . . 0.39000000000000001 111.992 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -120.71 134.02 55.31 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.752 -0.832 . . . . 1.3700000000000001 108.752 -176.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 62.3 mt -83.23 108.6 16.57 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 118.743 -1.183 . . . . 0.34000000000000002 108.012 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 2.6 m-20 -71.88 171.22 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.711 -1.218 . . . . 1.3899999999999999 107.711 171.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -57.6 -42.01 82.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.996 0.362 . . . . 1.6899999999999999 111.212 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -68.8 -42.21 77.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.291 0.567 . . . . 2.29 110.28 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.569 ' OE2' ' HB3' ' A' ' 96' ' ' ASP . 25.4 mt-10 -66.89 -38.63 86.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.516 -0.765 . . . . 0.39000000000000001 110.627 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 38.9 t80 -73.1 -25.06 60.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.28999999999999998 110.625 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 -41.57 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.244 -1.021 . . . . 0.34000000000000002 108.244 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 93' ' ' ALA . 40.7 tp -65.25 -35.52 81.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.449 -1.25 . . . . 1.74 109.826 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -55.88 29.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.133 -0.485 . . . . 0.27000000000000002 110.84 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.602 HD22 HD12 ' A' ' 113' ' ' ILE . 13.8 m120 -61.62 -28.16 69.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.69999999999999996 110.928 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.514 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.7 t60 -63.95 -48.01 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 0.75 110.585 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 mt -66.24 -33.39 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.792 -0.448 . . . . 0.27000000000000002 109.792 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.602 HD12 HD22 ' A' ' 110' ' ' ASN . 88.2 mt -60.49 -51.39 73.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.83 -0.623 . . . . 0.46000000000000002 111.511 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.28 -41.02 86.14 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 120.601 -0.439 . . . . 1.8100000000000001 110.444 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 111' ' ' HIS . 69.4 t -54.62 -47.83 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.027 0.442 . . . . 0.91000000000000003 109.867 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.563 ' HE2' HG11 ' A' ' 85' ' ' VAL . 44.4 tptt -57.8 -56.58 20.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.54 -0.755 . . . . 1.0600000000000001 111.306 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.89 -31.81 72.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 1.5900000000000001 111.73 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 44.4 mt-10 -80.5 4.29 18.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 2.0499999999999998 111.353 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.07 33.17 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.699 . . . . 0.68000000000000005 113.467 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 97.7 m-70 -131.5 173.55 10.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.778 0.289 . . . . 1.1599999999999999 110.444 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -120.0 155.13 33.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.269 -0.423 . . . . 2.6899999999999999 111.163 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.9 mt -93.47 128.16 43.48 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.946 -0.57 . . . . 1.21 109.582 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.49 -6.81 19.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.792 2.328 . . . . 1.28 113.57 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.89 9.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 1.0600000000000001 112.404 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -127.6 174.61 8.92 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.661 -0.496 . . . . 1.9299999999999999 109.661 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.468 HD11 ' CG1' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -124.36 88.96 52.6 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.696 -0.483 . . . . 1.8500000000000001 109.696 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 32.5 Cg_endo -66.57 150.34 83.97 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.859 2.373 . . . . 0.90000000000000002 112.256 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 32.3 Cg_exo -58.25 -21.4 52.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.218 2.612 . . . . 1.02 113.856 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -96.94 13.14 29.86 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.487 -0.485 . . . . 1.1399999999999999 111.576 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 mt . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 1.3400000000000001 111.418 177.06 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.2 p30 . . . . . 0 N--CA 1.457 -0.114 0 CA-C-O 121.056 0.455 . . . . 1.25 111.388 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.631 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 30.7 Cg_exo -63.24 0.22 1.86 Allowed 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 124.118 3.212 . . . . 0.48999999999999999 114.114 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.535 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 28.9 m-85 -100.4 -49.8 4.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.925 0.393 . . . . 0.56000000000000005 110.813 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 30.6 p . . . . . 0 C--N 1.32 -0.693 0 CA-C-N 116.054 -0.521 . . . . 1.8899999999999999 111.706 -177.072 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.4 t90 . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 107.542 -1.281 . . . . 0.95999999999999996 107.542 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 130' ' ' LEU . 16.5 m -57.82 -20.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.989 0.737 . . . . 1.3300000000000001 112.989 -169.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 108' ' ' LEU . 33.6 t -92.45 -25.81 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 0.53000000000000003 110.723 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -69.84 -23.58 76.82 Favored Glycine 0 CA--C 1.516 0.101 0 C-N-CA 121.167 -0.54 . . . . 0.78000000000000003 113.0 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -73.91 -20.48 60.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.583 0.706 . . . . 3.2200000000000002 109.907 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -134.48 34.38 3.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.413 1.101 . . . . 2.3900000000000001 108.683 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.507 ' HZ3' ' CG ' ' A' ' 103' ' ' ASP . 16.1 ttpp -79.57 -42.1 1.53 Allowed Pre-proline 0 C--O 1.215 -0.718 0 CA-C-N 114.637 -1.165 . . . . 1.1699999999999999 111.19 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.578 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 42.9 Cg_exo -44.0 -29.37 2.63 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.909 2.406 . . . . 0.65000000000000002 114.419 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -70.19 -46.54 64.4 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.461 0.648 . . . . 0.45000000000000001 109.792 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -74.75 -17.03 60.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.604 -0.725 . . . . 0.69999999999999996 109.567 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.578 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 10.7 t70 -72.86 -44.61 61.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.158 -0.928 . . . . 0.72999999999999998 109.442 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.64 -42.86 97.78 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.712 -0.676 . . . . 1.8600000000000001 109.671 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' HD13 ' A' ' 60' ' ' LEU . 60.7 mt -61.01 -42.44 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 0.32000000000000001 109.788 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -53.74 -35.08 60.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 0.39000000000000001 110.975 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.596 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 39.2 m-85 -84.83 -22.86 29.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.57 0.581 . . . . 0.91000000000000003 112.57 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 p -77.26 -11.27 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.3 -0.56 . . . . 0.57999999999999996 110.446 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.523 HD11 ' OE1' ' A' ' 75' ' ' GLU . 10.1 mp -99.76 7.04 45.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.959 -0.564 . . . . 1.1699999999999999 111.321 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m 64.92 88.12 0.11 Allowed Pre-proline 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 1.1399999999999999 110.793 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 90.4 Cg_endo -84.28 102.6 0.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.213 1.942 . . . . 1.1000000000000001 112.151 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.85 110.35 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.79 -0.641 . . . . 1.6599999999999999 110.918 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 65.38 26.5 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.799 . . . . 1.98 111.052 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.85 19.86 64.64 Favored Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 121.176 -0.535 . . . . 0.82999999999999996 112.269 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.79 ' HB3' HD11 ' A' ' 100' ' ' LEU . 52.7 mttm -139.9 155.53 47.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.866 -0.42 . . . . 0.96999999999999997 109.866 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 106' ' ' PHE . 38.1 pt -131.35 131.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.196 0.522 . . . . 0.37 110.247 171.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 p -66.98 161.89 23.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.683 -0.69 . . . . 1.3100000000000001 111.061 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.17 -16.8 62.81 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 121.304 -0.474 . . . . 0.33000000000000002 113.696 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.69 -51.45 68.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.104 0.478 . . . . 0.27000000000000002 110.829 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.577 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 18.2 m-80 -68.38 -43.05 78.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 1.79 109.954 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.22 -53.65 55.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.241 -0.891 . . . . 0.32000000000000001 111.425 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.667 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.7 tttt -61.59 -35.73 78.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 1.3600000000000001 110.296 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 16.7 ttpp -51.66 -47.26 63.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 2.48 110.344 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.523 ' OE1' HD11 ' A' ' 60' ' ' LEU . 3.4 tp10 -65.97 -38.08 87.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.454 0.645 . . . . 2.1600000000000001 110.155 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.779 ' HB3' HD22 ' A' ' 86' ' ' LEU . 76.4 mtp -71.56 -31.27 66.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.423 -0.808 . . . . 0.51000000000000001 111.486 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.56 -24.05 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.913 -0.315 . . . . 1.3400000000000001 110.46 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 27.0 mtpp -70.87 -28.29 64.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.24 0.543 . . . . 2.2000000000000002 109.904 172.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.5 m -66.48 -19.31 65.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.203 -0.908 . . . . 0.91000000000000003 111.058 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 62.43 36.3 14.31 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.871 -0.604 . . . . 2.3700000000000001 111.407 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 86' ' ' LEU . 85.9 mt -97.13 161.17 27.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.894 -0.41 . . . . 1.3500000000000001 109.894 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 81' ' ' LEU . 36.5 Cg_endo -67.19 143.08 63.36 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.463 2.109 . . . . 0.44 112.136 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -56.32 -31.47 63.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.849 -0.614 . . . . 1.9399999999999999 111.604 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p -59.68 -54.7 43.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 1.04 111.373 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 89' ' ' ILE . 59.9 t -66.1 -41.94 90.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 0.40999999999999998 110.187 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 76' ' ' MET . 90.6 mt -55.68 -52.71 62.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.16 -0.473 . . . . 0.44 111.113 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.549 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.53 -39.26 96.17 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 121.155 -0.545 . . . . 0.23000000000000001 112.116 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 25.6 ttmm -61.27 -44.13 97.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 1.71 110.419 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 85' ' ' VAL . 84.5 mt -62.85 -39.78 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.40000000000000002 110.614 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.458 ' HZ2' ' C ' ' A' ' 99' ' ' GLY . 57.7 t-105 -60.43 -49.05 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.46000000000000002 110.327 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -65.67 -16.22 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 2.3999999999999999 112.16 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 34.2 mt -92.37 -44.39 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.147 0.499 . . . . 1.0800000000000001 111.497 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.69 -27.26 45.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.588 -0.733 . . . . 0.29999999999999999 112.005 -172.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -86.23 85.54 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.608 0.718 . . . . 0.45000000000000001 110.624 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 105' ' ' GLU . 21.1 m -74.81 -25.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.897 -1.047 . . . . 1.28 112.174 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.631 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 9.0 m-20 -78.96 -13.59 59.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 121.116 -0.234 . . . . 1.1200000000000001 110.756 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttt 59.72 29.9 19.47 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 108.691 -0.855 . . . . 1.6799999999999999 108.691 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.631 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 17.9 p-10 -105.73 9.35 33.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.134 -0.939 . . . . 0.70999999999999996 111.308 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.458 ' C ' ' HZ2' ' A' ' 90' ' ' TRP . . . 64.54 20.66 66.07 Favored Glycine 0 CA--C 1.493 -1.336 0 CA-C-O 121.584 0.547 . . . . 0.39000000000000001 112.657 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -156.49 143.11 18.53 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.343 -0.984 . . . . 1.3700000000000001 108.343 -173.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 100' ' ' LEU . 88.0 mt -104.57 126.5 51.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.975 0.417 . . . . 0.34000000000000002 111.943 -171.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.86 -176.78 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.94 -0.573 . . . . 1.3899999999999999 109.772 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.507 ' CG ' ' HZ3' ' A' ' 50' ' ' LYS . 14.5 t0 -57.75 -42.76 84.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.777 -0.647 . . . . 1.6899999999999999 110.414 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -72.99 -43.97 61.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.508 -0.769 . . . . 2.29 110.822 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 52.3 mt-10 -63.37 -42.83 98.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.171 -0.468 . . . . 0.39000000000000001 110.784 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.546 ' CD1' HD11 ' A' ' 67' ' ' ILE . 44.9 t80 -65.84 -35.87 81.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.28999999999999998 110.094 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.69 89.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.34000000000000002 110.321 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 46' ' ' VAL . 78.6 mt -62.29 -45.8 91.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.161 -0.472 . . . . 1.74 110.832 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.74 -58.06 8.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.989 0.423 . . . . 0.27000000000000002 111.001 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -33.96 72.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.69999999999999996 111.564 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -69.51 -46.97 65.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.566 -0.288 . . . . 0.75 110.309 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.08 -47.63 83.83 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.955 0.407 . . . . 0.27000000000000002 110.608 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.9 mt -57.83 -52.23 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.46000000000000002 111.101 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.676 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.66 -30.44 69.13 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.343 -0.39 . . . . 1.8100000000000001 110.413 -176.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 120' ' ' HIS . 3.1 t -61.49 -43.83 97.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.763 0.316 . . . . 0.91000000000000003 110.361 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 25.7 mmmt -63.11 -37.48 87.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 1.0600000000000001 110.869 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.8 tp -70.14 -30.52 67.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.606 -0.27 . . . . 1.5900000000000001 111.01 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 29.9 mm-40 -66.01 -26.39 67.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 2.0499999999999998 110.216 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.35 21.8 8.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.935 -0.65 . . . . 0.68000000000000005 112.227 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.67 ' HB2' HG13 ' A' ' 115' ' ' VAL . 96.2 m-70 -104.91 165.97 10.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 1.1599999999999999 110.443 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -108.74 127.01 53.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.143 -0.48 . . . . 2.6899999999999999 110.06 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.64 146.72 80.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 1.21 110.08 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.54 -10.16 25.25 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.134 2.556 . . . . 1.28 113.548 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.33 19.33 10.98 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.214 -0.448 . . . . 1.0600000000000001 111.124 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -133.09 175.08 9.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.844 -0.616 . . . . 1.9299999999999999 110.232 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.62 90.51 50.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.452 -0.944 . . . . 1.8500000000000001 108.452 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.75 151.57 69.15 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.479 2.12 . . . . 0.90000000000000002 112.027 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.55 -25.91 61.31 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.191 2.594 . . . . 1.02 112.807 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -89.12 19.58 4.16 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.884 -0.326 . . . . 1.1399999999999999 111.658 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.531 HD21 HG22 ' A' ' 45' ' ' VAL . 31.5 mt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 1.3400000000000001 110.664 173.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 7.7 t70 . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.892 -0.41 . . . . 1.25 109.892 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.667 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.7 Cg_exo -76.82 -2.39 12.61 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.538 2.825 . . . . 0.48999999999999999 113.924 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.549 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 10.7 m-85 -106.78 -9.97 16.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.126 0.489 . . . . 0.56000000000000005 110.477 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 28.0 p . . . . . 0 C--N 1.319 -0.76 0 CA-C-N 115.805 -0.634 . . . . 1.8899999999999999 110.798 -177.598 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.616 0 N-CA-C 112.073 -0.411 . . . . 10.470000000000001 112.073 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -72.83 143.18 36.58 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.673 2.249 . . . . 10.449999999999999 111.845 178.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.4 tp 72.04 110.47 0.06 Allowed 'General case' 0 C--O 1.234 0.263 0 O-C-N 123.93 0.769 . . . . 9.0899999999999999 111.194 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 175.57 -110.96 0.33 Allowed Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.59 -0.732 . . . . 6.2400000000000002 111.528 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.4 p -148.49 -26.79 0.32 Allowed 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.648 0.261 . . . . 5.9800000000000004 111.169 178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -83.41 92.9 7.66 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.348 0.594 . . . . 3.9199999999999999 110.579 177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -118.94 126.35 51.56 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.275 -0.875 . . . . 4.9400000000000004 109.494 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.0 t -116.98 116.22 51.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.49 -0.323 . . . . 1.99 110.255 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -77.85 104.18 8.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.033 0.444 . . . . 2.3999999999999999 110.385 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.485 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 20.9 t90 -71.25 112.89 7.76 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.347 -0.842 . . . . 0.95999999999999996 109.115 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 40.5 t -52.96 -41.36 40.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.851 -0.613 . . . . 1.3300000000000001 112.04 -173.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.52 HG21 HD23 ' A' ' 108' ' ' LEU . 11.0 t -79.93 -1.37 4.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.363 0.602 . . . . 0.53000000000000003 110.708 -174.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.45 -13.13 76.95 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.673 -0.775 . . . . 0.78000000000000003 112.562 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -83.54 -28.46 28.6 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 120.863 0.363 . . . . 3.2200000000000002 110.952 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -124.18 34.7 4.98 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 122.172 0.987 . . . . 2.3900000000000001 109.227 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.411 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 17.8 ttpt -78.78 -44.29 1.88 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 114.066 -1.425 . . . . 1.1699999999999999 112.281 -178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 83.2 Cg_exo -49.15 -24.26 7.67 Favored 'Trans proline' 0 C--N 1.364 1.377 0 C-N-CA 122.632 2.222 . . . . 0.65000000000000002 113.67 -178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 m -69.89 -45.45 67.62 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.696 -0.483 . . . . 0.45000000000000001 109.696 176.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.455 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 5.9 m-85 -73.49 -22.95 60.01 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-N 115.916 -0.584 . . . . 0.69999999999999996 109.96 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.523 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -69.61 -44.59 70.38 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-O 121.48 0.657 . . . . 0.72999999999999998 110.32 176.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 tp10 -60.31 -45.58 92.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.279 -0.873 . . . . 1.8600000000000001 109.765 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.524 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 77.3 mt -64.83 -39.92 87.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.727 -0.669 . . . . 0.32000000000000001 110.455 176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 58.1 t80 -52.88 -50.72 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.747 -0.66 . . . . 0.39000000000000001 111.306 -178.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.454 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 45.1 m-85 -76.77 -22.4 53.78 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.275 -0.421 . . . . 0.91000000000000003 112.071 -177.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 15.9 p -88.73 8.24 29.8 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.677 -0.409 . . . . 0.57999999999999996 111.337 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 85.1 mt -104.88 1.34 28.86 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.199 -0.455 . . . . 1.1699999999999999 110.589 176.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.2 m 69.14 87.06 0.12 Allowed Pre-proline 0 N--CA 1.467 0.379 0 O-C-N 123.902 0.751 . . . . 1.1399999999999999 110.586 -177.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HA ' HG22 ' A' ' 67' ' ' ILE . 1.2 Cg_endo -84.61 163.84 12.4 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.174 2.583 . . . . 1.1000000000000001 112.755 -177.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 40.0 t -114.85 102.57 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 1.6599999999999999 110.087 177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 m120 68.87 23.23 6.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.765 -0.652 . . . . 1.98 110.358 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.04 4.16 65.06 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.771 -0.728 . . . . 0.82999999999999996 112.428 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.618 ' HD3' ' CB ' ' A' ' 100' ' ' LEU . 14.8 ttmm -133.4 126.78 32.0 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.982 -0.748 . . . . 0.96999999999999997 108.982 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.506 HG22 ' HA ' ' A' ' 62' ' ' PRO . 39.0 pt -87.36 151.18 3.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.094 -0.642 . . . . 0.37 110.473 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.405 ' HA ' HD13 ' A' ' 100' ' ' LEU . 80.5 p -90.42 177.43 6.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.192 -0.458 . . . . 1.3100000000000001 110.613 -176.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.15 -16.78 67.21 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.695 -0.764 . . . . 0.33000000000000002 112.088 178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -69.65 -59.37 3.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.049 0.452 . . . . 0.27000000000000002 110.381 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -62.8 -43.64 98.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.588 -0.733 . . . . 1.79 110.162 -177.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.65 -47.32 86.79 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.075 -0.966 . . . . 0.32000000000000001 111.35 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -68.27 -34.59 76.45 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.157 -0.312 . . . . 1.3600000000000001 110.157 -175.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 70' ' ' ALA . 52.2 mtpt -58.04 -46.92 84.56 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.208 0.528 . . . . 2.48 110.502 174.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -64.11 -44.72 91.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.885 -0.598 . . . . 2.1600000000000001 110.254 177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.611 ' HB3' HD22 ' A' ' 86' ' ' LEU . 94.5 mtp -67.12 -27.99 67.78 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.903 -0.589 . . . . 0.51000000000000001 112.209 -175.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -82.21 -24.82 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 119.944 -0.703 . . . . 1.3400000000000001 110.664 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -75.5 -12.03 60.15 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.787 0.327 . . . . 2.2000000000000002 110.476 172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.5 m -72.86 -14.93 61.6 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 109.49 -0.559 . . . . 0.91000000000000003 109.49 168.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 29.0 mmmt 68.25 29.96 5.82 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.133 -0.939 . . . . 2.3700000000000001 111.455 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HB2' HD21 ' A' ' 86' ' ' LEU . 80.7 mt -104.56 154.88 38.13 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.537 -0.301 . . . . 1.3500000000000001 110.651 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.501 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 40.4 Cg_endo -68.37 155.59 68.66 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.843 2.362 . . . . 0.44 112.558 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 56.9 m-80 -66.06 -25.18 66.92 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.486 -0.325 . . . . 1.9399999999999999 111.283 -177.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 20.3 m -63.35 -52.69 60.71 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.937 0.399 . . . . 1.04 110.675 177.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 89' ' ' ILE . 84.8 t -62.76 -46.08 97.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 CA-C-N 116.09 -0.505 . . . . 0.40999999999999998 109.806 177.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.611 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.0 mt -59.94 -37.7 80.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.199 -0.455 . . . . 0.44 111.4 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.32 -47.12 87.94 Favored Glycine 0 N--CA 1.452 -0.287 0 CA-C-N 116.133 -0.485 . . . . 0.23000000000000001 112.685 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 20.5 ptmt -66.54 -33.27 75.31 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 120.494 -0.482 . . . . 1.71 109.789 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.633 HG13 ' O ' ' A' ' 85' ' ' VAL . 83.8 mt -57.47 -50.04 78.37 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 N-CA-C 109.722 -0.473 . . . . 0.40000000000000002 109.722 174.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 34.1 t-105 -58.89 -49.92 75.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.545 -0.752 . . . . 0.46000000000000002 111.133 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 8.0 mtpm? -65.41 -20.27 66.3 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.184 0.438 . . . . 2.3999999999999999 112.184 -174.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' A' ' 124' ' ' ALA . 29.7 mt -93.58 -35.63 12.8 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.863 0.363 . . . . 1.0800000000000001 111.384 175.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -86.57 -16.39 36.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.054 -0.521 . . . . 0.29999999999999999 112.058 -172.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.631 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 40.3 t0 -79.13 80.56 5.47 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.692 0.758 . . . . 0.45000000000000001 109.83 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.486 HG21 ' HG2' ' A' ' 132' ' ' PRO . 96.2 t -58.78 -44.55 90.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.583 -1.189 . . . . 1.28 112.207 -176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.437 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 33.8 m-20 -70.63 -24.52 62.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.399 -0.364 . . . . 1.1200000000000001 110.089 179.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 57.12 51.48 10.31 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.608 -0.886 . . . . 1.6799999999999999 108.608 -169.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.631 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 18.2 p-10 -125.5 8.4 7.71 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.928 -1.033 . . . . 0.70999999999999996 112.146 -167.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 75.82 -0.13 62.65 Favored Glycine 0 CA--C 1.507 -0.406 0 C-N-CA 120.441 -0.885 . . . . 0.39000000000000001 112.785 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.618 ' CB ' ' HD3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -118.83 163.49 16.82 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.012 -0.736 . . . . 1.3700000000000001 109.012 -178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 45.8 mt -115.69 110.02 18.55 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 109.423 -0.584 . . . . 0.34000000000000002 109.423 169.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -76.43 -173.95 2.69 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.559 -0.746 . . . . 1.3899999999999999 109.274 171.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -55.85 -44.91 78.48 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.694 -0.685 . . . . 1.6899999999999999 111.239 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -81.63 -31.25 32.5 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.638 -0.71 . . . . 2.29 110.743 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -68.59 -47.43 66.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.7 -0.682 . . . . 0.39000000000000001 110.338 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -65.92 -35.1 79.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.705 -0.679 . . . . 0.28999999999999998 109.942 179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.455 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -57.3 -49.79 74.98 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-N 116.002 -0.544 . . . . 0.34000000000000002 110.693 174.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.52 HD23 HG21 ' A' ' 46' ' ' VAL . 12.9 mt -60.5 -43.95 96.5 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.59 -0.277 . . . . 1.74 111.509 177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.415 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.34 -56.74 17.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.207 -0.451 . . . . 0.27000000000000002 111.238 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -61.04 -33.68 73.67 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.079 -0.51 . . . . 0.69999999999999996 111.28 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.614 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.8 t60 -62.86 -50.49 70.7 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.929 -0.578 . . . . 0.75 110.733 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.622 HD12 HG23 ' A' ' 89' ' ' ILE . 49.2 mt -63.17 -36.83 84.94 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.673 0.273 . . . . 0.27000000000000002 110.447 -179.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 109' ' ' ALA . 89.7 mt -56.95 -48.53 81.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.117 -0.492 . . . . 0.46000000000000002 110.644 176.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 34.6 pttt -74.6 -24.1 58.82 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 120.678 -0.409 . . . . 1.8100000000000001 110.879 -177.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 111' ' ' HIS . 76.6 t -62.25 -39.71 85.08 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 N-CA-C 109.498 -0.556 . . . . 0.91000000000000003 109.498 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.893 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 2.4 mmmp? -67.19 -37.45 83.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.772 -0.649 . . . . 1.0600000000000001 109.957 176.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.413 ' O ' HD13 ' A' ' 117' ' ' LEU . 1.5 tm? -64.68 -38.69 91.85 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 115.695 -0.684 . . . . 1.5900000000000001 110.161 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 7.1 mm-40 -66.98 -9.0 34.06 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.152 -0.476 . . . . 2.0499999999999998 110.55 177.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.82 35.19 5.69 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.961 -0.638 . . . . 0.68000000000000005 112.417 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.541 ' HB2' HG12 ' A' ' 115' ' ' VAL . 99.5 m-70 -121.78 -176.98 3.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.185 0.517 . . . . 1.1599999999999999 111.283 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -124.7 160.61 28.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 2.6899999999999999 109.805 -177.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.893 ' HG ' ' HD3' ' A' ' 116' ' ' LYS . 26.6 mt -104.51 115.33 62.99 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.252 -0.647 . . . . 1.21 109.252 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -79.09 2.88 7.91 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 123.256 2.637 . . . . 1.28 113.333 -170.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 63.81 19.22 11.63 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.935 -0.575 . . . . 1.0600000000000001 111.243 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -111.24 147.11 35.72 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 115.874 -0.603 . . . . 1.9299999999999999 109.788 176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.471 ' HG ' ' HB ' ' A' ' 131' ' ' VAL . 17.0 tp -125.05 94.23 44.19 Favored Pre-proline 0 C--N 1.314 -0.975 0 CA-C-N 116.325 -0.398 . . . . 1.8500000000000001 110.382 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.45 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 25.7 Cg_exo -62.94 152.07 81.16 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.194 2.596 . . . . 0.90000000000000002 112.11 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -54.09 -26.9 43.59 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.371 2.714 . . . . 1.02 113.822 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 20.7 p-80 -99.85 5.84 45.4 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 120.781 -0.368 . . . . 1.1399999999999999 111.129 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.45 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 3.8 mm? -101.99 -28.67 12.24 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.704 -0.48 . . . . 1.3400000000000001 109.704 171.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.471 ' HB ' ' HG ' ' A' ' 126' ' ' LEU . 7.6 p -92.81 132.76 30.44 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.653 -0.703 . . . . 1.5700000000000001 109.937 176.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.486 ' HG2' HG21 ' A' ' 95' ' ' VAL . 76.4 Cg_exo -49.2 135.19 31.02 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.525 2.15 . . . . 1.3500000000000001 111.58 175.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -65.66 2.21 1.75 Allowed 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.155 2.57 . . . . 2.0499999999999998 113.196 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.5 m -80.81 -1.63 43.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.443 -0.344 . . . . 2.6600000000000001 111.381 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.7 mmmt -106.17 15.47 26.24 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.892 0.377 . . . . 3.1000000000000001 110.951 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -100.41 134.97 42.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.319 -0.4 . . . . 3.8599999999999999 111.243 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.405 HH11 ' HD2' ' A' ' 137' ' ' ARG . 1.1 ptp180 -90.2 173.61 8.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.915 -0.584 . . . . 5.0 110.391 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -104.13 99.06 8.8 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.792 0.329 . . . . 6.6299999999999999 110.222 179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.691 -0.671 . . . . 6.6600000000000001 109.328 176.906 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 . . . . . 0 N--CA 1.477 0.909 0 N-CA-C 109.978 -0.378 . . . . 10.529999999999999 109.978 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -78.8 92.23 4.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.593 0.235 . . . . 8.2200000000000006 110.942 -177.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.485 ' HD1' ' H ' ' B' ' 147' ' ' SER . 36.2 p90 43.41 -164.76 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 124.422 1.089 . . . . 7.4299999999999997 113.285 -178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -155.89 20.73 0.38 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.83 -0.623 . . . . 5.9199999999999999 109.84 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.485 ' H ' ' HD1' ' B' ' 145' ' ' TYR . 4.0 m -92.61 121.36 33.96 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.528 -0.76 . . . . 4.3399999999999999 111.945 -170.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 10.1 t -140.38 13.0 2.37 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.712 -0.848 . . . . 2.1200000000000001 108.712 172.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -87.52 150.99 49.95 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 114.991 -1.004 . . . . 1.25 111.327 -172.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -68.71 0.15 5.27 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 123.527 2.818 . . . . 0.48999999999999999 113.892 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -98.35 -45.51 6.13 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.687 0.279 . . . . 0.56000000000000005 111.038 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 70.1 p -89.65 25.28 2.06 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.181 0.438 . . . . 1.8899999999999999 112.181 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -98.3 1.49 47.19 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.443 -0.344 . . . . 3.1099999999999999 111.537 -177.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 35.4 mttp . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.197 -0.906 . . . . 6.9900000000000002 111.16 -179.35 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.631 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 112.156 -0.378 . . . . 10.470000000000001 112.156 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -95.0 16.14 1.01 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.478 2.786 . . . . 10.449999999999999 113.46 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 46.2 tp -123.0 -44.28 2.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.921 0.391 . . . . 9.0899999999999999 111.193 -176.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -112.58 156.07 15.84 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.458 -0.877 . . . . 6.2400000000000002 112.315 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 4.3 p -89.13 177.94 6.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.775 0.322 . . . . 5.9800000000000004 110.921 178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -100.45 134.57 43.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.374 0.607 . . . . 3.9199999999999999 110.942 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 41.8 m-20 -106.94 122.11 45.77 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.396 -0.82 . . . . 4.9400000000000004 109.838 177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 p -107.47 146.17 13.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 120.876 0.37 . . . . 1.99 111.045 -177.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -73.06 130.7 40.89 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 109.274 -0.639 . . . . 2.3999999999999999 109.274 174.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.478 ' CZ3' ' HG3' ' A' ' 50' ' ' LYS . 0.6 OUTLIER -77.95 112.66 15.08 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.33 -0.619 . . . . 0.95999999999999996 109.33 179.098 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.8 t -59.65 -36.67 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.269 0.557 . . . . 1.3300000000000001 110.75 -178.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.433 HG21 HD23 ' A' ' 108' ' ' LEU . 39.6 t -76.94 -17.44 14.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.744 -0.662 . . . . 0.53000000000000003 110.496 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -66.21 -14.86 62.35 Favored Glycine 0 C--N 1.331 0.28 0 CA-C-N 115.883 -0.599 . . . . 0.78000000000000003 112.989 -176.265 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -73.77 -25.55 60.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.075 0.464 . . . . 3.2200000000000002 109.912 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.4 t0 -131.1 33.23 4.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.714 0.768 . . . . 2.3900000000000001 109.342 -177.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.514 ' HB2' ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -79.46 -46.38 1.59 Allowed Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 115.338 -0.846 . . . . 1.1699999999999999 111.304 -177.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -54.62 -24.66 37.9 Favored 'Trans proline' 0 C--N 1.36 1.145 0 C-N-CA 122.418 2.079 . . . . 0.65000000000000002 112.715 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.2 m -70.14 -46.69 64.21 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.447 0.641 . . . . 0.45000000000000001 110.204 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.42 ' CD2' ' HA ' ' A' ' 107' ' ' ALA . 3.1 m-85 -75.1 -21.99 58.54 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.827 -0.624 . . . . 0.69999999999999996 109.329 179.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -73.61 -38.85 64.95 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.422 -0.808 . . . . 0.72999999999999998 109.16 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -54.02 -52.69 60.0 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 115.29 -0.868 . . . . 1.8600000000000001 109.591 171.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.467 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 60.4 mt -62.3 -41.48 91.74 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-N 115.658 -0.701 . . . . 0.32000000000000001 110.766 178.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -52.47 -42.82 64.55 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.616 -0.72 . . . . 0.39000000000000001 111.476 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.723 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 4.7 m-85 -83.18 -22.44 33.24 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 111.935 0.346 . . . . 0.91000000000000003 111.935 -176.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.08 -7.62 58.29 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.546 -0.462 . . . . 0.57999999999999996 111.161 178.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.586 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 89.1 mt -102.73 15.47 29.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.15 -0.477 . . . . 1.1699999999999999 110.877 -177.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.1 m 61.19 78.4 0.32 Allowed Pre-proline 0 C--O 1.235 0.305 0 CA-C-N 115.763 -0.653 . . . . 1.1399999999999999 111.127 -179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.723 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 94.2 Cg_endo -85.75 119.44 1.91 Allowed 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 122.532 2.155 . . . . 1.1000000000000001 112.241 -178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.2 p -92.57 132.86 35.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.93 -0.396 . . . . 1.6599999999999999 109.93 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 p30 48.39 25.37 0.88 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.926 0.89 . . . . 1.98 112.604 -178.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.86 15.24 78.02 Favored Glycine 0 CA--C 1.52 0.361 0 C-N-CA 120.981 -0.628 . . . . 0.82999999999999996 113.449 178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.683 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 10.0 ttmm -141.54 126.26 18.0 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.543 -0.539 . . . . 0.96999999999999997 109.543 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.445 HG22 ' HA ' ' A' ' 62' ' ' PRO . 44.7 pt -94.04 146.06 7.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 O-C-N 121.709 -0.619 . . . . 0.37 111.191 -177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.815 ' HA ' HD23 ' A' ' 100' ' ' LEU . 9.7 t -76.74 157.69 31.5 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 116.001 -0.545 . . . . 1.3100000000000001 110.115 175.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.56 -16.84 38.46 Favored Glycine 0 C--O 1.226 -0.402 0 CA-C-N 115.156 -0.929 . . . . 0.33000000000000002 114.232 -175.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.429 ' O ' ' HD3' ' A' ' 74' ' ' LYS . . . -61.83 -52.97 61.98 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 117.377 0.588 . . . . 0.27000000000000002 110.903 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.586 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 18.6 m-80 -65.81 -43.21 89.36 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.101 0.477 . . . . 1.79 110.07 -177.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.716 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.19 -49.19 78.62 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.297 -0.865 . . . . 0.32000000000000001 110.792 179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.732 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 84.0 tttt -61.56 -40.37 94.49 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 116.25 -0.432 . . . . 1.3600000000000001 110.391 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.651 ' HA ' HG12 ' A' ' 77' ' ' VAL . 27.8 mtpt -64.8 -30.94 71.97 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.927 -0.579 . . . . 2.48 111.6 179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.3 tp10 -70.67 -41.96 71.37 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.838 0.828 . . . . 2.1600000000000001 109.465 173.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.766 ' HB3' HD22 ' A' ' 86' ' ' LEU . 69.7 mtp -65.86 -31.47 72.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.139 -0.937 . . . . 0.51000000000000001 111.222 -178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.651 HG12 ' HA ' ' A' ' 74' ' ' LYS . 4.4 p -76.51 -27.5 17.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.599 -0.441 . . . . 1.3400000000000001 110.759 176.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 84.2 mttt -64.02 -28.14 69.59 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 120.299 -0.56 . . . . 2.2000000000000002 110.11 171.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 15.2 m -66.8 -26.78 67.11 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.562 -0.745 . . . . 0.91000000000000003 111.071 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.416 ' HB2' ' O ' ' A' ' 79' ' ' SER . 95.8 mttt 71.74 22.45 3.96 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.861 -0.609 . . . . 2.3700000000000001 112.213 178.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 81' ' ' LEU . 4.0 mm? -86.03 158.38 55.88 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.111 -0.7 . . . . 1.3500000000000001 109.111 172.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.531 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 2.0 Cg_endo -76.05 160.9 36.31 Favored 'Trans proline' 0 N--CA 1.454 -0.799 0 C-N-CA 122.434 2.09 . . . . 0.44 111.705 -178.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -62.63 -23.04 66.86 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.956 0.408 . . . . 1.9399999999999999 110.253 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 1.2 m -58.82 -53.67 55.74 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.725 -0.671 . . . . 1.04 110.217 174.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 89' ' ' ILE . 54.4 t -72.65 -42.72 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.40999999999999998 110.373 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.766 HD22 ' HB3' ' A' ' 76' ' ' MET . 67.3 mt -60.12 -39.26 85.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.294 -0.412 . . . . 0.44 110.489 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.23 -47.95 79.72 Favored Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.856 -0.687 . . . . 0.23000000000000001 111.859 176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -51.49 -51.4 55.36 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-O 120.755 0.312 . . . . 1.71 110.735 174.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.7 mt -62.36 -49.08 85.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.615 -0.721 . . . . 0.40000000000000002 110.748 -172.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.466 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 51.3 t-105 -57.79 -50.29 73.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.235 -0.439 . . . . 0.46000000000000002 111.764 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.3 mtmt -81.08 -14.7 57.52 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.57 -0.452 . . . . 2.3999999999999999 112.005 -170.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.756 HD22 ' HA ' ' A' ' 124' ' ' ALA . 0.3 OUTLIER -94.69 -27.39 15.87 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.926 0.393 . . . . 1.0800000000000001 110.26 176.232 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -88.17 -42.33 12.39 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.157 -0.474 . . . . 0.29999999999999999 111.609 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.642 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.0 t70 -77.52 71.78 4.02 Favored 'General case' 0 N--CA 1.462 0.17 0 N-CA-C 108.589 -0.893 . . . . 0.45000000000000001 108.589 176.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.1 m -65.68 -22.74 31.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.033 -0.985 . . . . 1.28 110.706 -178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.12 -23.66 51.77 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.69 -0.686 . . . . 1.1200000000000001 109.936 178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 46.4 mttt 57.78 49.25 12.48 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 115.173 -0.921 . . . . 1.6799999999999999 111.483 171.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.687 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.6 p-10 -117.26 9.25 13.39 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.282 -0.872 . . . . 0.70999999999999996 110.743 -175.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.12 17.64 66.02 Favored Glycine 0 C--N 1.336 0.566 0 N-CA-C 111.233 -0.747 . . . . 0.39000000000000001 111.233 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.815 HD23 ' HA ' ' A' ' 68' ' ' THR . 33.2 mt -139.24 140.58 37.75 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.353 -0.924 . . . . 1.3700000000000001 109.309 -175.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 51.3 mt -110.43 114.95 28.78 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.022 0.439 . . . . 0.34000000000000002 111.106 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -68.98 170.71 9.29 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.308 -0.997 . . . . 1.3899999999999999 108.308 165.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.72 -27.27 69.15 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.306 -0.558 . . . . 1.6899999999999999 110.035 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -66.27 -52.74 44.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.391 0.615 . . . . 2.29 110.625 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -68.65 -35.36 77.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.492 -0.776 . . . . 0.39000000000000001 110.898 -176.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -70.72 -32.23 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.097 -0.501 . . . . 0.28999999999999998 110.204 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.42 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -64.64 -44.74 89.5 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.679 -0.692 . . . . 0.34000000000000002 110.212 174.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 95.4 mt -58.23 -47.46 83.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.845 -0.616 . . . . 1.74 110.365 176.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.467 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -53.54 -56.56 16.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.006 -0.543 . . . . 0.27000000000000002 111.42 178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 15.4 m-80 -63.46 -35.65 81.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.034 -0.53 . . . . 0.69999999999999996 111.53 -176.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 54.7 t60 -66.25 -33.84 76.66 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.833 0.349 . . . . 0.75 110.557 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.517 ' O ' HG12 ' A' ' 115' ' ' VAL . 86.8 mt -76.31 -30.5 57.74 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.09 -0.504 . . . . 0.27000000000000002 111.042 178.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 109' ' ' ALA . 82.7 mt -75.53 -41.11 41.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.061 -1.088 . . . . 0.46000000000000002 108.061 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.584 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 29.9 ttmt -68.12 -40.71 82.45 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 114.056 -1.429 . . . . 1.8100000000000001 110.718 177.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.568 HG22 ' HB2' ' A' ' 120' ' ' HIS . 2.0 p -64.54 -37.55 80.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 110.115 -0.328 . . . . 0.91000000000000003 110.115 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.474 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 28.7 mmmt -66.97 -42.74 84.62 Favored 'General case' 0 N--CA 1.456 -0.138 0 CA-C-N 116.73 -0.213 . . . . 1.0600000000000001 110.513 173.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 48.6 tp -61.89 -37.9 86.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.185 -0.461 . . . . 1.5900000000000001 111.23 -178.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 31.4 mm-40 -71.73 -5.02 30.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 2.0499999999999998 111.239 179.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.11 36.23 6.4 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.725 -0.75 . . . . 0.68000000000000005 112.584 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.568 ' HB2' HG22 ' A' ' 115' ' ' VAL . 63.8 m-70 -118.44 170.34 9.01 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.59 -0.522 . . . . 1.1599999999999999 109.59 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -115.48 132.65 56.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.948 0.404 . . . . 2.6899999999999999 111.319 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 122' ' ' LEU . 1.7 pp -95.27 139.37 21.99 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 109.519 -0.549 . . . . 1.21 109.519 173.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.89 11.62 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.633 2.222 . . . . 1.28 113.348 -175.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.756 ' HA ' HD22 ' A' ' 92' ' ' LEU . . . 58.74 28.8 17.81 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.228 0.537 . . . . 1.0600000000000001 110.419 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -130.51 164.84 23.96 Favored 'General case' 0 CA--C 1.506 -0.728 0 CA-C-N 115.551 -0.75 . . . . 1.9299999999999999 109.79 -175.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.761 HD12 ' HB ' ' A' ' 131' ' ' VAL . 0.2 OUTLIER -125.37 88.66 53.84 Favored Pre-proline 0 N--CA 1.438 -1.03 0 N-CA-C 109.514 -0.551 . . . . 1.8500000000000001 109.514 177.855 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.537 ' HB2' HD23 ' A' ' 130' ' ' LEU . 55.2 Cg_exo -52.54 150.49 21.15 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 123.786 2.99 . . . . 0.90000000000000002 113.586 178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 73.4 Cg_exo -52.98 -30.32 48.13 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 123.386 2.724 . . . . 1.02 113.82 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.1 p-80 -94.47 9.05 39.96 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.206 -0.597 . . . . 1.1399999999999999 111.309 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.537 HD23 ' HB2' ' A' ' 127' ' ' PRO . 3.8 mm? -110.05 -27.55 9.14 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.043 -0.526 . . . . 1.3400000000000001 110.742 171.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.761 ' HB ' HD12 ' A' ' 126' ' ' LEU . 3.4 p -82.3 118.56 72.37 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-O 121.509 0.671 . . . . 1.5700000000000001 111.759 -174.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -72.6 177.93 6.88 Favored 'Trans proline' 0 CA--C 1.534 0.501 0 C-N-CA 123.074 2.516 . . . . 1.3500000000000001 112.089 178.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.917 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 21.5 Cg_exo -66.13 -3.7 9.03 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 122.922 2.415 . . . . 2.0499999999999998 113.051 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.59 -29.36 69.94 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.87 -0.604 . . . . 2.6600000000000001 112.006 -178.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 42.0 tptt -120.04 1.6 10.91 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.345 0.498 . . . . 3.1000000000000001 112.345 -175.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.917 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 18.1 ptp180 -99.26 143.06 29.95 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 121.882 -0.511 . . . . 3.8599999999999999 110.343 -179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 29.4 ttm180 -58.89 135.79 57.66 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.991 0.424 . . . . 5.0 111.325 -178.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.2 t-80 -106.38 124.22 49.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.096 -0.502 . . . . 6.6299999999999999 109.651 178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 C--O 1.246 0.917 0 N-CA-C 109.581 -0.525 . . . . 6.6600000000000001 109.581 173.687 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 110.33 -0.248 . . . . 10.529999999999999 110.33 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -56.27 -74.22 0.05 Allowed 'General case' 0 N--CA 1.467 0.393 0 O-C-N 123.81 0.693 . . . . 8.2200000000000006 112.319 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -129.46 99.6 5.25 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 122.154 0.978 . . . . 7.4299999999999997 111.743 177.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -101.75 75.45 1.56 Allowed 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.936 -1.135 . . . . 5.9199999999999999 107.936 170.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 71.1 m -78.6 66.38 4.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.458 -0.792 . . . . 4.3399999999999999 112.945 -169.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 6.2 p -112.86 18.4 18.21 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.777 -0.823 . . . . 2.1200000000000001 108.777 167.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -104.99 140.44 21.08 Favored Pre-proline 0 C--O 1.235 0.328 0 CA-C-N 114.974 -1.012 . . . . 1.25 110.5 -178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.732 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 61.5 Cg_endo -72.07 0.4 7.3 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 123.445 2.763 . . . . 0.48999999999999999 113.763 -176.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.646 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 36.3 m-85 -95.74 -30.1 13.9 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.16 -0.338 . . . . 0.56000000000000005 111.256 -174.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 20.5 p -81.74 102.09 10.53 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.277 0.473 . . . . 1.8899999999999999 112.277 -175.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 76.3 -36.11 0.27 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.016 0.926 . . . . 3.1099999999999999 113.134 172.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.415 ' HD3' ' N ' ' B' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.233 -0.889 . . . . 6.9900000000000002 111.067 -178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.648 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 111.494 -0.643 . . . . 10.470000000000001 111.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_endo -58.97 112.65 1.28 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.6 2.2 . . . . 10.449999999999999 111.578 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 95.1 mt 63.96 81.6 0.2 Allowed 'General case' 0 CA--C 1.53 0.198 0 O-C-N 123.912 0.757 . . . . 9.0899999999999999 110.833 -175.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 164.54 -158.54 31.29 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.846 -0.692 . . . . 6.2400000000000002 112.142 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 57.9 m -76.17 166.68 23.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.124 0.488 . . . . 5.9800000000000004 110.985 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -83.62 108.84 16.97 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 3.9199999999999999 110.419 179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -87.72 135.21 33.47 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.896 -0.409 . . . . 4.9400000000000004 109.896 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.6 p -123.71 127.83 74.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.197 0.522 . . . . 1.99 111.503 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 129' ' ' HIS . 59.2 mm-40 -83.34 85.17 7.27 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.686 -0.688 . . . . 2.3999999999999999 110.673 177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 4.2 t90 -80.81 95.7 6.75 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.843 -0.799 . . . . 0.95999999999999996 108.843 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 16.9 m -62.68 -17.22 18.41 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 115.726 -0.67 . . . . 1.3300000000000001 112.678 -170.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.4 t -73.22 -26.8 23.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.87 0.367 . . . . 0.53000000000000003 110.697 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.04 9.58 52.77 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.139 -0.553 . . . . 0.78000000000000003 112.91 -175.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -86.54 -25.65 24.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.749 0.309 . . . . 3.2200000000000002 111.062 178.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -143.44 36.26 1.33 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 2.3900000000000001 110.152 -177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HA ' ' HD2' ' A' ' 53' ' ' TYR . 0.1 OUTLIER -65.16 -43.49 66.25 Favored Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 115.095 -0.957 . . . . 1.1699999999999999 112.121 -174.208 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.532 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 73.2 Cg_exo -52.68 -22.46 17.34 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.448 2.099 . . . . 0.65000000000000002 114.197 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.6 m -72.65 -47.04 50.77 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 121.231 0.539 . . . . 0.45000000000000001 110.231 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.521 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 8.5 m-85 -71.74 -22.5 61.61 Favored 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 108.529 -0.915 . . . . 0.69999999999999996 108.529 176.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.532 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 15.0 t70 -69.4 -41.29 76.63 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 114.788 -1.096 . . . . 0.72999999999999998 109.801 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -60.26 -53.8 53.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 115.987 -0.551 . . . . 1.8600000000000001 109.594 175.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.486 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 54.6 mt -54.47 -43.21 62.76 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.081 0 CA-C-N 115.851 -0.613 . . . . 0.32000000000000001 109.979 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.476 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 73.4 t80 -55.15 -55.05 35.53 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.482 -0.781 . . . . 0.39000000000000001 111.55 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.614 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 38.4 m-85 -71.57 -21.18 61.91 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.217 0.451 . . . . 0.91000000000000003 112.217 -175.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 68.6 p -82.92 0.86 42.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 120.759 -0.376 . . . . 0.57999999999999996 111.046 177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 81.9 mt -104.67 6.38 34.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.239 -0.437 . . . . 1.1699999999999999 110.372 177.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.8 m 66.34 86.84 0.13 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 115.308 -0.86 . . . . 1.1399999999999999 111.569 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -83.28 117.81 2.52 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 123.11 2.54 . . . . 1.1000000000000001 112.192 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 53.5 t -90.15 118.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 1.6599999999999999 109.586 177.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 63.19 23.23 13.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.808 -0.633 . . . . 1.98 110.711 -178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 87.87 12.55 66.09 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.872 -0.68 . . . . 0.82999999999999996 113.05 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.652 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 11.4 ttmt -138.43 142.92 39.5 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.798 -0.445 . . . . 0.96999999999999997 109.798 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.611 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 49.8 pt -100.32 153.11 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.157 0.503 . . . . 0.37 111.097 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.643 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 15.5 p -88.74 160.89 17.09 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.48 -0.782 . . . . 1.3100000000000001 110.938 -178.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 72' ' ' ALA . . . -64.24 -8.65 31.72 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 120.649 -0.786 . . . . 0.33000000000000002 113.172 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.12 -58.17 5.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.914 0.388 . . . . 0.27000000000000002 110.996 178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.611 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 1.0 OUTLIER -74.76 -31.27 61.73 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.376 -0.374 . . . . 1.79 110.587 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.2 -50.99 70.9 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.219 -0.446 . . . . 0.32000000000000001 110.112 176.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.9 ttmt -64.09 -33.07 74.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.197 -0.456 . . . . 1.3600000000000001 110.137 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -57.55 -45.11 85.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.229 -0.441 . . . . 2.48 110.168 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -61.7 -51.76 67.08 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 108.979 -0.749 . . . . 2.1600000000000001 108.979 176.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.705 ' HB3' HD22 ' A' ' 86' ' ' LEU . 77.8 mtp -60.48 -32.1 71.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.542 -0.754 . . . . 0.51000000000000001 112.335 -174.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.4 m -81.72 -20.46 10.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 O-C-N 121.927 -0.483 . . . . 1.3400000000000001 110.811 177.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -78.54 -23.66 46.06 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 110.135 -0.32 . . . . 2.2000000000000002 110.135 173.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.5 m -64.41 -23.4 67.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.9 -0.591 . . . . 0.91000000000000003 110.083 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt 67.95 33.41 4.66 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.447 -0.797 . . . . 2.3700000000000001 111.531 177.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' HD21 ' A' ' 86' ' ' LEU . 88.7 mt -96.76 158.56 33.35 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.021 -0.536 . . . . 1.3500000000000001 109.661 175.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.435 ' HG2' HG23 ' A' ' 85' ' ' VAL . 38.3 Cg_endo -68.52 146.83 69.2 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.358 2.039 . . . . 0.44 112.229 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -58.72 -29.46 66.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.933 -0.576 . . . . 1.9399999999999999 111.723 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.42 -52.93 63.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.137 0.494 . . . . 1.04 110.375 177.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 89' ' ' ILE . 75.6 t -68.04 -42.02 84.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.56 -0.745 . . . . 0.40999999999999998 110.169 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.705 HD22 ' HB3' ' A' ' 76' ' ' MET . 83.9 mt -58.46 -46.63 86.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.471 -0.332 . . . . 0.44 111.458 179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.461 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -63.32 -41.85 99.37 Favored Glycine 0 C--O 1.235 0.205 0 C-N-CA 120.827 -0.701 . . . . 0.23000000000000001 111.483 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.585 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 39.9 ttmt -56.64 -46.77 80.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.219 -0.491 . . . . 1.71 110.298 176.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.533 HG13 ' O ' ' A' ' 85' ' ' VAL . 77.0 mt -63.02 -40.81 90.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.81 -0.632 . . . . 0.40000000000000002 110.884 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.432 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 45.0 t-105 -61.85 -51.67 67.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.614 -0.266 . . . . 0.46000000000000002 110.512 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.05 -21.14 66.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.427 -0.351 . . . . 2.3999999999999999 111.799 -176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 77.7 mt -85.51 -54.02 4.82 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.947 0.403 . . . . 1.0800000000000001 111.135 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.15 -34.07 72.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.31 -0.859 . . . . 0.29999999999999999 111.711 -173.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.61 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.0 t0 -87.58 93.24 9.37 Favored 'General case' 0 CA--C 1.518 -0.284 0 CA-C-O 121.363 0.601 . . . . 0.45000000000000001 109.836 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.641 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 2.7 m -74.12 -29.94 26.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.165 -0.925 . . . . 1.28 111.843 -174.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.61 -25.39 59.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.034 -0.53 . . . . 1.1200000000000001 109.985 -178.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 37.4 mttt 60.15 32.15 20.81 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.892 -1.049 . . . . 1.6799999999999999 108.541 -171.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.534 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 20.4 p-10 -94.69 10.19 35.93 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 114.663 -1.153 . . . . 0.70999999999999996 110.983 -172.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.16 20.58 62.99 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 111.369 -0.693 . . . . 0.39000000000000001 111.369 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.652 ' HB3' ' HD3' ' A' ' 66' ' ' LYS . 14.9 mt -141.52 145.51 35.25 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 114.84 -0.68 . . . . 1.3700000000000001 110.028 -173.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 63.0 mt -115.56 118.18 32.41 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.866 0.365 . . . . 0.34000000000000002 111.103 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -70.14 174.42 5.5 Favored 'General case' 0 CA--C 1.514 -0.438 0 N-CA-C 108.41 -0.959 . . . . 1.3899999999999999 108.41 168.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 14.8 p-10 -63.35 -32.62 74.09 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.959 -0.386 . . . . 1.6899999999999999 109.959 178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -67.98 -50.72 54.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.838 -0.619 . . . . 2.29 110.432 176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -61.54 -44.15 97.57 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.884 -0.598 . . . . 0.39000000000000001 110.69 -178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -69.82 -25.09 63.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.81 -0.632 . . . . 0.28999999999999998 111.081 -177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -79.33 -39.77 31.93 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 108.599 -0.889 . . . . 0.34000000000000002 108.599 -177.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.1 -36.5 79.88 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 114.347 -1.297 . . . . 1.74 110.057 173.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -60.45 -55.46 33.26 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.27000000000000002 110.712 176.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -59.51 -30.71 68.77 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.349 -0.387 . . . . 0.69999999999999996 110.568 178.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.438 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 32.2 t60 -69.01 -39.17 79.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.26 -0.427 . . . . 0.75 110.552 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.667 ' O ' HG12 ' A' ' 115' ' ' VAL . 95.5 mt -71.66 -40.77 69.44 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 121.257 0.551 . . . . 0.27000000000000002 110.318 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.588 HD11 ' HG2' ' A' ' 76' ' ' MET . 84.2 mt -58.29 -51.27 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.642 -0.708 . . . . 0.46000000000000002 110.722 177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.81 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 12.0 ptmm? -75.67 -24.34 56.32 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.58 -0.448 . . . . 1.8100000000000001 111.121 -177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.667 HG12 ' O ' ' A' ' 112' ' ' LEU . 1.4 p -66.46 -34.28 69.04 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 120.024 -0.67 . . . . 0.91000000000000003 109.246 177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 121' ' ' GLU . 27.8 mmmt -66.94 -43.67 82.62 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.25 -0.432 . . . . 1.0600000000000001 110.001 170.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 54.4 tp -59.25 -38.73 80.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.701 -0.681 . . . . 1.5900000000000001 111.894 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.81 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 3.7 mm-40 -73.86 -7.15 51.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.695 -0.229 . . . . 2.0499999999999998 110.825 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.18 23.46 10.48 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.518 -0.849 . . . . 0.68000000000000005 113.123 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.509 ' HB2' HG22 ' A' ' 115' ' ' VAL . 90.9 m-70 -105.84 172.96 6.52 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.885 0.374 . . . . 1.1599999999999999 110.315 178.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 116' ' ' LYS . 7.4 tp10 -124.67 134.56 52.83 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.377 -0.601 . . . . 2.6899999999999999 109.377 175.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.19 140.77 28.85 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-O 120.915 0.388 . . . . 1.21 110.26 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.47 1.23 7.65 Favored 'Trans proline' 0 N--CA 1.473 0.277 0 C-N-CA 123.387 2.724 . . . . 1.28 113.652 -172.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 60.14 22.72 12.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.164 0.507 . . . . 1.0600000000000001 110.864 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -130.47 171.99 12.38 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 109.241 -0.651 . . . . 1.9299999999999999 109.241 179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.433 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 0.5 OUTLIER -125.61 89.07 53.18 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-O 120.834 0.349 . . . . 1.8500000000000001 110.603 178.519 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 126' ' ' LEU . 32.5 Cg_endo -66.34 155.96 67.44 Favored 'Trans proline' 0 CA--C 1.531 0.364 0 C-N-CA 122.952 2.435 . . . . 0.90000000000000002 111.865 175.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 75.5 Cg_exo -50.3 -34.19 39.51 Favored 'Trans proline' 0 N--CA 1.474 0.352 0 C-N-CA 123.599 2.866 . . . . 1.02 114.298 -176.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 37.6 p-80 -88.32 14.4 9.59 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 120.612 -0.435 . . . . 1.1399999999999999 111.931 -176.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 51.3 mt -129.88 -32.25 1.88 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.423 -0.353 . . . . 1.3400000000000001 111.185 177.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.421 ' CA ' HD12 ' A' ' 126' ' ' LEU . 6.1 p -69.92 126.96 92.73 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 121.015 0.436 . . . . 1.5700000000000001 111.445 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.428 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 37.9 Cg_exo -61.75 155.23 55.4 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.449 2.766 . . . . 1.3500000000000001 112.733 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 22.5 Cg_exo -65.33 -7.03 14.63 Favored 'Trans proline' 0 C--N 1.349 0.561 0 C-N-CA 123.398 2.732 . . . . 2.0499999999999998 113.506 -176.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.9 p -86.63 1.56 51.43 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.501 -0.318 . . . . 2.6600000000000001 111.635 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.641 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 20.6 tptp -118.94 17.66 13.33 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.101 0.477 . . . . 3.1000000000000001 110.636 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 84.6 mtm180 -71.86 151.6 43.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 3.8599999999999999 111.024 -179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.479 ' HA ' ' NE ' ' A' ' 137' ' ' ARG . 4.6 mmp_? -98.42 136.6 38.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.261 -0.427 . . . . 5.0 110.326 177.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 24.1 p80 -132.46 143.34 49.72 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.464 -0.334 . . . . 6.6299999999999999 110.292 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 57.6 mm-40 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.737 -0.649 . . . . 6.6600000000000001 109.595 169.998 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 120.588 0.233 . . . . 10.529999999999999 110.619 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -85.26 137.82 32.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.344 -0.389 . . . . 8.2200000000000006 110.608 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . 0.413 ' CE2' ' HB2' ' B' ' 147' ' ' SER . 3.6 p90 -117.53 0.65 12.17 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.168 -0.469 . . . . 7.4299999999999997 110.727 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 63.41 23.43 13.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.456 -0.793 . . . . 5.9199999999999999 112.854 172.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . 0.472 ' HB3' ' HA ' ' B' ' 153' ' ' ALA . 69.5 m -81.33 82.87 7.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.332 0.587 . . . . 4.3399999999999999 110.266 176.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 8.6 m -123.87 1.77 8.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.158 -0.928 . . . . 2.1200000000000001 109.0 176.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 5.1 p-10 -92.67 156.46 41.02 Favored Pre-proline 0 N--CA 1.452 -0.333 0 CA-C-N 114.683 -1.144 . . . . 1.25 110.872 -177.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 14.9 Cg_exo -70.86 -2.18 10.56 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.219 2.613 . . . . 0.48999999999999999 113.48 -177.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.461 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 40.1 m-85 -102.54 -23.31 13.9 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 122.244 -0.285 . . . . 0.56000000000000005 111.376 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.2 t -151.93 116.22 5.01 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.458 0.647 . . . . 1.8899999999999999 111.155 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' B' ' 147' ' ' SER . . . -141.61 113.22 7.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.917 -0.583 . . . . 3.1099999999999999 110.779 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.776 -0.631 . . . . 6.9900000000000002 109.676 177.407 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.61 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.747 0 N-CA-C 112.016 -0.434 . . . . 10.470000000000001 112.016 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -78.72 121.82 5.22 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 C-N-CA 122.635 2.223 . . . . 10.449999999999999 112.109 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.56 -66.72 0.62 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.84 -0.618 . . . . 9.0899999999999999 110.471 -179.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -174.77 88.91 0.08 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.605 -0.807 . . . . 6.2400000000000002 112.053 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 32.2 t -154.96 151.97 29.13 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.173 -0.676 . . . . 5.9800000000000004 109.173 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -78.08 120.63 23.17 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.947 0.403 . . . . 3.9199999999999999 110.421 176.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.02 109.38 19.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.798 -0.637 . . . . 4.9400000000000004 109.799 176.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 t -77.07 138.93 19.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.249 -0.887 . . . . 1.99 110.672 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -66.03 128.82 37.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.79 -0.641 . . . . 2.3999999999999999 109.938 176.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 14.6 t90 -71.57 113.64 8.83 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.967 -0.561 . . . . 0.95999999999999996 110.031 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 46.8 t -53.44 -42.54 49.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.752 -0.658 . . . . 1.3300000000000001 111.826 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 18.7 t -83.02 -5.82 9.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.072 -0.513 . . . . 0.53000000000000003 111.042 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.37 -15.85 75.2 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.248 -1.141 . . . . 0.78000000000000003 110.248 173.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -80.28 -29.86 38.3 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.735 -0.733 . . . . 3.2200000000000002 111.226 -177.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 22.3 p-10 -124.39 34.64 4.98 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.617 0.723 . . . . 2.3900000000000001 109.824 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 22.1 ttpp -79.11 -43.98 1.72 Allowed Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 114.79 -1.095 . . . . 1.1699999999999999 112.031 177.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 12.4 Cg_exo -39.15 -40.72 1.8 Allowed 'Trans proline' 0 C--N 1.364 1.384 0 C-N-CA 123.43 2.753 . . . . 0.65000000000000002 115.015 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.402 ' O ' HG13 ' A' ' 56' ' ' ILE . 67.4 m -69.47 -43.96 72.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.995 0.426 . . . . 0.45000000000000001 110.515 -178.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -71.24 -22.16 62.02 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.224 -0.658 . . . . 0.69999999999999996 109.224 178.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.93 -41.2 71.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.872 . . . . 0.72999999999999998 109.595 179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -62.71 -45.32 93.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.692 -0.686 . . . . 1.8600000000000001 109.713 174.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 63.9 mt -58.7 -43.52 87.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.016 0.436 . . . . 0.32000000000000001 110.454 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -54.38 -38.46 66.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.533 -0.758 . . . . 0.39000000000000001 111.011 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.567 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 49.1 m-85 -98.83 7.84 45.62 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 113.004 0.742 . . . . 0.91000000000000003 113.004 -177.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.424 ' OG1' ' HA ' ' A' ' 56' ' ' ILE . 2.6 p -109.9 -3.02 16.85 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 120.791 -0.364 . . . . 0.57999999999999996 110.935 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 3.8 pp -118.13 18.56 13.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.398 -0.365 . . . . 1.1699999999999999 111.343 -179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.1 m 74.85 90.82 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.323 0 CA-C-N 115.051 -0.977 . . . . 1.1399999999999999 111.939 176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.766 ' HA ' HG22 ' A' ' 67' ' ' ILE . 97.0 Cg_endo -92.95 125.39 0.62 Allowed 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.947 2.431 . . . . 1.1000000000000001 111.976 174.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 9.2 t -89.21 113.0 25.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.691 -0.485 . . . . 1.6599999999999999 109.691 -179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.0 p30 48.48 26.95 1.28 Allowed 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.072 0.949 . . . . 1.98 113.029 -179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.74 11.34 58.05 Favored Glycine 0 CA--C 1.521 0.407 0 C-N-CA 120.916 -0.659 . . . . 0.82999999999999996 113.345 176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.629 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 8.6 ttmm -140.46 126.56 19.68 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.927 -0.768 . . . . 0.96999999999999997 108.927 175.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.766 HG22 ' HA ' ' A' ' 62' ' ' PRO . 36.7 pt -95.97 141.49 15.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 C-N-CA 120.128 -0.629 . . . . 0.37 111.141 -177.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.77 ' HA ' HD23 ' A' ' 100' ' ' LEU . 3.6 t -79.88 158.54 26.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.711 -0.677 . . . . 1.3100000000000001 110.75 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -53.84 -23.14 21.27 Favored Glycine 0 C--O 1.226 -0.358 0 CA-C-N 115.496 -0.775 . . . . 0.33000000000000002 113.414 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.19 -55.93 27.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.902 0.382 . . . . 0.27000000000000002 111.113 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.522 ' HA ' ' HE3' ' A' ' 74' ' ' LYS . 42.2 m-80 -78.25 -28.91 47.86 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.365 -0.379 . . . . 1.79 110.634 -176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.649 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.85 -52.88 61.42 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.915 -0.584 . . . . 0.32000000000000001 110.09 175.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.616 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 86.1 tttt -61.69 -35.43 77.98 Favored 'General case' 0 C--O 1.224 -0.265 0 CA-C-N 116.559 -0.291 . . . . 1.3600000000000001 110.432 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.522 ' HE3' ' HA ' ' A' ' 71' ' ' ASN . 26.2 ttpp -54.39 -46.16 73.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.228 0.537 . . . . 2.48 110.457 175.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -67.6 -41.44 84.04 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.402 0.62 . . . . 2.1600000000000001 110.234 177.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.785 ' HB3' HD22 ' A' ' 86' ' ' LEU . 72.8 mtp -67.66 -28.41 67.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.897 -0.592 . . . . 0.51000000000000001 112.012 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.0 m -83.51 -16.17 11.21 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 O-C-N 121.857 -0.527 . . . . 1.3400000000000001 110.638 176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 99.0 mttt -75.59 -22.47 56.9 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.254 0.549 . . . . 2.2000000000000002 109.626 168.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.9 m -73.78 -11.99 60.56 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.691 -0.686 . . . . 0.91000000000000003 111.331 178.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt 63.92 37.14 9.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 116.153 -0.476 . . . . 2.3700000000000001 111.697 177.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HB2' HD21 ' A' ' 86' ' ' LEU . 84.1 mt -106.16 153.15 40.48 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.846 -0.342 . . . . 1.3500000000000001 110.696 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.461 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 43.7 Cg_endo -67.8 152.65 77.23 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 123.164 2.576 . . . . 0.44 112.604 178.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -57.35 -34.63 69.0 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.863 -0.608 . . . . 1.9399999999999999 111.942 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 42.7 m -58.05 -54.13 50.45 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.14 0.495 . . . . 1.04 111.365 178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.459 HG23 ' HG2' ' A' ' 82' ' ' PRO . 60.6 t -67.11 -38.95 82.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.944 -0.571 . . . . 0.40999999999999998 110.402 -178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.785 HD22 ' HB3' ' A' ' 76' ' ' MET . 88.9 mt -59.59 -46.61 88.43 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.076 -0.511 . . . . 0.44 110.795 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.17 -42.6 97.24 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 121.263 -0.494 . . . . 0.23000000000000001 112.079 177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 66.5 mttm -55.6 -53.6 54.45 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.843 0.354 . . . . 1.71 110.279 175.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 83.3 mt -62.49 -36.71 76.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.847 -0.615 . . . . 0.40000000000000002 110.364 -174.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.468 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 74.4 t-105 -61.11 -56.45 20.76 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.032 -0.531 . . . . 0.46000000000000002 111.182 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -77.71 -0.88 28.53 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.057 0.392 . . . . 2.3999999999999999 112.057 -174.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 74.9 mt -94.37 -46.95 6.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.031 0.443 . . . . 1.0800000000000001 110.523 169.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.57 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -72.05 -36.21 69.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.531 -0.758 . . . . 0.29999999999999999 111.175 -176.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.626 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.4 t0 -86.71 70.42 10.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.896 0.855 . . . . 0.45000000000000001 109.947 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.675 ' HB ' ' HG2' ' A' ' 135' ' ' LYS . 15.8 m -68.7 -15.63 19.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 114.542 -1.208 . . . . 1.28 110.826 178.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -82.84 -18.27 40.99 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.724 -1.126 . . . . 1.1200000000000001 110.171 -178.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.2 mttt 61.58 35.66 17.19 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.089 -0.96 . . . . 1.6799999999999999 111.144 170.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.693 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.3 p-10 -116.64 7.99 13.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.916 -0.584 . . . . 0.70999999999999996 111.64 -172.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.16 10.53 59.62 Favored Glycine 0 C--N 1.335 0.483 0 N-CA-C 111.326 -0.71 . . . . 0.39000000000000001 111.326 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.77 HD23 ' HA ' ' A' ' 68' ' ' THR . 87.1 mt -133.68 141.19 47.48 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 114.726 -0.737 . . . . 1.3700000000000001 109.182 -175.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 64.1 mt -109.99 113.13 25.59 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-O 120.984 0.421 . . . . 0.34000000000000002 111.022 -178.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -69.58 172.26 7.65 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.963 -0.754 . . . . 1.3899999999999999 108.963 166.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -61.2 -32.27 72.03 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 120.825 -0.35 . . . . 1.6899999999999999 110.701 -177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -66.35 -51.52 56.35 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.884 0.374 . . . . 2.29 110.497 177.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -62.39 -41.5 98.69 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.925 -0.58 . . . . 0.39000000000000001 110.645 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CZ ' HD21 ' A' ' 60' ' ' LEU . 66.3 t80 -70.53 -23.82 62.7 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.749 -0.659 . . . . 0.28999999999999998 110.96 -179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -77.1 -43.79 32.89 Favored 'General case' 0 CA--C 1.51 -0.584 0 N-CA-C 108.579 -0.897 . . . . 0.34000000000000002 108.579 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.57 HD23 ' HA ' ' A' ' 93' ' ' ALA . 29.6 tp -59.41 -39.79 84.58 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 114.627 -1.17 . . . . 1.74 109.772 173.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -59.07 -55.44 35.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.011 -0.54 . . . . 0.27000000000000002 111.189 176.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.86 -33.63 75.67 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.287 -0.415 . . . . 0.69999999999999996 111.426 -177.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.7 t60 -63.5 -44.04 95.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.098 -0.501 . . . . 0.75 109.932 177.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.71 -39.2 90.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.781 0.324 . . . . 0.27000000000000002 110.655 176.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.2 mt -60.14 -53.51 47.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.815 -0.63 . . . . 0.46000000000000002 111.385 179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 16.0 pttp -70.9 -26.84 63.4 Favored 'General case' 0 C--O 1.223 -0.308 0 C-N-CA 120.584 -0.446 . . . . 1.8100000000000001 110.209 -177.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.707 HG13 ' HB2' ' A' ' 120' ' ' HIS . 2.6 t -56.6 -48.76 80.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 109.665 -0.495 . . . . 0.91000000000000003 109.665 172.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 28.7 mmmt -62.29 -46.15 90.05 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.223 -0.444 . . . . 1.0600000000000001 111.051 176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.441 ' HB2' ' HA ' ' A' ' 114' ' ' LYS . 8.9 mp -59.36 -38.22 79.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.122 -0.49 . . . . 1.5900000000000001 111.822 -178.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 12.2 mm-40 -81.92 6.63 15.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.529 -0.305 . . . . 2.0499999999999998 111.799 -177.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 86.84 27.84 27.9 Favored Glycine 0 N--CA 1.453 -0.182 0 C-N-CA 120.915 -0.66 . . . . 0.68000000000000005 112.913 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.707 ' HB2' HG13 ' A' ' 115' ' ' VAL . 90.6 m-70 -109.69 119.59 39.87 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.776 -0.453 . . . . 1.1599999999999999 109.776 177.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -83.25 106.37 14.97 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.995 0.426 . . . . 2.6899999999999999 110.845 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.49 ' O ' HD12 ' A' ' 122' ' ' LEU . 3.1 pp -68.66 146.98 97.95 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 115.923 -0.581 . . . . 1.21 110.34 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.5 Cg_endo -83.21 -1.86 10.47 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 122.911 2.408 . . . . 1.28 112.671 -173.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.83 19.24 11.3 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.774 -0.648 . . . . 1.0600000000000001 111.322 -177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -115.63 165.99 12.42 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.142 -1.058 . . . . 1.9299999999999999 108.142 171.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 127' ' ' PRO . 29.0 tp -118.34 95.35 48.48 Favored Pre-proline 0 C--N 1.321 -0.632 0 C-N-CA 120.481 -0.487 . . . . 1.8500000000000001 110.628 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 18.1 Cg_endo -61.66 150.37 85.89 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.767 2.312 . . . . 0.90000000000000002 112.255 178.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 52.0 Cg_exo -55.74 -25.44 51.37 Favored 'Trans proline' 0 N--CA 1.476 0.452 0 C-N-CA 123.713 2.942 . . . . 1.02 113.578 -175.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -86.27 3.92 41.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.68 0.252 . . . . 1.1399999999999999 111.68 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 36.7 mt -116.55 -30.67 5.78 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.352 -0.217 . . . . 1.3400000000000001 111.486 177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.8 p -76.39 127.4 84.76 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.762 0.315 . . . . 1.5700000000000001 110.768 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.26 136.59 5.54 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.425 2.75 . . . . 1.3500000000000001 112.944 177.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -63.31 -16.15 52.72 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.757 2.305 . . . . 2.0499999999999998 112.346 -176.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 9.9 m -84.3 -8.73 58.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.654 . . . . 2.6600000000000001 111.203 -178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.675 ' HG2' ' HB ' ' A' ' 95' ' ' VAL . 7.3 tppt? -118.08 10.31 12.96 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.051 0.453 . . . . 3.1000000000000001 111.066 -176.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.36 144.85 38.5 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.987 -0.551 . . . . 3.8599999999999999 110.221 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -128.22 132.23 48.81 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.217 0.532 . . . . 5.0 111.671 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.0 t-80 -132.26 121.3 23.38 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.774 -0.824 . . . . 6.6299999999999999 108.774 172.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 . . . . . 0 C--O 1.245 0.82 0 N-CA-C 108.448 -0.945 . . . . 6.6600000000000001 108.448 -178.164 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.479 1.025 0 CA-C-O 120.72 0.295 . . . . 10.529999999999999 110.305 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -161.09 -172.9 3.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.213 -0.449 . . . . 8.2200000000000006 110.111 178.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -130.65 151.48 51.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.214 -0.448 . . . . 7.4299999999999997 110.09 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -73.03 127.43 32.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.156 0.503 . . . . 5.9199999999999999 110.903 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 35.1 t -138.92 7.39 2.47 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.416 -0.811 . . . . 4.3399999999999999 109.497 176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 3.3 m -87.79 -36.84 17.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.75 -0.659 . . . . 2.1200000000000001 110.155 -178.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -106.7 112.39 63.56 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.423 -0.808 . . . . 1.25 110.121 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.616 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.8 Cg_exo -76.51 -2.35 12.55 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.566 2.844 . . . . 0.48999999999999999 113.488 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.468 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 15.4 m-85 -98.18 -9.68 25.32 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.188 0.518 . . . . 0.56000000000000005 110.077 -176.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 66.2 p -68.59 -7.17 30.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.68 -0.691 . . . . 1.8899999999999999 111.138 175.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -84.4 4.03 33.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.881 -0.599 . . . . 3.1099999999999999 111.571 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' B' ' 154' ' ' LYS . 10.8 mptt . . . . . 0 C--O 1.247 0.961 0 O-C-N 123.732 0.645 . . . . 6.9900000000000002 111.138 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.629 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.855 0 N-CA-C 112.111 -0.396 . . . . 10.470000000000001 112.111 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.57 -19.85 41.79 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.971 2.447 . . . . 10.449999999999999 112.232 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 54.0 tp 72.19 119.83 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.299 0 O-C-N 123.956 0.785 . . . . 9.0899999999999999 111.043 -178.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.99 -174.73 13.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.676 -0.773 . . . . 6.2400000000000002 112.169 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 29.5 t 63.34 42.54 6.79 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-O 121.061 0.458 . . . . 5.9800000000000004 110.798 178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -113.08 112.18 23.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.251 -0.431 . . . . 3.9199999999999999 110.025 177.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -69.78 116.99 10.81 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 4.9400000000000004 111.532 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 11.7 p -88.64 129.81 39.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.808 -0.633 . . . . 1.99 109.588 173.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -105.35 108.1 19.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.254 0.549 . . . . 2.3999999999999999 110.692 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.5 t90 -81.38 102.55 10.55 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.937 -0.574 . . . . 0.95999999999999996 109.553 178.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.9 m -59.76 -23.09 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 115.427 -0.806 . . . . 1.3300000000000001 112.625 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG21 HD23 ' A' ' 108' ' ' LEU . 21.2 t -82.27 -10.72 12.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 121.07 0.462 . . . . 0.53000000000000003 110.708 -176.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.09 -23.83 69.92 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.118 -0.563 . . . . 0.78000000000000003 113.176 -177.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -73.89 -23.38 59.57 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.913 0.387 . . . . 3.2200000000000002 111.549 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -134.13 32.95 3.4 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.965 0.888 . . . . 2.3900000000000001 109.648 -175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.412 ' N ' ' CD ' ' A' ' 51' ' ' PRO . 11.3 ttpp -82.99 -44.86 0.87 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.232 -0.895 . . . . 1.1699999999999999 110.841 177.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.478 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 84.6 Cg_exo -49.37 -28.0 14.67 Favored 'Trans proline' 0 C--N 1.365 1.408 0 C-N-CA 122.533 2.155 . . . . 0.65000000000000002 113.574 177.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.9 m -69.28 -47.08 65.62 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.349 0.595 . . . . 0.45000000000000001 109.987 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -75.85 -20.63 57.96 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.723 -0.843 . . . . 0.69999999999999996 108.723 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 14.7 t70 -70.03 -42.04 73.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.885 -1.052 . . . . 0.72999999999999998 109.431 178.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -64.31 -41.01 97.05 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.837 -0.62 . . . . 1.8600000000000001 109.808 174.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.0 mt -64.3 -34.78 71.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 121.395 0.616 . . . . 0.32000000000000001 110.283 175.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.94 -48.13 83.24 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.228 -0.896 . . . . 0.39000000000000001 111.021 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.477 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 64.9 m-85 -73.81 -22.49 59.78 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.039 0.385 . . . . 0.91000000000000003 112.039 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.6 p -85.24 1.73 46.95 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.508 -0.477 . . . . 0.57999999999999996 111.16 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 83.9 mt -106.42 3.29 27.18 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.716 0.293 . . . . 1.1699999999999999 110.473 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 55.3 m 67.08 80.98 0.21 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.47 -0.786 . . . . 1.1399999999999999 111.068 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 83.3 Cg_endo -88.63 111.23 0.61 Allowed 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 122.804 2.336 . . . . 1.1000000000000001 112.567 -178.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 49.6 t -88.07 121.9 39.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.139 -0.482 . . . . 1.6599999999999999 109.971 -177.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 65.29 23.59 12.14 Favored 'General case' 0 N--CA 1.468 0.438 0 O-C-N 123.48 0.488 . . . . 1.98 110.846 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.58 22.79 59.49 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.789 -0.72 . . . . 0.82999999999999996 112.528 179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -137.71 142.14 41.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.625 0.25 . . . . 0.96999999999999997 110.487 178.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.656 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 42.9 pt -104.78 132.83 50.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 109.215 -0.661 . . . . 0.37 109.215 170.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.7 t -73.39 162.42 29.34 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.119 -0.491 . . . . 1.3100000000000001 109.841 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.485 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -63.08 -11.54 39.11 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.967 -0.635 . . . . 0.33000000000000002 114.08 -175.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.73 -63.25 1.11 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.489 0.644 . . . . 0.27000000000000002 111.006 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.656 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 2.7 p30 -71.73 -29.42 64.51 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.43 -0.35 . . . . 1.79 110.9 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.14 -51.05 70.69 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.337 -0.392 . . . . 0.32000000000000001 110.502 175.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.6 tttt -61.78 -34.74 76.43 Favored 'General case' 0 CA--C 1.519 -0.213 0 N-CA-C 109.938 -0.393 . . . . 1.3600000000000001 109.938 177.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.551 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 36.1 ttmt -57.87 -45.8 85.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.143 -0.48 . . . . 2.48 110.994 178.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.862 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -65.87 -36.37 83.24 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.286 0.565 . . . . 2.1600000000000001 110.007 177.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.529 ' HB3' HD22 ' A' ' 86' ' ' LEU . 90.7 mtp -67.75 -34.29 76.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.821 -0.627 . . . . 0.51000000000000001 111.36 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.2 m -81.49 -15.38 12.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 C-N-CA 120.872 -0.331 . . . . 1.3400000000000001 110.822 177.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.862 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 50.2 mtpt -72.79 -28.95 62.9 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 108.922 -0.769 . . . . 2.2000000000000002 108.922 170.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 26.0 m -68.51 -29.73 68.39 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.963 -1.017 . . . . 0.91000000000000003 110.306 175.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.9 mttt 70.6 26.3 4.01 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.372 -0.831 . . . . 2.3700000000000001 112.48 173.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -81.07 159.87 67.19 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 109.269 -0.641 . . . . 1.3500000000000001 109.269 172.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -61.86 142.22 92.64 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.659 2.24 . . . . 0.44 112.32 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -54.76 -31.05 58.08 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.859 -0.61 . . . . 1.9399999999999999 111.763 -179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.8 p -63.54 -51.33 65.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.947 0.403 . . . . 1.04 111.139 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.536 HG11 ' HG2' ' A' ' 116' ' ' LYS . 98.2 t -66.83 -41.5 87.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.067 -0.515 . . . . 0.40999999999999998 110.317 177.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.531 ' HB3' ' CE1' ' B' ' 151' ' ' PHE . 75.2 mt -58.09 -43.07 86.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.367 -0.379 . . . . 0.44 110.797 177.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.453 ' O ' ' HG2' ' A' ' 91' ' ' LYS . . . -61.03 -43.84 98.93 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.042 -0.599 . . . . 0.23000000000000001 111.939 177.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.542 ' HE3' HD11 ' A' ' 122' ' ' LEU . 53.5 mtmt -57.21 -42.63 81.7 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.92 0.39 . . . . 1.71 110.437 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.534 HG13 ' O ' ' A' ' 85' ' ' VAL . 87.0 mt -64.76 -42.21 94.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.615 . . . . 0.40000000000000002 109.972 -176.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.596 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 75.2 t-105 -62.09 -51.78 66.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.28 -0.873 . . . . 0.46000000000000002 111.185 -179.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 87' ' ' GLY . 31.0 mmmt -70.14 -18.15 63.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.15 -0.477 . . . . 2.3999999999999999 111.907 -174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.863 HD11 ' HA ' ' A' ' 124' ' ' ALA . 92.7 mt -90.71 -45.58 8.77 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 1.0800000000000001 111.501 177.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.91 63.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 0.29999999999999999 111.301 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.654 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.9 t70 -95.55 95.24 8.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.496 0.665 . . . . 0.45000000000000001 110.77 179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.494 HG11 ' HD2' ' A' ' 132' ' ' PRO . 3.7 m -74.93 -16.36 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.095 -0.957 . . . . 1.28 111.806 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.652 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 23.5 m-20 -76.36 -25.28 54.47 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.121 -0.49 . . . . 1.1200000000000001 110.837 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 51.5 mttt 62.16 34.29 16.33 Favored 'General case' 0 C--O 1.234 0.268 0 O-C-N 124.124 0.89 . . . . 1.6799999999999999 109.434 -176.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 13.7 p-10 -129.64 8.19 5.34 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 116.349 -0.387 . . . . 0.70999999999999996 111.949 -173.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 72.41 12.47 76.94 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.686 -0.768 . . . . 0.39000000000000001 113.247 176.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.9 mt -112.47 126.98 55.9 Favored 'General case' 0 CA--C 1.512 -0.501 0 O-C-N 122.586 -0.361 . . . . 1.3700000000000001 110.138 176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.435 HD22 ' HB3' ' A' ' 105' ' ' GLU . 36.2 mt -102.93 112.86 25.88 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.1 0.476 . . . . 0.34000000000000002 111.323 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.78 170.12 11.64 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.495 -0.928 . . . . 1.3899999999999999 108.495 167.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -62.73 -30.6 71.55 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.926 0.393 . . . . 1.6899999999999999 110.67 -176.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.437 ' OE1' ' HD2' ' A' ' 133' ' ' PRO . 16.8 mt-10 -67.26 -46.92 72.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.008 -0.542 . . . . 2.29 110.061 177.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.435 ' HB3' HD22 ' A' ' 101' ' ' LEU . 47.9 mt-10 -65.19 -41.47 94.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.274 -0.875 . . . . 0.39000000000000001 110.952 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.528 ' CD1' HD11 ' A' ' 67' ' ' ILE . 47.3 t80 -65.84 -33.23 75.37 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.017 -0.538 . . . . 0.28999999999999998 110.094 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.51 -44.17 95.07 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.131 -0.486 . . . . 0.34000000000000002 110.192 175.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD23 HG21 ' A' ' 46' ' ' VAL . 92.0 mt -62.53 -41.68 99.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.154 -0.475 . . . . 1.74 110.633 176.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.461 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.13 -55.46 34.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.904 -0.589 . . . . 0.27000000000000002 111.089 178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.37 -37.19 84.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.319 -0.4 . . . . 0.69999999999999996 110.913 -178.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.51 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.7 t60 -58.29 -50.06 74.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.286 -0.416 . . . . 0.75 110.832 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 97.5 mt -63.99 -29.57 70.72 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.883 0.373 . . . . 0.27000000000000002 111.265 -179.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 109' ' ' ALA . 85.0 mt -75.18 -42.51 44.52 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.531 0 CA-C-O 121.537 0.684 . . . . 0.46000000000000002 109.468 -176.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 14.2 ttpt -65.24 -36.12 83.15 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 114.821 -1.081 . . . . 1.8100000000000001 110.79 176.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 111' ' ' HIS . 68.6 t -60.87 -54.2 38.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 120.748 0.309 . . . . 0.91000000000000003 110.455 175.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.536 ' HG2' HG11 ' A' ' 85' ' ' VAL . 40.7 tptt -55.35 -48.25 74.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 116.403 -0.362 . . . . 1.0600000000000001 111.619 175.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 53.2 tp -58.48 -40.05 81.67 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.159 -0.473 . . . . 1.5900000000000001 112.03 -175.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -73.97 7.78 2.42 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.037 0.384 . . . . 2.0499999999999998 112.037 -177.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 91.47 35.54 6.91 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.552 -0.832 . . . . 0.68000000000000005 112.966 176.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -121.83 -168.99 1.79 Allowed 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.449 -0.442 . . . . 1.1599999999999999 110.066 177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -139.55 150.44 45.08 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.213 -0.662 . . . . 2.6899999999999999 109.213 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.542 HD11 ' HE3' ' A' ' 88' ' ' LYS . 0.9 OUTLIER -104.01 129.39 25.3 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.667 -0.494 . . . . 1.21 109.667 178.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -72.43 6.64 2.19 Favored 'Trans proline' 0 N--CA 1.473 0.283 0 C-N-CA 123.271 2.647 . . . . 1.28 113.832 -169.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.863 ' HA ' HD11 ' A' ' 92' ' ' LEU . . . 58.77 28.67 17.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.389 -0.369 . . . . 1.0600000000000001 111.416 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -112.34 171.25 7.63 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-O 121.043 0.449 . . . . 1.9299999999999999 110.084 178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.582 HD22 HG22 ' A' ' 131' ' ' VAL . 0.5 OUTLIER -124.66 86.67 55.47 Favored Pre-proline 0 C--N 1.311 -1.106 0 N-CA-C 108.38 -0.97 . . . . 1.8500000000000001 108.38 168.545 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.441 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 80.7 Cg_exo -48.68 141.08 21.32 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.999 2.466 . . . . 0.90000000000000002 112.126 173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 52.1 Cg_exo -55.24 -31.27 75.61 Favored 'Trans proline' 0 N--CA 1.465 -0.167 0 C-N-CA 122.94 2.427 . . . . 1.02 112.664 -177.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 37.9 p-80 -91.51 12.94 19.16 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.755 -0.378 . . . . 1.1399999999999999 111.43 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 58.3 mt -116.49 5.45 13.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 1.3400000000000001 110.847 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.582 HG22 HD22 ' A' ' 126' ' ' LEU . 56.0 t -85.15 119.59 72.6 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 1.5700000000000001 111.025 -177.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.494 ' HD2' HG11 ' A' ' 95' ' ' VAL . 32.7 Cg_exo -62.41 142.37 90.47 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.101 2.534 . . . . 1.3500000000000001 112.244 177.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.437 ' HD2' ' OE1' ' A' ' 104' ' ' GLU . 41.6 Cg_endo -67.45 -9.56 25.73 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.286 2.657 . . . . 2.0499999999999998 113.103 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.1 m -76.97 -1.7 30.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.462 -0.336 . . . . 2.6600000000000001 111.807 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.8 tptt -114.39 13.41 17.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 3.1000000000000001 110.292 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -71.52 134.2 46.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.101 0.476 . . . . 3.8599999999999999 112.261 -177.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 8.6 tpp180 -121.37 131.39 54.15 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.454 -0.943 . . . . 5.0 108.454 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -63.81 113.07 3.18 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.107 0.48 . . . . 6.6299999999999999 111.078 -178.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 C--O 1.249 1.035 0 CA-C-N 115.072 -0.967 . . . . 6.6600000000000001 109.806 -177.909 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 60.2 t80 . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 109.665 -0.495 . . . . 10.529999999999999 109.665 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -128.63 161.26 30.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.206 -0.452 . . . . 8.2200000000000006 110.408 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 46.4 p90 46.16 -169.07 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 124.621 1.201 . . . . 7.4299999999999997 112.522 -173.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -141.61 139.03 33.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.091 -0.504 . . . . 5.9199999999999999 110.239 -174.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 63.5 p -131.1 77.73 1.8 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.03 0.443 . . . . 4.3399999999999999 111.207 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 69.1 p -117.42 9.05 13.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.647 0.737 . . . . 2.1200000000000001 109.051 170.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.482 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 9.5 t70 -111.8 116.6 49.74 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 114.814 -1.084 . . . . 1.25 110.075 -174.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.9 Cg_exo -74.85 -2.01 11.93 Favored 'Trans proline' 0 CA--C 1.535 0.547 0 C-N-CA 123.471 2.781 . . . . 0.48999999999999999 113.627 -176.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.596 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 20.0 m-85 -99.17 -12.86 20.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.025 0.441 . . . . 0.56000000000000005 110.359 -176.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 77.5 p -86.41 -169.17 2.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.847 -0.615 . . . . 1.8899999999999999 110.584 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -129.24 134.84 48.16 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 110.416 -0.216 . . . . 3.1099999999999999 110.416 179.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 22.9 tptm . . . . . 0 C--O 1.245 0.83 0 CA-C-O 118.515 -0.755 . . . . 6.9900000000000002 110.556 -174.484 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.654 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.666 0 N-CA-C 111.674 -0.57 . . . . 10.470000000000001 111.674 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.87 -0.75 9.77 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.694 2.262 . . . . 10.449999999999999 113.108 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.7 mt -116.55 113.97 23.5 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.513 0.197 . . . . 9.0899999999999999 110.589 -178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.96 106.22 2.75 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.642 -0.789 . . . . 6.2400000000000002 111.958 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 9.4 t -133.41 119.53 19.76 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.903 -0.406 . . . . 5.9800000000000004 109.903 -179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -77.02 93.88 3.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.84 0.353 . . . . 3.9199999999999999 111.013 -179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -87.92 96.02 10.33 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.706 0.765 . . . . 4.9400000000000004 109.24 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 129' ' ' HIS . 31.6 m -76.76 123.25 32.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.433 -0.803 . . . . 1.99 111.484 -175.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -91.34 121.67 33.28 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.31 -0.859 . . . . 2.3999999999999999 109.639 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.585 ' HZ3' ' HD3' ' A' ' 50' ' ' LYS . 0.1 OUTLIER -74.17 101.6 4.01 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.067 -0.716 . . . . 0.95999999999999996 109.067 178.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.672 HG22 HD21 ' A' ' 130' ' ' LEU . 21.2 m -62.71 -14.18 12.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.876 -0.602 . . . . 1.3300000000000001 112.398 -172.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.509 ' HB ' ' CZ3' ' A' ' 44' ' ' TRP . 15.7 t -90.75 -11.07 9.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.111 0.482 . . . . 0.53000000000000003 110.252 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.568 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -70.39 -10.42 66.3 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 121.171 -0.538 . . . . 0.78000000000000003 112.673 -178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -75.67 -27.75 58.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.045 0.45 . . . . 3.2200000000000002 110.435 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -128.8 34.0 4.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.961 0.886 . . . . 2.3900000000000001 109.332 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.585 ' HD3' ' HZ3' ' A' ' 44' ' ' TRP . 0.7 OUTLIER -70.17 -52.45 12.33 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 114.861 -1.063 . . . . 1.1699999999999999 111.825 -179.137 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.09 -24.48 58.43 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 122.041 1.827 . . . . 0.65000000000000002 113.667 -177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.2 m -69.07 -45.76 69.5 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.682 -0.69 . . . . 0.45000000000000001 109.895 178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.483 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 6.7 m-85 -74.18 -21.59 59.76 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.677 -0.692 . . . . 0.69999999999999996 109.385 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -68.89 -44.42 73.25 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.696 -0.684 . . . . 0.72999999999999998 110.208 175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -60.28 -44.19 95.56 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.871 -0.604 . . . . 1.8600000000000001 110.046 176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.479 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 61.0 mt -68.82 -36.79 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.32000000000000001 110.546 177.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.483 ' HB2' ' O ' ' A' ' 53' ' ' TYR . 51.8 t80 -59.31 -52.32 66.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.601 -0.727 . . . . 0.39000000000000001 110.931 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.683 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 33.5 m-85 -76.81 -11.4 59.82 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.57 0.582 . . . . 0.91000000000000003 112.57 -175.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 13.9 p -93.5 2.98 56.25 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.103 0.478 . . . . 0.57999999999999996 110.812 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 82.2 mt -101.11 1.32 39.17 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.005 -0.543 . . . . 1.1699999999999999 110.386 175.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m 69.45 85.07 0.13 Allowed Pre-proline 0 N--CA 1.467 0.416 0 CA-C-N 115.496 -0.775 . . . . 1.1399999999999999 111.103 -176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.683 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 4.8 Cg_endo -86.28 150.66 9.25 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.145 2.563 . . . . 1.1000000000000001 112.539 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.9 p -127.36 119.8 53.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 116.015 -0.539 . . . . 1.6599999999999999 110.532 178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 60.46 27.0 16.61 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.747 -0.66 . . . . 1.98 111.267 179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.28 4.9 83.34 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.734 -0.745 . . . . 0.82999999999999996 112.65 178.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.699 ' HB3' ' HB3' ' A' ' 100' ' ' LEU . 58.1 mttm -123.32 148.48 45.94 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.35 -0.241 . . . . 0.96999999999999997 110.35 179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.701 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 40.9 pt -112.45 128.52 69.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 109.723 -0.473 . . . . 0.37 109.723 170.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.521 ' HA ' ' HG ' ' A' ' 100' ' ' LEU . 8.2 t -70.97 161.74 30.59 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.029 -0.532 . . . . 1.3100000000000001 110.252 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -7.02 10.02 Favored Glycine 0 C--O 1.223 -0.534 0 CA-C-N 115.624 -0.716 . . . . 0.33000000000000002 113.992 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.13 -64.55 0.89 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.479 0.64 . . . . 0.27000000000000002 110.816 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.701 ' OD1' ' HB ' ' A' ' 67' ' ' ILE . 4.0 p30 -68.52 -34.06 75.21 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.848 0.356 . . . . 1.79 110.555 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.597 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -59.2 -52.6 64.98 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 116.012 -0.54 . . . . 0.32000000000000001 110.54 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.814 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.3 tttt -62.11 -35.51 78.92 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 116.535 -0.302 . . . . 1.3600000000000001 110.658 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -53.77 -49.97 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.962 0.41 . . . . 2.48 110.468 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -66.52 -38.28 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.003 0.43 . . . . 2.1600000000000001 110.54 178.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.824 ' HB3' HD22 ' A' ' 86' ' ' LEU . 93.0 mtp -64.99 -38.22 90.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.155 -0.475 . . . . 0.51000000000000001 111.356 -177.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -79.41 -16.53 13.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 1.3400000000000001 110.668 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -85.74 -12.53 50.86 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.072 0.463 . . . . 2.2000000000000002 110.327 172.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -77.54 -4.92 48.17 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.689 -0.687 . . . . 0.91000000000000003 110.135 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 85.4 mttt 67.97 22.02 8.7 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 115.597 -0.729 . . . . 2.3700000000000001 112.135 173.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' HD21 ' A' ' 86' ' ' LEU . 87.8 mt -93.84 153.92 40.93 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.825 0.345 . . . . 1.3500000000000001 110.36 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.508 ' HG2' HG23 ' A' ' 85' ' ' VAL . 57.0 Cg_endo -72.41 160.52 46.66 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.835 2.357 . . . . 0.44 112.526 178.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -55.45 -34.46 64.52 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.761 -0.654 . . . . 1.9399999999999999 111.092 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.0 m -57.39 -59.2 5.49 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.863 -0.608 . . . . 1.04 111.288 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.508 HG23 ' HG2' ' A' ' 82' ' ' PRO . 65.9 t -64.5 -45.15 96.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.572 -0.74 . . . . 0.40999999999999998 110.657 -177.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.824 HD22 ' HB3' ' A' ' 76' ' ' MET . 86.1 mt -60.65 -42.76 97.63 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.815 0.34 . . . . 0.44 110.864 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.495 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -61.37 -46.29 94.69 Favored Glycine 0 N--CA 1.447 -0.58 0 CA-C-N 116.002 -0.544 . . . . 0.23000000000000001 112.642 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.441 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 19.3 ptmt -72.17 -35.22 68.94 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 120.37 -0.532 . . . . 1.71 110.917 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.471 HG23 HD12 ' A' ' 112' ' ' LEU . 46.8 mt -60.65 -41.08 86.78 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 N-CA-C 109.996 -0.372 . . . . 0.40000000000000002 109.996 176.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.422 ' CD1' ' HB3' ' B' ' 149' ' ' ASP . 49.6 t-105 -64.25 -48.9 74.02 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.272 -0.422 . . . . 0.46000000000000002 110.541 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -58.5 -24.78 61.34 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.929 -0.578 . . . . 2.3999999999999999 111.878 -178.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 31.8 mt -92.41 -52.16 4.79 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.84 0.353 . . . . 1.0800000000000001 111.281 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.0 -32.03 73.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.539 -0.755 . . . . 0.29999999999999999 112.097 -172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.621 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 44.3 t0 -86.93 94.75 9.68 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.455 0.645 . . . . 0.45000000000000001 109.358 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.427 HG12 ' HE2' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -81.42 -26.91 10.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.323 -0.853 . . . . 1.28 111.381 -171.039 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.605 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 0.0 OUTLIER -80.3 -10.71 59.76 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.402 -0.592 . . . . 1.1200000000000001 109.402 174.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 45.92 46.42 12.27 Favored 'General case' 0 N--CA 1.467 0.388 0 O-C-N 124.081 0.863 . . . . 1.6799999999999999 109.873 -172.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -109.49 5.33 23.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.703 -0.68 . . . . 0.70999999999999996 111.676 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.491 ' C ' HD12 ' A' ' 100' ' ' LEU . . . 84.77 -4.88 84.03 Favored Glycine 0 N--CA 1.449 -0.486 0 N-CA-C 111.307 -0.717 . . . . 0.39000000000000001 111.307 174.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 66' ' ' LYS . 7.1 mp -122.41 142.89 50.05 Favored 'General case' 0 N--CA 1.437 -1.097 0 CA-C-N 115.151 -0.524 . . . . 1.3700000000000001 110.153 177.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 90.1 mt -99.53 115.22 28.85 Favored 'General case' 0 N--CA 1.436 -1.171 0 N-CA-C 108.89 -0.782 . . . . 0.34000000000000002 108.89 173.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 175.79 2.78 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.848 -0.797 . . . . 1.3899999999999999 108.848 167.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -56.67 -40.39 75.46 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.221 0.534 . . . . 1.6899999999999999 110.735 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -74.52 -33.18 62.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.166 -0.47 . . . . 2.29 110.631 -177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -71.34 -41.72 69.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.264 0.554 . . . . 0.39000000000000001 110.373 -178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -67.54 -32.27 72.94 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.807 -0.633 . . . . 0.28999999999999998 109.439 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.479 ' HA ' ' CD2' ' A' ' 53' ' ' TYR . . . -60.83 -46.75 89.34 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.485 -0.779 . . . . 0.34000000000000002 110.86 173.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.461 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 82.5 mt -61.84 -42.75 99.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.375 -0.375 . . . . 1.74 110.635 177.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.483 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.36 -57.17 13.8 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.147 -0.479 . . . . 0.27000000000000002 110.901 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.47 -34.22 75.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.115 -0.493 . . . . 0.69999999999999996 111.197 -178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.415 ' O ' HG23 ' A' ' 115' ' ' VAL . 59.3 t60 -65.41 -46.2 80.94 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.489 -0.323 . . . . 0.75 110.179 177.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.471 HD12 HG23 ' A' ' 89' ' ' ILE . 79.9 mt -60.43 -40.8 92.35 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.91 0.386 . . . . 0.27000000000000002 110.264 177.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 109' ' ' ALA . 83.8 mt -61.13 -54.38 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.38 -0.827 . . . . 0.46000000000000002 111.065 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.667 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 14.8 ptpt -67.37 -33.85 76.08 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.051 -0.659 . . . . 1.8100000000000001 111.23 -176.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 111' ' ' HIS . 39.9 t -58.92 -50.4 79.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 N-CA-C 110.127 -0.323 . . . . 0.91000000000000003 110.127 175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -53.96 -48.81 69.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.884 0.374 . . . . 1.0600000000000001 111.096 172.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -67.01 -20.16 65.82 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.389 0.515 . . . . 1.5900000000000001 112.389 -177.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.667 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 48.1 mt-10 -76.59 -6.22 51.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.83 0.348 . . . . 2.0499999999999998 110.626 176.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 92.75 27.51 14.27 Favored Glycine 0 N--CA 1.444 -0.771 0 N-CA-C 111.178 -0.769 . . . . 0.68000000000000005 111.178 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 42.1 m-70 -113.27 -176.98 3.02 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.865 -0.42 . . . . 1.1599999999999999 109.865 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -123.94 142.31 51.26 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.612 -0.885 . . . . 2.6899999999999999 108.612 172.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.453 ' HA ' ' HD3' ' A' ' 123' ' ' PRO . 0.9 OUTLIER -85.07 141.24 37.39 Favored Pre-proline 0 C--N 1.317 -0.805 0 CA-C-N 116.449 -0.341 . . . . 1.21 110.321 -179.092 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 39.3 Cg_exo -58.54 -16.44 29.84 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.438 2.759 . . . . 1.28 114.197 -170.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.34 18.03 8.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 123.701 0.626 . . . . 1.0600000000000001 110.992 -178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -135.58 173.63 11.5 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.717 -0.674 . . . . 1.9299999999999999 109.548 175.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -123.54 95.76 44.57 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.608 -0.516 . . . . 1.8500000000000001 109.608 174.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.448 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 51.2 Cg_exo -54.1 147.47 43.91 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.221 2.614 . . . . 0.90000000000000002 112.847 179.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 41.9 Cg_exo -58.42 -25.19 72.42 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 123.196 2.597 . . . . 1.02 112.763 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.424 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 7.4 p-80 -85.79 3.34 41.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.458 -0.337 . . . . 1.1399999999999999 111.03 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.672 HD21 HG22 ' A' ' 45' ' ' VAL . 31.2 mt -118.56 -28.76 5.6 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.344 -0.389 . . . . 1.3400000000000001 111.385 178.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 128' ' ' PRO . 32.0 m -66.51 132.56 94.23 Favored Pre-proline 0 N--CA 1.45 -0.434 0 C-N-CA 120.739 -0.384 . . . . 1.5700000000000001 110.549 178.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.87 160.06 35.07 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.321 2.681 . . . . 1.3500000000000001 112.589 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.6 -25.46 50.18 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.121 2.548 . . . . 2.0499999999999998 112.777 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 20.8 t -71.95 -7.46 48.72 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.808 0.337 . . . . 2.6600000000000001 111.276 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.427 ' HE2' HG12 ' A' ' 95' ' ' VAL . 26.1 mmmt -111.43 5.53 19.69 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.997 0.369 . . . . 3.1000000000000001 111.997 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 23.6 mmt180 -58.02 114.05 2.18 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 121.224 0.535 . . . . 3.8599999999999999 111.899 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 24.0 mmm180 -119.34 164.75 15.23 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.315 -0.857 . . . . 5.0 108.831 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 1.7 t-160 -117.42 115.79 25.9 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.102 -0.639 . . . . 6.6299999999999999 109.665 177.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.437 -0.792 . . . . 6.6600000000000001 110.795 -175.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 64.9 m-85 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.368 0.127 . . . . 10.529999999999999 111.12 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -88.72 149.25 23.57 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.865 0.364 . . . . 8.2200000000000006 110.956 -177.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -130.35 -174.43 3.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.001 -0.545 . . . . 7.4299999999999997 110.626 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.42 129.83 41.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.109 0.48 . . . . 5.9199999999999999 112.277 -176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 10.0 m -95.13 153.11 17.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.526 -0.761 . . . . 4.3399999999999999 109.87 178.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 5.6 p -104.29 27.87 7.39 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 111.989 0.366 . . . . 2.1200000000000001 111.989 -176.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.431 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.9 p30 -83.81 145.63 47.52 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 121.163 0.506 . . . . 1.25 110.906 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.814 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 14.3 Cg_exo -69.57 0.49 5.43 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 123.666 2.911 . . . . 0.48999999999999999 113.69 -175.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.495 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 28.5 m-85 -97.47 -45.93 6.25 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.006 0.431 . . . . 0.56000000000000005 110.312 -177.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 76.4 p -118.24 95.91 5.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.561 0.696 . . . . 1.8899999999999999 110.35 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -76.76 -30.55 56.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.46 -0.791 . . . . 3.1099999999999999 111.885 -174.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 4.1 tppp? . . . . . 0 C--O 1.252 1.185 0 O-C-N 123.452 0.47 . . . . 6.9900000000000002 110.054 -175.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.621 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.621 0 N-CA-C 111.959 -0.456 . . . . 10.470000000000001 111.959 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.33 -23.27 15.51 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.782 2.321 . . . . 10.449999999999999 112.241 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.42 39.62 1.06 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.003 -0.544 . . . . 9.0899999999999999 110.917 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.95 66.37 3.59 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.84 -0.695 . . . . 6.2400000000000002 111.476 174.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.4 m -90.37 -7.12 54.03 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.901 0.382 . . . . 5.9800000000000004 110.983 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -75.83 134.45 40.37 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.946 -0.391 . . . . 3.9199999999999999 109.946 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -83.45 144.85 29.31 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.417 -0.356 . . . . 4.9400000000000004 110.184 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 p -109.77 136.2 46.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.902 0.382 . . . . 1.99 111.099 -174.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -85.26 148.91 25.83 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 121.39 0.614 . . . . 2.3999999999999999 111.082 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -92.63 140.17 29.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.119 -0.946 . . . . 0.95999999999999996 112.349 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.9 m -77.49 -7.37 10.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.888 0.851 . . . . 1.3300000000000001 109.035 168.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.6 t -96.83 -11.93 8.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.887 -1.051 . . . . 0.53000000000000003 109.802 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.67 -23.68 69.09 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.773 -0.649 . . . . 0.78000000000000003 112.996 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 ptmt -74.35 -27.32 60.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.999 0.428 . . . . 3.2200000000000002 110.67 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -106.39 31.39 5.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.803 -0.635 . . . . 2.3900000000000001 109.637 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.436 ' HD2' ' HA ' ' A' ' 50' ' ' LYS . 0.0 OUTLIER -75.81 -56.44 1.73 Allowed Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.51 -0.314 . . . . 1.1699999999999999 111.692 -176.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.555 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 51.0 Cg_endo -66.94 -14.75 44.87 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 121.707 1.605 . . . . 0.65000000000000002 112.569 -173.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.5 m -70.41 -46.59 63.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.548 0.689 . . . . 0.45000000000000001 109.177 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.407 ' O ' ' HB2' ' A' ' 57' ' ' PHE . 13.5 m-85 -80.82 -20.8 41.65 Favored 'General case' 0 C--O 1.219 -0.517 0 CA-C-N 115.453 -0.794 . . . . 0.69999999999999996 109.922 178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.555 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 11.2 t70 -66.29 -44.55 83.18 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.212 -0.662 . . . . 0.72999999999999998 109.212 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -59.93 -50.89 72.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.405 -0.816 . . . . 1.8600000000000001 110.229 175.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 73.0 mt -59.51 -38.81 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.062 -0.517 . . . . 0.32000000000000001 110.338 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.49 ' HE1' HG12 ' A' ' 67' ' ' ILE . 65.2 t80 -56.72 -47.56 79.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.317 -0.856 . . . . 0.39000000000000001 111.134 -179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 35.3 m-85 -76.09 -22.36 55.67 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.27 0.471 . . . . 0.91000000000000003 112.27 -177.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 38.5 p -79.45 -6.71 57.49 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.6 -0.44 . . . . 0.57999999999999996 111.032 176.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.3 mt -101.14 0.73 38.24 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.27 -0.423 . . . . 1.1699999999999999 111.228 -179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.1 m 69.65 88.15 0.1 Allowed Pre-proline 0 N--CA 1.466 0.356 0 O-C-N 123.84 0.713 . . . . 1.1399999999999999 111.201 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -86.0 136.27 5.0 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 122.809 2.34 . . . . 1.1000000000000001 112.438 177.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 6.3 m -107.71 115.84 49.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.113 0.482 . . . . 1.6599999999999999 110.828 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 58.0 28.33 16.08 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.717 -0.674 . . . . 1.98 112.016 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.88 -2.4 69.4 Favored Glycine 0 C--O 1.224 -0.493 0 C-N-CA 120.94 -0.648 . . . . 0.82999999999999996 113.352 175.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.52 ' HD3' ' HB3' ' A' ' 100' ' ' LEU . 57.3 mttm -127.11 142.25 51.56 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 122.501 -0.411 . . . . 0.96999999999999997 110.546 177.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.49 HG12 ' HE1' ' A' ' 57' ' ' PHE . 36.5 pt -99.06 138.67 22.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 109.201 -0.666 . . . . 0.37 109.201 170.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.752 ' HA ' HD23 ' A' ' 100' ' ' LEU . 1.1 p -71.53 164.55 25.62 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.254 -0.43 . . . . 1.3100000000000001 111.067 178.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.56 -25.25 41.97 Favored Glycine 0 C--O 1.223 -0.536 0 CA-C-N 115.719 -0.673 . . . . 0.33000000000000002 113.175 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.26 -42.91 99.22 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.781 0.324 . . . . 0.27000000000000002 111.074 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.756 ' HA ' ' HE2' ' A' ' 74' ' ' LYS . 25.6 m-80 -76.72 -43.03 39.09 Favored 'General case' 0 CA--C 1.51 -0.579 0 CA-C-O 121.14 0.495 . . . . 1.79 110.234 -177.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.54 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.98 -41.15 86.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.022 -0.99 . . . . 0.32000000000000001 110.516 177.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.723 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.6 tttt -70.59 -35.93 73.28 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.009 -0.541 . . . . 1.3600000000000001 110.122 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.756 ' HE2' ' HA ' ' A' ' 71' ' ' ASN . 52.3 mtmt -54.45 -46.37 73.27 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.906 0.384 . . . . 2.48 110.203 174.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -61.76 -52.54 63.81 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.693 -0.685 . . . . 2.1600000000000001 110.176 177.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.54 ' HG3' ' O ' ' A' ' 72' ' ' ALA . 32.8 mtt -56.23 -41.96 76.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.128 0.49 . . . . 0.51000000000000001 112.01 -177.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 73' ' ' LYS . 99.6 t -68.74 -31.17 49.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.707 -0.678 . . . . 1.3400000000000001 110.72 -179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 98.4 mttt -71.53 -28.15 63.68 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 120.88 0.371 . . . . 2.2000000000000002 110.348 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 32.0 m -74.17 -15.07 61.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.963 -0.562 . . . . 0.91000000000000003 111.122 176.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 54.1 mttp 73.15 24.38 2.47 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.821 0.674 . . . . 2.3700000000000001 112.821 171.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.685 ' HB2' HD21 ' A' ' 86' ' ' LEU . 3.9 mm? -87.84 158.15 50.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.655 -0.418 . . . . 1.3500000000000001 110.271 176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.509 ' HG2' HG23 ' A' ' 85' ' ' VAL . 73.5 Cg_endo -76.31 157.21 37.35 Favored 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 123.125 2.55 . . . . 0.44 113.274 -178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -53.69 -42.99 68.58 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.661 -0.7 . . . . 1.9399999999999999 111.703 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 16.9 p -55.78 -56.88 15.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.235 0.54 . . . . 1.04 111.785 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.509 HG23 ' HG2' ' A' ' 82' ' ' PRO . 87.9 t -62.39 -45.15 99.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.81 -0.632 . . . . 0.40999999999999998 111.171 -177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.685 HD21 ' HB2' ' A' ' 81' ' ' LEU . 70.3 mt -63.42 -33.11 74.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.868 0.366 . . . . 0.44 110.376 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.94 -48.07 79.61 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.02 -0.536 . . . . 0.23000000000000001 112.48 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 40.9 pttt -74.05 -33.68 63.8 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.656 -0.418 . . . . 1.71 110.897 179.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.434 HG23 HD12 ' A' ' 112' ' ' LEU . 43.5 mt -60.66 -41.44 88.13 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.068 0 N-CA-C 109.851 -0.425 . . . . 0.40000000000000002 109.851 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 48.8 t-105 -60.88 -48.75 80.4 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.124 -0.489 . . . . 0.46000000000000002 110.377 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -67.84 -14.03 62.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.055 0.391 . . . . 2.3999999999999999 112.055 -175.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 61.5 mt -93.31 -51.18 5.12 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.796 0.331 . . . . 1.0800000000000001 110.79 174.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.03 -33.66 72.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.775 . . . . 0.29999999999999999 111.544 -175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.599 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 37.6 t0 -84.32 86.26 7.28 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-O 121.672 0.748 . . . . 0.45000000000000001 109.494 178.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.804 ' HB ' ' HD3' ' A' ' 135' ' ' LYS . 3.5 m -68.66 -30.62 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 114.562 -1.199 . . . . 1.28 112.405 -175.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.433 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 2.7 m-20 -72.78 -24.34 60.92 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-N 116.514 -0.312 . . . . 1.1200000000000001 110.265 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 39.3 mttt 58.37 40.33 24.42 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.277 -1.008 . . . . 1.6799999999999999 108.277 -167.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.602 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 12.2 p-10 -108.21 9.0 28.19 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 114.995 -1.002 . . . . 0.70999999999999996 111.22 -171.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 63.65 22.16 65.76 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.789 -0.72 . . . . 0.39000000000000001 111.793 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.752 HD23 ' HA ' ' A' ' 68' ' ' THR . 15.3 mt -140.67 143.95 35.39 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.503 -0.555 . . . . 1.3700000000000001 109.503 -175.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.495 HD22 ' HB3' ' A' ' 105' ' ' GLU . 71.0 mt -121.56 114.2 20.86 Favored 'General case' 0 C--N 1.318 -0.771 0 O-C-N 123.451 0.469 . . . . 0.34000000000000002 109.973 177.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 66' ' ' LYS . 0.9 OUTLIER -79.19 -177.57 5.73 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.971 -0.752 . . . . 1.3899999999999999 108.971 169.71 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -59.65 -30.85 69.03 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.985 -0.286 . . . . 1.6899999999999999 111.385 -175.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -71.36 -58.05 3.88 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.075 -0.343 . . . . 2.29 110.075 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.495 ' HB3' HD22 ' A' ' 101' ' ' LEU . 38.6 mt-10 -56.94 -39.71 75.04 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.323 0.582 . . . . 0.39000000000000001 110.653 -178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -69.75 -29.43 66.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.549 -0.751 . . . . 0.28999999999999998 110.945 -178.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.47 -42.23 30.34 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.918 0.866 . . . . 0.34000000000000002 108.925 -177.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 33.2 tp -61.44 -42.61 99.02 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 114.505 -1.225 . . . . 1.74 110.044 174.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.466 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.18 -52.02 67.32 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.965 -0.561 . . . . 0.27000000000000002 110.754 176.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -27.09 68.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.808 -0.633 . . . . 0.69999999999999996 111.668 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.474 ' O ' HG23 ' A' ' 115' ' ' VAL . 21.9 t60 -67.19 -47.18 71.7 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.841 -0.429 . . . . 0.75 109.841 176.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.434 HD12 HG23 ' A' ' 89' ' ' ILE . 87.6 mt -62.48 -41.88 99.09 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 120.996 0.427 . . . . 0.27000000000000002 110.234 176.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 109' ' ' ALA . 73.6 mt -61.22 -50.77 79.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.605 -0.725 . . . . 0.46000000000000002 111.313 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 45.4 pttt -73.48 -21.42 60.44 Favored 'General case' 0 C--O 1.226 -0.133 0 C-N-CA 120.336 -0.545 . . . . 1.8100000000000001 110.236 -178.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 111' ' ' HIS . 2.8 t -58.96 -46.45 91.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.638 -0.504 . . . . 0.91000000000000003 109.638 171.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HD3' ' HG ' ' A' ' 122' ' ' LEU . 13.1 mmmm -72.73 -31.98 65.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.397 -0.365 . . . . 1.0600000000000001 111.249 175.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.43 ' HB3' ' HA ' ' A' ' 114' ' ' LYS . 37.0 tp -65.41 -42.0 93.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.469 -0.332 . . . . 1.5900000000000001 111.317 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 80.8 mm-40 -69.98 -26.01 63.89 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.027 0.441 . . . . 2.0499999999999998 110.619 178.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.33 34.48 3.13 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.653 -0.784 . . . . 0.68000000000000005 112.65 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -107.66 177.24 4.89 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.962 -0.384 . . . . 1.1599999999999999 109.962 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.79 149.41 24.51 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.832 0.349 . . . . 2.6899999999999999 111.631 -178.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.571 ' O ' HD12 ' A' ' 122' ' ' LEU . 1.4 pp -124.91 130.67 24.14 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.117 -0.697 . . . . 1.21 109.117 167.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.57 -13.62 20.19 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.689 2.26 . . . . 1.28 113.726 -172.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.6 18.94 9.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.586 -0.734 . . . . 1.0600000000000001 110.571 -172.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -106.14 170.17 8.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.332 -0.849 . . . . 1.9299999999999999 108.904 174.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 33.1 tp -123.15 96.83 44.02 Favored Pre-proline 0 C--N 1.321 -0.653 0 C-N-CA 120.651 -0.419 . . . . 1.8500000000000001 110.758 178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.412 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 60.2 Cg_endo -75.21 152.67 40.1 Favored 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.899 2.4 . . . . 0.90000000000000002 112.125 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 77.1 Cg_exo -51.3 -39.69 62.42 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.537 2.825 . . . . 1.02 114.237 -175.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -81.02 13.92 2.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.81 0.338 . . . . 1.1399999999999999 111.716 -175.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 30.4 mt -122.53 5.14 9.58 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.281 -0.418 . . . . 1.3400000000000001 110.217 173.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.8 t -95.73 106.51 27.84 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.091 -0.504 . . . . 1.5700000000000001 110.171 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -68.65 161.43 45.29 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.801 2.334 . . . . 1.3500000000000001 112.962 -177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.589 ' O ' ' HG2' ' A' ' 136' ' ' ARG . 30.6 Cg_endo -64.05 2.9 0.89 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.188 2.592 . . . . 2.0499999999999998 113.274 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.8 t -73.5 -27.64 61.48 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.912 0.387 . . . . 2.6600000000000001 110.184 176.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.804 ' HD3' ' HB ' ' A' ' 95' ' ' VAL . 4.2 mmmp? -92.08 8.0 39.78 Favored 'General case' 0 N--CA 1.461 0.091 0 N-CA-C 112.647 0.61 . . . . 3.1000000000000001 112.647 -174.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.589 ' HG2' ' O ' ' A' ' 133' ' ' PRO . 14.4 ptp180 -100.14 124.07 45.12 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.103 0.477 . . . . 3.8599999999999999 110.386 178.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 39.0 ttm-85 -126.1 115.7 20.23 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.606 -0.725 . . . . 5.0 109.256 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -133.69 140.98 47.37 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.16 0.505 . . . . 6.6299999999999999 111.321 -176.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.563 ' H ' ' CD ' ' A' ' 139' ' ' GLU . 0.9 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 117.951 -1.023 . . . . 6.6600000000000001 111.375 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.984 -0.376 . . . . 10.529999999999999 109.984 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -64.37 -41.29 96.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.45 -0.341 . . . . 8.2200000000000006 111.409 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -156.6 151.25 25.74 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.217 -0.447 . . . . 7.4299999999999997 110.271 178.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -110.49 75.84 0.95 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.226 0.536 . . . . 5.9199999999999999 110.499 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 24.4 m -156.74 94.01 1.42 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.853 -0.612 . . . . 4.3399999999999999 109.753 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 14.3 p -120.14 -3.53 10.07 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.255 0.465 . . . . 2.1200000000000001 112.255 -177.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -133.86 152.98 79.67 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.676 0.274 . . . . 1.25 110.382 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.723 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 7.8 Cg_exo -72.75 -1.59 10.61 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 123.464 2.776 . . . . 0.48999999999999999 113.936 -175.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.447 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 25.2 m-85 -100.31 -20.31 15.93 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.101 0.476 . . . . 0.56000000000000005 110.91 -175.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 34.1 p -83.32 -2.75 56.45 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.8 -0.637 . . . . 1.8899999999999999 110.57 175.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -137.8 90.1 2.46 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.773 -0.649 . . . . 3.1099999999999999 110.541 178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 14.2 mmmm . . . . . 0 C--O 1.25 1.09 0 CA-C-N 115.555 -0.748 . . . . 6.9900000000000002 111.605 176.051 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.599 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.671 0 N-CA-C 111.33 -0.708 . . . . 10.470000000000001 111.33 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.11 -69.9 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.816 2.344 . . . . 10.449999999999999 112.14 -178.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 62.9 tp 65.23 -77.68 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.829 0.706 . . . . 9.0899999999999999 111.732 177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -75.75 79.41 1.12 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.272 -0.489 . . . . 6.2400000000000002 113.145 -176.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.9 m -94.77 69.61 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.248 -0.649 . . . . 5.9800000000000004 109.248 175.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.42 133.2 39.94 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.942 -0.572 . . . . 3.9199999999999999 111.185 -177.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -70.21 109.99 4.96 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.519 -0.764 . . . . 4.9400000000000004 111.174 179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 p -104.52 115.54 46.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 109.215 -0.661 . . . . 1.99 109.215 172.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -83.48 132.1 34.97 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.395 0.616 . . . . 2.3999999999999999 111.392 -175.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.459 ' HH2' ' O ' ' A' ' 104' ' ' GLU . 7.6 t90 -76.79 123.22 25.9 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.303 -0.862 . . . . 0.95999999999999996 109.895 -179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 47.7 t -55.85 -35.34 39.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 1.3300000000000001 111.786 -176.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.9 t -71.9 -21.0 20.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.145 -0.48 . . . . 0.53000000000000003 111.174 -177.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -68.67 -5.93 47.58 Favored Glycine 0 CA--C 1.519 0.323 0 C-N-CA 121.084 -0.579 . . . . 0.78000000000000003 112.98 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 10.8 mptt -74.64 -28.25 60.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.089 0.471 . . . . 3.2200000000000002 110.867 179.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -135.02 33.16 3.15 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.53 -0.915 . . . . 2.3900000000000001 108.53 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.607 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 82.3 tttt -84.33 -44.71 0.74 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 114.946 -1.025 . . . . 1.1699999999999999 113.409 -174.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 19.7 Cg_endo -56.18 -23.84 47.11 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.426 2.084 . . . . 0.65000000000000002 113.132 -176.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.4 m -69.9 -41.21 74.99 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 115.273 -0.876 . . . . 0.45000000000000001 110.378 174.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -73.59 -21.95 60.18 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 109.362 -0.607 . . . . 0.69999999999999996 109.362 176.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 3.6 t70 -66.3 -45.18 81.27 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.443 0.64 . . . . 0.72999999999999998 109.75 174.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tp10 -59.59 -40.8 88.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.072 -0.967 . . . . 1.8600000000000001 109.902 176.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.611 ' O ' ' HG ' ' A' ' 60' ' ' LEU . 65.9 mt -70.29 -37.89 72.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.071 0.462 . . . . 0.32000000000000001 110.731 177.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -61.54 -51.09 70.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.142 -0.481 . . . . 0.39000000000000001 111.235 -177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -82.24 14.18 3.07 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 112.231 0.456 . . . . 0.91000000000000003 112.231 -175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.1 p -118.5 3.58 11.8 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 0.57999999999999996 110.467 172.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 56' ' ' ILE . 72.5 mt -106.35 11.97 30.37 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.919 -0.582 . . . . 1.1699999999999999 110.513 178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.5 t 66.35 80.77 0.22 Allowed Pre-proline 0 C--O 1.234 0.243 0 CA-C-N 115.371 -0.831 . . . . 1.1399999999999999 111.325 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -81.77 128.67 6.04 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.313 2.008 . . . . 1.1000000000000001 111.526 175.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 52.0 t -106.81 107.79 23.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.398 -0.364 . . . . 1.6599999999999999 110.191 179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.3 m120 68.61 29.22 5.53 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.478 -0.783 . . . . 1.98 110.52 177.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.24 -3.62 72.93 Favored Glycine 0 C--O 1.23 -0.142 0 CA-C-N 115.655 -0.702 . . . . 0.82999999999999996 113.333 176.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -122.03 140.36 52.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 110.407 -0.22 . . . . 0.96999999999999997 110.407 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -101.13 145.73 10.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 108.835 -0.802 . . . . 0.37 108.835 169.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.73 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 72.0 p -80.75 164.94 22.38 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 120.483 -0.487 . . . . 1.3100000000000001 110.207 -176.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.38 -20.73 52.02 Favored Glycine 0 C--O 1.221 -0.688 0 C-N-CA 120.999 -0.62 . . . . 0.33000000000000002 112.802 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.16 -43.84 81.27 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.907 0.384 . . . . 0.27000000000000002 111.308 -179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.412 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 0.8 OUTLIER -76.3 -44.21 37.94 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-O 121.524 0.678 . . . . 1.79 109.767 -176.218 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.68 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.72 -50.82 72.48 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.771 -1.104 . . . . 0.32000000000000001 110.182 176.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.576 ' O ' HG23 ' A' ' 77' ' ' VAL . 76.3 tttt -56.73 -40.62 76.03 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 116.1 -0.5 . . . . 1.3600000000000001 110.539 178.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 35.9 ttpt -51.88 -49.25 63.34 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.003 0.43 . . . . 2.48 110.218 177.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.6 tp10 -66.27 -39.88 89.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.89 -0.595 . . . . 2.1600000000000001 110.517 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.741 ' HB3' HD22 ' A' ' 86' ' ' LEU . 66.4 mtp -67.26 -27.01 66.85 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.001 -0.545 . . . . 0.51000000000000001 110.451 -179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.576 HG23 ' O ' ' A' ' 73' ' ' LYS . 77.7 t -70.94 -38.05 70.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.144 -0.48 . . . . 1.3400000000000001 109.97 175.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -66.44 -21.87 66.21 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.915 0.388 . . . . 2.2000000000000002 110.885 174.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 41.4 t -73.88 -17.28 61.07 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.25 -0.432 . . . . 0.91000000000000003 111.069 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 99.0 mttt 65.65 24.22 11.62 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 112.581 0.585 . . . . 2.3700000000000001 112.581 174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.545 ' HB2' HD21 ' A' ' 86' ' ' LEU . 69.3 mt -85.59 151.61 56.01 Favored Pre-proline 0 C--N 1.322 -0.599 0 C-N-CA 120.574 -0.45 . . . . 1.3500000000000001 110.219 179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.481 ' HG2' HG23 ' A' ' 85' ' ' VAL . 33.1 Cg_endo -65.34 149.7 87.99 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.771 2.314 . . . . 0.44 111.918 176.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -53.13 -35.55 59.82 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.317 -0.401 . . . . 1.9399999999999999 111.621 -177.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.0 m -61.97 -45.05 95.36 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 116.348 -0.387 . . . . 1.04 111.017 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.639 ' O ' ' HG2' ' A' ' 88' ' ' LYS . 86.6 t -73.37 -39.19 54.94 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-O 120.971 0.415 . . . . 0.40999999999999998 110.332 179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.741 HD22 ' HB3' ' A' ' 76' ' ' MET . 84.4 mt -59.58 -48.76 80.42 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.262 -0.426 . . . . 0.44 110.563 176.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.57 -41.15 99.83 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.727 -0.669 . . . . 0.23000000000000001 112.415 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 85' ' ' VAL . 0.4 OUTLIER -66.67 -38.78 87.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 120.359 -0.536 . . . . 1.71 110.084 -179.013 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . . . . . . . . . 75.0 mt -65.81 -39.6 85.24 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.142 0 N-CA-C 110.085 -0.339 . . . . 0.40000000000000002 110.085 178.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 57.2 t-105 -62.26 -51.56 67.24 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.298 -0.41 . . . . 0.46000000000000002 110.445 177.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -67.39 -12.44 60.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.981 -0.554 . . . . 2.3999999999999999 112.159 -176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 73.3 mt -93.97 -49.77 5.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.103 0.478 . . . . 1.0800000000000001 111.21 174.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.532 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -72.34 -32.27 66.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.547 -0.751 . . . . 0.29999999999999999 111.705 -173.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.64 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 28.1 t70 -88.3 83.73 6.89 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.539 0.685 . . . . 0.45000000000000001 109.861 -178.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.446 HG11 ' HD2' ' A' ' 132' ' ' PRO . 4.2 m -70.14 -28.9 37.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.206 -0.906 . . . . 1.28 111.497 -177.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.555 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 57.5 m-20 -74.21 -19.9 60.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 C-N-CA 121.002 -0.279 . . . . 1.1200000000000001 110.271 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 53.9 mttt 58.75 27.81 16.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 121.898 0.856 . . . . 1.6799999999999999 109.097 178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.596 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 19.6 p-10 -98.69 9.7 42.75 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 114.347 -1.297 . . . . 0.70999999999999996 111.366 -169.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 66.94 9.23 52.75 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.93 -0.653 . . . . 0.39000000000000001 111.522 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.73 ' CD2' ' HA ' ' A' ' 68' ' ' THR . 15.5 mt -131.18 136.86 48.66 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 114.998 -0.601 . . . . 1.3700000000000001 110.046 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.419 HD22 ' HB3' ' A' ' 105' ' ' GLU . 47.8 mt -105.83 112.59 25.72 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.267 -0.424 . . . . 0.34000000000000002 110.414 178.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -74.11 -178.11 3.22 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.89 -0.595 . . . . 1.3899999999999999 109.55 170.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -56.8 -42.94 80.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.12 0.486 . . . . 1.6899999999999999 110.339 -178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.459 ' O ' ' HH2' ' A' ' 44' ' ' TRP . 19.2 mm-40 -66.08 -54.77 21.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.108 -0.496 . . . . 2.29 110.922 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' HB3' HD22 ' A' ' 101' ' ' LEU . 48.0 mt-10 -60.37 -39.19 86.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.067 -0.515 . . . . 0.39000000000000001 111.202 -175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -74.08 -25.47 59.83 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.879 0.371 . . . . 0.28999999999999998 110.959 -178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -76.77 -42.41 40.96 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 108.533 -0.914 . . . . 0.34000000000000002 108.533 -178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.532 HD23 ' HA ' ' A' ' 93' ' ' ALA . 22.8 tp -63.56 -37.62 88.02 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.608 -1.178 . . . . 1.74 109.845 174.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.74 -56.63 19.06 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-N 116.187 -0.46 . . . . 0.27000000000000002 110.972 176.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.73 -31.13 72.0 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.33 -0.396 . . . . 0.69999999999999996 111.242 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.486 ' O ' ' HB ' ' A' ' 115' ' ' VAL . 4.0 t60 -66.93 -40.91 87.72 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.477 -0.329 . . . . 0.75 110.319 179.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 115' ' ' VAL . 94.7 mt -70.6 -39.4 73.81 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.159 0.504 . . . . 0.27000000000000002 110.058 176.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.42 HD11 ' HG2' ' A' ' 76' ' ' MET . 65.7 mt -56.45 -53.7 37.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.342 -0.844 . . . . 0.46000000000000002 111.177 177.101 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.518 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 28.3 pttt -76.42 -25.05 54.05 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.293 -0.412 . . . . 1.8100000000000001 111.042 -175.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.587 HG12 ' O ' ' A' ' 112' ' ' LEU . 1.2 p -68.68 -38.88 79.54 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 109.245 -0.65 . . . . 0.91000000000000003 109.245 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -66.53 -39.53 88.67 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.163 -0.472 . . . . 1.0600000000000001 110.082 172.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 38.4 tp -61.51 -39.76 92.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.879 -0.6 . . . . 1.5900000000000001 111.149 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 71.3 mt-10 -71.55 -9.48 58.27 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 116.42 -0.354 . . . . 2.0499999999999998 111.023 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.06 20.92 16.84 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.612 -0.804 . . . . 0.68000000000000005 112.59 176.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.557 ' HB2' HG22 ' A' ' 115' ' ' VAL . 83.7 m-70 -99.49 121.16 40.76 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.336 -0.616 . . . . 1.1599999999999999 109.336 178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -81.07 100.6 9.1 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.911 0.386 . . . . 2.6899999999999999 110.411 -177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.406 ' O ' HD12 ' A' ' 122' ' ' LEU . 2.6 pp -61.09 133.47 92.68 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 115.912 -0.585 . . . . 1.21 109.81 177.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -73.26 4.84 3.52 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 122.952 2.434 . . . . 1.28 113.56 -172.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.59 27.63 14.98 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.172 0.511 . . . . 1.0600000000000001 110.854 -177.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -117.68 163.49 16.39 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.926 -0.579 . . . . 1.9299999999999999 109.97 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 41.8 tp -126.56 85.65 59.98 Favored Pre-proline 0 C--N 1.304 -1.393 0 CA-C-N 115.128 -0.942 . . . . 1.8500000000000001 109.124 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 11.1 Cg_endo -62.55 145.62 95.39 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.18 1.92 . . . . 0.90000000000000002 111.612 174.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 84.8 Cg_exo -47.39 -32.33 14.76 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.494 2.796 . . . . 1.02 114.277 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -81.28 3.88 22.47 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.032 0.382 . . . . 1.1399999999999999 112.032 -176.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.7 mt -115.83 -9.15 11.9 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.59 0.233 . . . . 1.3400000000000001 111.128 176.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.66 121.8 77.22 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.25 -0.432 . . . . 1.5700000000000001 111.151 -176.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.446 ' HD2' HG11 ' A' ' 95' ' ' VAL . 44.6 Cg_exo -57.97 139.99 92.32 Favored 'Trans proline' 0 CA--C 1.532 0.387 0 C-N-CA 122.81 2.34 . . . . 1.3500000000000001 112.286 177.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 24.7 Cg_exo -63.41 3.09 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 123.329 2.686 . . . . 2.0499999999999998 113.807 -178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.4 t -72.05 -33.39 67.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.839 0.352 . . . . 2.6600000000000001 110.66 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 15.3 tptm -92.32 14.18 17.17 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.438 -0.346 . . . . 3.1000000000000001 111.663 -172.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 41.2 mtm180 -75.55 111.75 11.18 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.964 -0.384 . . . . 3.8599999999999999 109.964 178.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.9 mtp180 -90.83 149.06 22.11 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.119 0.485 . . . . 5.0 111.098 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 -127.97 100.35 5.87 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.733 -0.84 . . . . 6.6299999999999999 108.733 173.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.526 -0.75 . . . . 6.6600000000000001 110.35 -177.206 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 120.879 0.371 . . . . 10.529999999999999 110.801 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 16.9 m120 69.39 -168.64 0.17 Allowed 'General case' 0 C--O 1.234 0.248 0 CA-C-N 115.133 -0.94 . . . . 8.2200000000000006 111.257 176.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 38.8 p90 -95.12 147.05 23.85 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.058 -0.519 . . . . 7.4299999999999997 110.712 -178.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -84.45 102.51 12.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.776 -0.647 . . . . 5.9199999999999999 109.968 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.4 t -99.1 144.83 27.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.254 -0.43 . . . . 4.3399999999999999 109.993 -179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 12.9 t -124.92 -7.18 7.25 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.163 -0.472 . . . . 2.1200000000000001 109.784 178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.526 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 6.3 t70 -117.98 117.61 35.23 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 1.25 110.373 -176.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.526 ' HD3' ' HA ' ' B' ' 149' ' ' ASP . 6.5 Cg_exo -74.61 -2.02 11.88 Favored 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 123.43 2.754 . . . . 0.48999999999999999 113.825 -174.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.469 ' HZ ' ' SD ' ' A' ' 76' ' ' MET . 10.1 m-85 -105.13 -25.23 12.58 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.84 0.352 . . . . 0.56000000000000005 110.771 -175.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 4.3 p -79.79 21.75 0.52 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.134 -0.485 . . . . 1.8899999999999999 111.775 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -80.75 -5.89 57.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.142 -0.481 . . . . 3.1099999999999999 110.791 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.563 -0.732 . . . . 6.9900000000000002 110.132 177.294 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.64 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.726 0 N-CA-C 111.638 -0.585 . . . . 10.470000000000001 111.638 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -79.68 -162.24 0.18 Allowed 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 123.286 2.657 . . . . 10.449999999999999 112.335 -179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.422 ' N ' HD12 ' A' ' 37' ' ' LEU . 5.4 mp -93.72 147.81 22.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.025 -0.534 . . . . 9.0899999999999999 109.655 179.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -178.44 119.17 0.65 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.288 -0.958 . . . . 6.2400000000000002 112.54 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.6 m -155.4 104.07 2.37 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 110.087 -0.338 . . . . 5.9800000000000004 110.087 177.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -100.1 92.22 5.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.127 0.965 . . . . 3.9199999999999999 110.339 176.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -124.22 95.02 4.39 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.93 -1.032 . . . . 4.9400000000000004 109.116 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 40.5 t -98.46 92.28 2.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.028 0.442 . . . . 1.99 110.315 -176.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -104.23 110.5 22.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.896 -0.593 . . . . 2.3999999999999999 110.246 177.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 10.1 t90 -72.99 102.05 3.38 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.089 -0.708 . . . . 0.95999999999999996 109.089 178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.17 -17.33 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.708 -0.678 . . . . 1.3300000000000001 112.56 -172.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 t -89.25 -7.5 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.313 0.578 . . . . 0.53000000000000003 110.049 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.39 -20.82 78.51 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.723 -0.751 . . . . 0.78000000000000003 112.852 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HG3' ' H ' ' A' ' 48' ' ' LYS . 2.1 mtmm -75.0 -29.37 60.86 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.137 0.494 . . . . 3.2200000000000002 109.703 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.49 33.36 5.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.447 -0.797 . . . . 2.3900000000000001 109.992 -172.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.439 ' HB3' ' HD3' ' A' ' 51' ' ' PRO . 18.5 ttpp -83.88 -48.96 0.69 Allowed Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.87 -0.604 . . . . 1.1699999999999999 111.401 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 84.8 Cg_exo -50.13 -29.29 21.88 Favored 'Trans proline' 0 C--N 1.362 1.276 0 C-N-CA 122.654 2.236 . . . . 0.65000000000000002 114.359 -176.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.6 m -70.78 -46.5 62.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.318 0.58 . . . . 0.45000000000000001 110.209 178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -73.94 -20.07 60.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.353 -0.61 . . . . 0.69999999999999996 109.353 177.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.506 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 14.4 t70 -68.94 -42.34 76.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.24 -0.891 . . . . 0.72999999999999998 109.467 175.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -64.64 -41.84 95.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.031 -0.532 . . . . 1.8600000000000001 110.135 174.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 61.3 mt -61.98 -39.4 83.52 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 121.104 0.478 . . . . 0.32000000000000001 110.029 174.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -57.11 -52.88 63.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.318 -0.855 . . . . 0.39000000000000001 111.584 -179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.689 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 63.8 m-85 -74.9 -21.25 59.33 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.123 0.416 . . . . 0.91000000000000003 112.123 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 12.7 p -83.25 2.31 36.53 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.411 . . . . 0.57999999999999996 111.374 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.5 mt -107.21 9.28 30.22 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.64 0.257 . . . . 1.1699999999999999 110.485 177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.7 m 66.72 87.37 0.12 Allowed Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.321 -0.854 . . . . 1.1399999999999999 111.095 -178.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.689 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.7 Cg_endo -81.08 132.51 8.42 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 122.776 2.317 . . . . 1.1000000000000001 112.044 179.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.6 m -110.95 123.63 67.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.832 -0.622 . . . . 1.6599999999999999 110.464 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 65.43 23.2 11.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.655 -0.702 . . . . 1.98 110.817 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.79 -0.62 79.94 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.886 -0.673 . . . . 0.82999999999999996 112.628 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.687 ' HB2' HD12 ' A' ' 100' ' ' LEU . 44.6 mttm -123.5 164.82 18.19 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.999 -0.371 . . . . 0.96999999999999997 109.999 -178.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.685 ' HB ' ' OD1' ' A' ' 71' ' ' ASN . 48.2 pt -111.5 130.24 65.39 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 119.925 -0.71 . . . . 0.37 109.302 167.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.7 p -71.25 154.89 41.3 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.973 -0.558 . . . . 1.3100000000000001 110.674 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -55.4 -9.01 2.01 Favored Glycine 0 CA--C 1.523 0.592 0 CA-C-N 115.9 -0.591 . . . . 0.33000000000000002 113.981 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.75 -67.32 0.49 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.14 0.47 . . . . 0.27000000000000002 110.581 177.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.855 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 4.3 p30 -69.32 -28.25 66.08 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.392 -0.367 . . . . 1.79 110.62 -179.197 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.6 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -60.68 -49.09 78.9 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.994 -0.548 . . . . 0.32000000000000001 110.333 174.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.631 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 42.8 tttp -64.54 -36.81 85.43 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-O 120.905 0.383 . . . . 1.3600000000000001 110.22 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.855 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 28.5 mtpp -54.85 -42.15 71.64 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.811 -0.632 . . . . 2.48 110.82 176.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -71.16 -38.86 72.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.487 0.661 . . . . 2.1600000000000001 110.123 177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.764 ' HB3' HD22 ' A' ' 86' ' ' LEU . 87.5 mtp -68.17 -28.08 66.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.481 -0.781 . . . . 0.51000000000000001 111.41 -178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.1 m -81.11 -22.69 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 120.362 -0.535 . . . . 1.3400000000000001 110.28 175.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.548 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 44.2 mttp -66.49 -28.93 68.95 Favored 'General case' 0 C--O 1.234 0.238 0 C-N-CA 120.304 -0.558 . . . . 2.2000000000000002 109.666 170.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.0 m -67.03 -17.56 64.96 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 115.569 -0.741 . . . . 0.91000000000000003 110.797 177.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.0 mttp 67.28 22.83 9.5 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.839 -0.619 . . . . 2.3700000000000001 111.582 176.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.582 ' HB2' HD21 ' A' ' 86' ' ' LEU . 84.5 mt -89.4 155.76 48.59 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 109.657 -0.498 . . . . 1.3500000000000001 109.657 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.525 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 35.4 Cg_endo -66.53 147.26 81.93 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.564 2.176 . . . . 0.44 112.232 178.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -56.29 -36.9 69.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.652 -0.704 . . . . 1.9399999999999999 111.276 -176.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 7.2 m -60.02 -48.51 81.41 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-N 115.838 -0.619 . . . . 1.04 111.214 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.563 HG11 ' HE2' ' A' ' 116' ' ' LYS . 78.7 t -67.6 -38.31 80.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.884 -0.598 . . . . 0.40999999999999998 110.162 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.764 HD22 ' HB3' ' A' ' 76' ' ' MET . 81.8 mt -57.49 -42.27 82.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.44 110.556 175.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.43 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.67 -41.21 98.86 Favored Glycine 0 C--N 1.333 0.399 0 CA-C-N 115.953 -0.567 . . . . 0.23000000000000001 112.132 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 54.8 mttp -63.03 -47.74 81.74 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.23 -0.188 . . . . 1.71 110.84 176.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 85' ' ' VAL . 69.3 mt -53.35 -45.55 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 O-C-N 123.339 0.4 . . . . 0.40000000000000002 110.365 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.535 ' HB2' ' HE2' ' B' ' 151' ' ' PHE . 32.0 t-105 -59.71 -52.68 64.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.731 -0.668 . . . . 0.46000000000000002 110.963 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.93 -13.55 61.88 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.308 0.484 . . . . 2.3999999999999999 112.308 -174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 32.1 mt -93.49 -39.77 10.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.142 0.496 . . . . 1.0800000000000001 110.648 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.529 ' HA ' HD23 ' A' ' 108' ' ' LEU . . . -78.53 -36.18 45.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.605 -0.725 . . . . 0.29999999999999999 111.56 -176.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.431 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 44.0 t0 -83.56 70.61 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.869 0.842 . . . . 0.45000000000000001 109.467 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.468 ' CG1' HD11 ' A' ' 126' ' ' LEU . 15.0 m -77.32 -16.57 14.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 114.944 -1.025 . . . . 1.28 109.619 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.569 ' HB3' ' OE2' ' A' ' 105' ' ' GLU . 2.1 t70 -86.23 -20.72 28.09 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.186 -1.37 . . . . 1.1200000000000001 109.295 177.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 63.2 mttt 60.77 40.34 16.2 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 114.667 -1.152 . . . . 1.6799999999999999 111.359 166.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.62 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 7.2 p-10 -114.27 9.21 16.96 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 120.505 -0.478 . . . . 0.70999999999999996 111.299 -174.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 78.6 -2.41 67.87 Favored Glycine 0 CA--C 1.5 -0.851 0 C-N-CA 120.843 -0.694 . . . . 0.39000000000000001 111.992 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.687 HD12 ' HB2' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -120.71 134.02 55.31 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.752 -0.832 . . . . 1.3700000000000001 108.752 -176.729 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.434 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 62.3 mt -83.23 108.6 16.57 Favored 'General case' 0 N--CA 1.434 -1.243 0 C-N-CA 118.743 -1.183 . . . . 0.34000000000000002 108.012 172.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.402 ' HB2' ' HG3' ' A' ' 105' ' ' GLU . 2.6 m-20 -71.88 171.22 12.13 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.711 -1.218 . . . . 1.3899999999999999 107.711 171.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -57.6 -42.01 82.37 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.996 0.362 . . . . 1.6899999999999999 111.212 -173.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.408 ' OE1' ' HB2' ' A' ' 132' ' ' PRO . 8.0 mt-10 -68.8 -42.21 77.65 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.291 0.567 . . . . 2.29 110.28 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.569 ' OE2' ' HB3' ' A' ' 96' ' ' ASP . 25.4 mt-10 -66.89 -38.63 86.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.516 -0.765 . . . . 0.39000000000000001 110.627 -176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.434 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 38.9 t80 -73.1 -25.06 60.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.97 -0.559 . . . . 0.28999999999999998 110.625 179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -78.45 -41.57 32.37 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.244 -1.021 . . . . 0.34000000000000002 108.244 -178.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 93' ' ' ALA . 40.7 tp -65.25 -35.52 81.29 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 114.449 -1.25 . . . . 1.74 109.826 174.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.41 -55.88 29.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.133 -0.485 . . . . 0.27000000000000002 110.84 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.602 HD22 HD12 ' A' ' 113' ' ' ILE . 13.8 m120 -61.62 -28.16 69.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.238 -0.437 . . . . 0.69999999999999996 110.928 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.514 ' O ' HG23 ' A' ' 115' ' ' VAL . 61.7 t60 -63.95 -48.01 78.17 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.338 -0.392 . . . . 0.75 110.585 177.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 36.4 mt -66.24 -33.39 75.64 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.792 -0.448 . . . . 0.27000000000000002 109.792 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.602 HD12 HD22 ' A' ' 110' ' ' ASN . 88.2 mt -60.49 -51.39 73.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.83 -0.623 . . . . 0.46000000000000002 111.511 178.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.486 ' O ' ' HG3' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -67.28 -41.02 86.14 Favored 'General case' 0 C--O 1.22 -0.469 0 C-N-CA 120.601 -0.439 . . . . 1.8100000000000001 110.444 -179.024 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 111' ' ' HIS . 69.4 t -54.62 -47.83 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.027 0.442 . . . . 0.91000000000000003 109.867 177.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.563 ' HE2' HG11 ' A' ' 85' ' ' VAL . 44.4 tptt -57.8 -56.58 20.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 115.54 -0.755 . . . . 1.0600000000000001 111.306 175.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 9.2 tt -62.89 -31.81 72.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.025 -0.534 . . . . 1.5900000000000001 111.73 -173.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 114' ' ' LYS . 44.4 mt-10 -80.5 4.29 18.77 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.987 0.422 . . . . 2.0499999999999998 111.353 -178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 102.07 33.17 4.71 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.831 -0.699 . . . . 0.68000000000000005 113.467 172.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.53 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 97.7 m-70 -131.5 173.55 10.98 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.778 0.289 . . . . 1.1599999999999999 110.444 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -120.0 155.13 33.46 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.269 -0.423 . . . . 2.6899999999999999 111.163 -174.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.9 mt -93.47 128.16 43.48 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.946 -0.57 . . . . 1.21 109.582 176.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.49 -6.81 19.76 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.792 2.328 . . . . 1.28 113.57 -171.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.27 18.89 9.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.975 -0.557 . . . . 1.0600000000000001 112.404 178.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -127.6 174.61 8.92 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 109.661 -0.496 . . . . 1.9299999999999999 109.661 174.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.468 HD11 ' CG1' ' A' ' 95' ' ' VAL . 0.5 OUTLIER -124.36 88.96 52.6 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 109.696 -0.483 . . . . 1.8500000000000001 109.696 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 128' ' ' PRO . 32.5 Cg_endo -66.57 150.34 83.97 Favored 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.859 2.373 . . . . 0.90000000000000002 112.256 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 127' ' ' PRO . 32.3 Cg_exo -58.25 -21.4 52.04 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.218 2.612 . . . . 1.02 113.856 -174.07 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -96.94 13.14 29.86 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.487 -0.485 . . . . 1.1399999999999999 111.576 -176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 35.4 mt -121.74 5.5 9.99 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 121.056 -0.258 . . . . 1.3400000000000001 111.418 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 32.8 m -81.53 126.69 75.47 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-O 121.125 0.488 . . . . 1.5700000000000001 110.846 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.408 ' HB2' ' OE1' ' A' ' 104' ' ' GLU . 56.5 Cg_endo -71.02 164.21 36.55 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.743 2.296 . . . . 1.3500000000000001 112.347 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -56.17 -31.12 82.43 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.978 2.452 . . . . 2.0499999999999998 113.15 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 8.4 t -78.95 9.37 4.36 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 120.794 0.331 . . . . 2.6600000000000001 111.034 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 17.6 tptm -109.41 15.73 22.82 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.446 0.641 . . . . 3.1000000000000001 110.291 175.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.512 ' HA ' ' NE ' ' A' ' 136' ' ' ARG . 4.5 mmp_? -81.54 119.31 23.6 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.239 0.542 . . . . 3.8599999999999999 110.543 175.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.0 ttm180 -80.83 132.02 35.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.703 -0.68 . . . . 5.0 110.482 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -115.06 112.34 22.47 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.662 -0.496 . . . . 6.6299999999999999 109.662 175.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.548 -0.739 . . . . 6.6600000000000001 110.714 -179.762 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 58.8 t80 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.1 0.476 . . . . 10.529999999999999 109.857 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -106.48 -154.79 0.53 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.301 -0.629 . . . . 8.2200000000000006 109.301 175.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -129.84 148.98 51.77 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.589 -0.523 . . . . 7.4299999999999997 109.589 176.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -107.33 175.15 5.59 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.736 0.303 . . . . 5.9199999999999999 110.344 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 20.0 m -90.86 124.89 35.52 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.287 0.565 . . . . 4.3399999999999999 111.859 -172.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 13.3 t -122.55 13.48 10.13 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.342 -0.845 . . . . 2.1200000000000001 109.25 178.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.44 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 3.2 p30 -80.38 152.39 73.16 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.235 -0.893 . . . . 1.25 111.388 -175.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.631 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 30.7 Cg_exo -63.24 0.22 1.86 Allowed 'Trans proline' 0 N--CA 1.474 0.374 0 C-N-CA 124.118 3.212 . . . . 0.48999999999999999 114.114 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.535 ' HE2' ' HB2' ' A' ' 90' ' ' TRP . 28.9 m-85 -100.4 -49.8 4.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.925 0.393 . . . . 0.56000000000000005 110.813 -177.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 30.6 p -87.09 -13.73 43.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.054 -0.521 . . . . 1.8899999999999999 111.706 -177.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . -78.91 104.52 9.6 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.129 -0.487 . . . . 3.1099999999999999 111.299 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 66.3 mttm . . . . . 0 C--O 1.253 1.263 0 CA-C-N 115.289 -0.868 . . . . 6.9900000000000002 111.361 177.7 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.62 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.757 0 N-CA-C 112.116 -0.394 . . . . 10.470000000000001 112.116 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.7 -17.43 23.11 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.887 2.391 . . . . 10.449999999999999 113.003 -178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 41.4 tp -123.77 120.48 32.78 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.859 -0.423 . . . . 9.0899999999999999 109.859 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.92 -38.18 1.9 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.552 -0.832 . . . . 6.2400000000000002 112.788 -177.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.8 t 71.65 -69.97 0.17 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.32 0.648 . . . . 5.9800000000000004 110.508 -178.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -108.25 121.39 44.79 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.25 -0.432 . . . . 3.9199999999999999 110.064 179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -80.69 138.05 36.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.206 0.527 . . . . 4.9400000000000004 109.961 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.3 p -101.55 137.67 28.47 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.702 -0.681 . . . . 1.99 111.975 -171.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -92.05 117.93 30.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.633 -0.712 . . . . 2.3999999999999999 109.612 171.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -72.27 101.01 2.74 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 107.542 -1.281 . . . . 0.95999999999999996 107.542 171.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.531 HG22 HD21 ' A' ' 130' ' ' LEU . 16.5 m -57.82 -20.09 13.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 112.989 0.737 . . . . 1.3300000000000001 112.989 -169.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 108' ' ' LEU . 33.6 t -92.45 -25.81 5.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.818 0.342 . . . . 0.53000000000000003 110.723 -179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.44 ' HA2' ' HB2' ' A' ' 50' ' ' LYS . . . -69.84 -23.58 76.82 Favored Glycine 0 CA--C 1.516 0.101 0 C-N-CA 121.167 -0.54 . . . . 0.78000000000000003 113.0 -175.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 23.2 pttm -73.91 -20.48 60.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.583 0.706 . . . . 3.2200000000000002 109.907 -178.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -134.48 34.38 3.24 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 122.413 1.101 . . . . 2.3900000000000001 108.683 -177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.507 ' HZ3' ' CG ' ' A' ' 103' ' ' ASP . 16.1 ttpp -79.57 -42.1 1.53 Allowed Pre-proline 0 C--O 1.215 -0.718 0 CA-C-N 114.637 -1.165 . . . . 1.1699999999999999 111.19 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.578 ' HA ' ' HB3' ' A' ' 54' ' ' ASP . 42.9 Cg_exo -44.0 -29.37 2.63 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.909 2.406 . . . . 0.65000000000000002 114.419 175.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 m -70.19 -46.54 64.4 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 121.461 0.648 . . . . 0.45000000000000001 109.792 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 16.3 m-85 -74.75 -17.03 60.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.604 -0.725 . . . . 0.69999999999999996 109.567 177.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.578 ' HB3' ' HA ' ' A' ' 51' ' ' PRO . 10.7 t70 -72.86 -44.61 61.16 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.158 -0.928 . . . . 0.72999999999999998 109.442 177.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -60.64 -42.86 97.78 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.712 -0.676 . . . . 1.8600000000000001 109.671 174.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.437 ' O ' HD13 ' A' ' 60' ' ' LEU . 60.7 mt -61.01 -42.44 93.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.196 0.522 . . . . 0.32000000000000001 109.788 174.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -53.74 -35.08 60.83 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.684 -0.689 . . . . 0.39000000000000001 110.975 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.596 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 39.2 m-85 -84.83 -22.86 29.3 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.57 0.581 . . . . 0.91000000000000003 112.57 -179.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.2 p -77.26 -11.27 59.81 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.3 -0.56 . . . . 0.57999999999999996 110.446 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.523 HD11 ' OE1' ' A' ' 75' ' ' GLU . 10.1 mp -99.76 7.04 45.37 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.959 -0.564 . . . . 1.1699999999999999 111.321 176.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.1 m 64.92 88.12 0.11 Allowed Pre-proline 0 C--O 1.232 0.168 0 CA-C-O 121.27 0.557 . . . . 1.1399999999999999 110.793 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.596 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 90.4 Cg_endo -84.28 102.6 0.91 Allowed 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.213 1.942 . . . . 1.1000000000000001 112.151 -176.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 12.4 m -87.85 110.35 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-N 115.79 -0.641 . . . . 1.6599999999999999 110.918 -176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.8 m-20 65.38 26.5 12.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.443 -0.799 . . . . 1.98 111.052 174.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 81.85 19.86 64.64 Favored Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 121.176 -0.535 . . . . 0.82999999999999996 112.269 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.79 ' HB3' HD11 ' A' ' 100' ' ' LEU . 52.7 mttm -139.9 155.53 47.14 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.866 -0.42 . . . . 0.96999999999999997 109.866 178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.546 HD11 ' CD1' ' A' ' 106' ' ' PHE . 38.1 pt -131.35 131.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.196 0.522 . . . . 0.37 110.247 171.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 11.8 p -66.98 161.89 23.24 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.683 -0.69 . . . . 1.3100000000000001 111.061 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.17 -16.8 62.81 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 121.304 -0.474 . . . . 0.33000000000000002 113.696 -174.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.69 -51.45 68.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.104 0.478 . . . . 0.27000000000000002 110.829 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.577 ' O ' ' HB3' ' A' ' 74' ' ' LYS . 18.2 m-80 -68.38 -43.05 78.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.839 -0.618 . . . . 1.79 109.954 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -58.22 -53.65 55.85 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.241 -0.891 . . . . 0.32000000000000001 111.425 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.667 ' HD2' ' HB2' ' B' ' 150' ' ' PRO . 87.7 tttt -61.59 -35.73 78.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.415 -0.357 . . . . 1.3600000000000001 110.296 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.577 ' HB3' ' O ' ' A' ' 71' ' ' ASN . 16.7 ttpp -51.66 -47.26 63.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.984 -0.553 . . . . 2.48 110.344 174.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' OE1' HD11 ' A' ' 60' ' ' LEU . 3.4 tp10 -65.97 -38.08 87.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.454 0.645 . . . . 2.1600000000000001 110.155 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.779 ' HB3' HD22 ' A' ' 86' ' ' LEU . 76.4 mtp -71.56 -31.27 66.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.423 -0.808 . . . . 0.51000000000000001 111.486 -175.402 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.9 m -80.56 -24.05 11.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.913 -0.315 . . . . 1.3400000000000001 110.46 177.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 27.0 mtpp -70.87 -28.29 64.46 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.24 0.543 . . . . 2.2000000000000002 109.904 172.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.5 m -66.48 -19.31 65.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.203 -0.908 . . . . 0.91000000000000003 111.058 176.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 90.9 mttt 62.43 36.3 14.31 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.871 -0.604 . . . . 2.3700000000000001 111.407 177.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.691 ' HB2' HD21 ' A' ' 86' ' ' LEU . 85.9 mt -97.13 161.17 27.12 Favored Pre-proline 0 C--N 1.327 -0.396 0 N-CA-C 109.894 -0.41 . . . . 1.3500000000000001 109.894 178.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 81' ' ' LEU . 36.5 Cg_endo -67.19 143.08 63.36 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.463 2.109 . . . . 0.44 112.136 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -56.32 -31.47 63.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.849 -0.614 . . . . 1.9399999999999999 111.604 -177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 3.2 p -59.68 -54.7 43.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.973 0.416 . . . . 1.04 111.373 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.415 ' O ' HG13 ' A' ' 89' ' ' ILE . 59.9 t -66.1 -41.94 90.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.761 -0.654 . . . . 0.40999999999999998 110.187 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.779 HD22 ' HB3' ' A' ' 76' ' ' MET . 90.6 mt -55.68 -52.71 62.92 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 116.16 -0.473 . . . . 0.44 111.113 178.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.549 ' HA2' ' CD2' ' B' ' 151' ' ' PHE . . . -60.53 -39.26 96.17 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 121.155 -0.545 . . . . 0.23000000000000001 112.116 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.498 ' O ' ' HG ' ' A' ' 92' ' ' LEU . 25.6 ttmm -61.27 -44.13 97.74 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.683 0.278 . . . . 1.71 110.419 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 85' ' ' VAL . 84.5 mt -62.85 -39.78 86.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.40000000000000002 110.614 -179.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.458 ' HZ2' ' C ' ' A' ' 99' ' ' GLY . 57.7 t-105 -60.43 -49.05 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.46000000000000002 110.327 177.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -65.67 -16.22 63.53 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 2.3999999999999999 112.16 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 88' ' ' LYS . 34.2 mt -92.37 -44.39 8.73 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.147 0.499 . . . . 1.0800000000000001 111.497 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -78.69 -27.26 45.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.588 -0.733 . . . . 0.29999999999999999 112.005 -172.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.612 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 26.0 t0 -86.23 85.54 7.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.608 0.718 . . . . 0.45000000000000001 110.624 -178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.461 HG22 ' HG2' ' A' ' 105' ' ' GLU . 21.1 m -74.81 -25.43 18.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 114.897 -1.047 . . . . 1.28 112.174 -176.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.631 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 9.0 m-20 -78.96 -13.59 59.71 Favored 'General case' 0 CA--C 1.511 -0.524 0 C-N-CA 121.116 -0.234 . . . . 1.1200000000000001 110.756 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 47.6 mttt 59.72 29.9 19.47 Favored 'General case' 0 C--O 1.231 0.125 0 N-CA-C 108.691 -0.855 . . . . 1.6799999999999999 108.691 -178.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.631 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 17.9 p-10 -105.73 9.35 33.1 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.134 -0.939 . . . . 0.70999999999999996 111.308 -170.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.458 ' C ' ' HZ2' ' A' ' 90' ' ' TRP . . . 64.54 20.66 66.07 Favored Glycine 0 CA--C 1.493 -1.336 0 CA-C-O 121.584 0.547 . . . . 0.39000000000000001 112.657 173.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.79 HD11 ' HB3' ' A' ' 66' ' ' LYS . 0.1 OUTLIER -156.49 143.11 18.53 Favored 'General case' 0 N--CA 1.415 -2.188 0 N-CA-C 108.343 -0.984 . . . . 1.3700000000000001 108.343 -173.105 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 100' ' ' LEU . 88.0 mt -104.57 126.5 51.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.975 0.417 . . . . 0.34000000000000002 111.943 -171.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -77.86 -176.78 4.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.94 -0.573 . . . . 1.3899999999999999 109.772 170.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.507 ' CG ' ' HZ3' ' A' ' 50' ' ' LYS . 14.5 t0 -57.75 -42.76 84.64 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.777 -0.647 . . . . 1.6899999999999999 110.414 176.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.475 ' OE2' ' HD2' ' A' ' 133' ' ' PRO . 18.8 mt-10 -72.99 -43.97 61.6 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.508 -0.769 . . . . 2.29 110.822 -177.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.483 ' OE1' ' HA ' ' A' ' 101' ' ' LEU . 52.3 mt-10 -63.37 -42.83 98.87 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.171 -0.468 . . . . 0.39000000000000001 110.784 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.546 ' CD1' HD11 ' A' ' 67' ' ' ILE . 44.9 t80 -65.84 -35.87 81.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.28999999999999998 110.094 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -58.74 -45.69 89.09 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.938 -0.574 . . . . 0.34000000000000002 110.321 174.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 46' ' ' VAL . 78.6 mt -62.29 -45.8 91.63 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 116.161 -0.472 . . . . 1.74 110.832 177.025 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.74 -58.06 8.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.989 0.423 . . . . 0.27000000000000002 111.001 178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -59.69 -33.96 72.26 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.668 -0.696 . . . . 0.69999999999999996 111.564 -177.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -69.51 -46.97 65.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.566 -0.288 . . . . 0.75 110.309 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -62.08 -47.63 83.83 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 120.955 0.407 . . . . 0.27000000000000002 110.608 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 92.9 mt -57.83 -52.23 60.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.483 -0.78 . . . . 0.46000000000000002 111.101 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.676 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 0.0 OUTLIER -68.66 -30.44 69.13 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-N 116.343 -0.39 . . . . 1.8100000000000001 110.413 -176.102 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 120' ' ' HIS . 3.1 t -61.49 -43.83 97.52 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-O 120.763 0.316 . . . . 0.91000000000000003 110.361 176.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.418 ' HD2' ' O ' ' A' ' 120' ' ' HIS . 25.7 mmmt -63.11 -37.48 87.38 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.436 -0.347 . . . . 1.0600000000000001 110.869 174.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.8 tp -70.14 -30.52 67.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.606 -0.27 . . . . 1.5900000000000001 111.01 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.676 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 29.9 mm-40 -66.01 -26.39 67.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.893 0.378 . . . . 2.0499999999999998 110.216 176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 106.35 21.8 8.19 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.935 -0.65 . . . . 0.68000000000000005 112.227 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.67 ' HB2' HG13 ' A' ' 115' ' ' VAL . 96.2 m-70 -104.91 165.97 10.7 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.846 0.355 . . . . 1.1599999999999999 110.443 178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -108.74 127.01 53.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.143 -0.48 . . . . 2.6899999999999999 110.06 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.64 146.72 80.7 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 116.254 -0.43 . . . . 1.21 110.08 175.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.54 -10.16 25.25 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.134 2.556 . . . . 1.28 113.548 -172.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.33 19.33 10.98 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 116.214 -0.448 . . . . 1.0600000000000001 111.124 -177.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -133.09 175.08 9.69 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 115.844 -0.616 . . . . 1.9299999999999999 110.232 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 1.1 tt -123.62 90.51 50.52 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 108.452 -0.944 . . . . 1.8500000000000001 108.452 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -69.75 151.57 69.15 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.479 2.12 . . . . 0.90000000000000002 112.027 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -56.55 -25.91 61.31 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.191 2.594 . . . . 1.02 112.807 -176.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -89.12 19.58 4.16 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.884 -0.326 . . . . 1.1399999999999999 111.658 -178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.531 HD21 HG22 ' A' ' 45' ' ' VAL . 31.5 mt -130.47 4.75 4.71 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.566 -0.288 . . . . 1.3400000000000001 110.664 173.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.4 ' HA ' ' HD2' ' A' ' 132' ' ' PRO . 48.7 t -83.99 119.62 73.68 Favored Pre-proline 0 C--N 1.332 -0.18 0 CA-C-N 116.253 -0.431 . . . . 1.5700000000000001 110.567 -177.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 17.7 Cg_endo -60.06 148.77 87.99 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 123.064 2.509 . . . . 1.3500000000000001 113.004 -179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 52.7 Cg_exo -56.45 -22.73 43.78 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.469 2.779 . . . . 2.0499999999999998 113.11 -178.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 34.0 t -67.59 -8.33 33.46 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.981 -0.554 . . . . 2.6600000000000001 111.449 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 32.6 mmtm -117.36 21.95 12.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.997 0.427 . . . . 3.1000000000000001 111.526 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 70.5 mtm180 -106.46 147.2 29.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.166 -0.47 . . . . 3.8599999999999999 110.581 178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 30.1 mtp180 -66.7 108.29 2.44 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 109.022 -0.733 . . . . 5.0 109.022 168.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 27.5 p-80 -114.59 99.66 7.7 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.408 0.623 . . . . 6.6299999999999999 110.826 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.247 0.955 0 CA-C-N 115.175 -0.92 . . . . 6.6600000000000001 109.596 -177.849 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' PHE . . . . . . . . . . . . . 88.1 t80 . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 120.764 0.316 . . . . 10.529999999999999 111.573 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -64.42 -26.37 68.42 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 112.922 0.712 . . . . 8.2200000000000006 112.922 -168.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -107.34 4.98 27.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.724 -0.216 . . . . 7.4299999999999997 111.572 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 50.01 -152.98 0.15 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 116.256 -0.429 . . . . 5.9199999999999999 111.233 -177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 28.0 m -155.93 115.39 3.58 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.636 -0.505 . . . . 4.3399999999999999 109.636 176.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' THR . . . . . . . . . . . . . 12.1 t -140.35 -3.85 1.33 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.846 0.355 . . . . 2.1200000000000001 111.504 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' B' ' 150' ' ' PRO . 7.7 t70 -127.81 127.69 23.94 Favored Pre-proline 0 C--N 1.325 -0.491 0 CA-C-N 116.265 -0.425 . . . . 1.25 109.892 -178.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.667 ' HB2' ' HD2' ' A' ' 73' ' ' LYS . 2.7 Cg_exo -76.82 -2.39 12.61 Favored 'Trans proline' 0 C--O 1.237 0.428 0 C-N-CA 123.538 2.825 . . . . 0.48999999999999999 113.924 -174.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.549 ' CD2' ' HA2' ' A' ' 87' ' ' GLY . 10.7 m-85 -106.78 -9.97 16.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.126 0.489 . . . . 0.56000000000000005 110.477 -177.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' THR . . . . . . . . . . . . . 28.0 p -129.25 -176.38 3.86 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.805 -0.634 . . . . 1.8899999999999999 110.798 -177.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' ALA . . . . . . . . . . . . . . . 64.47 -163.4 0.26 Allowed 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.883 -0.598 . . . . 3.1099999999999999 111.289 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' LYS . . . . . . . . . . . . . 3.0 tppp? . . . . . 0 C--O 1.247 0.953 0 CA-C-O 118.39 -0.814 . . . . 6.9900000000000002 110.181 -179.724 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.612 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_